Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGRP,Agouti-related protein,29786,0.218679986104633,0.0032892796950356,0.212232997902363,0.225126974306903,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APCS,Serum amyloid P-component,24726,0.113926603458283,0.00220892083249914,0.109597118626585,0.118256088289982,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOC1,Apolipoprotein C-I,24914,0.101837486318246,0.00242463978572001,0.097085192338235,0.106589780298257,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOM,Apolipoprotein M,29545,0.0858439110070463,0.0017820436920824,0.0823511053705648,0.0893367166435278,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCHE,Cholinesterase,24528,0.0829322672029557,0.0018026712400258,0.0793990315725051,0.0864655028334062,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL23,C-C motif chemokine 23,29581,0.114982740337051,0.00268940916285017,0.109711498377865,0.120253982296237,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL27,C-C motif chemokine 27,29478,0.197355899143739,0.00392044072684653,0.18967183531912,0.205039962968359,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN1,CCN family member 1,29301,0.313862162533481,0.00468905145130968,0.304671621688914,0.323052703378048,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CES1,Liver carboxylesterase 1,29489,0.22095015281244,0.00523095805084631,0.210697475032781,0.231202830592098,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFH,Complement factor H,23693,0.0596914392326187,0.00151687487597526,0.0567183644757072,0.0626645139895302,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFP,Properdin,24966,0.0678123211976346,0.00148254862917518,0.0649065258844513,0.070718116510818,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN3,Contactin-3,29443,0.085387113350275,0.00209347773692616,0.0812838969858997,0.0894903297146502,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB1,DnaJ homolog subfamily B member 1,29349,0.22844590242525,0.00563939931476703,0.217392679768307,0.239499125082193,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,0.0609570934307487,0.00125034880329565,0.0585064097762892,0.0634077770852082,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F7,Coagulation factor VII,29544,0.107158027121053,0.00194509178274794,0.103345647226867,0.110970407015239,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.130446539783872,0.00205261886158035,0.126423406815175,0.13446967275257,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FURIN,Furin,29566,0.0960802771518148,0.00216340606691282,0.0918400012606657,0.100320553042964,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GHR,Growth hormone receptor,24381,0.0892181888982879,0.00183698375065076,0.0856177007470124,0.0928186770495634,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,0.240181798316838,0.0048718958171492,0.230632882515226,0.249730714118451,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,29594,0.0790086883093178,0.00193327236117184,0.075219474481421,0.0827979021372146,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLKB1,Plasma kallikrein,24454,0.0692863613362286,0.00162586225330566,0.0660996713197495,0.0724730513527077,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,0.0506724439415585,0.00127449542865474,0.0481744329013952,0.0531704549817218,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,0.0883480993101351,0.00137795015050603,0.0856473170151433,0.0910488816051269,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LDLR,Low-density lipoprotein receptor,29500,0.366082134528002,0.00279714186116144,0.360599736480126,0.371564532575879,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPL,Lipoprotein lipase,29478,-0.120095318716804,0.00305470326168981,-0.126082537109716,-0.114108100323892,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFGE8,Lactadherin,29443,0.161223941653724,0.00276946474430475,0.155795790754887,0.166652092552562,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPY,Pro-neuropeptide Y,29725,0.29194298078788,0.00404928165976957,0.284006388734732,0.299879572841028,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRP1,Neuropilin-1,29628,-0.0759318331618452,0.00180072516385491,-0.0794612544830008,-0.0724024118406895,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,P4HB,Protein disulfide-isomerase,29313,0.0990266038327315,0.00251776382098805,0.094091786743595,0.103961420921868,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAMR1,Inactive serine protease PAMR1,29443,0.0803940068813897,0.00177916126771541,0.0769068507966675,0.0838811629661119,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G10,Group 10 secretory phospholipase A2,29218,-0.186024136082468,0.00378735168136705,-0.193447345377948,-0.178600926786989,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.190657247036536,0.00180964036410731,0.187110351922886,0.194204142150187,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROC,Vitamin K-dependent protein C,29545,0.0998078511623017,0.00162404807866145,0.0966247169281253,0.102990985396478,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROS1,Vitamin K-dependent protein S,24966,0.0698853079567914,0.0016510012395401,0.0666493455272928,0.07312127038629,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTH,Parathyroid hormone,24195,0.223384219836496,0.00522825683878133,0.213136836432485,0.233631603240508,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RARRES2,Retinoic acid receptor responder protein 2,29628,0.137156770476764,0.00304495106158966,0.131188666396048,0.14312487455748,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA4,Kallistatin,24557,0.0647668718511277,0.00154508170857012,0.0617385117023303,0.0677952319999252,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA5,Plasma serine protease inhibitor,24644,0.0885528138073582,0.00205763565883435,0.0845198479160428,0.0925857796986735,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINF2,Alpha-2-antiplasmin,24515,0.0361827146715891,0.000883780885090525,0.0344505041368117,0.0379149252063666,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC39A5,Zinc transporter ZIP5,29434,0.135508931262661,0.0034686782956272,0.128710321803231,0.14230754072209,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD1,Mothers against decapentaplegic homolog 1,28797,0.222607384099203,0.00532024406991587,0.212179705722168,0.233035062476239,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,29725,0.101941528596104,0.00210782644568873,0.0978101887625538,0.106072868429654,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,0.301654690033464,0.00740867662272032,0.287133683852933,0.316175696213996,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,0.138910861903076,0.0027175143724556,0.133584533733064,0.144237190073089,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFPI,Tissue factor pathway inhibitor,29435,0.130255685985063,0.00197074933104883,0.126393017296207,0.134118354673918,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.0731753347847295,0.00168256501024366,0.0698775073646519,0.0764731622048071,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TTR,Transthyretin,24707,0.0747092364619633,0.00163168775929867,0.0715111284537379,0.0779073444701886,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KDR,Vascular endothelial growth factor receptor 2,29566,0.06423069213246,0.00165119067978731,0.0609943584000769,0.0674670258648431,1.1125369292536e-308
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,0.267437079199293,0.00687933476708244,0.253953583055812,0.280920575342775,1.11253692925361e-308
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATRN,"Attractin, Isoform 2",24966,0.0420267045205087,0.00108111240852789,0.039907724199794,0.0441456848412233,1.11253692925387e-308
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,0.200449837440468,0.00517469112222838,0.190307442840901,0.210592232040036,1.11253692925537e-308
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL6,C-X-C motif chemokine 6,29786,0.192925097864137,0.00499957809625786,0.183125924795472,0.202724270932802,1.11253692957478e-308
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,0.0850727002926028,0.00222761953037043,0.0807065660130768,0.0894388345721289,1.11325071790024e-308
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INHBC,Inhibin beta C chain,29443,0.102556776970039,0.00268876566220564,0.097286796272116,0.107826757667962,1.1172192392392e-308
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHMP6,Charged multivesicular body protein 6,24922,0.140160021113741,0.00367530254292128,0.132956428129615,0.147363614097867,1.23964035842466e-308
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,0.0613917029376103,0.00161532175845999,0.0582256722910287,0.0645577335841919,1.74088635477482e-308
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F10,Coagulation factor X,24951,0.0679340567423607,0.00179187293389513,0.0644219857919263,0.0714461276927952,7.64567971347254e-306
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNCA,Alpha-synuclein,24381,0.285466463438364,0.00753787008760358,0.27069223806666,0.300240688810067,5.26924746784517e-305
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFI,Complement factor I,24966,0.0487559400150891,0.00129817476936764,0.0462115174671286,0.0513003625630497,2.43327264871168e-300
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,29036,0.358106595251845,0.00960109663115133,0.339288445854788,0.376924744648901,1.84711671354732e-297
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYAP1,Synapse-associated protein 1,24381,0.139470812658455,0.00374614765451152,0.132128363255612,0.146813262061297,4.00654842849784e-295
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.0885768813829571,0.00240380157349811,0.0838654302989008,0.0932883324670135,1.8974444542753e-289
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL4A1,Collagen alpha-1(IV) chain,29478,-0.0947678255766694,0.00258572603960732,-0.0998358486142997,-0.089699802539039,1.31111853656669e-287
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPB2,Carboxypeptidase B2,24914,0.05388760781895,0.00147493370632211,0.0509967377545587,0.0567784778833414,9.85144520032555e-285
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD4,T-cell surface glycoprotein CD4,29383,0.07085934832953,0.00195017877050229,0.0670369979393456,0.0746816987197145,8.43348604134464e-283
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,0.195815163946013,0.00546239384096439,0.185108872017722,0.206521455874303,2.15277480176417e-275
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLAT,Tissue-type plasminogen activator,29736,0.117289386584039,0.00328131474994664,0.110858009674143,0.123720763493934,5.13916698087466e-274
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,0.0475927193327099,0.00133910748996486,0.0449680686523788,0.0502173700130411,5.51697381384362e-271
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSG2,Desmoglein-2,29443,-0.0625498733400549,0.00176370457825033,-0.0660067343134256,-0.0590930123666843,8.22172573142939e-270
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,0.156915006230051,0.00444578799541492,0.148201261759037,0.165628750701064,2.73903774587197e-267
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AFM,Afamin,24966,0.0449612058363934,0.00127340275853888,0.0424653364296572,0.0474570752431296,1.59663014401564e-266
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPIND1,Heparin cofactor 2,24914,0.0649602365921585,0.00184359662218421,0.0613467872126774,0.0685736859716395,1.87247761163772e-265
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FN1,Fibronectin,24966,0.0615671845751356,0.00174993592773738,0.0581373101567703,0.0649970589935009,1.07873386987282e-264
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLI1,Friend leukemia integration 1 transcription factor,28797,0.250587328157791,0.00719561114067522,0.236483930322067,0.264690725993514,2.59097076373743e-260
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCG,Pro-glucagon,28797,0.282004739071387,0.00813272186687828,0.266064604212306,0.297944873930469,3.83329279770416e-258
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCN2,Ficolin-2,29381,0.0924792463218797,0.00268312948132555,0.0872203125384817,0.0977381801052778,3.08711821701388e-255
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF9,Protein turtle homolog A,24922,0.186871476667678,0.005418445629887,0.176251323233099,0.197491630102256,1.17811778838316e-254
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDHR5,Cadherin-related family member 5,29478,0.0867787100593923,0.00254408209936531,0.0817923091446363,0.0917651109741484,3.87640711287926e-250
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,0.0488548033786166,0.00143029057055302,0.0460514338603327,0.0516581728969005,8.07242386103049e-250
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENO3,Beta-enolase,24240,0.134292384861925,0.00393725702456209,0.126575361093784,0.142009408630067,4.32484160723397e-249
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORT1,Sortilin,29433,0.0825213332438124,0.00243514964204426,0.0777484399454057,0.0872942265422192,5.73793968654672e-247
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAPIN,SNARE-associated protein Snapin,24867,0.128261455756666,0.00378779454379343,0.120837378450831,0.135685533062502,9.31366474016218e-246
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCS1,Neuronal calcium sensor 1,29725,0.062793848538992,0.00187258883572899,0.0591235744209632,0.0664641226570208,5.18875798923956e-242
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,0.307545376198362,0.00915667075453169,0.28959830151948,0.325492450877244,6.81659036534655e-242
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,0.161087453750355,0.00482419185164407,0.151632037721133,0.170542869779578,5.95422349823872e-240
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD2,Mothers against decapentaplegic homolog 2,24793,0.150882651359106,0.00453975634870434,0.141984728915646,0.159780573802567,5.20703069623933e-237
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,0.113303718708859,0.00341805931345198,0.106604322454493,0.120003114963225,1.23781641962575e-236
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,29757,-0.134726121161808,0.00407607310330154,-0.142715224444279,-0.126737017879337,2.57539283085636e-235
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL3,Angiopoietin-related protein 3,29518,0.0771287938916777,0.00233338018515719,0.0725553687287696,0.0817022190545858,2.64353868964569e-235
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPM,Carboxypeptidase M,29584,0.0740143941498259,0.00224432385054781,0.0696155194027522,0.0784132688968996,2.92087046029116e-234
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUSB,Beta-glucuronidase,29604,0.128610145800369,0.00391191652928669,0.120942789402967,0.136277502197771,7.42587850940966e-233
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGR3,Anterior gradient protein 3,28764,0.128120571490177,0.00389637688741982,0.120483672790834,0.13575747018952,8.22098511570897e-233
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUMB,Protein numb homolog,24229,0.18040020254273,0.00548101217844025,0.169657418672987,0.191142986412473,1.84541309803814e-232
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KYNU,Kynureninase,29786,0.09755619306551,0.00297169914698496,0.0917316627374194,0.1033807233936,3.22383813917167e-232
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTD,Biotinidase,24966,0.0443985632542913,0.00135777318415103,0.0417373278133553,0.0470597986952273,1.11279965179282e-229
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LATS1,Serine/threonine-protein kinase LATS1,24229,0.182474547111891,0.00559852134137658,0.171501445282793,0.19344764894099,4.29814209229644e-228
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAT2,Linker for activation of T-cells family member 2,29349,0.264449737061267,0.00813398134256217,0.248507133629845,0.280392340492689,8.09867962317416e-228
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRP,Gastrin-releasing peptide,24240,0.115168764788415,0.00353750677524046,0.108235251508943,0.122102278067886,1.35289034129551e-227
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTA3,Glutathione S-transferase A3,28797,0.161890665329358,0.0050174598367255,0.152056444049376,0.17172488660934,2.13530034039064e-224
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOST,Sclerostin,29433,0.0817283834248734,0.00253611056496697,0.0767576067175382,0.0866991601322087,6.03868657740248e-224
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAA80,N-alpha-acetyltransferase 80,24195,0.255731232517359,0.00792415040076914,0.240199897731851,0.271262567302866,9.47400284429817e-224
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F9,Coagulation factor IX,29545,0.0383408191952441,0.00119147409133351,0.0360055299762304,0.0406761084142578,2.48996942820245e-223
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAB2,Stabilin-2,24938,0.0595148840480291,0.00184802621790585,0.0558927526609336,0.0631370154351245,5.64024289907615e-223
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRIP2,Cysteine-rich protein 2,29218,0.0764024283002193,0.00238080565105891,0.0717360492241439,0.0810688073762948,4.26615400624025e-222
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F13B,Coagulation factor XIII B chain,24833,0.0545086218518451,0.00169673456106559,0.0511830221121566,0.0578342215915337,6.76136783966555e-222
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERP44,Endoplasmic reticulum resident protein 44,29301,0.0543254130549955,0.00169448556884975,0.05100422134005,0.057646604769941,1.08458626132972e-221
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADIPOQ,Adiponectin,24966,-0.141214197344074,0.00443362363445983,-0.149904099667615,-0.132524295020532,3.00669524100993e-218
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD5,Mothers against decapentaplegic homolog 5,29349,0.0424146412696416,0.00133401861738434,0.0397999647795683,0.0450293177597149,3.89163398035697e-218
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS15,Enteropeptidase,29349,0.188084569436717,0.00592663271134443,0.176468369322482,0.199700769550952,2.39786470275106e-217
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR37,Prosaposin receptor GPR37,28916,0.137847870710487,0.00434404557822195,0.129333541377172,0.146362200043802,2.96567198484406e-217
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL2,Angiopoietin-related protein 2,29491,0.0826262047166244,0.00261081591966752,0.077509005514076,0.0877434039191727,3.40936092722491e-216
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,0.139741151882822,0.00444695475845713,0.131025120556246,0.148457183209398,3.81674577140191e-213
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,0.121666279682454,0.00388190327145853,0.114057749270396,0.129274810094513,4.62052519277529e-212
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,-0.214690968680387,0.00685464615990931,-0.228126075153809,-0.201255862206964,7.34974439262482e-212
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,0.0533291030423746,0.0017137679444602,0.0499701178712326,0.0566880882135166,1.73725390519787e-208
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,0.0600950379987884,0.00193968879831629,0.0562932479540885,0.0638968280434883,7.96183136008316e-207
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTYMK,Thymidylate kinase,24922,0.139179531570362,0.00449512270309989,0.130369091072287,0.147989972068438,1.42298692827936e-206
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,0.045298785005906,0.00147038184373612,0.0424168365921833,0.0481807334196288,4.21770755964954e-205
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTA1,Glutathione S-transferase A1,29426,0.169793333391522,0.00552287664218342,0.158968495172843,0.180618171610202,2.55863349235879e-204
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAP29,Synaptosomal-associated protein 29,29566,0.184245469079698,0.00599587994933673,0.172493544378998,0.195997393780398,3.86127591449061e-204
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDHR2,Cadherin-related family member 2,29349,0.146119569935037,0.00476255709908394,0.136784958020832,0.155454181849241,1.68992356190278e-203
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRAP1,Proline-rich acidic protein 1,24938,0.0820529269761513,0.00268447354435523,0.076791358829215,0.0873144951230876,1.82440192118504e-201
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINF1,Pigment epithelium-derived factor,24579,0.0523237375971591,0.00171994226484076,0.0489526507580712,0.055694824436247,1.42182993000553e-199
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EEF1D,Elongation factor 1-delta,24922,0.181970866419595,0.00600009277004245,0.170210684590312,0.193731048248878,1.98356156951885e-198
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINC1,Antithrombin-III,24914,0.0294791779015483,0.000972734901240306,0.0275726174951173,0.0313857383079793,3.8478259716517e-198
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YES1,Tyrosine-protein kinase Yes,29349,0.225623900679151,0.00747246112735714,0.210977876869531,0.240269924488771,2.97278554620179e-197
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP1G2,AP-1 complex subunit gamma-like 2,24793,0.157502200506027,0.00522787228373198,0.147255570829913,0.167748830182142,7.21813635959515e-196
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,29820,-0.0673802933678486,0.00224112263605049,-0.0717728937345075,-0.0629876930011896,1.15248041760792e-195
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TJAP1,Tight junction-associated protein 1,29566,0.163349166222658,0.00543949184517494,0.152687762206115,0.174010570239201,3.4073642765506e-195
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL22,C-C motif chemokine 22,29169,0.101851686991391,0.00339175990726028,0.0952038375731607,0.108499536409621,3.84703725810696e-195
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,0.0802494653654169,0.0026757819839109,0.0750049326769515,0.0854939980538822,3.72229166167144e-194
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYH9,Myosin-9,24938,0.220968321983466,0.00742402267277425,0.206417237544829,0.235519406422104,2.54620501067259e-191
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FYB1,FYN-binding protein 1,29400,0.178842871056205,0.00604010342364913,0.167004268345853,0.190681473766557,7.02197602567595e-190
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SARG,Specifically androgen-regulated gene protein,24820,0.211925769226807,0.0071834592609522,0.197846189075341,0.226005349378273,4.81162582520017e-188
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YTHDF3,YTH domain-containing family protein 3,28931,0.164110667048359,0.00559982170542432,0.153135016505728,0.175086317590991,4.53424509928083e-186
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MLN,Promotilin,29434,0.171410156304577,0.00585136254463906,0.159941485717084,0.182878826892069,5.80403488590052e-186
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,0.0762130120439658,0.0026048068502592,0.0711075906174578,0.0813184334704739,1.62115978768825e-185
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GH1,Somatotropin,29433,-0.340851784916137,0.0116647210934538,-0.363714638259307,-0.317988931572968,4.67884876472848e-185
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEG1,Protein HEG homolog 1,24381,0.0523561758608226,0.00179416442318855,0.048839613591373,0.0558727381302721,4.88920265873634e-184
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTSS1,Protein MTSS 1,24805,0.212171854733013,0.0073071695907424,0.197849802335158,0.226493907130868,2.59374806356538e-182
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADH1B,All-trans-retinol dehydrogenase,24381,0.144480107876301,0.00497684498726149,0.134725491701268,0.154234724051333,3.42672587255087e-182
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,0.185428714941069,0.0064085735437922,0.172867910795236,0.197989519086902,1.54249495905998e-181
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EHBP1,EH domain-binding protein 1,24922,0.142039696240713,0.0049175617299938,0.132401275249925,0.1516781172315,1.78216757365136e-180
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABL1,Tyrosine-protein kinase ABL1,29349,0.128142389599025,0.00445398996290629,0.119412569271729,0.136872209926321,1.5809958877539e-179
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,0.169231348623736,0.00588245678912435,0.157701733317052,0.18076096393042,1.70367729265937e-179
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHBG,Sex hormone-binding globulin,24951,-0.0977955976532248,0.00339771340869987,-0.104455115934277,-0.091136079372173,3.00513179900746e-179
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP4,Metalloproteinase inhibitor 4,29443,-0.0760500489133904,0.00264950127283677,-0.0812430714081505,-0.0708570264186304,1.00451257338786e-178
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFR2,Fibroblast growth factor receptor 2,29566,0.0416397034136032,0.00145217842723152,0.0387934336962294,0.044485973130977,2.24298172342141e-178
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,29655,0.05921234475617,0.00206611603849186,0.0551627573207259,0.063261932191614,3.3715176575314e-178
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F2,Prothrombin,24966,0.0279305997356297,0.000976443228228617,0.0260167710083016,0.0298444284629578,4.26720111941359e-177
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,-0.0714195879395191,0.00250860983513048,-0.0763364632163748,-0.0665027126626633,6.56148163502887e-176
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPK9,Mitogen-activated protein kinase 9,29434,0.080299254190676,0.00282435522569942,0.0747635179483051,0.0858349904330468,1.9798199977517e-175
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,0.0559689032427253,0.00197481441057354,0.0520982669980011,0.0598395394874494,6.34313619643218e-174
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MASP1,Mannan-binding lectin serine protease 1,29163,0.0440092863714008,0.00155580601798645,0.0409599065761473,0.0470586661666543,1.10876855549264e-173
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACY1,Aminoacylase-1,29478,0.114478559168346,0.00405518152475492,0.106530403379827,0.122426714956866,5.02743761844673e-173
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL17,C-X-C motif chemokine 17,29786,0.0779455420994082,0.00276316985577617,0.0725297291820869,0.0833613550167294,8.59618552170574e-173
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,0.209286856010575,0.0074187283743379,0.194746148396873,0.223827563624277,2.50514017691038e-172
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,0.0500068869578465,0.00177762024799081,0.0465227512717845,0.0534910226439085,7.75356843704391e-172
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.053001815377732,0.0018857844969779,0.0493056777636553,0.0566979529918087,1.44512653935754e-171
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOMO1,Nodal modulator 1,29443,0.0434303297840243,0.00154819035071785,0.0403958766966173,0.0464647828714313,6.66264715628583e-171
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF8,Immunoglobulin superfamily member 8,29478,0.0561583291137136,0.00200439348181247,0.0522297178893611,0.060086940338066,1.71031658869124e-170
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,0.180085721418166,0.00642892859906836,0.167485021363992,0.19268642147234,5.11119577508918e-170
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP10,Stromelysin-2,29439,-0.108536952414344,0.00388839495787849,-0.116158206531785,-0.100915698296902,2.98336671634121e-169
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELN,Elastin,24922,0.0645818749792379,0.00231523532817933,0.0600440137360064,0.0691197362224694,1.22273269085999e-168
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,29434,0.194370217782975,0.006984571467815,0.180680457706057,0.208059977859892,2.97359579920118e-168
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL5,C-X-C motif chemokine 5,29384,0.20828080724589,0.00748655491365702,0.193607159615123,0.222954454876658,3.71209501601756e-168
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KAZN,Kazrin,24805,0.191238123095063,0.00686785097504309,0.177777135183978,0.204699111006147,4.71913789784987e-168
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL17,C-C motif chemokine 17,29414,0.166247609731625,0.00598568966056461,0.154515657996918,0.177979561466332,1.30246367701691e-167
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELPLG,P-selectin glycoprotein ligand 1,29434,0.0507754964627423,0.00182833163580088,0.0471919664565726,0.0543590264689121,1.39615791866742e-167
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPC5,Glypican-5,29218,0.102870030501721,0.00370639292440728,0.0956055003698823,0.110134560633559,2.27778462354838e-167
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,0.0797639864917982,0.00287605773957301,0.0741269133222351,0.0854010596613613,3.93035020382246e-167
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL16,Pro-interleukin-16,29786,0.0753848199507338,0.00272087738021045,0.0700519002855213,0.0807177396159463,7.74545934433324e-167
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB11FIP3,Rab11 family-interacting protein 3,24922,0.195804480451765,0.00707181416475085,0.181943724688853,0.209665236214676,3.20178788377691e-166
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THPO,Thrombopoietin,28916,0.0702412724739702,0.0025430793481396,0.0652568369516166,0.0752257079963238,8.99180316523781e-166
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AXIN1,Axin-1,29434,0.172802943462772,0.00626159095556917,0.160530225189857,0.185075661735688,1.54477225907037e-165
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAB2,Disabled homolog 2,29725,0.200625394879478,0.00727481706079469,0.18636675344032,0.214884036318636,2.47400135519022e-165
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UPB1,Beta-ureidopropionase,24922,0.166266419941734,0.00603063712010125,0.154446371186336,0.178086468697133,7.54647673364325e-165
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,29761,-0.220763053863393,0.00802646846188918,-0.236494932048696,-0.20503117567809,1.78437900939641e-164
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HBEGF,Proheparin-binding EGF-like growth factor,29632,0.131203189682246,0.00478197072160342,0.121830527067903,0.140575852296589,1.10823217886032e-163
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5E,5'-nucleotidase,29566,0.10135170754686,0.00369846016467208,0.0941027256241025,0.108600689469617,2.7309386802384e-163
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C9,Complement component C9,24951,-0.0961826116488148,0.00350638242990784,-0.103055121211434,-0.0893101020861954,3.12517237566796e-163
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1S,Complement C1s subcomponent,24966,0.0378693672400211,0.0013806261594258,0.0351633399675465,0.0405753945124957,3.25067275098393e-163
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL16,C-C motif chemokine 16,29820,0.0943171736287377,0.00344338216254347,0.0875681445901525,0.101066202667323,3.70825836307388e-163
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKK1,Dickkopf-related protein 1,29694,0.106886793310046,0.00390617753699488,0.0992306853375356,0.114542901282555,7.85111551320349e-163
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F11,Coagulation factor XI,24606,0.0560693436916508,0.00204773896670903,0.0520557753169011,0.0600829120664004,1.26503764356373e-162
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TARBP2,RISC-loading complex subunit TARBP2,28774,0.142282806115101,0.00520240633636614,0.132086089695824,0.152479522534379,1.32456191717021e-162
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJA2,DnaJ homolog subfamily A member 2,29704,0.147000154272352,0.00538936624687819,0.136436996428471,0.157563312116233,8.11083878966152e-162
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPD52L2,Tumor protein D54,24381,0.195027669878425,0.007144918445374,0.181023629725492,0.209031710031358,1.27594410696667e-161
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,0.194110974631765,0.0071231072648306,0.180149684392697,0.208072264870833,3.80879387489227e-161
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,0.145935081052327,0.00536643433356638,0.135416869758537,0.156453292346117,1.72922128568233e-160
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,0.148862538734136,0.0054750091614635,0.138131520777668,0.159593556690605,2.14141438894988e-160
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTSS2,Protein MTSS 2,24793,0.177862165329906,0.00654245751786551,0.165038948594889,0.190685382064922,2.15424795053784e-160
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP5,Retinol-binding protein 5,29349,0.100418154496711,0.00369814965616986,0.093169781170618,0.107666527822804,2.21361292197023e-160
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,0.0956745930977316,0.00352572867655983,0.0887641648916744,0.102585021303789,3.59236339439866e-160
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORD,Sorbitol dehydrogenase,29595,0.12161864262923,0.00448355575516867,0.112830873349099,0.13040641190936,4.49603571071599e-160
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLA,Alpha-galactosidase A,24329,0.0673475640544774,0.00248053433332429,0.0624857167611618,0.072209411347793,6.07202060185184e-160
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXNA4,Plexin-A4,29434,0.145719813175241,0.00537443911838216,0.135185912503212,0.15625371384727,6.33022497950353e-160
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,0.173734172716365,0.0064150222178011,0.161160729169475,0.186307616263255,1.46058998205956e-159
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXLNA,Alpha-taxilin,29218,0.158078389646344,0.00584038053029146,0.146631243806972,0.169525535485715,2.27146620516645e-159
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CKB,Creatine kinase B-type,24938,-0.105796143693993,0.00390624928017067,-0.113452392283128,-0.0981398951048588,3.08437719449485e-159
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFC,Platelet-derived growth factor C,28797,0.0514791763636931,0.00190580302475375,0.0477438024351757,0.0552145502922105,1.02642345449544e-158
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDLIM7,PDZ and LIM domain protein 7,29581,0.222397091065007,0.0082414848443451,0.206243780770091,0.238550401359923,1.84472112314183e-158
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,29374,0.0582338330199444,0.00216217767712027,0.0539959647727887,0.0624717012671002,7.50883634328526e-158
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GHRL,Appetite-regulating hormone,29478,0.143081252415696,0.00532281713897197,0.132648530823311,0.153513974008081,2.91923710742407e-157
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFC,Vascular endothelial growth factor C,29566,0.0984499432132825,0.00366662105460642,0.0912633659462539,0.105636520480311,6.40683361586298e-157
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP4,Dipeptidyl peptidase 4,28990,0.0530587554339439,0.00197827328022077,0.0491813398047112,0.0569361710631766,1.51464032097544e-156
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,0.149490502325512,0.00557725474380452,0.138559083027655,0.160421921623369,5.52363751429529e-156
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,0.107669269354334,0.00402586635631953,0.0997785712959472,0.11555996741272,1.04772926535479e-155
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARF6,ADP-ribosylation factor 6,24805,0.188549862227673,0.00705258003729073,0.174726805354583,0.202372919100763,2.9440077015081e-155
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGFR,Epidermal growth factor receptor,29820,0.0288573271394363,0.00108169054546837,0.0267372136703183,0.0309774406085543,5.61878910275407e-155
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP20,Centrosomal protein 20,28797,0.130544571643649,0.00489722329697569,0.120946013981576,0.140143129305721,1.12853906673275e-154
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLIN1,Perilipin-1,28774,0.0612470491629765,0.0022984715760829,0.0567420448738541,0.065752053452099,1.46913337492527e-154
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MINK1,Misshapen-like kinase 1,24845,0.163075915467823,0.00612613439810336,0.15106869204754,0.175083138888105,5.81320596679093e-154
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,0.116793385547054,0.00439522649947297,0.108178741608087,0.125408029486021,1.00533150329557e-153
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLTP,Phospholipid transfer protein,29702,-0.0628646761455851,0.00236690307956451,-0.0675038061815316,-0.0582255461096387,1.23631301404448e-153
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CES3,Carboxylesterase 3,29349,0.122095112149091,0.00460002564441959,0.113079061886028,0.131111162412153,2.05153577400062e-153
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD63,CD63 antigen,29169,0.0896552293104393,0.00338511892042237,0.0830203962264115,0.0962900623944672,9.26249836679049e-153
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,24922,0.115324445226527,0.00435112689668337,0.106796236509028,0.123852653944026,1.12744882839114e-152
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPON2,Spondin-2,29311,-0.0607528755002735,0.00229869555833041,-0.0652583187946011,-0.0562474322059459,3.84970738643119e-152
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATG16L1,Autophagy-related protein 16-1,24805,0.14766794347004,0.00563296716036495,0.136627327835725,0.158708559104355,1.95396780223148e-149
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,0.178852877250395,0.00684129246714271,0.165443944014795,0.192261810485995,5.94707869825885e-149
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,0.145381142351924,0.00555551010737993,0.13449234254146,0.156269942162389,6.27030602845076e-149
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CANT1,Soluble calcium-activated nucleotidase 1,29370,0.0348432723085752,0.00133348400364917,0.0322296436614228,0.0374569009557276,8.50129395866963e-149
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC1B,C-type lectin domain family 1 member B,29694,0.165186056880942,0.00632247432220844,0.152794007209413,0.17757810655247,8.73222285868253e-149
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SKAP1,Src kinase-associated phosphoprotein 1,29163,0.125329287704873,0.00480287379346033,0.115915655069691,0.134742920340055,2.12913843519573e-148
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,0.0500835391010252,0.00192226043000291,0.0463159086582195,0.0538511695438309,5.448303347003e-148
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F11R,Junctional adhesion molecule A,29443,0.0964724126388218,0.00370279923434285,0.0892149261395098,0.103729899138134,5.80369955839289e-148
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDC4,Syndecan-4,29478,0.0793816189714482,0.00305567707539587,0.0733924919036723,0.0853707460392241,3.95323788619252e-147
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGT1,Glutathione hydrolase 1 proenzyme,29390,0.0860856002973615,0.0033164504746256,0.0795853573670953,0.0925858432276277,6.86333441406077e-147
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CMIP,C-Maf-inducing protein,24793,0.14188056722436,0.00547301368928133,0.131153460393368,0.152607674055351,3.20929538364198e-146
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,24804,0.14589804286297,0.00562843185117375,0.134866316434669,0.15692976929127,3.37327646170025e-146
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,0.088192421315764,0.00340762298964945,0.0815134802560511,0.0948713623754769,5.14301039846169e-146
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,0.12167131562872,0.00471127975336305,0.112437207312128,0.130905423945311,2.08244675764028e-145
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCXR,L-xylulose reductase,29566,0.0912503663465479,0.00353787227697911,0.0843161366836688,0.0981845960094269,4.35875763176149e-145
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,0.0453657010631448,0.00176250361235302,0.0419111939829329,0.0488202081433567,1.6785546301225e-144
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSNK2A1,Casein kinase II subunit alpha,24867,-0.0764224430569673,0.00296750427654679,-0.082238751438999,-0.0706061346749356,2.33004739617745e-144
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCTN3,Tectonic-3,24922,0.050628424341721,0.00196814437425157,0.046770861368188,0.0544859873152541,4.80057217613372e-144
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,24240,0.123033483245393,0.00479098750496467,0.113643147735662,0.132423818755124,1.61943501786333e-143
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AAMDC,Mth938 domain-containing protein,24240,0.0905412681922784,0.00352712754940578,0.083628098195443,0.0974544381891137,2.09156929239269e-143
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNIP1,TNFAIP3-interacting protein 1,24845,0.149736343477965,0.00584212110594205,0.138285786110318,0.161186900845611,5.0564548820103e-143
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBIN,Erbin,29349,0.172972173538501,0.0067565758618562,0.159729284849263,0.186215062227739,5.60264985604301e-143
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OTUD7B,OTU domain-containing protein 7B,24867,0.10692286753838,0.00417387692117151,0.098742068772884,0.115103666303876,7.02795444023732e-143
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHACTR2,Phosphatase and actin regulator 2,24867,0.192539373734072,0.00753292450517376,0.177774841703932,0.207303905764213,2.9498462520131e-142
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,24240,0.173444823047026,0.00678577285312895,0.160144708254893,0.186744937839159,3.25581854433975e-142
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL3,C-X-C motif chemokine 3,29453,0.1582784398989,0.0062066325517566,0.146113440097457,0.170443439700343,6.60739897882559e-142
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KHK,Ketohexokinase,24240,0.107958002533818,0.00423458190592079,0.0996582219982137,0.116257783069423,1.67115547610554e-141
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP3S2,AP-3 complex subunit sigma-2,24845,0.0795269645501247,0.00312598155586441,0.0734000407006304,0.0856538883996189,5.73330341822476e-141
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCLY,Selenocysteine lyase,29632,0.081193489540574,0.00319542105352205,0.0749304642756707,0.0874565148054772,6.45029438900472e-141
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCR,Breakpoint cluster region protein,29434,0.153408815906264,0.00604063436610136,0.141569172548705,0.165248459263822,9.16465726757349e-141
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R9B,Neurabin-2,29786,0.157788215569273,0.00621767653445304,0.145601569561745,0.169974861576801,1.40424617424064e-140
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,0.114385465715773,0.00450742003874748,0.105550922439828,0.123220008991718,3.13207223431274e-140
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPY30,Protein dpy-30 homolog,29604,0.0999098381574414,0.00394402560349485,0.0921795479745915,0.107640128340291,4.43325963373634e-140
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,29604,0.0547767284536823,0.00216380108390919,0.0505356783292203,0.0590177785781443,6.74356964759662e-140
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMBP,Protein AMBP,29683,0.0335401624538128,0.00132697730190264,0.0309392869420836,0.0361410379655419,1.77717549577e-139
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM20A,Pseudokinase FAM20A,24922,0.0473949822232237,0.00187392060572165,0.0437220978360092,0.0510678666104381,2.25351867208292e-139
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCK2,Cytoplasmic protein NCK2,29581,0.175839287162806,0.006962062523347,0.162193644617045,0.189484929708566,2.86634782304637e-139
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELP,P-selectin,29594,0.0946178031465333,0.00374742798722431,0.0872728442915737,0.101962762001493,3.49331991528177e-139
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP85,Centrosomal protein of 85 kDa,28797,0.106503217418842,0.00421782284582845,0.0982362846410186,0.114770150196666,3.6453416781695e-139
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTBDN,Retbindin,29349,0.0493504803006923,0.00195787210771061,0.0455130509695795,0.0531879096318051,1.02891751915777e-138
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A4,Protein S100-A4,29566,0.0947397742468176,0.00376024746803923,0.0873696892094607,0.102109859284174,1.32040920002289e-138
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CIRBP,Cold-inducible RNA-binding protein,24805,0.159607497194979,0.00633384123229358,0.147193168379683,0.172021826010274,2.25779729563347e-138
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BECN1,Beclin-1,24240,0.100363364516217,0.00398355640288281,0.0925555939665662,0.108171135065867,2.78192647470487e-138
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOK2,Docking protein 2,29478,0.201883592130974,0.00802591291400561,0.186152802819523,0.217614381442425,3.67954256037506e-138
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTN1,Dynactin subunit 1,29725,0.107357160625856,0.0042823668307905,0.0989637216375071,0.115750599614206,2.86054162378567e-137
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD6,T-cell differentiation antigen CD6,29760,0.0870922841096508,0.00347440307982596,0.0802824540731919,0.0939021141461097,3.04912511217942e-137
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUGP1,SURP and G-patch domain-containing protein 1,24805,0.0664320005224447,0.00264870804162097,0.0612405327608676,0.0716234682840218,4.11822425521521e-137
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,29434,0.185419676366823,0.00740831064814171,0.170899387496465,0.199939965237181,8.08308552844614e-137
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,0.123303828841875,0.00492260640626501,0.113655520285596,0.132952137398154,9.96487120550981e-137
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,0.157026529615059,0.00627762536240799,0.14472238390474,0.169330675325379,1.14895285500852e-136
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC3B,Tetranectin,24381,0.0354571655805025,0.00141656508568581,0.0326806980125583,0.0382336331484467,1.51631408244659e-136
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IKBKG,NF-kappa-B essential modulator,29434,0.1509778842751,0.00604601358630176,0.139127697645949,0.162828070904251,3.28023920189714e-136
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAS6,Growth arrest-specific protein 6,29639,-0.0419173859631804,0.0016823872931609,-0.0452148650577757,-0.038619906868585,1.26451846398158e-135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAP23,Synaptosomal-associated protein 23,29478,0.142829244558676,0.00573412391188163,0.131590361691388,0.154068127425964,1.51838282563392e-135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,0.178772492160777,0.00717350365407173,0.164712424998796,0.192832559322758,2.03506318261515e-135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,0.179601336642562,0.00721076832632346,0.165468230722968,0.193734442562156,2.87915189697303e-135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFX1,Transcriptional repressor NF-X1,24111,0.111525859175789,0.00447797330079842,0.102749031506224,0.120302686845354,3.33138079239824e-135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLA2,Src-like-adapter 2,24867,0.172215003732444,0.00692023447729504,0.158651344156946,0.185778663307942,4.78359002164266e-135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,0.0521474591533913,0.00209898862243316,0.0480334414534223,0.0562614768533603,7.44016286045788e-135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4B,Eukaryotic translation initiation factor 4B,29218,0.0949202289364767,0.00382122766955445,0.08743062270415,0.102409835168803,8.28772733463312e-135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,0.113490239970283,0.00458440301200862,0.104504810066746,0.12247566987382,6.68078117165626e-134
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CREG1,Protein CREG1,29079,0.0621013504809046,0.00251481910651371,0.0571723050321377,0.0670303959296715,2.92659163226232e-133
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAT5B,Signal transducer and activator of transcription 5B,29349,0.223794993714441,0.00907114848780608,0.206015542678341,0.241574444750541,4.97412421346958e-133
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,0.172060607385721,0.00699238227873031,0.15835553811941,0.185765676652032,4.32712325895073e-132
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,24793,0.0850321995137892,0.00346570261580404,0.0782394223868133,0.0918249766407651,2.29233337918283e-131
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,0.0929922809629866,0.00379015612866273,0.0855635749508076,0.100420986975166,2.49372963791018e-131
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAK4,Serine/threonine-protein kinase PAK 4,28774,0.0989797151356571,0.004042865323569,0.0910556991014618,0.106903731169852,4.98211841075162e-131
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCBP2,Poly(rC)-binding protein 2,24867,0.117063324079421,0.00478326494989793,0.107688124777621,0.126438523381221,9.98073796159754e-131
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,0.0637561203154986,0.00260776871009436,0.0586448936437137,0.0688673469872836,1.0139164077409e-130
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CES2,Cocaine esterase,29349,0.088253807642274,0.00361160707206077,0.0811750577810349,0.0953325575035131,1.43006753196825e-130
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,0.120444737422369,0.00492353875368551,0.110794601465145,0.130094873379593,1.43132131902374e-130
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THOP1,Thimet oligopeptidase,29343,0.0496233655812122,0.00203698118209206,0.0456308824643118,0.0536158486981127,8.61209122266943e-130
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,0.0443980836207592,0.00182114803013118,0.0408286334817021,0.0479675337598163,9.59222780303043e-130
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXNB3,Plexin-B3,29383,0.0759866818205852,0.00312548610114591,0.0698607290623393,0.0821126345788312,2.78429461639583e-129
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP45,Rho GTPase-activating protein 45,24381,0.132905902485188,0.00546565854262437,0.122193211741644,0.143618593228732,4.52624137342791e-129
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB6,DnaJ homolog subfamily B member 6,24170,0.136043759397234,0.00560989712663974,0.12504836102902,0.147039157765447,2.22964936399735e-128
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USO1,General vesicular transport factor p115,29349,0.143752700997265,0.00593430418863678,0.132121464787537,0.155383937206993,2.27133083748339e-128
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,24793,0.1825335784177,0.00754096611730301,0.167753284827786,0.197313872007614,5.94732657680895e-128
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN2,CCN family member 2,29478,0.0911146280629781,0.00376801463154656,0.0837293193851468,0.0984999367408093,6.22612694349897e-128
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,0.145084399883081,0.00599933677190707,0.133325699810143,0.156843099956019,1.00410431971155e-127
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL5,C-C motif chemokine 5,29594,0.160150381714515,0.00662918093870528,0.147157187074652,0.173143576354377,1.05483034793619e-127
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,0.164086239549159,0.00680528184369317,0.15074788713552,0.177424591962797,3.19489903365065e-127
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOXO1,Forkhead box protein O1,29434,0.135863631704118,0.0056445694355054,0.124800275610527,0.146926987797708,8.73553895216358e-127
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300LG,CMRF35-like molecule 9,29443,-0.05963870548788,0.00248007765424868,-0.0644996576902074,-0.0547777532855526,1.49194700714156e-126
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GDF2,Growth/differentiation factor 2,29478,0.0565335818967454,0.00235591668210093,0.0519159851998276,0.0611511785936632,4.91854247707256e-126
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEC31A,Protein transport protein Sec31A,24240,0.122086651745068,0.00508788928347612,0.112114388749454,0.132058914740681,9.08884888880386e-126
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BPIFB1,BPI fold-containing family B member 1,29333,-0.0997880928453431,0.00416317973196811,-0.107947925120001,-0.0916282605706856,9.4697895285819e-126
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD99L2,CD99 antigen-like protein 2,29443,0.0382412467311732,0.00160012807803851,0.0351049956982177,0.0413774977641287,4.90064849730439e-125
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL10,C-X-C motif chemokine 10,29581,0.105437909422665,0.00441255168580586,0.0967893081184853,0.114086510726844,5.29933632680361e-125
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,0.0867985502859855,0.00363401684807196,0.0796758772637644,0.0939212233082066,7.12668753150748e-125
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C4BPB,C4b-binding protein beta chain,29566,0.0631685506747386,0.00265188976833414,0.0579708467288037,0.0683662546206735,3.0652652115923e-124
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YOD1,Ubiquitin thioesterase OTU1,24111,0.0985071113369006,0.00413300410060691,0.090406423299711,0.10660779937409,4.02987227697722e-124
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASGR1,Asialoglycoprotein receptor 1,29218,0.04685524008749,0.0019682704671255,0.042997429971924,0.0507130502030559,4.48591364000549e-124
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CMC1,COX assembly mitochondrial protein homolog,24922,0.142725488568859,0.00599311770788821,0.130978977861398,0.15447199927632,5.69466617657696e-124
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,0.161305859331142,0.00678637863774665,0.148004557201158,0.174607161461125,1.6817478348401e-123
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18R1,Interleukin-18 receptor 1,29786,0.0513880547758312,0.00216712017433685,0.047140499234131,0.0556356103175314,3.71350928567784e-123
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIT1,ARF GTPase-activating protein GIT1,24229,0.153010955486019,0.00644716713303138,0.140374507905277,0.16564740306676,4.18562773338565e-123
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGCC,Regulator of cell cycle RGCC,24867,0.118580575511345,0.00500340540252618,0.108773900922394,0.128387250100297,8.31701764495404e-123
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,28797,0.0773745927700126,0.00326779863391945,0.0709697074475305,0.0837794780924948,9.10919183342303e-123
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RILPL2,RILP-like protein 2,24922,0.153326307774532,0.00647938781258263,0.14062670766187,0.166025907887194,1.91635796611157e-122
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,0.174078743024178,0.00738402183358349,0.159606060230354,0.188551425818001,9.59690559393638e-122
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD1,Sushi domain-containing protein 1,28916,0.0762005909886216,0.00323767503462577,0.0698547479207551,0.0825464340564881,2.44691267401571e-121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,0.140872298944361,0.00598292356035848,0.129145768766058,0.152598829122664,2.96191061436247e-121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPL,N-acetylneuraminate lyase,24922,0.0698318772465559,0.00296986075726061,0.0640109501623252,0.0756528043307867,6.16732174141195e-121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL13,C-X-C motif chemokine 13,29694,0.0943809364490113,0.00401827147370912,0.0865051243605414,0.102256748537481,6.87886241463913e-121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,0.180584149753535,0.00768928473050122,0.165513151681753,0.195655147825318,7.55397189933465e-121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOS3,"Nitric oxide synthase, endothelial",28774,0.0820231365961923,0.00349250017710694,0.0751778362490627,0.0888684369433219,7.88532475359247e-121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA3F,Semaphorin-3F,29478,0.0408414976417957,0.00174077896443996,0.0374295708714934,0.044253424412098,1.28651659171064e-120
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,0.036306538389877,0.00155041546667508,0.0332677240751938,0.0393453527045601,3.58480968957938e-120
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL13,C-C motif chemokine 13,29732,0.106774928291082,0.00456004212769588,0.0978372457207982,0.115712610861366,3.66006371673303e-120
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,24729,0.0687855747496886,0.0029349865476081,0.0630330011163768,0.0745381483830005,3.71980439087267e-120
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRPK2,SRSF protein kinase 2,29434,0.129575035788024,0.00553747537827732,0.118721584046601,0.140428487529448,5.38447721061433e-120
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD2AP,CD2-associated protein,29478,0.098167669691145,0.00419655214725099,0.0899424274825331,0.106392911899757,6.3312617181081e-120
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,0.152760748417755,0.00653548084509138,0.139951205961376,0.165570290874134,9.42038566980738e-120
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEFTY2,Left-right determination factor 2,29674,0.0801714401419656,0.00343100724129196,0.0734466659490334,0.0868962143348978,1.12528447655927e-119
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHSG,Alpha-2-HS-glycoprotein,24951,0.0415427376135641,0.00178069086969237,0.0380525835089671,0.0450328917181611,4.19583819225094e-119
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MME,Neprilysin,29349,0.123596329918221,0.00530611612242663,0.113196342318264,0.133996317518177,6.25343396412953e-119
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLSCR3,Phospholipid scramblase 3,24804,0.0907704061665062,0.00389724419863542,0.0831318075371808,0.0984090047958316,1.03221324409708e-118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA5,Integrin alpha-5,29443,0.0384914085743315,0.001654803358303,0.0352479939920576,0.0417348231566054,1.31398085654059e-118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1R2,Interleukin-1 receptor type 2,29404,0.0305738497942046,0.00131557991521872,0.0279953131603759,0.0331523864280333,2.11092545493581e-118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF21,Fibroblast growth factor 21,29674,0.181872137791427,0.00783129275853353,0.166522803984702,0.197221471598153,2.98038952449923e-118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINH1,Serpin H1,24445,0.19777575372496,0.00851185098356589,0.181092525797171,0.214458981652749,3.82480253756617e-118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,0.0727436947516202,0.00313660668787422,0.0665959456433867,0.0788914438598536,6.47687940587297e-118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLK1,Protein delta homolog 1,29820,0.0853160204839777,0.00368345306703595,0.0780964524725872,0.0925355884953681,1.20714930385891e-117
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK10,Kallikrein-10,29466,0.0611931140573485,0.00264481270098005,0.0560092811634276,0.0663769469512694,2.19174557602972e-117
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,0.0626288595817688,0.0027089452951447,0.0573193268032852,0.0679383923602524,3.37359258228639e-117
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPPC,C-type natriuretic peptide,29434,0.0730739350625735,0.00316285658251724,0.0668747361608397,0.0792731339643073,4.6824211999104e-117
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPING1,Plasma protease C1 inhibitor,24914,0.0287641964669821,0.0012458703587845,0.0263222905637645,0.0312061023701997,1.03744656623786e-116
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,0.105784072810316,0.00458926355580241,0.0967891162409431,0.114779029379689,2.4311763876519e-116
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SKAP2,Src kinase-associated phosphoprotein 2,29581,0.158508243300432,0.00688359963500365,0.145016388015825,0.17200009858504,2.64753559138264e-116
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTBS,Di-N-acetylchitobiase,24653,0.0415505971457971,0.00180519171553358,0.0380124213833513,0.045088772908243,5.24274235504873e-116
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HJV,Hemojuvelin,24867,0.0674577008395654,0.00293125550131661,0.0617124400569848,0.0732029616221459,5.6065782346357e-116
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBC1D23,TBC1 domain family member 23,29349,0.13650798069885,0.0059368211187221,0.124871811306155,0.148144150091546,5.75763865137903e-116
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUCB2,Nucleobindin-2,29652,0.0566356154246551,0.00246382926492645,0.0518065100653993,0.061464720783911,6.53044545474454e-116
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,0.153492215537811,0.0066777790817833,0.140403768537515,0.166580662538106,6.84259563374206e-116
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLG,Plasminogen,24421,0.033786745285835,0.00146880006914219,0.0309078971503163,0.0366655934213537,7.43616558519056e-116
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BID,BH3-interacting domain death agonist,29434,0.101100281684172,0.00440549014600536,0.0924655209980018,0.109735042370343,1.57274564005452e-115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDLIM5,PDZ and LIM domain protein 5,24867,0.17996999225587,0.00784021571701125,0.164603169450527,0.195336815061212,2.09777311281749e-115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RL2,Interleukin-1 receptor-like 2,28931,0.0596554931424127,0.0026018803406566,0.0545558076747258,0.0647551786100997,2.62193598183268e-115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH2B3,SH2B adapter protein 3,28797,0.148510911000622,0.00647855093820483,0.135812951161741,0.161208870839504,2.92475819571485e-115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BACH1,Transcription regulator protein BACH1,29434,0.111572496733105,0.00486825901996822,0.102030709053967,0.121114284412243,3.11997797399187e-115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OPHN1,Oligophrenin-1,24845,0.163140457600949,0.00712037624862382,0.149184520153646,0.177096395048251,5.52710867846924e-115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EZR,Ezrin,29694,0.0363305937220799,0.00158838900355834,0.0332173512751055,0.0394438361690542,8.57610903818167e-115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,0.143116999509824,0.00626410444840763,0.130839354790945,0.155394644228703,1.57736260692069e-114
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFB,Platelet-derived growth factor subunit B,29581,0.12916877749561,0.00565979717149769,0.118075575039474,0.140261979951745,2.69071315069321e-114
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APPL2,DCC-interacting protein 13-beta,24381,0.169615390647284,0.00742902085836036,0.155054509764898,0.18417627152967,3.52681485643916e-114
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ISM1,Isthmin-1,29434,0.0592759733585313,0.00259864785643115,0.0541826235599262,0.0643693231571363,3.55040650996927e-114
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MXRA8,Matrix remodeling-associated protein 8,24381,-0.0462981759053401,0.00202873402439148,-0.0502744945931474,-0.0423218572175328,4.43612346934342e-114
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,0.140880825892978,0.00618256268168011,0.128763003036885,0.152998648749071,6.26566745217269e-114
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,0.161584204190291,0.0070912455484744,0.147685362915281,0.175483045465301,9.16158178474019e-114
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRHBP,Corticotropin-releasing factor-binding protein,29454,0.0418159350074967,0.00183884045256129,0.0382118077204765,0.0454200622945168,1.70078236060948e-113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBPL,FK506-binding protein-like,24805,0.0891303596549415,0.00391994839759548,0.0814472607956544,0.0968134585142286,2.74332329272151e-113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPOCK1,Testican-1,29218,0.0387307683493568,0.00170543821559245,0.0353881094467956,0.042073427251918,3.405353445515e-113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TANK,TRAF family member-associated NF-kappa-B activator,28931,0.10537615167036,0.00464471003383254,0.0962725200040479,0.114479783336671,5.79592658937359e-113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AFP,Alpha-fetoprotein,29132,0.102158685782032,0.00450476198195906,0.0933293522973927,0.110988019266672,7.04221821369824e-113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MITD1,MIT domain-containing protein 1,29218,0.144672216745906,0.00638949607917965,0.132148804430714,0.157195629061098,1.55291071498046e-112
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAXX,Protein PAXX,24381,0.0687305607253592,0.00303461110384346,0.0627827229618261,0.0746783984888924,2.07204774653352e-112
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBCC,Tubulin-specific chaperone C,29218,0.121020125754944,0.00534823359159405,0.110537587915419,0.131502663594468,2.1282053484372e-112
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,28797,0.0957703121899981,0.00423421002116193,0.0874712605485207,0.104069363831475,2.73579470819429e-112
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,0.0945952261331723,0.00418400255715278,0.0863945811211529,0.102795871145192,3.37534601205028e-112
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,0.116015752751015,0.00512987995197291,0.105961188045148,0.126070317456881,4.11496631584844e-112
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RABEP1,Rab GTPase-binding effector protein 1,24381,0.116941534217544,0.00517216885811122,0.106804083255646,0.127078985179442,4.93934005309743e-112
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGL1,Fibrinogen-like protein 1,24951,-0.0955611656672651,0.00422771789012027,-0.103847492731901,-0.0872748386026294,5.34824146664001e-112
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IST1,IST1 homolog,24636,0.148702754683412,0.00658289250889872,0.13580028536597,0.161605224000853,7.57422336462895e-112
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,0.0952727857066957,0.00421970307057986,0.0870021676883591,0.103543403725032,9.42456978384071e-112
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PON2,Serum paraoxonase/arylesterase 2,28916,0.0516736934026844,0.002297032651412,0.0471715094059168,0.0561758773994519,4.10701852328666e-111
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4G,C-type lectin domain family 4 member G,29434,0.0494488939750612,0.0021997663014309,0.0451373520242566,0.0537604359258657,5.72070921580625e-111
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEXIM1,Protein HEXIM1,29434,0.1203445008204,0.00536936132646895,0.109820552620521,0.130868449020279,2.46019717023515e-110
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP3B1,AP-3 complex subunit beta-1,24805,0.113893668305521,0.00507752222567848,0.103941724743191,0.123845611867851,2.46262327499303e-110
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,0.106558708144224,0.00475056354215552,0.0972476036015995,0.115869812686849,2.58340887747032e-110
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,0.125691147138317,0.00560975436491108,0.114696028583092,0.136686265693543,3.03253490560628e-110
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,0.132129465338764,0.00589768778322837,0.120569997283636,0.143688933393892,4.49667855757467e-110
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,0.07886768246189,0.00352767597916772,0.0719534375427213,0.0857819273810587,1.30341413621001e-109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBNL,Drebrin-like protein,29581,0.136522546218124,0.00611324296790185,0.124540590001037,0.148504502435212,1.44933125827939e-109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNPY4,Protein canopy homolog 4,29349,0.110705799103658,0.0049588765366719,0.100986401091781,0.120425197115535,1.73701241647545e-109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,0.0973571973938994,0.00436103832539362,0.0888095622761279,0.105904832511671,2.5503959764972e-109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,0.122703230489559,0.00550331093221851,0.111916741062411,0.133489719916707,4.75152277408567e-109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,0.113083236684375,0.00507629719358595,0.103133694184947,0.123032779183804,4.99341464646524e-109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP43,Centrosomal protein 43,28705,0.102529575265447,0.00460627440581064,0.0935012774300584,0.111557873100836,7.76818351342215e-109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,0.10645626380882,0.00478646476011357,0.0970747928789974,0.115837734738643,1.07421836786097e-108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HYOU1,Hypoxia up-regulated protein 1,29820,0.0327376983417047,0.00147385529123389,0.0298489419708862,0.0356264547125231,1.98494733695534e-108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDHD2,Phospholipase DDHD2,24867,0.0976237135138542,0.00439152112494374,0.0890163321089645,0.106231094918744,2.00724944938548e-108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GTPBP2,GTP-binding protein 2,24195,0.119072152477534,0.00535984504672832,0.108566856185947,0.129577448769122,2.9412079265006e-108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRAP,BRCA1-associated protein,24565,0.161365879117374,0.00726477780432957,0.147126914620888,0.17560484361386,3.05958958463968e-108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HCLS1,Hematopoietic lineage cell-specific protein,29786,0.0815715263357533,0.00367678862994569,0.0743650206210597,0.0887780320504468,3.5724879462054e-108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STK11,Serine/threonine-protein kinase STK11,28916,0.106950018417926,0.00482771024646144,0.0974877063348617,0.116412330500991,7.66101909746692e-108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,0.161054756177007,0.00727212162770935,0.146801397786696,0.175308114567317,8.43020725400899e-108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUOM,Fucose mutarotase,24381,0.0935869947134913,0.00422334910372811,0.0853092304701842,0.101864758956798,9.81666977667892e-108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRKL,Crk-like protein,29491,0.155191405884722,0.00701079046676034,0.141450256569872,0.168932555199572,1.07349927434847e-107
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GMPR,GMP reductase 1,29786,0.0725944915111339,0.00328264228762555,0.0661605126273879,0.07902847039488,1.67941595106336e-107
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,0.117326966819886,0.00530211120362181,0.106934828860787,0.127719104778985,1.84121140372408e-107
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,0.140243001602372,0.00634427399674221,0.127808224568757,0.152677778635986,2.17800097497339e-107
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNST,Consortin,29478,0.15817745931487,0.00716204781700524,0.14413984559354,0.1722150730362,3.23477252852623e-107
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GASK1A,Golgi-associated kinase 1A,24111,0.0631714385929838,0.00285817620384853,0.0575694132334407,0.0687734639525269,3.51306733789806e-107
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AZI2,5-azacytidine-induced protein 2,24867,0.0808897117847181,0.00366274522857712,0.0737107311367069,0.0880686924327292,4.77841399304344e-107
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VNN1,Pantetheinase,24951,0.106223965078961,0.00482288348153083,0.0967711134551608,0.115676816702762,1.72033897095946e-106
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAGK,N-acetyl-D-glucosamine kinase,24209,0.0830320475165209,0.00377074244705411,0.0756413923202948,0.090422702712747,2.05352908911688e-106
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,0.080007988408316,0.00364102373236515,0.0728715818928804,0.0871443949237517,3.8531544016548e-106
NMR metabolomics,X23503.Total Lipids in Medium VLDL,METAP2,Methionine aminopeptidase 2,29674,0.0834531639817877,0.00380048230453427,0.0760042186649005,0.0909021092986749,5.02446679018564e-106
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA1,Ephrin type-A receptor 1,29536,0.0482795115968946,0.00220128214218644,0.0439649985982092,0.05259402459558,8.92212755365144e-106
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NIT2,Omega-amidase NIT2,24813,0.108252144346229,0.00493349041691826,0.0985825031290692,0.117921785563389,1.04027011911737e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYTL4,Synaptotagmin-like protein 4,24922,0.106040554356056,0.00483337497040921,0.0965671394140535,0.115513969298058,1.10035746723528e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASAH2,Neutral ceramidase,29218,0.0768454095124241,0.00350521086662637,0.0699751962138364,0.0837156228110118,1.11300931052734e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNMBP,Dynamin-binding protein,29218,0.0887009900633221,0.00404639319412135,0.0807700594028442,0.0966319207237999,1.16696530598559e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKT1S1,Proline-rich AKT1 substrate 1,28774,0.0971923417144551,0.00443714125382005,0.0884955448569678,0.105889138571942,1.72586694624913e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA11,Annexin A11,29373,0.0967548181452077,0.00441871047621815,0.0880941456118201,0.105415490678595,1.95588458109564e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIGYF2,GRB10-interacting GYF protein 2,24867,0.110319425408561,0.0050383374594431,0.100444283988053,0.12019456682907,2.80754527469542e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,0.11176032846031,0.00510469368408251,0.101755128839508,0.121765528081112,2.9389523981735e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD5,Programmed cell death protein 5,29694,0.0836734209203972,0.0038283784212493,0.0761697992147486,0.0911770426260458,4.59141339710826e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,0.0609708986834485,0.0027885154439015,0.0555054084134016,0.0664363889534955,5.5056631819897e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM5,Tripartite motif-containing protein 5,29434,0.12407477231926,0.00567945186199486,0.11294304666975,0.13520649796877,5.77154858314944e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ORM1,Alpha-1-acid glycoprotein 1,24846,0.029017220257035,0.00132752270887942,0.0264152757476313,0.0316191647664386,6.34567235098622e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAG1,Dystroglycan,29581,0.0684978540722644,0.00313684503588177,0.0623496378019362,0.0746460703425927,7.04787486208753e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOK1,Docking protein 1,24845,0.197811079082773,0.00905855205389795,0.180056317057133,0.215565841108413,1.00130588236245e-104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,0.110931459458827,0.00508432156659768,0.100966189188296,0.120896729729359,1.05274291318955e-104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE4,Ribonuclease 4,24194,0.039831197468867,0.00182415286732562,0.0362558578489088,0.0434065370888252,1.09819566269033e-104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FETUB,Fetuin-B,29545,0.0476061195795158,0.00218475532440726,0.0433239991436776,0.051888240015354,1.91697455950149e-104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAT,Linker for activation of T-cells family member 1,29786,0.109000951222343,0.00500408192446949,0.0991929506503824,0.118808951794303,2.22928309350942e-104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,0.0683077209718737,0.0031334743118266,0.0621661113206935,0.0744493306230538,2.3431741509748e-104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM13A,Protein FAM13A,24805,0.0975986219894225,0.0044794196156446,0.088818959542759,0.106378284436086,2.85665463160795e-104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMMD1,COMM domain-containing protein 1,24240,0.0882190728441107,0.0040632886849114,0.0802550270216843,0.096183118666537,1.55992536627736e-103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,0.0455496560421524,0.00209908985126061,0.0414354399336816,0.0496638721506232,1.99508924942518e-103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAMBP,STAM-binding protein,29163,0.0917406639835092,0.00423258710789193,0.0834447932520411,0.100036534714977,2.32477451334331e-103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIA1,Nucleolysin TIA-1 isoform p40,28538,0.174838169249971,0.00807372630466371,0.15901366569283,0.190662672807111,3.68377644571704e-103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYN,Tyrosine-protein kinase Lyn,29349,0.12055803615166,0.00558423358700421,0.109612938321132,0.131503133982188,1.4345754409299e-102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAP,Prolyl endopeptidase FAP,29820,0.0392904160259788,0.00182013286331054,0.0357229556138901,0.0428578764380674,1.46819216483496e-102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAMP8,Vesicle-associated membrane protein 8,24229,0.12655318253397,0.00585838992758516,0.115070738275903,0.138035626792037,1.59700466022257e-102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,0.149653904597971,0.00693593236997002,0.136059477152829,0.163248332043112,1.87262735509095e-102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS1BP3,HCLS1-binding protein 3,24240,0.12911112737447,0.005983741322378,0.117382994382609,0.140839260366331,2.71529978079446e-102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX15,Sorting nexin-15,24381,0.077222312159422,0.00358774568146108,0.0701903306237583,0.0842542936950857,8.25780340934737e-102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMOX2,Heme oxygenase 2,28774,0.0664572381985214,0.00309144305725656,0.0603980098062985,0.0725164665907442,1.04714593978188e-101
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EREG,Proepiregulin,29163,0.114180962482976,0.00531365989438699,0.103766189089978,0.124595735875975,1.23581119114902e-101
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,0.130235035444373,0.00607203358106873,0.118333849625479,0.142136221263268,2.82760152786702e-101
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP5,Fatty acid-binding protein 5,29624,0.096501878981392,0.00450113424994672,0.0876796558514965,0.105324102111288,3.37371337957072e-101
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,0.118017849135799,0.00550946232026623,0.107219302988077,0.12881639528352,5.03473895282906e-101
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRELD2,Protein disulfide isomerase CRELD2,29536,0.0736372308814409,0.00344091356346805,0.0668930402970436,0.0803814214658383,7.72903207605449e-101
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,0.070224108500975,0.00328167190416342,0.0637920315688147,0.0766561854331353,1.15623376918703e-100
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,0.1023346080678,0.00478432777807871,0.0929573256227652,0.111711890512834,1.35880803290697e-100
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEP,Leptin,29478,0.0949513855105416,0.00444564005118101,0.0862379310102268,0.103664840010856,1.88818942130666e-100
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TWF2,Twinfilin-2,24938,0.11879920499873,0.00556141782059595,0.107898826070362,0.129699583927098,2.43137016314658e-100
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,29349,0.119331149374714,0.00559625678846279,0.108362486069327,0.130299812680101,3.97046728208407e-100
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,0.111952849590893,0.00525140938850468,0.101660087189424,0.122245611992362,5.99430121148826e-100
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MGLL,Monoglyceride lipase,29536,0.122207396200254,0.00573938499236834,0.110958201615212,0.133456590785296,7.47713126635719e-100
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,0.0980347787456033,0.00460042815769753,0.0890179395565161,0.10705161793469,7.58388048822335e-100
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,24229,0.127442712052661,0.00598694016420028,0.115708309330828,0.139177114774493,1.23271006210675e-99
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,0.0890506399504786,0.00419413711828545,0.0808301311986391,0.0972711487023181,2.78582485220262e-99
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,0.120842830513234,0.00568799274195996,0.109694364738992,0.131991296287475,2.91462198417539e-99
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAEP,Glycodelin,29218,-0.18546780367717,0.00873768137489513,-0.202593659171964,-0.168341948182376,3.07885079781322e-99
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPHOSPH8,M-phase phosphoprotein 8,28916,0.10639432927512,0.00501406101505956,0.096566769685603,0.116221888864636,3.63004519988068e-99
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGFR,Opioid growth factor receptor,29349,0.0459245150683088,0.00216464083823714,0.041681819025364,0.0501672111112536,3.8020212751065e-99
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP3,Metalloproteinase inhibitor 3,29581,0.182017519488615,0.00859729411383759,0.165166823025493,0.198868215951736,9.47450782222185e-99
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STC1,Stanniocalcin-1,29694,0.0608723779517017,0.00287660451942753,0.0552342330936237,0.0665105228097796,1.16749544782713e-98
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYDGF,Myeloid-derived growth factor,24922,0.140263842170455,0.00662565436408379,0.127277559616851,0.153250124724059,1.3408154656149e-98
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOL1,Apolipoprotein L1,24951,0.0843306975305649,0.00398466119722559,0.0765207615840028,0.0921406334771271,1.51522591303248e-98
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKG1,cGMP-dependent protein kinase 1,24381,0.176401890667934,0.00833466685393193,0.160065943634228,0.192737837701641,1.5537830111262e-98
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.0340237281711929,0.00161016485908375,0.0308678050473888,0.0371796512949971,2.24326884083262e-98
NMR metabolomics,X23503.Total Lipids in Medium VLDL,A1BG,Alpha-1B-glycoprotein,24966,0.0239924046298458,0.00113498999798482,0.0217678242337956,0.0262169850258961,2.54523941149621e-98
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPART,Spartin,24381,0.108580746788479,0.00513641116584505,0.0985133809034228,0.118648112673535,2.63764202405532e-98
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,0.106647606858453,0.00505128058866034,0.0967470969046787,0.116548116812227,3.36116720778074e-98
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD36,Platelet glycoprotein 4,24229,0.0634400646405582,0.00300899977427829,0.0575424250829727,0.0693377041981436,8.54657194582326e-98
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINE1,Plasminogen activator inhibitor 1,29820,0.0933697583007484,0.00443535668203724,0.0846764592039554,0.102063057397541,1.14663510223944e-97
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DIABLO,"Diablo homolog, mitochondrial",29395,0.152587450875388,0.00724971859406757,0.138378002431016,0.166796899319761,1.27239048372891e-97
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,0.0463044809176507,0.0021994781929922,0.041993503659386,0.0506154581759155,1.67599878347718e-97
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRAF2,TNF receptor-associated factor 2,29434,0.0979260962956181,0.00465859773422525,0.0887952447365366,0.1070569478547,2.21758906304388e-97
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,0.0885777283064159,0.00421408918278103,0.0803181135081651,0.0968373431046667,3.18032161507994e-97
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,0.087758861712666,0.00418797448562012,0.0795504317208506,0.0959672917044815,1.16173595901722e-96
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC27,Cell division cycle protein 27 homolog,28797,0.0842655257550316,0.00402695171335414,0.0763727003968575,0.0921583511132057,1.64770184686264e-96
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRADD,Death domain-containing protein CRADD,29163,0.105002220578037,0.00502061720629694,0.0951618108536945,0.114842630302379,2.03354848298015e-96
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA4D,Semaphorin-4D,29694,0.0414345925789986,0.00198397190211494,0.0375460076508533,0.0453231775071438,3.63510695627007e-96
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FIS1,Mitochondrial fission 1 protein,29453,0.106452522645756,0.00510369533911665,0.0964492797810877,0.116455765510425,6.38983414880246e-96
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,0.0526383717308707,0.00252389356837198,0.0476915403368617,0.0575852031248798,6.6838961513068e-96
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GYS1,"Glycogen [starch] synthase, muscle",28916,0.127837821377197,0.00615622839642584,0.115771613720202,0.139904029034191,4.38823861436369e-95
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAVS,Mitochondrial antiviral-signaling protein,28797,0.12610453387432,0.00607342237006002,0.114200626029002,0.138008441719638,4.62727660897223e-95
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,0.0493274520027219,0.00237656177271384,0.0446693909282028,0.053985513077241,5.18163821716755e-95
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAX,Protein max,28774,0.144636540989081,0.00696899953602853,0.130977301898465,0.158295780079697,5.57920199574353e-95
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBM17,Splicing factor 45,24867,0.105348408292043,0.00507523077820997,0.0954009559667512,0.115295860617334,6.72110761588441e-95
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOP2B,DNA topoisomerase 2-beta,24229,0.109561851231103,0.005287548576311,0.0991982560215336,0.119925446440673,1.49067337908674e-94
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VASP,Vasodilator-stimulated phosphoprotein,24951,0.0997752979762823,0.00481763887060265,0.0903327257899011,0.109217870162664,1.74305196944758e-94
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGRN,Agrin,29581,0.0471451943744683,0.00227913585287468,0.0426780881028339,0.0516123006461026,2.18109096641256e-94
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,0.0621764450755328,0.00301513726495156,0.0562667760362278,0.0680861141148379,1.12465424236634e-93
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GORASP2,Golgi reassembly-stacking protein 2,24805,0.0646213343827149,0.00313658629276386,0.0584736252488978,0.0707690435165321,1.58635713397741e-93
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNLR1,Interferon lambda receptor 1,29434,0.0505107569307022,0.00245465820238857,0.0456996268540206,0.0553218870073838,1.98845019336093e-93
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB6A,Ras-related protein Rab-6A,29434,0.0631494110574235,0.00306930719492354,0.0571335689553733,0.0691652531594736,2.11469576496878e-93
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,0.200380724411445,0.00973607841392217,0.181298010720158,0.219463438102733,2.43841232633104e-93
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIFBP,KIF-binding protein,29349,0.112116039430163,0.00545969863438119,0.101415030106776,0.122817048753551,4.71622335684426e-93
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,0.0850132469762064,0.00413686993044837,0.0769049819125276,0.0931215120398852,4.82076334676513e-93
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,24867,0.0919968733404017,0.0044812572846384,0.0832136090625104,0.100780137618293,6.96167230395295e-93
NMR metabolomics,X23503.Total Lipids in Medium VLDL,QDPR,Dihydropteridine reductase,29345,0.0585150085812326,0.00285465142968236,0.0529198917790552,0.06411012538341,1.00037957037553e-92
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGA,Protein O-GlcNAcase,24805,0.0962022476942708,0.00469282426945678,0.0870043121261355,0.105400183262406,1.26687675685198e-92
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB27B,Ras-related protein Rab-27B,24922,0.111700656394905,0.00545105136082951,0.101016595727679,0.122384717062131,1.4853437562819e-92
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMN,Protein amnionless,28931,0.0642337694609649,0.00314464572588026,0.0580702638382396,0.0703972750836902,4.35773292949569e-92
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS8,Galectin-8,29694,0.0820137217899299,0.00401570842435168,0.0741429332782006,0.0898845103016591,4.47155722678493e-92
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3GLB2,Endophilin-B2,24845,0.0898906574439066,0.00441426991844534,0.0812386884037537,0.0985426264840594,1.96335853910508e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAT2,Signal transducer and activator of transcription 2,24229,0.104933340728703,0.00515270490054937,0.0948340391236265,0.11503264233378,2.00712754565226e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAX1BP1,Tax1-binding protein 1,24845,0.085302250005229,0.00419145148163538,0.0770870051012237,0.0935174949092343,2.50660112891165e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH2,Cadherin-2,29478,0.0476355744287012,0.0023447622282091,0.0430398404614113,0.052231308395991,3.93537760825956e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST13,Hsc70-interacting protein,24381,0.0753150701085903,0.00370822460950243,0.0680469498739655,0.082583190343215,5.91202291524987e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICA1,Islet cell autoantigen 1,28931,0.107016134625582,0.00527277620567845,0.0966814932624524,0.117350775988712,6.01093720387034e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F12,Coagulation factor XII,24966,0.0560773580428678,0.00276162210238713,0.0506645787221891,0.0614901373635466,6.19308849100608e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASC3,Protein CASC3,24195,0.0565561276335222,0.00278665337787993,0.0510942870128776,0.0620179682541669,8.07465626262855e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASHC3,WASH complex subunit 3,24845,0.101508318445929,0.00500495269024936,0.0916986111730401,0.111318025718818,1.01691959052046e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM172A,Cotranscriptional regulator FAM172A,24240,0.0827662051579006,0.00408086712976562,0.07476770558356,0.0907647047322413,1.06139877112712e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDC,Nuclear migration protein nudC,29786,0.0848884640320772,0.00419505610255587,0.0766661540710677,0.0931107739930867,1.94273819103198e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPP,Lipoma-preferred partner,24111,0.0894859319436618,0.00442412901023499,0.0808146390836012,0.0981572248037224,3.19451830572767e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHMP1A,Charged multivesicular body protein 1a,29218,0.106263729347095,0.00525908943751205,0.0959559140495717,0.116571544644619,3.6089932548648e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMVK,Phosphomevalonate kinase,28757,0.146839917420866,0.0072732517963078,0.132584343900103,0.161095490941629,5.15152461583593e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANG,Angiogenin,29435,0.0450233347443971,0.00223409620903157,0.0406445061746952,0.049402163314099,1.02647952262572e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,0.13904075099021,0.00691349982190349,0.12549029133928,0.152591210641141,2.33732424697745e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,29349,0.0751984584945383,0.00373991536452048,0.0678682243800781,0.0825286926089984,2.56581945354336e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,0.0401143745609299,0.00199531072981224,0.0362035655304979,0.0440251835913619,2.73354991839928e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL18A1,Collagen alpha-1(XVIII) chain,29559,0.0311455433240963,0.00155071761536983,0.0281061367979715,0.0341849498502212,3.96524835313666e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EHD3,EH domain-containing protein 3,24240,0.156527434996851,0.00779889825472452,0.141241594417591,0.171813275576112,7.06672435143522e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL7,Interleukin-7,29434,0.0855079443154441,0.00426933971626729,0.0771400384715602,0.093875850159328,1.21645788672118e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,0.100376932065314,0.00501219527726766,0.0905530293218689,0.110200834808758,1.26926633418848e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R2,Protein phosphatase inhibitor 2,29478,0.105875449109722,0.0052895921018945,0.0955078485900084,0.116243049629435,1.5571530273683e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK13,Kallikrein-13,28845,0.0584903492154403,0.00292228309520984,0.052762674348829,0.0642180240820516,1.62018521084595e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,0.1484215515367,0.00741809102321977,0.133882093131189,0.162961009942211,1.876065459305e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RWDD1,RWD domain-containing protein 1,29694,0.0840084809707955,0.00420422583674273,0.0757681983307798,0.0922487636108112,3.01475546437799e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,24240,0.0974846977100467,0.00487680783966949,0.0879261543442945,0.107043241075799,3.5004650786116e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNDP1,Beta-Ala-His dipeptidase,29594,0.0608331654045387,0.00304574121006256,0.054863512632816,0.0668028181762613,3.59814336374305e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAG4,BAG family molecular chaperone regulator 4,24229,0.0657629022635862,0.00329135749685523,0.05931184156975,0.0722139629574225,4.18034728190259e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRAP2,GRB2-related adapter protein 2,29478,0.168935283778069,0.00846893667347144,0.152336167898065,0.185534399658073,5.99010063868666e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,0.0370931657863937,0.00186028478579641,0.0334470076062328,0.0407393239665547,7.03196487554481e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NIT1,Deaminated glutathione amidase,24240,0.0625903825635929,0.00314257425019252,0.0564309370332156,0.0687498280939702,1.45899489925354e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,0.128878838977987,0.00648385310849177,0.116170486885344,0.141587191070631,3.07913487236165e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOLGA3,Golgin subfamily A member 3,24867,0.102809196185066,0.0051771430981079,0.0926619957127744,0.112956396657357,4.42830474934723e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,0.0652342806552804,0.00328723803467218,0.0587912941073229,0.0716772672032379,5.93317828974246e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP1BB,Platelet glycoprotein Ib beta chain,24111,0.0901552037576644,0.00454691754549089,0.0812432453685022,0.0990671621468265,8.44664380320418e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESM1,Endothelial cell-specific molecule 1,29454,-0.0448946387439695,0.00227039117448108,-0.0493446054459524,-0.0404446720419866,1.81894964348189e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DGKA,Diacylglycerol kinase alpha,24229,0.0718865163475958,0.00363929748617827,0.0647534932746864,0.0790195394205052,3.61849053317036e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT5,"Keratin, type II cytoskeletal 5",28774,0.0666424513329538,0.00337730329547529,0.0600229368738222,0.0732619657920854,4.22000085296736e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BGLAP,Osteocalcin,24938,0.116180470909717,0.00588745417331319,0.104641060730023,0.127719881089411,5.04278260827732e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLG4,Disks large homolog 4,24845,0.0929053770021983,0.00471354055272275,0.0836668375188617,0.102143916485535,7.97402552774352e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM40,E3 ubiquitin ligase TRIM40,24195,0.0946733323098623,0.0048038280421358,0.0852578293472761,0.104088835272448,8.70167308333082e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,0.113016044336018,0.00573699656975664,0.101771531059295,0.124260557612741,9.86948412522868e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C2,Complement C2,29545,0.0304711352551464,0.00154828941977974,0.0274364879923781,0.0335057825179147,1.12289164423298e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF19,Fibroblast growth factor 19,29581,0.10041654539593,0.00510586315470412,0.0904090536127096,0.11042403717915,1.46127491215797e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDNF,Cerebral dopamine neurotrophic factor,29349,0.042490428136975,0.00216088845926515,0.0382550867568153,0.0467257695171347,1.57987481246962e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,0.112300287080534,0.00571195170353421,0.101104861741607,0.123495712419461,1.65592240725025e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAMDC4,Apical endosomal glycoprotein,24793,0.0725375913530462,0.00368742624144313,0.0653102359198176,0.0797649467862747,1.69757686560847e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS1,Galectin-1,29478,0.0446389053928448,0.00227093803885613,0.0401878668366868,0.0490899439490028,1.79389440215309e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CETN3,Centrin-3,24805,0.101335710389193,0.00515293799971581,0.0912359519097498,0.111435468868636,1.90545388415293e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,0.130166733091951,0.00662458851089619,0.117182539610594,0.143150926573307,2.08208009058455e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,0.127859758610273,0.00651035004507174,0.115099472521933,0.140620044698614,2.57803550577212e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1R,Complement C1r subcomponent,24966,0.0253527038089329,0.00129028829588641,0.0228237387489955,0.0278816688688703,2.61226849038169e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOLM2,Protein GOLM2,29694,0.0294041099022132,0.00149760526682374,0.0264688035792387,0.0323394162251877,2.75358295639601e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPI,Mannose-6-phosphate isomerase,29349,0.111255657064243,0.00567137746625237,0.100139757230389,0.122371556898098,3.89007902682239e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NSFL1C,NSFL1 cofactor p47,29694,0.0844413172900989,0.00430633761498182,0.0760008955647345,0.0928817390154633,4.51560883836471e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFB1,Transforming growth factor beta-1 proprotein,29760,0.0497059519937058,0.00253895443055169,0.0447296013098245,0.0546823026775871,8.26073689543531e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA2,Integrin alpha-2,24381,0.0446867208185589,0.00228116263962922,0.0402156420448857,0.0491577995922322,8.55132047068355e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,0.0652143003395543,0.00333022162169104,0.0586870659610399,0.0717415347180688,9.91485917674096e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARSB,Arylsulfatase B,29349,0.0715391922839773,0.00365621802515633,0.0643730049546709,0.0787053796132837,1.03755514536586e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",29566,0.079305868654855,0.00405569871040162,0.0713566991824678,0.0872550381272422,1.30375706384289e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.0330507632813817,0.00169190456967591,0.0297346303248169,0.0363668962379465,1.91692496513638e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAV3,Guanine nucleotide exchange factor VAV3,24101,0.12872267369482,0.00659547355892487,0.115795545519327,0.141649801870313,3.5337721099114e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD22,B-cell receptor CD22,29786,0.0539844590395599,0.00277355722902941,0.0485482868706623,0.0594206312084576,7.37664216076222e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,0.0685451036501549,0.00352053723496655,0.0616448506696204,0.0754453566306893,8.33272599336874e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YJU2,Splicing factor YJU2,24793,0.0419638167433291,0.00215633370112761,0.037737402689119,0.0461902307975392,9.97922670602452e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,0.0932008276289594,0.00479602292275299,0.0838006227003635,0.102601032557555,1.36007407496169e-83
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,0.113767516741271,0.00585567287471866,0.102290397906823,0.12524463557572,1.48367948049975e-83
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,0.0573446154316749,0.00295319430775813,0.051556354588469,0.0631328762748809,1.8674890485666e-83
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED8,Protein TMED8,24805,0.132691870330284,0.00683427035103323,0.119296700442259,0.146087040218309,2.36866699633988e-83
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,29434,0.0486408448674607,0.00250715240889951,0.0437268261460177,0.0535548635889037,2.521120295503e-83
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,0.100071660951685,0.00515845211149886,0.0899610948131474,0.110182227090223,2.65281827930232e-83
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLMH,Bleomycin hydrolase,29820,0.0408698394466604,0.00210896450436919,0.0367362690180967,0.045003409875224,3.76780875884987e-83
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,0.0292731718214222,0.00151230642699861,0.0263090512245049,0.0322372924183395,5.8679378405757e-83
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,0.105764911948548,0.0054713668624038,0.0950410328982365,0.116488790998859,9.94264820315944e-83
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,24229,0.0743404604436454,0.0038464180350398,0.0668014810949674,0.0818794397923234,1.33028313171533e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEXN,Nexilin,24951,0.088443130603392,0.00457666334932151,0.0794728704387219,0.0974133907680621,1.33623137521154e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FSHB,Follitropin subunit beta,24240,0.0830733966565403,0.00430183090369962,0.0746418080852891,0.0915049852277916,1.80463683444291e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,0.0782863421103871,0.0040577965976377,0.0703330607790172,0.086239623441757,1.99642647565337e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.0483341239386844,0.00250558783135326,0.043423171789232,0.0532450760881368,2.13932241818017e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD3,Mothers against decapentaplegic homolog 3,24793,0.0657498251904524,0.00340830647877325,0.0590695444920569,0.072430105888848,2.5660478079971e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRY2,Protein sprouty homolog 2,28931,0.118118700958379,0.0061270637739383,0.10610965596146,0.130127745955298,2.69285837489264e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,0.109235328167893,0.00566577118535267,0.0981304166446021,0.120340239691185,3.16249212959192e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN2L,Ataxin-2-like protein,24867,0.0615680304176751,0.00319815111964505,0.0552996542231708,0.0678364066121794,5.46469659731771e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.0504012906456009,0.00262179947932053,0.0452625636661326,0.0555400176250691,7.57393651674269e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53,Cellular tumor antigen p53,28797,0.0556237248553176,0.00289539715764366,0.049948746426336,0.0612987032842992,9.72311410590949e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,0.138087599238414,0.00718439518429634,0.124006184677194,0.152169013799635,1.05057185633429e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD69,Early activation antigen CD69,29344,0.11163314773781,0.00581400634261308,0.100237695306289,0.123028600169332,1.1585040744495e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,0.0937542256912352,0.00488949924680672,0.0841708071674941,0.103337644214976,2.39058227954582e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,24938,0.0643084770933505,0.00335586810864841,0.0577309756003996,0.0708859785863014,2.89952435808009e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGF,Pro-epidermal growth factor,29379,0.130977219321,0.00684294346754559,0.11756505012461,0.144389388517389,3.63116177187895e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT5,ADP-sugar pyrophosphatase,29443,0.0649348249624041,0.00339263815795692,0.0582852541728085,0.0715843957519997,3.66083065164821e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,0.0600634880926521,0.00314203644523232,0.0539050966599968,0.0662218795253075,7.06533821445601e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,0.0468983685867003,0.00245481683129691,0.0420869275973584,0.0517098095760423,9.00863103500638e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,0.073669711089542,0.00386098367655379,0.0661021830834966,0.0812372390955874,1.41867631825398e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP7,Caspase-7,24845,0.10639251935471,0.00558430347205759,0.0954472845494767,0.117337754159942,2.36663995448184e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,0.107972258241592,0.00567204438576893,0.0968550512454849,0.119089465237699,3.29124432477694e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,0.0972600280545532,0.00511463016230047,0.0872353529364442,0.107284703172662,3.80357907176235e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPY,Pancreatic prohormone,29400,0.128288780141296,0.00674871371425547,0.115061301261355,0.141516259021237,4.32007698770167e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBXN1,UBX domain-containing protein 1,24381,0.0870867364110719,0.00458589646856927,0.0780983793326761,0.0960750934894676,7.7722952439123e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,0.119399534325308,0.00629425677277495,0.10706279105067,0.131736277599947,9.10533658471262e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BIN2,Bridging integrator 2,29443,0.11318314636411,0.00596791217735949,0.101486038496486,0.124880254231735,9.88341757341902e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,0.118160053492495,0.00624597204382329,0.105917948286601,0.130402158698389,2.41754605623738e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,0.0605513396100605,0.00320195454590613,0.0542755087000845,0.0668271705200365,3.36354502613918e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NACC1,Nucleus accumbens-associated protein 1,24793,0.069245606584844,0.0036628293057539,0.0620664611455663,0.0764247520241216,3.74815230545985e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MOCS2,Molybdopterin synthase catalytic subunit,24381,0.0845245992413655,0.00447153411986212,0.0757603923664358,0.0932888061162953,3.98517732500235e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD226,CD226 antigen,24229,0.052996188739902,0.00280393162872666,0.0475004827475978,0.0584918947322063,4.18209561204423e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STXBP1,Syntaxin-binding protein 1,24867,0.0974021221447209,0.00515489487254524,0.0872985281945323,0.10750571609491,4.49067206463067e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C3,Complement C3,23779,0.0584743033919513,0.0030948549448559,0.0524083877000338,0.0645402190838689,4.85138092143591e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPPB,Natriuretic peptides B,28916,-0.167758143258891,0.00889738579354414,-0.185197019414237,-0.150319267103544,7.989689560058e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,0.128151445607388,0.00679569693620026,0.114831879612436,0.141471011602341,9.31205581528925e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH9,Protocadherin-9,24805,0.0424360953493931,0.00225128425228221,0.0380235782149199,0.0468486124838662,1.0498159704486e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB9,Serpin B9,29218,0.0414992949480825,0.00220329252161572,0.0371808416057157,0.0458177482904493,1.14006382499087e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUGT1,Protein SGT1 homolog,28797,0.100737332325874,0.00534817237633678,0.0902549144682543,0.111219750183495,1.14262899752828e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,0.105882780717234,0.00562891973402607,0.0948500980385425,0.116915463395925,1.83294718551975e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FNDC1,Fibronectin type III domain-containing protein 1,24845,0.0583875819037968,0.00310294435045411,0.0523058109769068,0.0644693528306869,1.93308702151219e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,0.0722382790900988,0.00384317056524381,0.064705664782221,0.0797708933979767,2.37753959538292e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,0.110633802656562,0.00588319939257525,0.0991027318471142,0.122164873466009,2.39787027859066e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,0.119581814810121,0.00636773166332387,0.107101060750007,0.132062568870236,3.1990693642373e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GMPR2,GMP reductase 2,24381,0.0838774039335325,0.00446799606550945,0.075120131645134,0.0926346762219311,4.47430146352035e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,0.0974571943474347,0.00520069379963228,0.0872638345001554,0.107650554194714,6.7904628346919e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATOX1,Copper transport protein ATOX1,29566,0.0887186113951669,0.00473491987167037,0.079438168446693,0.0979990543436408,6.98448714555601e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,-0.038892657915398,0.00207629875705419,-0.0429622034792242,-0.0348231123515718,7.71710870111145e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COCH,Cochlin,24922,0.0576177871864122,0.00307491139778884,0.051590960846746,0.0636446135260783,8.31775314290638e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,0.034693981796482,0.00185389834033987,0.0310603410494159,0.0383276225435481,1.07885832594033e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERP29,Endoplasmic reticulum resident protein 29,24381,0.147990781636518,0.00790759475021197,0.132491895926102,0.163489667346933,1.3086127776763e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,0.0546031375902665,0.00292309261155877,0.0488738760716113,0.0603323991089217,2.03126100246049e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,0.0554351473467895,0.00296796618305158,0.0496179336280084,0.0612523610655706,2.11167943262271e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL24,C-C motif chemokine 24,29536,0.102557147180103,0.00549283750887644,0.0917911856627052,0.113323108697501,2.37736869122448e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTDH,Protein LYRIC,24229,0.1157176565277,0.00619376259040876,0.103577881850499,0.127857431204901,2.38656496538517e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGBP1,Immunoglobulin-binding protein 1,24867,0.0752981697744905,0.00403295213889988,0.0673935835822467,0.0832027559667343,2.89607709845471e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,0.0701609130189216,0.00376198462859099,0.0627874231468833,0.0775344028909599,3.52309554760872e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRAS,Ras-related protein R-Ras,24195,0.162116145954641,0.00869512722772654,0.145073696588297,0.179158595320985,4.86018095080389e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSO,Cathepsin O,29786,0.0374690948130209,0.00201177712864991,0.0335260116408671,0.0414121779851747,5.53655548562589e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VCAM1,Vascular cell adhesion protein 1,29545,-0.0337787549224549,0.00181365254342812,-0.037333513907574,-0.0302239959373358,5.5987118584291e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LBR,Delta(14)-sterol reductase LBR,29694,0.0823289680397177,0.00442313471639454,0.0736596239955844,0.090998312083851,6.88109487645684e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBCB,Tubulin-folding cofactor B,29218,0.124124844264132,0.00667154715970281,0.111048611831114,0.137201076697149,8.12974217811323e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTF1,Cardiotrophin-1,28916,0.104249667584056,0.00560608263836807,0.093261745612855,0.115237589555258,9.75164389973427e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSIP1,PC4 and SFRS1-interacting protein,29434,0.0786215996962171,0.00423021805892425,0.0703303723007256,0.0869128270917086,1.15376766093915e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACYBP,Calcyclin-binding protein,24329,0.127302761479333,0.00684552027651534,0.113885541737363,0.140719981221303,1.16765588772629e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,0.115369695559912,0.00620987114839136,0.103198348109065,0.127541043010759,1.58557032548629e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP2,Microtubule-associated protein 2,24845,0.0570813378886305,0.00307403250373354,0.0510562341813127,0.0631064415959482,1.8918914009137e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,0.0821096994842626,0.00442185484850926,0.0734428639811845,0.0907765349873408,1.92236632671604e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OTUD6B,Deubiquitinase OTUD6B,24805,0.0721074993283404,0.00388387047250327,0.064495113202234,0.0797198854544468,2.00258778170137e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT4,Vascular endothelial growth factor receptor 3,29566,0.0413309431628142,0.00222807087222405,0.036963924253255,0.0456979620723733,2.21208611235285e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PENK,Proenkephalin-A,24381,0.0380838350570171,0.00205572363403417,0.0340546167343102,0.0421130533797241,4.26754322354294e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,0.0891219351244954,0.00481996093299554,0.0796748116958241,0.0985690585531666,7.97694538441373e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MESD,LRP chaperone MESD,29443,0.148721552969615,0.00804758046123165,0.132948295265601,0.164494810673629,8.00167823991521e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD207,C-type lectin domain family 4 member K,28835,0.0473291935375581,0.00256501527885855,0.0423017635909953,0.0523566234841208,1.37541587543576e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,0.056330737308309,0.00305501218384798,0.0503429134279669,0.062318561188651,1.70978649322456e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB6,Serpin B6,29623,0.0723579893837352,0.00392567625821866,0.0646636639176267,0.0800523148498438,1.92510154966066e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STIP1,Stress-induced-phosphoprotein 1,29386,0.0791347130043545,0.00429571380775749,0.0707151139411498,0.0875543120675591,2.33743833290669e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNDC5,Thioredoxin domain-containing protein 5,29694,0.0826556374978424,0.00449606697042371,0.0738433462358119,0.0914679287598728,4.61229179041031e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOXJ3,Forkhead box protein J3,24229,0.0542617839764084,0.00295227184822522,0.0484753311538869,0.0600482367989298,6.18421865835837e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTX3,Pentraxin-related protein PTX3,29434,-0.0601947404904664,0.00328132337357078,-0.0666261343026651,-0.0537633466782677,9.52007846839488e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,0.127117067693833,0.00692732586312822,0.113539509002101,0.140694626385564,1.05077234103993e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAP25,Synaptosomal-associated protein 25,24101,0.0577836108821917,0.0031492984028703,0.0516109860125659,0.0639562357518175,1.10430491390603e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,0.135915486628461,0.00741353533230984,0.121384957377134,0.150446015879788,1.16248294561877e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKD2,Polycystin-2,24111,0.0720946770245701,0.00393141839863403,0.0643890969632474,0.0798002570858928,1.32352923887076e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,0.095390585237471,0.00521189023578922,0.0851752803753242,0.105605890099618,2.09203046893295e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REN,Renin,29478,-0.0922667651794215,0.00504747503909584,-0.102159816256049,-0.0823737141027936,3.08753005824357e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,0.0895835768138595,0.00490414343375321,0.0799714556837032,0.0991956979440158,3.98893065928371e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEP1B,Meprin A subunit beta,29478,0.141410183867227,0.00775490299030567,0.126210574006228,0.156609793728227,6.95470241839916e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDRKH,Tudor and KH domain-containing protein,28774,0.102826098700065,0.00563866976699379,0.0917743059567574,0.113877891443373,6.99490537570869e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP5,Platelet glycoprotein V,24381,0.0438890328990658,0.00240719997318712,0.039170920951619,0.0486071448465125,8.84110111617825e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,0.092142433035626,0.00506193280495527,0.0822210447379137,0.102063821333338,1.23603294309768e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STK24,Serine/threonine-protein kinase 24,28774,0.0747783934851388,0.00410815953877625,0.0667264007891373,0.0828303861811402,1.28051930089664e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,0.0835252316587546,0.0045892565322114,0.0745302888556202,0.0925201744618889,1.59425878211433e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,0.0684476932873422,0.0037642796175443,0.0610697052369554,0.0758256813377291,1.74991726286137e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLUL1,Clusterin-like protein 1,29435,-0.05432610210475,0.00299019988601985,-0.0601868938813489,-0.0484653103281511,2.32966060938714e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUB1,NEDD8 ultimate buster 1,29434,0.100620215650712,0.00555354726432774,0.0897352630126295,0.111505168288794,5.71501313126549e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BPIFB2,BPI fold-containing family B member 2,24852,0.0780407907820085,0.00431647342195717,0.0695805028749725,0.0865010786890446,1.34492928057977e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACAN,Aggrecan core protein,29192,0.0339300264501182,0.00187893418011384,0.030247315457095,0.0376127374431413,1.69165965483643e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPB1,Heat shock protein beta-1,29039,0.0823697623317783,0.00456325991478371,0.0734257728988022,0.0913137517647543,1.94351035000036e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD1C,T-cell surface glycoprotein CD1c,29566,0.0290496447454898,0.00161395864708667,0.0258862857972,0.0322130036937797,4.81527501409129e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CERT,Ceramide transfer protein,28774,0.0733653212689947,0.00407712085343153,0.0653741643962689,0.0813564781417205,5.35633418391979e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP2,Caspase-2,29434,0.0810268543919319,0.00450324460492445,0.0722004949662799,0.0898532138175838,5.38171743090188e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TALDO1,Transaldolase,24888,0.0532488970694179,0.00296028508573197,0.0474467383013832,0.0590510558374525,6.94104007071769e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MVK,Mevalonate kinase,28931,0.0949751604079667,0.00528353599152158,0.0846194298645844,0.105330890951349,7.44266051416405e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSTN,Growth/differentiation factor 8,28916,0.062808108690679,0.00349423467856997,0.0559594087206818,0.0696568086606761,7.56643565447659e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBC1D5,TBC1 domain family member 5,29434,0.0931412943687946,0.00518215578115516,0.0829842690377305,0.103298319699859,7.62521149124449e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPARC,SPARC,29566,0.0838630631407764,0.00466638093701594,0.0747169565042252,0.0930091697773277,7.83022229389641e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT18,"Keratin, type I cytoskeletal 18",29349,0.0968970887518927,0.00539253692055926,0.0863277163875965,0.107466461116189,8.31672190384099e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,0.142266488871638,0.00792180110613126,0.126739758703621,0.157793219039655,9.85036305955242e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAG3,BAG family molecular chaperone regulator 3,29169,0.0477690689849987,0.00266278482475052,0.0425500107284877,0.0529881272415097,1.40729853245899e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPA1A,Heat shock 70 kDa protein 1A,29536,0.0842694016514707,0.00470153232634019,0.075054398291844,0.0934844050110975,1.84054099587218e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,0.104379335027863,0.00582634309156649,0.0929597025683931,0.115798967487334,2.16065870922403e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAG6,Large proline-rich protein BAG6,28916,0.043258116132098,0.00241736916467267,0.0385200725693396,0.0479961596948565,3.14505060872474e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PF4,Platelet factor 4,24822,0.115707672917688,0.00647357444998747,0.103019466995712,0.128395878839663,5.26088889901975e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,0.128046638148471,0.00716825828444927,0.113996851910951,0.142096424385992,6.38098496367832e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,29453,0.0591218506702634,0.00331168108795961,0.0526309557378625,0.0656127456026642,6.54093313313336e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,28662,0.0682893582610641,0.00382514994482299,0.0607920643692111,0.0757866521529172,6.6726706827049e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2L1,Bcl-2-like protein 1,24845,0.118334724598007,0.006629016432876,0.10534185238957,0.131327596806444,7.87044384287162e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,24381,0.103670438247205,0.00580805717423768,0.0922866461856997,0.115054230308711,8.25438623534483e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKT2,RAC-beta serine/threonine-protein kinase,24867,0.150148064463256,0.00841267011838542,0.133659231031221,0.166636897895292,8.31726275302823e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMT,Catechol O-methyltransferase,28591,0.0996116997781448,0.00559268150772549,0.0886500440230028,0.110573355533287,1.39707842915443e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YWHAQ,14-3-3 protein theta,24381,0.087541020998088,0.00491821275016997,0.0779013240077548,0.0971807179884211,1.99719409576102e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL8,C-C motif chemokine 8,29683,0.0713053373430671,0.00401339492971424,0.0634390832808271,0.079171591405307,2.95473268109959e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,0.0603906673105154,0.00340082965010102,0.0537250411963174,0.0670562934247134,4.09248081447951e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THTPA,Thiamine-triphosphatase,24755,0.104018127434019,0.00586156922582717,0.0925294517513982,0.115506803116641,5.05034900329387e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,29581,-0.0241064272067345,0.00135936384095172,-0.0267707803349999,-0.0214420740784691,5.32131438669556e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,0.111324206381428,0.00627728962815064,0.099020718710253,0.123627694052604,6.15503162932112e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP2B1,AP-2 complex subunit beta,24195,0.0575468376475476,0.00324514197619614,0.0511863593742032,0.063907315920892,6.44285410216525e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,28931,0.0703904144525114,0.00397307429597878,0.062603188832393,0.0781776400726298,7.27855324784675e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL11,Eotaxin,29786,0.0441906548779544,0.00249881119251891,0.0392929849406173,0.0490883248152914,1.25076084800205e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LACTB2,Endoribonuclease LACTB2,29478,0.0772682055793384,0.00437621828240472,0.0686908177458251,0.0858455934128516,2.07175880906166e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTD,Deoxycytidylate deaminase,24381,0.11163645485878,0.00632000088256744,0.0992492531289477,0.124023656588612,2.15174391741534e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIAE,Sialate O-acetylesterase,29495,0.054510265530416,0.00309273498589809,0.0484485049580557,0.0605720261027762,3.5715431533084e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC59,Leucine-rich repeat-containing protein 59,24922,0.0555978645931476,0.00316403478091774,0.0493963564225488,0.0617993727637464,1.05252580455877e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,28774,0.0325985970887524,0.00185627772223586,0.0289602927531701,0.0362369014243347,1.11423328785957e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GMFG,Glia maturation factor gamma,24922,0.0838467033541465,0.00477392067954813,0.0744898188222321,0.0932035878860608,1.21689839567128e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA4,Protein disulfide-isomerase A4,24938,0.0709412428437,0.00404288362329306,0.0630171909420456,0.0788652947453544,1.61489074693146e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,0.0713196655591962,0.00406873843667086,0.0633449382233213,0.0792943928950711,2.2922615306192e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CETN2,Centrin-2,28774,0.0785505527551704,0.00448409525812255,0.0697617260492502,0.0873393794610906,2.3836061081565e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYO9B,Unconventional myosin-IXb,28931,0.0767986638905691,0.00438770448234379,0.0681987631051753,0.0853985646759629,3.05016633132518e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CIAPIN1,Anamorsin,29566,0.0726998196609682,0.00415869560109163,0.0645487762828286,0.0808508630391078,4.37423877086121e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARA5,Scavenger receptor class A member 5,29694,0.0349036427966932,0.00199751710486316,0.0309885092711614,0.038818776322225,4.99887206059303e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,0.0782709477289085,0.00448025569327714,0.0694896465700853,0.0870522488877317,5.42513057251891e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POMC,Pro-opiomelanocortin,24240,0.0822147500762266,0.00470440330603338,0.0729941195964012,0.091435380556052,5.69293981139098e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAO1,Hydroxyacid oxidase 1,29725,0.148328858880054,0.00849412434801638,0.131680375157942,0.164977342602166,6.04371777506709e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMEM106A,Transmembrane protein 106A,24793,0.0821796410220966,0.00470405208665316,0.0729596989322564,0.0913995831119368,6.20035309414559e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL16,C-X-C motif chemokine 16,29786,0.0272981352324506,0.00156411338147186,0.0242324730047657,0.0303637974601354,7.14407600181259e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP4,"Fatty acid-binding protein, adipocyte",29820,0.0577421603897808,0.00331544250990403,0.0512438930703689,0.0642404277091927,1.34660990610167e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,0.085224476405232,0.00489506363445819,0.0756301516816939,0.09481880112877,1.7311831914506e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,0.0439463523740427,0.00252446890211276,0.0389983933259017,0.0488943114221837,1.8046245713871e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINE2,Glia-derived nexin,24922,0.0745639981837691,0.00428465567944655,0.0661660730520539,0.0829619233154843,1.97800513854827e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL18,C-C motif chemokine 18,29166,0.0810926619507875,0.00466621666383974,0.0719468772896616,0.0902384466119134,2.61622869567665e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFHR4,Complement factor H-related protein 4,24892,0.0848437716432595,0.00488066833880869,0.0752776616991945,0.0944098815873246,2.74422129197871e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSNL1,Visinin-like protein 1,24845,0.0441764141561308,0.00254162471706729,0.0391948297106789,0.0491579986015826,2.86830696048095e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,0.0630436627672024,0.00363296172610551,0.0559230577840356,0.0701642677503692,4.08204223560601e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,0.0781606482149979,0.00450519525358864,0.0693304655179641,0.0869908309120316,4.29426475996191e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFHR5,Complement factor H-related protein 5,24623,0.0482894505132068,0.00278235924150171,0.0428360263998634,0.0537428746265501,4.49300096067926e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNMA1,Paraneoplastic antigen Ma1,24240,0.0652393420383125,0.00375962342323128,0.0578704801287792,0.0726082039478458,4.79556486779024e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,0.138378020791037,0.0079854645569568,0.122726510259401,0.154029531322672,6.14292358621729e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G4A,Cytosolic phospholipase A2,29581,0.100621206631701,0.00580808272513956,0.0892373644904279,0.112005048772975,6.60071547179788e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB1,Leukocyte elastase inhibitor,29354,0.102555852272299,0.00592126655179305,0.0909501698307845,0.114161534713813,7.16437831444347e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPT,Dermatopontin,29820,0.0302701020362747,0.00174994973166354,0.0268402005622141,0.0337000035103352,1.03734975123704e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFA,Platelet-derived growth factor subunit A,29820,0.082295372266795,0.00476514678175801,0.0729556845745493,0.0916350599590407,1.66128034829213e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLOD4,Glyoxalase domain-containing protein 4,29408,0.0405976705055287,0.00235212257053205,0.0359875102672859,0.0452078307437715,2.0013928986236e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,29581,0.0442432092070998,0.00256860085574669,0.0392087515298363,0.0492776668843633,3.65264773896702e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,0.138711190946187,0.00805418748653884,0.122924983472571,0.154497398419804,3.81909917353826e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,0.0934429382071588,0.00542663816366952,0.0828067274063666,0.104079149007951,4.01607972214116e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,0.113847892902524,0.00661465766795447,0.100883163873333,0.126812621931715,5.26185685300273e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JPT2,Jupiter microtubule associated homolog 2,24805,0.100411111272422,0.00583476625027515,0.0889749694218832,0.111847253122962,5.48918742337202e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNCG,Gamma-synuclein,29218,0.0763424277357578,0.00443882891292872,0.0676423230664175,0.0850425324050981,5.73560758932821e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCRG1,Scrapie-responsive protein 1,24922,0.0314877505951141,0.00183057603701346,0.0278998215625678,0.0350756796276605,6.2766689544636e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP3,Caspase-3,29820,0.100386259205498,0.00583954571465171,0.0889407496047805,0.111831768806215,6.47875004301827e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,29478,0.0771010053010867,0.00448524423720969,0.0683099265961557,0.0858920840060177,6.62830273622628e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMPACT,Protein IMPACT,24845,0.0637129645261577,0.00370770453047393,0.0564458636464288,0.0709800654058866,8.41920624737353e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TADA3,Transcriptional adapter 3,24793,0.045244479989218,0.00263297185848989,0.0400838551465778,0.0504051048318582,8.45344388238096e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,0.1121988670979,0.00653659647581973,0.0993871380052937,0.125010596190507,1.01675323596099e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MICALL2,MICAL-like protein 2,24195,0.0781419533466912,0.00455199039576812,0.0692200521709857,0.0870638545223967,1.15883263527763e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRGN,Neurogranin,24951,0.104268174337405,0.00607529663645639,0.0923605929299504,0.116175755744859,1.20539003074007e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFB,Complement factor B,24538,0.0375331097451578,0.00218730242409496,0.0332459969939316,0.0418202224963839,1.28935660693933e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPBP,Platelet basic protein,24816,0.0965986573030014,0.0056332309158165,0.0855575247080011,0.107639789898002,1.55368238524808e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FST,Follistatin,29536,0.0574455105485387,0.00335426126734349,0.0508711584645455,0.064019862632532,1.96355626152987e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSC22D1,TSC22 domain family protein 1,24867,0.0759825629432304,0.00443536018684615,0.067289256977012,0.0846758689094489,2.06736805567646e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,0.102066369553735,0.00596225823776522,0.0903803434077154,0.113752395699755,2.54490194093697e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBLN4,Cerebellin-4,29725,0.0360929114848326,0.00210945277999031,0.0319583840360516,0.0402274389336136,2.56785526230965e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,24240,0.10488658333817,0.00612696467096549,0.092877732583078,0.116895434093263,2.60217896087348e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,0.087081030769047,0.00509743362541165,0.0770900608632401,0.0970720006748538,4.75369577350581e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LSP1,Lymphocyte-specific protein 1,29434,0.0455194708345308,0.00266648238870909,0.0402931653526609,0.0507457763164006,5.02338637526658e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP3R1,Calcineurin subunit B type 1,29218,0.04643259616256,0.00272034726510622,0.0411007155229518,0.0517644768021682,5.25569386134076e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIPC3,PDZ domain-containing protein GIPC3,24805,0.111538078462909,0.00653797552465901,0.0987236464345772,0.124352510491241,6.91118363371222e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RFC4,Replication factor C subunit 4,24793,0.0241147103335265,0.00141496659797041,0.0213413758015045,0.0268880448655485,9.28459334574273e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,0.0708449347600152,0.00415933295088244,0.0626926421762856,0.0789972273437447,9.53196959752526e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,0.0659490519976062,0.00387286736770083,0.0583582319569125,0.0735398720382998,1.04989044881237e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RP2,Protein XRP2,29349,0.0472414188188061,0.00278187501405533,0.0417889437912577,0.0526938938463546,2.27338557907793e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,0.0542793385676491,0.00319632145635146,0.0480145485132003,0.060544128622098,2.63907212405417e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,0.0343459022506365,0.00202347122784954,0.0303798986440514,0.0383119058572215,2.97511910305634e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLB1,Beta-galactosidase,29218,0.0471470389116023,0.00278056154684525,0.0416971382797856,0.052596939543419,3.53066999148814e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,0.0681211371880109,0.00402076999076193,0.0602404280061175,0.0760018463699043,5.10402000394321e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP25,Rho GTPase-activating protein 25,28797,0.0673482342553405,0.00398035846028005,0.0595467316731916,0.0751497368374894,6.51576046421952e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DFFA,DNA fragmentation factor subunit alpha,29786,0.0756321787346996,0.00447067023328354,0.0668696650774639,0.0843946923919354,6.66325825013864e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP170,Centrosomal protein of 170 kDa,24240,0.0868506474904224,0.00513646977781518,0.0767831667259046,0.0969181282549401,9.02802359921005e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,0.0902182226893828,0.00533575475198725,0.0797601433754878,0.100676302003278,9.09011267177823e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UROD,Uroporphyrinogen decarboxylase,24381,0.0778953205552355,0.00460766966804204,0.0688642880058731,0.0869263531045979,9.45557320758036e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,24381,0.0437289747465567,0.00258846508613627,0.0386555831777296,0.0488023663153838,1.15221412305795e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD244,Natural killer cell receptor 2B4,29786,0.0303330361778824,0.00179664450679673,0.0268116129445608,0.033854459411204,1.18461930500245e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,0.039566590701863,0.00234409184777973,0.0349721706802147,0.0441610107235113,1.4489780521726e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADD1,Alpha-adducin,24381,0.0786469913648263,0.0046615275058015,0.0695103974534554,0.0877835852761973,1.6732478074005e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,29349,-0.0773221409287581,0.00459085759688654,-0.0863202218186557,-0.0683240600388604,2.36005694981298e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPP1,Inositol polyphosphate 1-phosphatase,29349,0.0599052801426295,0.00355735611504202,0.0529328621571471,0.0668776981281118,2.47343337554841e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH2D1A,SH2 domain-containing protein 1A,29434,0.063822939139018,0.00379213018232103,0.0563903639816688,0.0712555142963672,2.89224985886434e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,0.0691193184111143,0.00410523432207196,0.0610730591398532,0.0771655776823753,2.93285369449297e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C19orf12,Protein C19orf12,28774,0.0720701495008701,0.00428252805480123,0.0636763945134596,0.0804639044882805,3.01152757475654e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NHLRC3,NHL repeat-containing protein 3,23825,0.0359627453874225,0.00213602630394667,0.031776133831687,0.0401493569431579,3.07313744323707e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.0290342854157301,0.00172525043401876,0.0256527945650533,0.0324157762664069,3.3389508288991e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB14,DnaJ homolog subfamily B member 14,24805,0.0719470653198323,0.00427541782572583,0.0635672463814096,0.0803268842582549,3.40985466031254e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA13,Carbonic anhydrase 13,29114,0.116407639594859,0.00692683005129622,0.102831052694319,0.1299842264954,4.42829049930826e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AREG,Amphiregulin,29349,-0.0509477359394357,0.0030371137006258,-0.0569004787926623,-0.0449949930862092,7.29965171236854e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL4,C-C motif chemokine 4,29498,0.0726289907426275,0.00433234841057038,0.0641375878579095,0.0811203936273454,8.69604309646843e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBN1,Drebrin,24229,0.0572665339269324,0.00342124279061669,0.0505608980573237,0.0639721697965411,1.54377602056714e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4E,Eukaryotic translation initiation factor 4E,24229,0.101007215116371,0.00604407203203705,0.0891608339335787,0.112853596299164,2.40573236506231e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM24,Transcription intermediary factor 1-alpha,24396,0.0721502566365302,0.00432644372925845,0.0636704269271837,0.0806300863458768,4.2870174200326e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MZT1,Mitotic-spindle organizing protein 1,28797,0.0582004776295069,0.00349236237237624,0.0513554473796495,0.0650455078793643,4.59837646900022e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT16,U8 snoRNA-decapping enzyme,24769,0.097089205562162,0.00582652705525801,0.0856692125338562,0.108509198590468,5.27628624389383e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN3,Ataxin-3,24845,0.0684824716037838,0.00411211381530858,0.060422728525779,0.0765422146817887,6.15598850279409e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRELD1,Protein disulfide isomerase CRELD1,24381,0.0415815130442954,0.00249796287549209,0.0366855058083309,0.0464775202802599,7.09035129972661e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP6,Platelet glycoprotein VI,29400,0.0971298531424917,0.00584260326764098,0.0856783507379153,0.108581355547068,8.88972930207977e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,0.101343162337189,0.00609890543471357,0.0893893076851501,0.113297016989227,1.02223266727046e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFA,Vascular endothelial growth factor A,29683,0.0636223852019915,0.00383162585067773,0.0561123985346632,0.0711323718693199,1.2268690004155e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROBO2,Roundabout homolog 2,29694,0.0255333509405173,0.00153847729850754,0.0225179354354425,0.0285487664455921,1.40047924527353e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPI,Glucose-6-phosphate isomerase,24951,0.0522296357152735,0.00314604621148442,0.0460633851407641,0.058395886289783,1.45132719349802e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESYT2,Extended synaptotagmin-2,24845,0.090916840351599,0.00547909403536935,0.0801778160422751,0.101655864660923,1.66846276313984e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMTN,Smoothelin,24776,0.104444338395774,0.00629491571080223,0.092106303602602,0.116782373188947,1.71524852142289e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC37,Hsp90 co-chaperone Cdc37,29566,0.0920334586850067,0.00555299323915735,0.0811495919362583,0.102917325433755,2.04675873310307e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGCT,Gamma-glutamylcyclotransferase,24904,0.052876662573407,0.00319161633453911,0.0466210945577103,0.0591322305891037,2.55686035394287e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,0.0595053309931085,0.00359394016456552,0.0524612082705601,0.0665494537156569,2.70026514208572e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL1,Growth-regulated alpha protein,29420,0.10473266240747,0.00632572398116754,0.0923342434043817,0.117131081410559,2.71841915720914e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPT1,Angiopoietin-1,29322,0.0924594797164397,0.00558812586110906,0.081506753028666,0.103412206404213,3.26074349910773e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FRMD4B,FERM domain-containing protein 4B,24111,0.0775476109579751,0.00468613680100081,0.0683627828280135,0.0867324390879367,3.58460712999897e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB33A,Ras-related protein Rab-33A,24111,0.0733076963182781,0.00443302007677793,0.0646189769677934,0.0819964156687629,4.33395693688844e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PXN,Paxillin,28774,0.0564768335425077,0.00342018258524251,0.0497732756754324,0.063180391409583,5.66663938090028e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB3A2,Secretoglobin family 3A member 2,29536,-0.08982589540155,0.00544059859759822,-0.100489468652843,-0.0791623221502575,5.80844542446918e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN9,Septin-9,29349,0.0311574131716453,0.00188807052136767,0.0274567949497647,0.0348580313935259,6.6549780991454e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYBB1,Beta-crystallin B1,24922,0.0715286120398024,0.00434881814261377,0.0630049284802794,0.0800522955993254,1.8123551411407e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.0431915378967119,0.0026319037548025,0.038033006537299,0.0483500692561248,2.96808846715012e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHAD,Chondroadherin,24381,0.0566830833211662,0.00345440389069149,0.0499124516954109,0.0634537149469215,3.47333993387098e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRG2,Bone marrow proteoglycan,24938,-0.0566163365008072,0.00345259743703194,-0.0633834274773898,-0.0498492455242246,4.07006904805924e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNM3,Dynamin-3,24867,0.0597796127604487,0.00365446208694091,0.0526168670700445,0.0669423584508528,7.84301689107612e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F2R,Proteinase-activated receptor 1,29536,0.0622201092803391,0.00380682414453305,0.0547587339570543,0.0696814846036239,8.73940781191637e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MIF,Macrophage migration inhibitory factor,29386,0.0738395621001038,0.00451773281545482,0.0649848057818123,0.0826943184183952,8.76299708885518e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,0.0725998451243357,0.00444220545583185,0.0638931224309053,0.0813065678177661,1.01956631001278e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,24867,0.0417279928770865,0.00255445326147718,0.0367212644845912,0.0467347212695817,1.1316767524061e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,0.0648063359420529,0.0039677431708884,0.0570295593271116,0.0725831125569941,1.17282083157989e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RN,Interleukin-1 receptor antagonist protein,29379,0.058488597762873,0.00358251973179823,0.0514668590885485,0.0655103364371975,1.17949726910844e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSME1,Proteasome activator complex subunit 1,29192,0.04018644955533,0.00246476330747968,0.0353555134726698,0.0450173856379901,1.68445530483489e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX8,Syntaxin-8,29434,0.0523214374383333,0.00321067308369978,0.0460285181942817,0.0586143566823849,1.91723185053279e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP10,Caspase-10,28774,0.0773318838581849,0.00475103295212457,0.0680198592720208,0.0866439084443491,2.65437500230753e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,0.0340031949479459,0.00209302095760923,0.0299008738710318,0.03810551602486,4.81022208145693e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL7,C-C motif chemokine 7,29434,0.0632558416010552,0.00389776951087917,0.055616213359732,0.0708954698423784,5.70169985914928e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,-0.0493266680248167,0.00304450336144715,-0.0552938946132531,-0.0433594414363803,8.74806327558907e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,0.10575559263282,0.00652801445013114,0.0929606843105626,0.118550500955077,1.00273150366076e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,28916,0.119455750370287,0.00738160788525857,0.10498779891518,0.133923701825393,1.20638556185601e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNDC9,Thioredoxin domain-containing protein 9,24845,0.0573736924570098,0.00354784325154765,0.0504199196839764,0.0643274652300432,1.5976804443445e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REEP4,Receptor expression-enhancing protein 4,24867,0.0669317439749039,0.00413934631945096,0.05881862518878,0.0750448627610278,1.64321548225465e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,0.0500874917246525,0.00310656302519005,0.04399862819528,0.056176355254025,3.1044080469304e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FADD,FAS-associated death domain protein,29478,0.0816971751147803,0.00506781494915829,0.0717642578144301,0.0916300924151306,3.23617238299103e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRA1,GDNF family receptor alpha-1,29674,0.0302810453186202,0.00187958198758784,0.026597064622948,0.0339650260142923,3.80106882190213e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,0.0492812160224408,0.00305944195544968,0.0432847097897594,0.0552777222551222,4.49855354938804e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX6,Peroxiredoxin-6,29725,-0.064009640482186,0.00397579466735915,-0.0718021980302099,-0.056217082934162,4.50670941088513e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB2B,Ras-related protein Rab-2B,24793,0.0662361708182458,0.00411329533240761,0.0581741119667269,0.0742982296697647,4.79599149346184e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,0.100732142874911,0.0062601050030698,0.0884623370688945,0.113001948680928,5.23211693837059e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,24111,0.0743083180863844,0.00461870387949111,0.0652556584825818,0.083360977690187,6.15175545833336e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PARP1,Poly [ADP-ribose] polymerase 1,29434,0.0601395698940582,0.00374321182157166,0.0528028747237777,0.0674762650643386,7.75096907151277e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DYNLT1,Dynein light chain Tctex-type 1,24195,0.0858599250154805,0.00534256935148023,0.0753884890865792,0.0963313609443817,8.13666962696975e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QA,Complement C1q subcomponent subunit A,29646,-0.0242287217664186,0.00150881583078768,-0.0271860007947625,-0.0212714427380748,8.80057082391503e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6AP2,Renin receptor,28797,0.0430856803428916,0.0026960815766662,0.0378013604526259,0.0483700002331574,3.06504019533436e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOE,Apolipoprotein E,24966,0.0774606873619136,0.00484612403465156,0.0679622842539966,0.0869590904698307,3.17665502758709e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDHB,Succinate dehydrogenase,24805,0.073251631759121,0.00458322867466262,0.0642685035567822,0.0822347599614597,3.26755247768793e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GDF15,Growth/differentiation factor 15,29820,-0.0470690782903548,0.00295341997437043,-0.0528577814401208,-0.0412803751405887,6.0195653299331e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MIA,Melanoma-derived growth regulatory protein,29566,0.0390691083855037,0.00245477466683965,0.034257750038498,0.0438804667325094,8.51507926699892e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,0.0845456066451712,0.00531569083611675,0.0741268526063823,0.09496436068396,1.1355432389498e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTC,Probetacellulin,28797,0.0785313431743217,0.00494337641905796,0.0688423253929681,0.0882203609556753,1.37528995429513e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,29454,0.0548642767970594,0.00345520071555761,0.0480920833945665,0.0616364701995524,1.52762045588896e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,29683,0.0662776616792198,0.00418138574779366,0.0580821456135442,0.0744731777448953,2.37136233820655e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C7,Complement component C7,24374,-0.0343674616103704,0.0021673753924788,-0.0386155173796288,-0.0301194058411119,2.41858426157222e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,0.0705050936764935,0.00444773881990775,0.0617875255894743,0.0792226617635127,2.62790880225491e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA3,Annexin A3,29640,0.0732538110818195,0.00462859017925255,0.0641817743304845,0.0823258478331545,3.47951304708717e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACE2,Angiotensin-converting enzyme 2,28916,0.0543699755435098,0.00343527367741286,0.0476368391357806,0.061103111951239,3.4929648244594e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGLN1,Egl nine homolog 1,29434,0.0570989976373604,0.0036081472737683,0.0500270289807746,0.0641709662939463,3.56791348762866e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOXO3,Forkhead box protein O3,28797,0.10134407652908,0.00640628036053695,0.0887877670224277,0.113900386035733,3.93860650593758e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,0.125528573769428,0.00793877310990296,0.109968578474018,0.141088569064838,4.36658357831322e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.0344190540809645,0.00218697645462022,0.0301325802299089,0.0387055279320201,1.38886471690921e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUS,RNA-binding protein FUS,28765,0.0412051006275219,0.00262639209810478,0.0360573721152365,0.0463528291398072,3.05662140052974e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGACT,Gamma-glutamylaminecyclotransferase,24922,0.074074617301594,0.00472086566089383,0.0648217206062421,0.0833275139969459,3.21071530786904e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB2,DnaJ homolog subfamily B member 2,24381,0.0559782291966931,0.00357061203986796,0.0489798295985519,0.0629766287948343,4.01072804258529e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,0.0423711014867449,0.0027028980510943,0.0370734213066,0.0476687816668897,4.12206446177305e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TTF2,Transcription termination factor 2,24195,0.0512812732502551,0.00327222849648846,0.0448677053971377,0.0576948411033724,4.41241122164616e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCT5,T-complex protein 1 subunit epsilon,28797,0.047119186301332,0.00301010146259438,0.041219387434647,0.053018985168017,5.28827156435263e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAV,Integrin alpha-V,29725,0.0172757555681681,0.00110399287732404,0.015111929528613,0.0194395816077232,5.64732923095557e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC26,Anaphase-promoting complex subunit CDC26,24764,0.0731638457048015,0.00468090479329013,0.0639892723099529,0.0823384190996502,8.28268774464022e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFRP1,Secreted frizzled-related protein 1,29120,0.0450239478367089,0.00288192227991149,0.0393753801680824,0.0506725155053354,8.49346293562195e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIF1,Allograft inflammatory factor 1,28797,0.0544277586696773,0.00348733699385278,0.0475925781617258,0.0612629391776287,1.08922938698809e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,0.0416509923804298,0.00266864957170428,0.0364204392198894,0.0468815455409702,1.17501049867554e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PARK7,Parkinson disease protein 7,29443,0.0540860873258797,0.00346884200788006,0.0472871569904348,0.0608850176613247,1.36562621503563e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TST,Thiosulfate sulfurtransferase,28706,0.0784099276163504,0.00503124983010321,0.0685486779493481,0.0882711772833527,1.55140563320434e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX4,Syntaxin-4,29349,0.0614584619501757,0.00394408986907021,0.0537280458067981,0.0691888780935534,1.58644711424536e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,0.0592224312430654,0.00380236580834683,0.0517697942587056,0.0666750682274252,1.79285396858945e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASEH2A,Ribonuclease H2 subunit A,24867,0.0505511544587433,0.00324706604813835,0.0441869050043921,0.0569154039130945,2.16221119867209e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS9,Galectin-9,29453,0.0329520064243335,0.00211862588073607,0.0287994996980908,0.0371045131505763,2.48033426168069e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELE,E-selectin,29820,0.0520176598479683,0.00334490524032211,0.0454616455769369,0.0585736741189996,2.5495218533912e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDUA,Alpha-L-iduronidase,29725,0.0476205922773795,0.00306233665266335,0.0416184124381593,0.0536227721165997,2.58935366705828e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGS10,Regulator of G-protein signaling 10,24867,0.0617154407140456,0.00397581026212237,0.0539228526002857,0.0695080288278054,4.37045545206167e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,0.0496862817426241,0.00320177430274328,0.0434108041092473,0.055961759376001,4.67572345945491e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HPSE,Heparanase,24688,0.0969867943921514,0.00625662577951683,0.0847238078642984,0.109249780920004,6.09415288251228e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCS,Copper chaperone for superoxide dismutase,29218,0.0488240652408781,0.00315534875484151,0.0426395816813887,0.0550085488003674,8.57783361175069e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH1A1,Retinal dehydrogenase 1,29443,0.0546970151045799,0.00353580609587639,0.0477668351566622,0.0616271950524977,9.08464436113718e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,24922,0.0293612874520449,0.0018983835667326,0.0256404556612491,0.0330821192428408,1.03878777945238e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSR,"Glutathione reductase, mitochondrial",24867,0.0233523454047677,0.00151022713140675,0.0203923002272104,0.0263123905823249,1.10039840482841e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTN4R,Reticulon-4 receptor,29725,0.0347198434555302,0.00224629401575153,0.0303171071846572,0.0391225797264032,1.10410734582034e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NID1,Nidogen-1,29518,0.0389512338212114,0.00252142394638804,0.0340092428862908,0.0438932247561319,1.2605408090015e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,0.0594548415309199,0.00384940358117201,0.0519100105118228,0.066999672550017,1.31624095672209e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNM1,Dynamin-1,24805,0.117530952146602,0.00762072384104244,0.102594333418159,0.132467570875045,2.04510490649286e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRP14,Signal recognition particle 14 kDa protein,29349,0.0609446533514475,0.00395529918135306,0.0531922669559955,0.0686970397468995,2.32858269648506e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,0.0669373336119715,0.00434602207530769,0.0584191303443684,0.0754555368795746,2.55375053857219e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSD,Cathepsin D,27442,0.0415675033060607,0.00270308629570185,0.0362694541664851,0.0468655524456364,3.84556859216897e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPK1,Thiamin pyrophosphokinase 1,24922,0.028198205803209,0.001835165274013,0.0246012818661435,0.0317951297402745,4.88664829890327e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,0.037599043232264,0.00244800087109604,0.0328009615249158,0.0423971249396123,5.39844715231578e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARFIP1,Arfaptin-1,24867,0.0704381605490359,0.00458778226763608,0.0614461073044692,0.0794302137936026,5.88289972538649e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,0.0430698320849214,0.00280930707118174,0.0375635902254052,0.0485760739444376,8.35979998104209e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,0.0665264856809203,0.00434269772752067,0.0580147981349798,0.0750381732268608,9.20149408874707e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,0.0518116465486582,0.00338759145336688,0.0451719673000591,0.0584513257972573,1.33939604365471e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,0.0293833932593688,0.00192093835000538,0.0256183540933582,0.0331484324253793,1.41924847586851e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DXO,Decapping and exoribonuclease protein,24845,0.0464101028122246,0.00303710993631038,0.0404573673370563,0.052362838287393,1.77429602740672e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL5RA,Interleukin-5 receptor subunit alpha,29434,-0.0570350344263779,0.00373395701564807,-0.0643535901770482,-0.0497164786757077,1.79358101890924e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAP3,Cytosol aminopeptidase,28931,0.0493919280941465,0.00323371053067546,0.0430538554540226,0.0557300007342704,1.82510725264474e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP5,Microfibrillar-associated protein 5,29820,0.041403458878599,0.00271402933111487,0.0360839613896138,0.0467229563675841,2.39278622381203e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLR2,Folate receptor beta,29694,-0.0296898628747947,0.00194756662528938,-0.0335070934603619,-0.0258726322892275,2.82294402253357e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,28931,0.0664757686445579,0.00436596932295898,0.0579184687715583,0.0750330685175575,3.79491402040492e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,0.0648603396581842,0.00426208449896868,0.0565066540402056,0.0732140252761628,4.28905061191265e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,0.0873600197340822,0.00574606644491738,0.0760977295020441,0.0986223099661203,5.36166503634278e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,0.0567783651328165,0.00373713628106765,0.0494535780219239,0.0641031522437091,6.82790990475911e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JAM3,Junctional adhesion molecule C,24381,0.0513159492032609,0.00337781083635792,0.0446954399639994,0.0579364584425224,6.9021099301595e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFAT5,Nuclear factor of activated T-cells 5,24229,0.0875397007672731,0.00576369315498462,0.0762428621835033,0.098836539351043,7.35134184089053e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBI,Acyl-CoA-binding protein,29329,0.0790315261496837,0.00521029796210305,0.0688193421439617,0.0892437101554057,9.01580114302517e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF3,Immunoglobulin superfamily member 3,29349,0.0361849218455399,0.00238634954071643,0.0315076767457357,0.0408621669453442,9.72584046426252e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABHD14B,Protein ABHD14B,29121,0.0577482754005962,0.00381360812966927,0.0502736034664445,0.065222947334748,1.33227045217033e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,0.05758215114807,0.00380924227479874,0.0501160362894644,0.0650482660066755,1.96959299514792e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.0514369692765108,0.00341156616859834,-0.0581236389669635,-0.044750299586058,3.54727702497783e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEMIP2,Cell surface hyaluronidase,24229,0.0333082507837955,0.00221035175025013,0.0289759613533052,0.0376405402142857,4.40282700974788e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,0.0491415255723613,0.00326168266647584,0.0427486275460686,0.0555344235986539,4.59828909125718e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53I3,Quinone oxidoreductase PIG3,23906,0.0534847414384733,0.00356011834142374,0.0465069094892828,0.0604625733876638,8.81637691330775e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL6R,Interleukin-6 receptor subunit alpha,29361,0.0338481980371739,0.00225453609389059,0.0294293072931484,0.0382670887811995,9.26650025448346e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST3,Cystatin-C,29530,0.0282720242680072,0.00188386005740739,0.0245796585554887,0.0319643899805256,1.00935129875442e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.0327428483186734,0.00218224432527136,0.0284656494411415,0.0370200471962053,1.147678527822e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNAR1,Interferon alpha/beta receptor 1,24805,0.0256292311145034,0.00170913174938331,0.0222793328857121,0.0289791293432947,1.31078244412408e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HRG,Histidine-rich glycoprotein,24833,0.0313978583685178,0.00209396415557452,0.0272936886235917,0.0355020281134439,1.32992969635029e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APP,Amyloid-beta precursor protein,29395,0.0662673870209383,0.00442241365214402,0.057599456262736,0.0749353177791406,1.42752957164672e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAD23B,UV excision repair protein RAD23 homolog B,28797,0.0467338029752538,0.00312178193025136,0.0406151103919611,0.0528524955585465,1.78050781645443e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD164,Sialomucin core protein 24,29443,0.0266474333303864,0.00178065736039494,0.0231573449040123,0.0301375217567605,1.90843916731002e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRI1,Methylthioribose-1-phosphate isomerase,24195,0.067955122534113,0.00454040591342118,0.0590559269438075,0.0768543181244185,2.03724059379021e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOA2,Apolipoprotein A-II,24951,-0.0481831264630756,0.00322300613188755,-0.0545002184815752,-0.041866034444576,2.58342529631687e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA6,Integrin alpha-6,29434,0.051688181665008,0.00346418998585537,0.0448983692927315,0.0584779940372845,3.68865309441143e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK7,Kallikrein-7,23801,0.038938124091759,0.00261134701799755,0.0338198839364838,0.0440563642470342,4.69765921453553e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LARP1,La-related protein 1,24793,0.0623686677217295,0.00418572483860542,0.0541646470380629,0.0705726884053962,5.40098145067569e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD40LG,CD40 ligand,29786,0.0769171914987235,0.00516513536553719,0.0667935261822707,0.0870408568151764,5.65628268312311e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,29736,0.0322976573034989,0.00216926778785059,0.0280458924393117,0.0365494221676861,5.90703608166325e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWA1,von Willebrand factor A domain-containing protein 1,29674,0.0416885321480153,0.00280064526048675,0.0361992674374613,0.0471777968585693,6.21867883976546e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD276,CD276 antigen,29454,-0.0355889509336867,0.00239107051051915,-0.0402754491343043,-0.0309024527330692,6.35221014152185e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BDNF,Brain-derived neurotrophic factor,24938,0.082382701003489,0.00554060270354912,0.0715231197045327,0.0932422823024453,8.57914112726896e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HGF,Hepatocyte growth factor,29786,0.033936404976031,0.0022853042140082,0.029457208716575,0.0384156012354871,1.0507715485211e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",24852,0.0396321760820991,0.00266931357097417,0.0344003214829897,0.0448640306812085,1.18251298060362e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,0.0238696253193952,0.00160885908037423,0.0207162615218617,0.0270229891169287,1.29045002101947e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMPA1,Inositol monophosphatase 1,29218,0.0601502527513598,0.00405776544336018,0.0521970324823738,0.0681034730203457,1.56395985438221e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.0253686650763534,0.00171193436811922,0.0220132737148397,0.0287240564378671,1.67228045781742e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB10,Ras-related protein Rab-10,24922,0.0528205986064473,0.00356710889983227,0.045829065162776,0.0598121320501185,2.12056166144004e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCRN1,Secernin-1,29434,0.05490122356763,0.00371259082717569,0.0476245455463656,0.0621779015888943,2.63901394048955e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCEMP1,Mast cell-expressed membrane protein 1,24229,0.0893061812862712,0.00603929468185618,0.0774691637098331,0.101143198862709,2.89337996288417e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GET3,ATPase GET3,24922,0.0542345086803603,0.00367413709628923,0.0470331999716334,0.0614358173890872,4.20633832053153e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFT20,Intraflagellar transport protein 20 homolog,24195,0.0425787659466366,0.00288802861119476,0.0369182298686949,0.0482393020245784,5.55492067004513e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DYNLT3,Dynein light chain Tctex-type 3,24793,0.0428392179418505,0.00290701895234877,0.0371414607952469,0.0485369750884541,6.05885341841797e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,0.0276939161101016,0.00188010833288633,0.0240089037776444,0.0313789284425589,6.73734873898678e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENO2,Gamma-enolase,29694,0.0640981347202795,0.00435393835610933,0.0555644155423052,0.0726318538982538,6.94182797525871e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL26,C-C motif chemokine 26,29434,0.0870547928279912,0.00592725714364264,0.0754373688264516,0.0986722168295308,1.15834732303115e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGH,Gamma-glutamyl hydrolase,28984,0.033170857884608,0.00226776860910113,0.0287260314107698,0.0376156843584462,2.80572402075517e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.0334126858584053,0.00228375835505427,-0.0378888522343116,-0.0289365194824989,2.85044374044102e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FRZB,Secreted frizzled-related protein 3,29123,0.0249846339883406,0.00171467462517126,0.0216238717230049,0.0283453962536763,6.33155612323518e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLMAP,Sarcolemmal membrane-associated protein,24805,0.0808436660362708,0.00554788571829206,0.0699698100284184,0.0917175220441233,6.68350543212443e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,0.0626815988708732,0.00430956118579047,0.0542348589467239,0.0711283387950225,9.91592545376983e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKN3,Serine/threonine-protein kinase N3,24445,0.0731659600639982,0.00503070819518622,0.0633057720014332,0.0830261481265632,1.01138972553105e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTNB,Dystrobrevin beta,24752,0.0420883903197649,0.00289684095323066,0.0364105820514328,0.047766198588097,1.24611261269098e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,28797,0.0488639071170412,0.00336926340217814,0.042260150848772,0.0554676633853104,1.70987594731191e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNRD2,Protein ZNRD2,24805,0.066340452021995,0.00458255929949056,0.0573586357949935,0.0753222682489965,2.65197195474739e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEP1A,Meprin A subunit alpha,24805,0.0694461027933179,0.00480191949120122,0.0600343405905635,0.0788578649960723,3.27184596001798e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RILP,Rab-interacting lysosomal protein,29632,0.0570911780192586,0.00395152612442838,0.049346186815379,0.0648361692231383,3.7410735428993e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,28797,0.0725481775586327,0.00502315567241406,0.0627027924407011,0.0823935626765643,4.07139060928217e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PARD3,Partitioning defective 3 homolog,24445,0.0713512646120774,0.00494079644158709,0.0616673035865667,0.0810352256375881,4.44974801419016e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBCA,Tubulin-specific chaperone A,24381,0.0825265978363086,0.00571482578068057,0.0713255393061747,0.0937276563664425,4.48437910011584e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,0.0345753688246248,0.00239480169038712,0.029881557511466,0.0392691801377835,4.70638010375733e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.0232420512672907,0.00161490022243886,0.0200768468313106,0.0264072557032709,8.3329628928868e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLU,Clusterin,24966,0.0305015320142089,0.00211907277234329,0.0263481493804161,0.0346549146480018,8.71526870879386e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AK2,"Adenylate kinase 2, mitochondrial",24845,0.101818373132444,0.00707508309392971,0.0879512102683415,0.115685535996546,9.07705036747043e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLNK,B-cell linker protein,24229,0.0383020814193926,0.00266286717704656,0.0330828617523813,0.0435213010864038,1.0196151011767e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD84,SLAM family member 5,29434,0.0298828936867731,0.00207850046185648,0.0258090327815344,0.0339567545920118,1.03715669504446e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,24523,0.053519849993289,0.00372163266081,0.0462254499781014,0.0608142500084766,1.05923769929348e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SULT2A1,Bile salt sulfotransferase,29434,0.0534715642003655,0.003722751780856,0.0461749707098877,0.0607681576908433,1.26209001438611e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH7,Protocadherin-7,24805,0.033348787471123,0.00232267866627643,0.0287963372852212,0.0379012376570248,1.461866806321e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CORO1A,Coronin-1A,28847,0.0852622593586318,0.00594491357849276,0.073610228744786,0.0969142899724776,1.72730500953949e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,0.0840883462779288,0.00587219254920065,0.0725788488814955,0.095597843674362,2.37388374228535e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,-0.0302181598072659,0.00211724781885572,-0.0343679655322231,-0.0260683540823087,4.61551180629846e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJC9,DnaJ homolog subfamily C member 9,24805,0.072257871835161,0.00508879451258405,0.0622838345904963,0.0822319090798257,1.39461019304106e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELOA,Elongin-A,29349,0.0492880734283272,0.00347619590143278,0.0424747294615189,0.0561014173951354,1.75389377416148e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,0.0506754256610002,0.00357733498181433,0.0436638490966441,0.0576870022253563,2.12330292817055e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARF1,Scavenger receptor class F member 1,29820,0.0399049621043691,0.00281795171267251,0.034381776747531,0.0454281474612072,2.24242298151627e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MATN2,Matrilin-2,29497,0.0279752416404428,0.00197830855217457,0.0240977568781807,0.031852726402705,2.98510467942606e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL3,C-C motif chemokine 3,29434,0.0568294870848951,0.00402249133722858,0.0489454040639271,0.0647135701058631,3.59154999445049e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASPN,Asporin,24922,0.025940011072951,0.0018369024564899,0.0223396822582308,0.0295403398876712,4.17462518443107e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP7,Matrilysin,28870,0.0469012351815449,0.00332484477354254,0.0403845394254015,0.0534179309376883,4.90427133707208e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,0.0539777456750523,0.0038301996372477,0.0464705543860468,0.0614849369640578,5.91637478464113e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C5,Complement C5,24966,0.0142387004544223,0.00101186779262589,0.0122554395808755,0.016221961327969,8.41258614031106e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STXBP3,Syntaxin-binding protein 3,28797,0.0409537732117767,0.00291406240275038,0.035242210902386,0.0466653355211674,1.02584497406921e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.0383464791173915,0.00273031217216287,-0.0436978909748308,-0.0329950672599523,1.15777342467764e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPM1F,Protein phosphatase 1F,24922,0.0493065803242192,0.00351562887852809,0.0424159477223042,0.0561972129261343,1.62006391526525e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,0.0262306889717595,0.00187258867893409,0.0225604151610487,0.0299009627824703,1.93845563695982e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSC2,Desmocollin-2,29135,-0.0319486700394884,0.00228756883235121,-0.0364323049508968,-0.0274650351280801,3.48065454019391e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VGF,Neurosecretory protein VGF,24867,0.0282446540498718,0.00202478629479322,0.0242760729120771,0.0322132351876665,4.64904891536761e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,0.0226589161194459,0.00162502926761211,0.0194738587549262,0.0258439734839657,4.74929368472911e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHB4,Ephrin type-B receptor 4,29820,-0.0230985410545971,0.00166059322432282,-0.0263533037742699,-0.0198437783349244,7.57365988507841e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,24966,-0.0241732214282066,0.00173838700938973,-0.0275804599666105,-0.0207659828898028,8.54194756323409e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,0.0490876552787189,0.003531760698452,0.042165404309753,0.0560099062476848,9.46965282104419e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPT2,Angiopoietin-2,29725,-0.0352147948797597,0.00253776880861155,-0.0401888217446383,-0.030240768014881,1.20721278084418e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACRBP,Acrosin-binding protein,24793,0.0358693611528955,0.00258493119574396,0.0308028960092373,0.0409358262965536,1.28374129587613e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNMT,Histamine N-methyltransferase,29082,0.0434714282251678,0.00313492079892275,0.0373269834592792,0.0496158729910564,1.38552645426151e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRK5,G protein-coupled receptor kinase 5,28916,0.0480203284949556,0.00346333052207825,0.0412322006716823,0.054808456318229,1.41667122626356e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,0.0406730450742344,0.00293797638940885,0.034914611350993,0.0464314787974757,2.02116143486578e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF7,SLAM family member 7,29434,-0.0538401721265614,0.00389990985098534,-0.0614839954344926,-0.0461963488186301,3.22165617170614e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,0.0671944875238063,0.00487268266355522,0.0576440295032381,0.0767449455443746,3.99757325485467e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MARCO,Macrophage receptor MARCO,29478,0.024093565939563,0.00175101173019144,0.0206615829483878,0.0275255489307382,6.04027770573697e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL2,C-C motif chemokine 2,29169,0.0480516779447058,0.00349317392521885,0.0412050570512768,0.0548982988381347,6.39498957466266e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,0.0804633301305006,0.00584871094697432,0.0689998566744309,0.0919268035865702,6.60684245315706e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDZD2,PDZ domain-containing protein 2,24111,0.0552400963987151,0.00402172439360093,0.0473575165872572,0.0631226762101729,9.02901196339395e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,0.0558061126634759,0.00406473970562949,0.0478392228404421,0.0637730024865097,9.18254600630297e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBKS,Ribokinase,28795,0.0454255775128407,0.00331162630176707,0.0389347899613772,0.0519163650643041,1.09449415923065e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTRB1,Chymotrypsinogen B,29443,0.0506556266328337,0.00370253935471804,0.0433986494975863,0.0579126037680811,1.77136807229754e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C8B,Complement component C8 beta chain,24966,0.0277664898412377,0.00203044421006609,0.0237868191895082,0.0317461604929673,2.0347621150267e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSNAX,Translin-associated protein X,24111,0.0359656548086598,0.00263042680974734,0.030810018261555,0.0411212913557646,2.12144087821884e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF2,Fibroblast growth factor 2,29434,0.0613222308800017,0.00448792885864462,0.0525258903170582,0.0701185714429452,2.24999733008443e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITPA,Inosine triphosphate pyrophosphatase,24111,0.0616188209335925,0.00450949267093626,0.0527802152985574,0.0704574265686276,2.38825053010955e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA4,Annexin A4,29341,0.0653930596997949,0.00479044472995732,0.0560037880290785,0.0747823313705112,2.69235053736715e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC134,Coiled-coil domain-containing protein 134,24793,0.0442866164777037,0.00324809778998658,0.03792034480933,0.0506528881460774,3.539368331012e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS2,Trypsin-2,29594,0.0484574487894136,0.00355935302680031,0.041481116856885,0.0554337807219422,4.42160271789619e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATG4A,Cysteine protease ATG4A,28797,0.0531594134536151,0.00391612647335885,0.0454838055658317,0.0608350213413984,7.63476926369045e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GZMA,Granzyme A,29786,0.0312306049510673,0.00230519174192679,0.0267124291368908,0.0357487807652438,1.08330644619633e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUC13,Mucin-13,28774,0.0462976877341749,0.00342483194030345,0.0395850171311801,0.0530103583371697,1.63497158525772e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,0.0425072368041776,0.00314481501255042,0.0363433993795788,0.0486710742287764,1.75089882616792e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJC21,DnaJ homolog subfamily C member 21,24845,0.0346215248227381,0.00256181279465927,0.029600371745206,0.0396426779002703,1.80135637100932e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,0.0741145728603115,0.00548646690479168,0.0633610977269198,0.0848680479937032,1.84966263592977e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,0.0686569658434584,0.00509504422440779,0.0586706791636192,0.0786432525232977,3.05668230145068e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC5A,C-type lectin domain family 5 member A,29395,-0.0261760460128622,0.0019453485171708,-0.029988929106517,-0.0223631629192074,3.77398539464036e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMSB10,Thymosin beta-10,29443,0.0679090806102819,0.00504690357945545,0.0580171495945492,0.0778010116260146,3.77821546722281e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,0.0394235062834751,0.00293351750273758,0.0336738119781094,0.0451732005888407,4.73289324513092e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UNC79,Protein unc-79 homolog,24016,0.0503258855057255,0.00375088465475501,0.0429741515824057,0.0576776194290453,6.74552824337922e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX9,Sorting nexin-9,29478,0.0609219774653894,0.0045427359190586,0.0520182150640346,0.0698257398667443,6.88605212579911e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMOT,Angiomotin,24381,0.0360715319545487,0.00268944276217451,0.0308002241406867,0.0413428397684108,7.15708498098013e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL15A1,Collagen alpha-1(XV) chain,24938,0.0236706299112867,0.00176666748237223,0.0202079616458371,0.0271332981767363,8.5457762801047e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,0.0795281159778155,0.00593765101049394,0.0678903199972473,0.0911659119583836,9.1548308802936e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OPLAH,5-oxoprolinase,24240,0.0613190501180165,0.00457830121060781,0.0523455797452252,0.0702925204908078,9.22924761211974e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS3,Galectin-3,29544,0.0265229526367528,0.00198328158768289,0.0226357207248944,0.0304101845486113,1.13817212151022e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,-0.0309878612432184,0.00232147497545696,-0.035537952195114,-0.0264377702913227,1.58716944334878e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP1,Rho GTPase-activating protein 1,28797,0.0410041145668199,0.00307222272846904,0.0349825580190206,0.0470256711146192,1.63365239573992e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1RL,Complement C1r subcomponent-like protein,24925,0.0173862617947869,0.00130256221756689,0.0148332398483558,0.019939283741218,1.68243514229736e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WDR46,WD repeat-containing protein 46,24793,0.0320507830281326,0.00240268779878084,0.0273415149425221,0.036760051113743,1.879487863623e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,0.0205245665698565,0.00154106180444225,0.0175040854331496,0.0235450477065633,2.35859610135427e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,0.0388896265772235,0.0029203258934591,0.0331657878260437,0.0446134653284034,2.42836833291032e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGA,Glycoprotein hormones alpha chain,29443,0.0710828050071708,0.00533993101169383,0.0606165402242509,0.0815490697900907,2.59420236834323e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACYP1,Acylphosphatase-1,24297,0.0583298268950881,0.00438155153096339,0.0497419858943998,0.0669176678957763,2.70783383535907e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WAS,Wiskott-Aldrich syndrome protein,28931,0.0593238352176198,0.0044585063056189,0.0505851628586068,0.0680625075766328,2.81535144693712e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18,Interleukin-18,29335,0.0406839740191716,0.00305771961695867,0.0346908435699326,0.0466771044684106,2.82101664219395e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,0.0515984312713192,0.00387915162703823,0.0439952940823242,0.0592015684603141,2.97272788327081e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,0.0811959331841757,0.00610593818834814,0.0692282943350133,0.093163572033338,3.26886903356167e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HGFAC,Hepatocyte growth factor activator,24720,0.024873436418689,0.00187433567457826,0.0211997384965156,0.0285471343408624,4.70585770326709e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,0.0860404134509491,0.00648545624644718,0.0733289192079127,0.0987519076939856,4.98393168006699e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,29327,0.0389117263290998,0.00293730871711441,0.0331546012435556,0.0446688514146441,6.08534415153853e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,0.0605867003447672,0.00457552142348232,0.0516186783547419,0.0695547223347926,6.94243064227004e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,0.0525616529737166,0.00397628708876358,0.04476813027974,0.0603551756676932,8.93023456437514e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,29478,0.0238587297175316,0.00180510835628611,0.0203207173392108,0.0273967420958523,9.04572521359867e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNAS,Neuroendocrine secretory protein 55,24867,0.0778902790798648,0.00590132524768332,0.0663236815944055,0.0894568765653241,1.21254437293124e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUOX,"Sulfite oxidase, mitochondrial",24867,0.0548131345912466,0.0041715405660382,0.0466369150818117,0.0629893541006815,2.63441481810426e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGF1R,Insulin-like growth factor 1 receptor,29349,0.0189980273752349,0.0014491210276106,0.0161577501611181,0.0218383045893517,3.71763726337157e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPA1,Carboxypeptidase A1,29820,0.0528829293373175,0.00404475115007788,0.0449552170831648,0.0608106415914701,5.89959878506772e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,0.0244757543838794,0.00187226727368049,0.0208061105274656,0.0281453982402931,6.39123941052753e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LBP,Lipopolysaccharide-binding protein,29594,-0.0507611955131941,0.00388520356228338,-0.0583761944952695,-0.0431461965311186,6.66573765327246e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASS1,Argininosuccinate synthase,24111,0.0692308217295111,0.00530114765888316,0.0588405723181001,0.0796210711409221,7.59238689476352e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLB,Beta-klotho,28774,-0.0642046592106177,0.00493434947650311,-0.0738759841845638,-0.0545333342366716,1.34811620091743e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTN6,Dynactin subunit 6,28774,0.0617577857091247,0.00475002597516203,0.0524477347978071,0.0710678366204423,1.53956386827961e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BOLA2_BOLA2B,BolA-like protein 2,24240,0.0473914666349088,0.00364451032235421,0.0402482264030945,0.054534706866723,1.57266236212445e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARAF,Serine/threonine-protein kinase A-Raf,24445,0.058678990606324,0.00451408277643937,0.0498313883645028,0.0675265928481452,1.6615844384662e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMP6,Bone morphogenetic protein 6,28884,0.0356459218340126,0.00274798506325794,0.0302598711100271,0.0410319725579982,2.26820481158375e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAL,Integrin alpha-L,24229,0.037721550366498,0.00291366953493969,0.0320107580780162,0.0434323426549798,3.29750730419189e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS4,Galectin-4,29454,-0.0469739552863466,0.0036296616280392,-0.0540880920773035,-0.0398598184953898,3.32868559084285e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEBPB,CCAAT/enhancer-binding protein beta,28916,0.0324545944635838,0.00250931929777142,0.0275363286399518,0.0373728602872158,3.71131078482069e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREH,Trehalase,24938,0.0645967951015928,0.00499954068887218,0.0547976953514034,0.0743958948517823,4.56808576206931e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LONP1,"Lon protease homolog, mitochondrial",24240,0.0749937034947567,0.00581040496419139,0.0636053097649415,0.0863820972245718,5.49909019240848e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALM,Paralemmin-1,24657,0.0257480587222508,0.00199585898621569,0.021836175109268,0.0296599423352335,5.9167117439325e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANSC1,MANSC domain-containing protein 1,29566,-0.0236671521626422,0.00183612135298749,-0.0272659500144977,-0.0200683543107867,6.50551243008669e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,0.0374838098396718,0.00291632152231472,0.031767819655935,0.0431998000234087,1.04922274652842e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,0.0470832721751469,0.00367333079135506,0.0398835438240909,0.0542830005262028,1.65358810922499e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FXN,"Frataxin, mitochondrial",29725,0.0624512646434576,0.00487939885568735,0.0528876428863104,0.0720148864006048,2.08634778482037e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPHS1,Nephrin,24229,0.0291564817574645,0.00227798532145652,0.0246916305274097,0.0336213329875193,2.18883607637604e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD27,CD27 antigen,29566,-0.0354129190614431,0.00277086076809612,-0.0408438061669115,-0.0299820319559748,2.64653377253577e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,0.0531612159225631,0.00416635878705854,0.0449951526999283,0.0613272791451978,3.60149496074662e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREML1,Trem-like transcript 1 protein,24951,0.0449355397989203,0.00352209644640384,0.0380322307639688,0.0518388488338718,3.66842889306874e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMOTL2,Angiomotin-like protein 2,24711,0.0411807534631304,0.00322818645194813,0.0348535080173121,0.0475079989089488,3.75174276760398e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,0.0370769796880299,0.00290839368271569,0.0313765280699072,0.0427774313061527,4.19512626880878e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPXM1,Probable carboxypeptidase X1,29566,0.0580823665130847,0.00456936806146755,0.0491264051126083,0.0670383279135611,6.39900928856874e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA12,Carbonic anhydrase 12,29349,-0.027612106686343,0.00217235311120476,-0.0318699187843043,-0.0233542945883816,6.45511123451832e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDT,D-dopachrome decarboxylase,24938,0.0346395791569893,0.00272459525724632,0.0292993724527865,0.039979785861192,6.46667297216835e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,0.0482459341496188,0.00380160000467425,0.0407947981404573,0.0556970701587803,8.6408714022918e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR3,Toll-like receptor 3,29786,0.0515827554699971,0.00406664133712129,0.0436121384492394,0.0595533724907548,8.98999046828051e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDS,Iduronate 2-sulfatase,29786,0.00749737769157537,0.000591903786260087,0.0063372462705056,0.00865750911264514,1.12694582585772e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FMNL1,Formin-like protein 1,28774,0.0516873173739393,0.00408743616322324,0.0436759424940218,0.0596986922538569,1.48408977984206e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,29478,0.0303409397766717,0.00240132043345977,0.0256343517270905,0.0350475278262528,1.68174811238442e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,0.0357271068476419,0.00283084345951785,0.030178653666987,0.0412755600282969,2.02693790364822e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGFL7,Epidermal growth factor-like protein 7,28797,0.0332610326456294,0.00263661762951609,0.0280932620917779,0.038428803199481,2.17821541035098e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPCAM,Epithelial cell adhesion molecule,29457,-0.0811991773996867,0.00645166193639646,-0.0938444347950238,-0.0685539200043496,3.13478562314914e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALM2,Paralemmin-2,24845,0.0317842475627566,0.00252824659495506,0.0268288842366447,0.0367396108888685,3.89585133657616e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECE1,Endothelin-converting enzyme 1,28774,0.0294991380463289,0.00235109836957657,0.0248909852419588,0.034107290850699,5.13356240812755e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EBI3_IL27,Interleukin-27,29674,-0.0258289125594439,0.00205997456712662,-0.0298664627110121,-0.0217913624078758,5.67417165952542e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STK4,Serine/threonine-protein kinase 4,29478,0.072186670790056,0.00575860467306409,0.0608998056308504,0.0834735359492616,5.90133825936287e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,0.0728367320253142,0.00580919646617052,0.06145070695162,0.0842227570990084,5.955429062276e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PEPD,Xaa-Pro dipeptidase,24951,0.0218869928396597,0.00174817018122202,0.0184605792844645,0.0253134063948548,7.44533863064547e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,24381,0.0309568959869531,0.00247471336088231,0.0261064577996238,0.0358073341742824,8.55696670037584e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGF,Placenta growth factor,29786,0.021665684514255,0.00174537033430544,0.0182447586590164,0.0250866103694937,2.70919617102589e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SWAP70,Switch-associated protein 70,24805,0.029667576503597,0.00239197500715944,0.0249793054895645,0.0343558475176295,3.20385982467341e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB6,Integrin beta-6,28931,0.0251202783615024,0.00202597830108576,0.0211493608913743,0.0290911958316305,3.24871075610617e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL5,Fc receptor-like protein 5,29443,-0.0473438688064863,0.00383142798541521,-0.0548534676579001,-0.0398342699550725,5.47269021767958e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX16,Syntaxin-16,28797,0.0476744657888848,0.00386656721857229,0.0400959940404831,0.0552529375372865,7.65519170116282e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,0.0430611080825546,0.00350264963757556,0.0361959147929065,0.0499263013722027,1.23970162038573e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOD1,Superoxide dismutase [Cu-Zn],28826,0.0394586891079171,0.00321183823393691,0.0331634861694008,0.0457538920464335,1.32489312421855e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,29820,0.012950986818233,0.00105572082344534,0.0108817740042802,0.0150201996321859,1.64125395444547e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,24922,0.0264560390722233,0.00215764208961653,0.0222270605765749,0.0306850175678717,1.83167921843003e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.0211343437897836,0.00172435832606269,0.0177546014707008,0.0245140861088665,1.8816861704833e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3BP1,SH3 domain-binding protein 1,24805,0.0391052434456051,0.00319929807076901,0.0328346192268978,0.0453758676643123,2.93781148225851e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCA,Calcitonin,29163,0.0505330097595806,0.00413938945155854,0.0424198064345259,0.0586462130846353,3.42161188354665e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF6,SLAM family member 6,28797,0.0310756932823094,0.00254688691242712,0.0260837949339522,0.0360675916306665,3.70900155192227e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREML2,Trem-like transcript 2 protein,29443,0.0275588197698232,0.00225881003013841,0.0231315521107519,0.0319860874288945,3.73182356794244e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPDC1,Neural proliferation differentiation and control protein 1,29478,0.025910583643719,0.0021328480982799,0.0217302013710904,0.0300909659163476,7.05495798290186e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCAN,Neurocan core protein,29694,0.0302298501942404,0.0024890946936956,0.025351224594597,0.0351084757938838,7.34580811551262e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPMT,Thiopurine S-methyltransferase,28797,0.0588229990787564,0.00484667946824565,0.049323507320995,0.0683224908365179,8.1583479244112e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASGR2,Asialoglycoprotein receptor 2,24951,0.0211187330949823,0.00174101883138043,0.0177063361854767,0.024531130004488,9.1083280568023e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD5,T-cell surface glycoprotein CD5,29683,0.0277279029504736,0.00228816130456171,0.0232431067935327,0.0322126991074146,1.01910065472435e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB1,Integrin beta-1,29474,0.0175318737807904,0.0014471105889943,0.0146955370263615,0.0203682105352192,1.05692047917115e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMIGO2,Amphoterin-induced protein 2,29349,0.0185274298400663,0.00152940356417089,0.0155297988542914,0.0215250608258413,1.06982575021834e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC27A4,Long-chain fatty acid transport protein 4,28774,0.054230908737537,0.00447777338706206,0.0454544728988954,0.0630073445761786,1.11386820978513e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK4,Kallikrein-4,29725,-0.050725242902083,0.00419139978147039,-0.058940386473765,-0.0425100993304011,1.23356554067081e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PECAM1,Platelet endothelial cell adhesion molecule,29443,0.0242201688326919,0.00200331107313867,0.0202936791293401,0.0281466585360437,1.43174411727783e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFCAB2,Dynein regulatory complex protein 8,24445,0.0281915104833255,0.00233479322828424,0.0236153157558884,0.0327677052107626,1.7936550372295e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RASSF2,Ras association domain-containing protein 2,28797,0.0448206615496794,0.00371954570421364,0.0375303519694207,0.0521109711299382,2.33266228623156e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,0.032622132029232,0.00270803381818761,0.0273143857455843,0.0379298783128797,2.52261675705431e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP3,Stromelysin-1,29443,-0.0393323846821769,0.00326703370828832,-0.0457357707504221,-0.0329289986139318,2.64864953074835e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAP18,Chromatin complexes subunit BAP18,24845,0.0533276806637256,0.00442849834968425,0.0446478238983444,0.0620075374291067,2.64865182741917e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSR1,Macrophage scavenger receptor types I and II,29694,0.036763910061704,0.00305679060595857,0.0307726004740252,0.0427552196493828,3.06402357421559e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS27,Serine protease 27,29395,0.0322381442857754,0.00268132040292131,0.0269827562960497,0.0374935322755012,3.21062116822386e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIF22,Kinesin-like protein KIF22,24111,0.0987847247523243,0.00822014706408318,0.0826732365067213,0.114896212997927,3.58229174690574e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGA,Fibrinogen alpha chain,24407,0.0248205537109728,0.00206616063713061,0.0207708788621968,0.0288702285597488,3.77173586382281e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,0.0783158278119549,0.00653509434284718,0.0655070428999744,0.0911246127239353,5.15988682915311e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC80,Coiled-coil domain-containing protein 80,29478,0.0280904041953534,0.00234474089986681,0.0234947120316144,0.0326860963590923,5.38580927284902e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSCAM,Down syndrome cell adhesion molecule,24867,0.0285482971162614,0.00238615246851261,0.0238714382779767,0.0332251559545461,6.74239235448758e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,29789,0.0457520871152471,0.0038335924822131,0.0382382458501094,0.0532659283803848,9.2902613330398e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ING1,Inhibitor of growth protein 1,28719,0.036414723939848,0.00306425058915255,0.030408792785109,0.042420655094587,1.71406591261893e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,0.059505104923918,0.00500952469452457,0.0496864365226498,0.0693237733251861,1.87575319553146e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALB2,Calretinin,28774,0.0241368794425266,0.00203509557932486,0.0201480921070499,0.0281256667780033,2.2638304675625e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMM2,Phosphomannomutase 2,24111,0.0475860446415481,0.00402171951356298,0.0397034743949647,0.0554686148881315,3.26515738283094e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,0.0424867566528898,0.00359367716306993,0.0354431494132727,0.0495303638925069,3.65663406997344e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DMD,Dystrophin,24240,0.0407958958269558,0.00345138627875298,0.0340311787205999,0.0475606129333116,3.76475268906764e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPB1,Carboxypeptidase B,29820,0.0464154136944731,0.00392911401449399,0.0387143502260649,0.0541164771628814,3.93526366536014e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPAG1,Sperm-associated antigen 1,24867,0.045567488820861,0.00386536363897743,0.0379913760884652,0.0531436015532568,5.43418179637727e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LIPF,Gastric triacylglycerol lipase,24240,0.0480711932406721,0.00407921468769717,0.0400759324527857,0.0560664540285586,5.74234669928748e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRDT,Bromodomain testis-specific protein,24111,0.0289933995057128,0.00246548507705163,0.0241610487546916,0.033825750256734,7.6922681652014e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSL,Cathepsin L1,29478,0.0190483951135849,0.00162068078041327,0.0158718607839749,0.0222249294431949,7.99686429228878e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSL3,Insulin-like 3,24845,0.0592216554837256,0.00504405426181967,0.049335309130559,0.0691080018368921,9.54405319179272e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMA4,Laminin subunit alpha-4,29581,0.0260792733504863,0.00222539828745697,0.0217174927070707,0.030441053993902,1.19804024957694e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLTA,Clathrin light chain A,28916,0.0367545834306506,0.00313635716044735,0.0306073233961738,0.0429018434651274,1.20314587774867e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HPCAL1,Hippocalcin-like protein 1,29786,0.0571049054039945,0.00488428441950423,0.0475317079417662,0.0666781028662227,1.64988593720486e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPPK1,Epiplakin,24240,0.0575610961010876,0.00492418918037954,0.0479096853075437,0.0672125068946315,1.75335670752798e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PQBP1,Polyglutamine-binding protein 1,28797,0.0433410024121192,0.00371051820711367,0.0360683867261764,0.050613618098062,1.88660910571175e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP8,Caspase-8,29632,0.0478268941850699,0.00409820390339538,0.0397944145344149,0.0558593738357248,2.12035873542923e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SF3B4,Splicing factor 3B subunit 4,29349,0.0566519283550962,0.00485523067184701,0.047135676238276,0.0661681804719163,2.17342424203398e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,29674,0.0518516221777501,0.00444984790320067,0.0431299202874768,0.0605733240680234,2.60913849402352e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL7,Angiopoietin-related protein 7,29725,0.0286160955714575,0.00245860638780116,0.0237972270513672,0.0334349640915478,3.04652786841198e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,0.0257898383872948,0.00221615624714866,0.0214461721428834,0.0301335046317062,3.12322506220211e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,-0.0888131432189605,0.00765103888790001,-0.103809179439244,-0.0738171069986764,4.3927379802687e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1R1,Interleukin-1 receptor type 1,29390,-0.0177753912381852,0.00153377557921372,-0.0207815913734441,-0.0147691911029263,5.45373676411201e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PYY,Peptide YY,24111,0.0752444830568397,0.00649507082678426,0.0625141442363425,0.0879748218773368,5.9404917708199e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCT,Secretin,24195,0.0363012626661228,0.0031352081783378,0.0301562546365807,0.0424462706956649,6.38518897603553e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,0.0235890601906334,0.00203808216294191,0.0195944191512673,0.0275837012299995,6.49456486276508e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17D,Interleukin-17D,28931,0.0263211162857703,0.00227677990438688,0.021858627673172,0.0307836048983686,7.62183080030023e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERI1,3'-5' exoribonuclease 1,24445,0.0261706320679752,0.0022651898987614,0.0217308598664028,0.0306104042695475,8.53286787304982e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NID2,Nidogen-2,29443,0.0563447378684723,0.00488195018902827,0.0467761154979769,0.0659133602389677,9.49850684348282e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4A,C-type lectin domain family 4 member A,29434,-0.0268432652726369,0.00232841115649677,-0.0314069511393706,-0.0222795794059032,1.10231577289745e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,0.0329381357073483,0.00286136781411458,0.0273298547916838,0.0385464166230129,1.38377350626638e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,0.0611695524637182,0.00532037673192317,0.0507416140691488,0.0715974908582876,1.62761566215565e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PODXL,Podocalyxin,29349,0.0116052451320768,0.00101041017433401,0.00962484119038219,0.0135856490737715,1.80928881315592e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,0.0365277402803848,0.00318965668402025,0.0302760131797051,0.0427794673810645,2.7398286437263e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAGED1,Melanoma-associated antigen D1,28797,0.036873699935089,0.00322120315332712,0.0305601417545678,0.0431872581156102,2.82494264939819e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRD1,Natural killer cells antigen CD94,29786,0.0353290922986694,0.0030883643805634,0.0292758981127651,0.0413822864845737,3.07286410956481e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,0.0506853195641033,0.00443054430739381,0.0420014527216114,0.0593691864065951,3.15938682483488e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,0.0432974035711869,0.00378811231339542,0.0358727034369319,0.0507221037054419,3.43830385099652e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAA10,N-alpha-acetyltransferase 10,24111,0.0389076889030935,0.00340725042213856,0.0322294780757019,0.0455858997304851,4.01336773518284e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THBD,Thrombomodulin,29478,0.0217100084065837,0.00190861485427551,0.0179691232922037,0.0254508935209637,6.45059284415246e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRH,Corticoliberin,28751,0.0656889880517623,0.00578650900171906,0.0543474304083929,0.0770305456951316,8.38139338539107e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTN2,Dynactin subunit 2,29349,0.0712346417046682,0.00628320828188553,0.0589195534721725,0.0835497299371638,9.8884154308969e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,0.0543681763891371,0.00479989432873726,0.0449603835048121,0.0637759692734621,1.11461695765275e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD72,B-cell differentiation antigen CD72,24381,0.0323989802805113,0.00286159585050237,0.0267902524135266,0.0380077081474959,1.21115929199753e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSS,Cathepsin S,23389,0.0185081647806443,0.00163503841566779,0.0153034894859355,0.0217128400753532,1.2519647533571e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP6,Gastrotropin,28872,0.0423584730362901,0.00375104366923909,0.0350064274445815,0.0497105186279987,1.64919972156936e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,0.0275852583677348,0.00244685744703553,0.0227894177715451,0.0323810989639244,2.02921150079846e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NBN,Nibrin,28931,0.0394149159248351,0.00349648873755729,0.0325617979992228,0.0462680338504473,2.06146572612884e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY75,Lymphocyte antigen 75,29434,0.0291532681677092,0.00258846920076861,0.0240798685342028,0.0342266678012157,2.30185703483493e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMB1,Laminin subunit beta-1,24240,0.0228775406966805,0.00203226841184134,0.0188942946094715,0.0268607867838896,2.52569015520948e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MILR1,Allergin-1,28931,-0.0378643490969862,0.00336456639124389,-0.0444588992238242,-0.0312697989701482,2.55108138924638e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,0.0228646783817701,0.00203298016132737,0.0188800372655684,0.0268493194979717,2.75282067092351e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENAH,Protein enabled homolog,28931,0.0357069942860245,0.00317730867040033,0.0294794692920399,0.0419345192800092,3.04661905321347e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP1,Guanylate-binding protein 1,24816,0.0483894628212092,0.00431562315842593,0.0399308414306944,0.056848084211724,4.1543861942029e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK6,Kallikrein-6,29519,0.0228766544182997,0.0020407831278626,0.018876719487689,0.0268765893489104,4.18266020526943e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PER3,Period circadian protein homolog 3,24229,0.0898223299106786,0.00802641435329843,0.0740905577782136,0.105554102043143,5.32663278911291e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL31RA,Interleukin-31 receptor subunit alpha,24134,0.0295996967750147,0.00264607310156226,0.0244133934959526,0.0347860000540767,5.61032977680213e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FSTL1,Follistatin-related protein 1,24240,-0.0170713591220824,0.0015267705425545,-0.0200638293854892,-0.0140788888586756,5.92439051089627e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.0229184012206446,0.00205539273182375,-0.0269469709750191,-0.01888983146627,8.1648977266085e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,0.0611690476831218,0.00549390612051326,0.0504009916869158,0.0719371036793278,1.0028541019144e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRL,Prolactin,29694,-0.0561933330422783,0.00504939134635412,-0.0660901400811324,-0.0462965260034243,1.03634303432289e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTR1,Endosome-associated-trafficking regulator 1,24240,0.0439895732113067,0.00396056993056952,0.0362268561473904,0.051752290275223,1.36170331646859e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DENR,Density-regulated protein,24229,0.042614061615623,0.00384181578584222,0.0350841026753723,0.0501440205558738,1.60413420138386e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP2,Retinol-binding protein 2,29349,-0.0567903508167765,0.00512234020946167,-0.0668301376273214,-0.0467505640062316,1.65665264944926e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA9,Carbonic anhydrase 9,29725,-0.0337701072414405,0.0030476181494143,-0.0397434388142926,-0.0277967756685885,1.76768298093421e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,0.0496130632566565,0.00447982170563793,0.0408326127136062,0.0583935137997069,1.93822218388697e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLF4,Krueppel-like factor 4,24101,0.0293886141927448,0.00265626376417023,0.0241823372149712,0.0345948911705185,2.19804539412833e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,0.0205187588863027,0.00185540296847691,0.0168821690680879,0.0241553487045174,2.32144152278646e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,0.0348941929492009,0.0031580207393171,0.0287044723001394,0.0410839135982624,2.51663105702053e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL1,Fc receptor-like protein 1,29478,0.033403911556206,0.00302571905110533,0.0274735022160395,0.0393343208963724,2.78452052044051e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEK7,Serine/threonine-protein kinase Nek7,24445,0.0552135469735241,0.00500928965979018,0.0453953392403353,0.0650317547067129,3.4792922451365e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAN,Brevican core protein,29218,0.0249845485228751,0.00226806660589549,0.0205391379753199,0.0294299590704302,3.64416227188065e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C7orf50,Uncharacterized protein C7orf50,24845,0.016418579092009,0.00149065990035542,0.0134968856873124,0.0193402724967056,3.78864384784202e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,0.0508369648008974,0.00462119927074883,0.0417794142302297,0.0598945153715651,4.29761920051962e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMPER,BMP-binding endothelial regulator protein,24381,0.0167850641930867,0.00152636407860606,0.0137933905990189,0.0197767377871546,4.61122532772534e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCRIB,Protein scribble homolog,24240,0.0663333525140847,0.00604360170351094,0.0544878931752033,0.0781788118529662,5.81492995932714e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,0.0754929846146705,0.00690455689370925,0.0619600531030003,0.0890259161263406,9.1953257528949e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSZ,Cathepsin Z,29487,0.02297526671749,0.00210341721778969,0.0188525689706222,0.0270979644643578,1.01335786526387e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS3BP,Galectin-3-binding protein,24966,0.0221481941709391,0.00202940331864221,0.0181705636664003,0.0261258246754778,1.14564273862176e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOB,Apolipoprotein B-100,24951,0.0164128314408034,0.00150397515789105,0.0134650401313369,0.0193606227502698,1.15432118856082e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,0.0325639634659409,0.00298504978184054,0.0267132658935334,0.0384146610383484,1.210485505078e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSHB,Thyrotropin subunit beta,29478,0.0554878832943459,0.00512504018222177,0.0454428045371912,0.0655329620515006,2.89178338156607e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PON3,Serum paraoxonase/lactonase 3,29581,-0.0203176676148789,0.00188668399635158,-0.024015568247728,-0.0166197669820298,5.41280432993324e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL11,C-X-C motif chemokine 11,29694,0.0564490539362632,0.00524483268558992,0.046169181872507,0.0667289260000195,5.78495924858489e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,24922,0.0181783416568619,0.00168963351097753,0.014866659975346,0.0214900233383779,6.1771993427447e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GC,Vitamin D-binding protein,24966,0.018582502829546,0.00173056573797886,0.0151905939831075,0.0219744116759846,7.7403056932081e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGXT,Serine--pyruvate aminotransferase,29478,0.0550737918557087,0.00513348360499468,0.0450121639899191,0.0651354197214983,8.39764332091149e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,24805,0.0813288644926753,0.00759862152516886,0.0664355663033444,0.0962221626820063,1.12559409133238e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VIT,Vitrin,24922,0.0269101202603627,0.00251544979510091,0.0219798386619649,0.0318404018587605,1.18915714832011e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASAH1,Acid ceramidase,24732,0.0332669415135069,0.00311262060771528,0.027166205122385,0.0393676779046289,1.32777725566254e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PVALB,Parvalbumin alpha,29599,0.0798733614772005,0.00747921642764047,0.0652140972790252,0.0945326256753758,1.4212534097021e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,0.0214849630735306,0.00201161123307074,0.0175422050567119,0.0254277210903493,1.43423949794126e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDCP1,CUB domain-containing protein 1,29218,0.0369911722658665,0.00347002541429904,0.0301899224538404,0.0437924220778926,1.74810636291917e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DGKZ,Diacylglycerol kinase zeta,28931,0.0252122313847983,0.00236711773148546,0.0205726806310868,0.0298517821385098,1.93070810090362e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM1,Intercellular adhesion molecule 1,29391,0.0204397613702099,0.0019208491846432,0.0166748969683092,0.0242046257721106,2.14542589732967e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,0.0361275188464149,0.00339889207839377,0.0294656903727631,0.0427893473200667,2.43240020699239e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP9,Caspase-9,24229,0.044750780790688,0.00421320386091761,0.0364929012232895,0.0530086603580865,2.70322511458866e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,0.025156545097546,0.0023717085328647,0.0205079963731311,0.0298050938219608,3.08864421281591e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XRCC4,DNA repair protein XRCC4,28774,0.0261893387179598,0.00246925622967617,0.0213495965077945,0.0310290809281251,3.11919311909228e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANPEP,Aminopeptidase N,29531,0.0198382911672544,0.00187062157030684,0.016171872889453,0.0235047094450558,3.14288859995789e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THBS2,Thrombospondin-2,29443,-0.0264121675754274,0.00249407433112846,-0.0313005532644392,-0.0215237818864156,3.69707153469695e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINT2,Kunitz-type protease inhibitor 2,29581,0.0287157446491876,0.00271682257873593,0.0233907723948652,0.03404071690351,4.58840705015234e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BOLA1,BolA-like protein 1,24101,0.0385859513126946,0.00365109337817656,0.0314298082914685,0.0457420943339207,4.76549502390381e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,0.0414766798087411,0.00392699578981371,0.0337797680607062,0.0491735915567759,5.07932848408678e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,-0.0256806097149261,0.00243584633104924,-0.0304548685237826,-0.0209063509060695,6.10164718148097e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,0.0348912759742862,0.00330949644222317,0.0284046629475288,0.0413778890010436,6.26094398747405e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,0.0336418440047923,0.00319724038380367,0.0273752528525371,0.0399084351570474,7.61164083835033e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CR1,Complement receptor type 1,24903,0.0252490021508037,0.00240155234012117,0.0205419595641662,0.0299560447374411,8.46886422720044e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLITRK6,SLIT and NTRK-like protein 6,28916,-0.0240011122879293,0.00228759839909333,-0.0284848051501523,-0.0195174194257064,1.04755422255215e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL4,Angiopoietin-related protein 4,29536,-0.0315369381783794,0.00300919283603334,-0.0374349561370048,-0.0256389202197541,1.18165540694418e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1F,V-type proton ATPase subunit F,28719,0.0461891355526398,0.00442033754587343,0.0375252739627279,0.0548529971425517,1.64144128541931e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGMN,Legumain,29581,0.0249130862643057,0.00238701321081065,0.0202345403711168,0.0295916321574946,1.86205744080603e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,-0.0245184983823422,0.00235152228369141,-0.0291274820583773,-0.019909514706307,2.12080872978152e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD46,Membrane cofactor protein,29331,0.0198959982152752,0.00190923796185136,0.0161538918100465,0.0236381046205039,2.20446268948492e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLIT2,Slit homolog 2 protein,28774,0.0361176392353456,0.00347029914960244,0.0293158529021248,0.0429194255685664,2.53791825935033e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD274,Programmed cell death 1 ligand 1,29218,0.0237593884247633,0.00228343384436301,0.0192838580898118,0.0282349187597148,2.60192031418694e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERMAP,Erythroid membrane-associated protein,24229,0.0309750960155399,0.00298845056784736,0.025117732902559,0.0368324591285207,4.04053642574344e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSTN3,Calsyntenin-3,24845,0.0211417224081779,0.00204040902520838,0.0171425207187695,0.0251409240975863,4.17464381535698e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCN1,Ficolin-1,24919,0.0387064549201559,0.00374299896213028,0.0313701769543805,0.0460427328859312,5.16418347992409e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.026451219884759,0.00255902156845126,-0.0314669021589235,-0.0214355376105946,5.31446826892501e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,0.0157463717645715,0.0015232552085282,0.0127607915558563,0.0187319519732868,5.3666803393397e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSAP,Prosaposin,24761,0.0196307012195351,0.00190078809631948,0.0159051565507489,0.0233562458883213,5.93733390575801e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL2A1,Collagen alpha-1(II) chain,24240,0.0554882711958528,0.00539580595521389,0.0449124915236336,0.066064050868072,9.39469999586648e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMS,Spermine synthase,24101,0.0438548117927746,0.00427705453292306,0.0354717849082454,0.0522378386773038,1.28233471919911e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NGRN,Neugrin,24845,0.015185245137261,0.00148155364537758,0.0122813999923209,0.018089090282201,1.3311853987444e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRTAC1,Cartilage acidic protein 1,29820,0.0205363715438142,0.00200496715944341,0.0166066359113051,0.0244661071763233,1.4011409176003e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A13,Protein S100-A13,24229,0.0240442915347214,0.00235328620980241,0.0194318505635087,0.0286567325059342,1.85942436436099e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAPK2,Death-associated protein kinase 2,24229,0.036594532434747,0.00359012872925394,0.0295578801254092,0.0436311847440847,2.38400312567305e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,29725,0.0365498314972858,0.00358825824454369,0.0295168453379802,0.0435828176565915,2.51206516889634e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,0.0405573492241288,0.00398867607027614,0.0327395441263875,0.04837515432187,3.0782167720448e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,0.0650317973025937,0.00640663185265384,0.0524747988713922,0.0775887957337953,3.6091426195516e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHGA,Chromogranin-A,24938,-0.0595769425921263,0.00586984673434236,-0.0710818421914373,-0.0480720429928153,3.70523310718609e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINI1,Neuroserpin,24329,0.0207555632110649,0.00204651623291347,0.0167443913945545,0.0247667350275753,4.02121439941426e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL32,Interleukin-32,29434,-0.029410851724302,0.00290186990985191,-0.0350985167476117,-0.0237231867009922,4.22666689236675e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,0.0448056721790327,0.00442492118391454,0.0361328266585602,0.0534785176995052,4.72885133974834e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPL,Periplakin,24229,0.0221126800304226,0.00218866293680945,0.0178229006742761,0.0264024593865691,5.9597580281421e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,0.0329369958876619,0.00326520608937562,0.0265371919524857,0.0393367998228381,6.8777842059835e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XG,Glycoprotein Xg,29693,0.0216274371706221,0.00214636306242191,0.0174205655682752,0.0258343087729691,7.68053435544337e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAM,Signal transducing adapter molecule 1,24793,0.024804676142142,0.0024627586585342,0.0199776691714149,0.029631683112869,8.17267272914217e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX6,Syntaxin-6,28797,0.0451410908213208,0.00448304324051236,0.0363543260699166,0.053927855572725,8.26967854416571e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLRX,Glutaredoxin-1,29291,0.0376142327029153,0.00373730291330371,0.03028911899284,0.0449393464129905,8.66463802171761e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA6,Corticosteroid-binding globulin,24966,0.0113233525449351,0.00112707749184329,0.00911428066092224,0.0135324244289479,1.05440850161699e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,29478,-0.0190512811374939,0.00189868242548811,-0.0227726986914506,-0.0153298635835372,1.17991902189862e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMARCA2,Probable global transcription activator SNF2L2,28774,0.0489596527200505,0.00488561280718925,0.0393838516179596,0.0585354538221414,1.34489768655939e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,0.042283560948367,0.00422150051399773,0.0340094199409314,0.0505577019558025,1.41071825383587e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TF,Serotransferrin,24966,0.0144566984686977,0.00144528025774986,0.011623949163508,0.0172894477738875,1.64233655608659e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDGF,Hepatoma-derived growth factor,29688,0.0622582545191912,0.00623032870656879,0.0500468102543164,0.074469698784066,1.78563006964894e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSNK1D,Casein kinase I isoform delta,24229,0.0427265417564596,0.00427505174509254,0.0343474403360782,0.051105643176841,1.79089095913895e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,28774,0.0340134471481066,0.00342072921437264,0.0273088178879363,0.040718076408277,2.94012221904242e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB103A_DEFB103B,Beta-defensin 103,24109,0.0274620130771196,0.00276389998845608,0.0220447690997457,0.0328792570544935,3.21814378374651e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GDNF,Glial cell line-derived neurotrophic factor,28774,0.0253663491760933,0.0025536155155211,0.0203612627656719,0.0303714355865146,3.24385886114567e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABCA2,ATP-binding cassette sub-family A member 2,24111,0.0242433331110364,0.00244271097924966,0.0194556195917071,0.0290310466303657,3.59901426821654e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFF3,Trefoil factor 3,29426,-0.0306211543174126,0.00308957445693088,-0.0366767202529971,-0.024565588381828,4.04865219667642e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL19,C-C motif chemokine 19,29694,0.0811167801123888,0.00818941466693882,0.0650655273651887,0.0971680328595889,4.29711703366722e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLITRK2,SLIT and NTRK-like protein 2,29725,0.0257666400507308,0.00260814675255634,0.0206546724157204,0.0308786076857413,5.55471758634025e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AFAP1,Actin filament-associated protein 1,24381,0.0555221969056634,0.00562532290661078,0.0444965640087063,0.0665478298026205,6.19867601479554e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,0.021775951612621,0.00220716072470168,0.0174499165922057,0.0261019866330363,6.45343198765636e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,0.0603384686067353,0.00611704077034892,0.0483490686968515,0.0723278685166192,6.58611278311876e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCG2,Secretogranin-2,29559,0.0214239278884359,0.00217279620515222,0.0171652473263376,0.0256826084505343,6.72655695925984e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POSTN,Periostin,24938,-0.024984222166867,0.00253366307727141,-0.029950201798319,-0.0200182425354151,6.77215273181687e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGMB,RGM domain family member B,29694,0.0176898135239183,0.0017949354620156,0.0141717400183677,0.0212078870294689,7.04296727352083e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,0.042153015203213,0.00427829913213705,0.0337675489042244,0.0505384815022017,7.36322647207731e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX1,Peroxiredoxin-1,28669,-0.0592617216500396,0.00601884005240919,-0.0710586481527616,-0.0474647951473176,7.75086007671252e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.0241075069023124,0.00245310118993918,-0.0289155852345932,-0.0192994285700316,9.30560203669265e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPE,Ribulose-phosphate 3-epimerase,24445,0.0463333165550504,0.00471796542928942,0.0370861043136432,0.0555805287964577,1.0112111062214e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,0.0550095594454913,0.00561743331379558,0.043999390150452,0.0660197287405306,1.31350272259382e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,24764,0.0267974132663123,0.00274122747962778,0.0214246074062419,0.0321702191263827,1.57265596750427e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LACRT,Extracellular glycoprotein lacritin,24732,0.032523903145306,0.00332769064979609,0.0260016294717056,0.0390461768189063,1.60382143071463e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFAP,Glial fibrillary acidic protein,28753,0.0301194993548745,0.00308248708748598,0.024077824663402,0.036161174046347,1.62310497473938e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FES,Tyrosine-protein kinase Fes/Fps,28797,0.0308953791196788,0.00316245577011369,0.024696965810256,0.0370937924291016,1.65095084105821e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OCLN,Occludin,24867,0.028658698715935,0.00293423912412269,0.0229075900326546,0.0344098073992155,1.712521305294e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFHR2,Complement factor H-related protein 2,24789,0.0372237556807248,0.00381635994913744,0.0297436901804154,0.0447038211810342,1.95137116996556e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCTS1,Malignant T-cell-amplified sequence 1,24805,0.0169698049112618,0.00174155318786181,0.0135563606630527,0.020383249159471,2.14544394701993e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTGES2,Prostaglandin E synthase 2,24037,0.0358177126795379,0.00368580807495343,0.0285935288526292,0.0430418965064466,2.78463339391879e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXN,Thioredoxin,24647,0.0284306083926599,0.00292726989118472,0.0226931594059379,0.034168057379382,2.92899884509238e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB8,DnaJ homolog subfamily B member 8,28916,0.0372474136038496,0.00383784000483524,0.0297252471943725,0.0447695800133267,3.09494318433212e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,24922,0.0385572712648154,0.00397536232553212,0.0307655611067724,0.0463489814228584,3.33108494596311e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RANBP1,Ran-specific GTPase-activating protein,24240,0.0339410275077955,0.00350331260060616,0.0270745348106074,0.0408075202049836,3.71036293213422e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C2orf69,UPF0565 protein C2orf69,24195,0.0386124936110504,0.00398570586093059,0.0308005101236264,0.0464244770984744,3.73001169095175e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD101,Immunoglobulin superfamily member 2,24805,0.0277333678899063,0.0028638776157131,0.0221201677631086,0.033346568016704,3.86541066525921e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELOB,Elongin-B,24111,0.0257011353034947,0.00265428218864838,0.0204987422137439,0.0309035283932455,3.91179048106155e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,0.0350878043425621,0.00362591013373452,0.0279810204804424,0.0421945882046817,4.13393521141365e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OXT,Oxytocin-neurophysin 1,29694,0.0895614996560442,0.00925929440583916,0.0714132826205995,0.107709716691489,4.249759291985e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NXPH3,Neurexophilin-3,24229,0.0195947179839289,0.00202581390587834,0.0156241227284073,0.0235653132394504,4.32600220481636e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPM1A,Protein phosphatase 1A,28797,0.0200746119867078,0.00207605264068178,0.0160055488109715,0.0241436751624441,4.385964994052e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICOSLG,ICOS ligand,29349,0.0123019285486424,0.00127431444250364,0.00980427224133531,0.0147995848559496,5.10977179493861e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,0.0557183516925995,0.00577554554670911,0.0443982824210497,0.0670384209641494,5.51628221667422e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMMT,MICOS complex subunit MIC60,24793,0.0286546779916851,0.00297212813738554,0.0228293068424095,0.0344800491409608,5.85717294348972e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,24845,0.020462649978446,0.00212610200515426,0.0162954900483437,0.0246298099085484,6.88168030725807e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEPR,Leptin receptor,29478,-0.0199046725584051,0.00206965443918939,-0.0239611952592163,-0.0158481498575939,7.27092108410314e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SV2A,Synaptic vesicle glycoprotein 2A,24195,0.039816932219958,0.00414219371073052,0.0316982325469261,0.0479356318929898,7.74551902680073e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTN,Pleiotrophin,28916,0.032059349896325,0.00333712035272439,0.0255185940049852,0.0386001057876648,8.06053328312198e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDM1,Nuclear protein MDM1,24195,0.0201115905208751,0.00209454709454641,0.0160062782155641,0.024216902826186,8.58531037705511e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APRT,Adenine phosphoribosyltransferase,29192,0.0305617321741981,0.00318551005792697,0.0243181324606612,0.0368053318877349,9.12577065074843e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIP,Gastric inhibitory polypeptide,24240,0.0327835981477664,0.00341907146714639,0.0260822180721594,0.0394849782233733,9.77300386313249e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,0.0270491928842164,0.00282266854273254,0.0215167625404606,0.0325816232279721,1.0316382248095e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AK1,Adenylate kinase isoenzyme 1,29478,0.0401370788003859,0.00418945065490142,0.0319257555167791,0.0483484020839927,1.03866564059371e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSG4,Desmoglein-4,29242,0.0316662740377707,0.00330805318193,0.0251824898011879,0.0381500582743535,1.12300644709288e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDF1,Endothelial differentiation-related factor 1,24867,0.0435148096351574,0.0045480095111158,0.0346007109933704,0.0524289082769444,1.18910502199184e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX7,Syntaxin-7,24229,0.0317398761729131,0.00332422352008188,0.0252243980735526,0.0382553542722736,1.44229703023315e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL24A1,Collagen alpha-1(XXIV) chain,24805,0.0353499543588629,0.00371509043307279,0.0280683771100402,0.0426315316076855,1.97246976579583e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA3,Protein disulfide-isomerase A3,24381,0.0159539459909852,0.00167710168787531,0.0126668266827496,0.0192410652992208,2.02181284053583e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",29478,0.0463801375779805,0.00487772045259617,0.036819805490892,0.055940469665069,2.07474905203456e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,0.0314855501306344,0.00331359949539216,0.0249908951196658,0.0379802051416031,2.24511970406095e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL25,C-C motif chemokine 25,29786,0.0310865466383588,0.00327540540640944,0.0246667520417963,0.0375063412349213,2.45531888215432e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGER,Advanced glycosylation end product-specific receptor,29378,0.0257146581852624,0.00271459211932914,0.0203940576313773,0.0310352587391475,2.92309331030856e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADA,Adenosine deaminase,29786,0.0218694907210267,0.00231902027523956,0.0173242109815572,0.0264147704604962,4.36809617454416e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECM1,Extracellular matrix protein 1,24349,0.0231753364815269,0.00246102004474608,0.0183517371938246,0.0279989357692292,5.0420236021499e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDA,Cytidine deaminase,24890,0.0292262375464615,0.00312191870764848,0.0231072768794705,0.0353451982134525,8.49524442600195e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,0.0260913008207036,0.00278846368373982,0.0206259120005736,0.0315566896408336,8.88600786517881e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,0.0376746069272719,0.00403599793866447,0.0297640509674895,0.0455851628870542,1.08249724161403e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,0.0735526982549139,0.00787997611187777,0.0581079450756334,0.0889974514341943,1.10100009455808e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESAM,Endothelial cell-selective adhesion molecule,29820,0.0197914762709621,0.00212237084423215,0.0156316294162671,0.0239513231256571,1.18214173560401e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPD1,Sphingomyelin phosphodiesterase,29530,-0.0305903524019511,0.00328436323806558,-0.0370277043485596,-0.0241530004553425,1.3146229309135e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST5,Cystatin-D,28890,0.0344962795261261,0.00370822090864711,0.0272281665451777,0.0417643925070744,1.46363760283333e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,29443,-0.0217831395162885,0.0023458901220412,-0.0263810841554893,-0.0171851948770878,1.71412274891963e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,0.0260281927691635,0.00280581499899151,0.0205287953711402,0.0315275901671869,1.8666444602935e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEK,Angiopoietin-1 receptor,29566,0.0134866062749179,0.00145667190819337,0.0106315293348589,0.0163416832149769,2.20898785114498e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNF,Tumor necrosis factor,28868,0.0236152416782891,0.00255091129007864,0.018615455549735,0.0286150278068433,2.23178799028135e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPQ,Carboxypeptidase Q,24920,0.0227799773337557,0.00246587365119862,0.0179468649774064,0.027613089690105,2.7036878589969e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,0.0208234200506019,0.00225569022586047,0.0164022672079153,0.0252445728932884,2.87469337739737e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYM,Ketimine reductase mu-crystallin,24101,0.0471066823176127,0.00510348510345884,0.0371038515148334,0.057109513120392,2.9146101389362e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCAM,Cell surface glycoprotein MUC18,29594,-0.0204272557753422,0.00221602968136588,-0.0247706739508194,-0.0160838375998651,3.22304208675041e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX5,Sorting nexin-5,24240,0.0183695390540058,0.00199614295461371,0.0144570988629629,0.0222819792450486,3.77111153763337e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSR,Insulin receptor,24229,0.0104439757236176,0.00113672189461609,0.00821600081017006,0.0126719506370652,4.3223394014575e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,0.0207814439419958,0.00226326520897838,0.0163454441323982,0.0252174437515934,4.49502703268899e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF21,Immunoglobulin superfamily member 21,24240,0.0243717899682783,0.00265692370680856,0.0191642195029336,0.0295793604336231,4.95970662443691e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCOF1,Treacle protein,24922,0.0191810824515925,0.00209160167408018,0.0150815431703953,0.0232806217327897,5.06124234356522e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,0.0334203342349077,0.00364434506869663,0.0262774179002623,0.0405632505695531,5.07506885757225e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,-0.0273444380369548,0.00298492185458451,-0.0331948848719405,-0.0214939912019692,5.4694679784581e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP2,"Fatty acid-binding protein, intestinal",29478,-0.0478809489373154,0.00523024388854979,-0.058132226958873,-0.0376296709157579,5.79689562339183e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS53,Serine protease 53,24845,0.0228477057117269,0.00249888640745071,0.0179498883531235,0.0277455230703303,6.5176513274145e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMG3,Proteasome assembly chaperone 3,29434,0.030590627592801,0.00335743273413729,0.0240100594338919,0.0371711957517101,8.64095358072627e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECI2,Enoyl-CoA delta isomerase 2,24111,0.0376764579467135,0.00413609074241654,0.0295697200915771,0.0457831958018499,8.92786871199301e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,0.0211356482472464,0.00232544147050105,0.0165777829650644,0.0256935135294285,1.06199223655891e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NXPH1,Neurexophilin-1,28774,0.0231387855547049,0.00254953080910119,0.0181417051688665,0.0281358659405432,1.19963915209197e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA2,Annexin A2,23907,0.0430184396460478,0.00474734635567094,0.0337136407889328,0.0523232385031629,1.38191084551089e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,0.0269534913369708,0.00298628098511907,0.0211003806061374,0.0328066020678042,1.91376850914864e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADA2,Adenosine deaminase 2,29328,-0.0257379871209295,0.0028546141649559,-0.0313330308842431,-0.0201429433576159,2.06137542929588e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA9,Serpin A9,29227,0.0434675703846074,0.00482510007583016,0.0340103742359803,0.0529247665332345,2.21013902259393e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMP,Cartilage oligomeric matrix protein,29214,0.0202074471209701,0.0022448935795009,0.0158074557051484,0.0246074385367919,2.35792804476119e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRK1,Protein BRICK1,28774,0.0268068713067131,0.00298602995770459,0.0209542525896121,0.0326594900238141,2.9364513270873e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSE,Cathepsin E,24381,0.0313294745980182,0.00349470414035284,0.0244798544829266,0.0381790947131097,3.32507122157096e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLO1,Lactoylglutathione lyase,28916,0.0346166402745416,0.00386284177578937,0.0270454703939944,0.0421878101550887,3.39271521774572e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,0.0335645703567319,0.00374825630087463,0.0262179880070176,0.0409111527064462,3.60340234143791e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC14A,C-type lectin domain family 14 member A,29443,-0.0189608506341413,0.00211748396705678,-0.0231111192095726,-0.01481058205871,3.61134947825673e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGHMBP2,DNA-binding protein SMUBP-2,24111,0.0333627745140736,0.0037320063359345,0.026048042095642,0.0406775069325053,4.17832502630974e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH1,Protocadherin-1,29713,0.012625070637582,0.00141535043662929,0.00985098378178859,0.0153991574933754,4.9196597076892e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.0415817136050367,0.00466184047474092,0.0324445062745445,0.0507189209355289,4.94689189763323e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.0219930758861551,0.0024683850960308,0.0171550410979348,0.0268311106743755,5.45896320615872e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYGD,Gamma-crystallin D,24845,0.0575856361335821,0.00647257125182902,0.0448993964799973,0.070271875787167,6.12717651619634e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTGR1,Prostaglandin reductase 1,24922,0.0485338423684245,0.00545568508237949,0.0378406996069607,0.0592269851298883,6.17339716367812e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA4,Carbonic anhydrase 4,29820,-0.0140632733394758,0.0015854721693027,-0.0171707987913091,-0.0109557478876425,7.70790246073091e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,0.0229092834757291,0.00258322189837262,0.0178461685549187,0.0279723983965394,7.91490016730329e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL9A1,Collagen alpha-1(IX) chain,29434,0.0276351491026445,0.00312265534022347,0.0215147446358065,0.0337555535694825,9.24085985675952e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,0.0219356517136039,0.0024794599668375,0.0170759101786024,0.0267953932486054,9.58180700883852e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,24571,0.0330993123097226,0.00374806374054637,0.0257531073782518,0.0404455172411935,1.10487665676409e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD83,CD83 antigen,29434,0.0199579501714561,0.00226671009013131,0.0155151983947987,0.0244007019481134,1.38111473331269e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARSA,Arylsulfatase A,29443,0.0262068144762708,0.00298508481205731,0.0203560482446385,0.0320575807079032,1.73291993178514e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COPB2,Coatomer subunit beta',24111,0.0252699540510257,0.00288253007851839,0.0196201950971297,0.0309197130049218,1.96084442269099e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENSA,Alpha-endosulfine,24793,0.0309250318609261,0.00353061299022374,0.0240050304000876,0.0378450333217647,2.09132699106143e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17RB,Interleukin-17 receptor B,29034,-0.0313119967129242,0.003577966634225,-0.0383248113160052,-0.0242991821098432,2.2203527572957e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,0.0210282882481076,0.00240307097907823,0.0163182691291143,0.0257383073671009,2.25810799541316e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD93,Complement component C1q receptor,28353,-0.0183594267958893,0.00209950935180082,-0.0224744651254189,-0.0142443884663597,2.35892013159549e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKD1,Polycystin-1,24922,0.0155090389392406,0.00177681999653935,0.0120264717460235,0.0189916061324578,2.73847926360495e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.0187805885774296,0.00215516334578463,-0.0230047087351675,-0.0145564684196917,3.11026920272634e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,28774,0.0369644128318138,0.00426011356743739,0.0286145902396365,0.0453142354239911,4.27909238892773e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CABP2,Calcium-binding protein 2,24195,0.0379130178138065,0.00436980167987498,0.0293482065212516,0.0464778291063615,4.3474273215873e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN4,CCN family member 4,29725,0.0231554490639289,0.00267209752886731,0.017918137907349,0.0283927602205088,4.71332863110144e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKK4,Dickkopf-related protein 4,29169,0.0265259773831365,0.0030613842707882,0.0205256642123916,0.0325262905538814,4.7568805304951e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.0356384216984373,0.00413009683552012,-0.0437334114960567,-0.0275434319008178,6.49373793974487e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLAUR,Urokinase plasminogen activator surface receptor,29278,-0.0158210698071557,0.00183387551040584,-0.0194154658075511,-0.0122266738067602,6.60413291872165e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA12,Serpin A12,28628,0.0643400734154428,0.00746152014397198,0.0497154939332578,0.0789646528976279,6.85822171010036e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFRP4,Secreted frizzled-related protein 4,24381,0.0238509088043661,0.00276776508575326,0.0184260892362897,0.0292757283724425,7.25865437906915e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTSL4,ADAMTS-like protein 4,24240,0.0137965987080661,0.00160673600922563,0.0106473961299839,0.0169458012861483,9.47801173590295e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSDE1,Cold shock domain-containing protein E1,24111,0.06806222935436,0.00793034899185163,0.0525187453303309,0.0836057133783892,9.83454236672382e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLC,Galectin-10,29426,-0.0378844675748666,0.00442230889118523,-0.0465521930015897,-0.0292167421481435,1.11638542572384e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEPE,Matrix extracellular phosphoglycoprotein,29454,0.0143879736663747,0.00168021766772731,0.0110947470376292,0.0176812002951203,1.15078720420167e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BST2,Bone marrow stromal antigen 2,29694,0.0299174698152268,0.00349909209792609,0.0230592493032916,0.0367756903271619,1.28829733392934e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHCY,Adenosylhomocysteinase,29478,0.03845327751142,0.00450193617571467,0.0296294826070193,0.0472770724158208,1.38774346067405e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY96,Lymphocyte antigen 96,29218,-0.0202743307526363,0.00237477937046451,-0.0249288983187468,-0.0156197631865259,1.43887863618001e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17C,Interleukin-17C,28931,-0.0401335349084662,0.00470107024563201,-0.049347632589905,-0.0309194372270275,1.44262073790787e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRPX,Sushi repeat-containing protein SRPX,24922,-0.0202393463576666,0.00237167158229878,-0.0248878226589722,-0.015590870056361,1.49575106552597e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,0.0398046441800597,0.00466947477268461,0.0306524736255979,0.0489568147345216,1.62377961165879e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD86,T-lymphocyte activation antigen CD86,24805,0.0170640047766267,0.00200315824864184,0.0131378146092887,0.0209901949439647,1.70603637995278e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,0.0270077155418283,0.00317574203960349,0.0207832611442055,0.0332321699394512,1.92691413567958e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RABEPK,Rab9 effector protein with kelch motifs,28797,0.033408297932202,0.00393105424797876,0.0257034316061636,0.0411131642582404,2.01090606620971e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DHPS,Deoxyhypusine synthase,24793,0.0231027133948499,0.00272402267769033,0.0177636289465768,0.0284417978431229,2.3533997090193e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BPIFA2,BPI fold-containing family A member 2,23405,-0.0628940659667015,0.00741905523259888,-0.0774354142225953,-0.0483527177108077,2.43760433140206e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD14,Monocyte differentiation antigen CD14,28954,0.0234041621865217,0.00276202983482665,0.0179905837102614,0.0288177406627819,2.49181587673409e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QL2,Complement C1q-like protein 2,24229,0.0242750697526785,0.00287678133606445,0.0186365783339922,0.0299135611713648,3.39824910700746e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FEN1,Flap endonuclease 1,28797,0.0354020727753206,0.0041976100301553,0.0271747571162162,0.043629388434425,3.49862891945782e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,0.0288656043526654,0.00342312895140197,0.0221562716079175,0.0355749370974132,3.53380153079484e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12A_IL12B,Interleukin-12,29349,0.0436273237553826,0.00517805731365124,0.0334783314206261,0.053776316090139,3.75646929249722e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX58,Antiviral innate immune response receptor RIG-I,28797,0.0318707521655749,0.00379394470573818,0.0244346205423281,0.0393068837888218,4.65057497833329e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOM3,Myomesin-3,24381,-0.0524252322968776,0.00624957242371189,-0.0646743942473529,-0.0401760703464023,5.18247886513359e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2RA,Interleukin-2 receptor subunit alpha,29223,-0.0226279668607749,0.00269931849941196,-0.0279186311196223,-0.0173373026019275,5.39549093237716e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELENOP,Selenoprotein P,24966,0.0126909426950772,0.00151483132186361,0.00972187330422449,0.0156600120859298,5.67320432924167e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,0.057507250377137,0.00687025675032921,0.0440415471464918,0.0709729536077823,6.03824217668796e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPM3,Tropomyosin alpha-3 chain,24111,-0.0247256095683347,0.00295857057356127,-0.0305244078925148,-0.0189268112441546,6.76018548007862e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.0210829512669722,0.002531454268316,-0.0260446016328716,-0.0161213009010728,8.61204183022716e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALCAM,CD166 antigen,29820,0.0108606486963781,0.00130494529432101,0.00830295591950893,0.0134183414732473,8.96216086304358e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,0.0493946560551171,0.0059392036876193,0.0377538168273833,0.0610354952828509,9.42786430335671e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAFA5,Chemokine-like protein TAFA-5,29349,0.0200803627551723,0.00241754717338482,0.0153419702953381,0.0248187552150066,1.03116086664493e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFDC1,WAP four-disulfide core domain protein 1,24326,0.0301001334106503,0.00362971791811276,0.0229858862911493,0.0372143805301513,1.16383154916791e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX2,Sorting nexin-2,24793,0.0450593224718994,0.00543798113526111,0.0344008794467877,0.0557177654970112,1.2294376394028e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCP1,Plastin-2,24938,0.026270933723939,0.00317290418923912,0.0200520415130303,0.0324898259348477,1.29530218460755e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAM,Basal cell adhesion molecule,29443,-0.0132644789976871,0.00160601245893514,-0.0164122634172,-0.0101166945781742,1.52651211113863e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR15L,Protein GPR15L,24805,0.0337705245803422,0.00409090106657326,0.0257523584898586,0.0417886906708258,1.59344063370796e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL8,Interleukin-8,29218,0.0372313486483917,0.00452106411819931,0.028370062976721,0.0460926343200623,1.86838650559796e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,24195,0.0424199280511625,0.00515260126443169,0.0323208295728764,0.0525190265294486,1.92159756040706e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB3A1,Secretoglobin family 3A member 1,24381,-0.0140621644630272,0.00170901650052161,-0.0174118368040496,-0.0107124921220049,1.9942212700575e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH5,Cadherin-5,29820,-0.0166420386347911,0.00202553398339181,-0.0206120852422391,-0.0126719920273432,2.18607873092176e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROBO1,Roundabout homolog 1,29497,0.0131871342997498,0.00160627013914992,0.010038844827016,0.0163354237724837,2.30532737190476e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTB,Lymphotoxin-beta,24793,0.0191709974154185,0.00233549904666553,0.0145934192839541,0.023748575546883,2.34718594952045e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS7_LGALS7B,Galectin-7,29320,0.0229750681472944,0.00280010851622141,0.0174868554555005,0.0284632808390884,2.39813518385e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG1A,Lithostathine-1-alpha,29353,-0.026891136987382,0.003283377238357,-0.0333265563745617,-0.0204557176002023,2.71537479519618e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,29349,0.0114503025567766,0.00139953902251976,0.00870720607263784,0.0141933990409153,2.91601149351586e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,0.0196007224741582,0.00239865335620794,0.0148993618959907,0.0243020830523258,3.16536152460951e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XCL1,Lymphotactin,29725,0.0301612384870668,0.00369792417672022,0.0229133071006952,0.0374091698734384,3.59041382762663e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFPI2,Tissue factor pathway inhibitor 2,29473,0.0211340859904064,0.00260436772646822,0.0160295252465287,0.0262386467342841,5.05097797851993e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYTL1,Cytokine-like protein 1,24938,0.0131045178290234,0.00161532335788023,0.00993848404757814,0.0162705516104686,5.18000028332508e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARF2,Scavenger receptor class F member 2,29694,-0.0157192398435156,0.00194539804333863,-0.0195322200084593,-0.0119062596785719,6.70844073218962e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRN,Progranulin,29313,0.0132902145288996,0.00164546548145924,0.0100651021852395,0.0165153268725597,6.89788137452272e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLITRK1,SLIT and NTRK-like protein 1,24229,0.0174842069489292,0.00217050488762455,0.0132300173691851,0.0217383965286733,8.28669590628844e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,25976,-0.0167468645907641,0.00208636198846226,-0.0208361340881501,-0.0126575950933781,1.04227609503578e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP1,Interstitial collagenase,28424,0.0489119776508003,0.00610324856074611,0.0369496104717379,0.0608743448298627,1.15180562797634e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,0.0194705812653506,0.00243140999156101,0.014705017681891,0.0242361448488101,1.20995739894854e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,0.026390451049343,0.00329571070512842,0.0199308580672913,0.0328500440313947,1.2129846643594e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,-0.0164204046033306,0.00205076061453501,-0.0204398954078192,-0.012400913798842,1.22852544347699e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,0.0203896751111146,0.002547295752967,0.0153969754352992,0.0253823747869299,1.2531431956387e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,0.0240654920965072,0.00300823876867233,0.0181693441099095,0.029961640083105,1.30128058703367e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSN,Gelsolin,24845,0.0102010388639952,0.00127528315129324,0.00770148388746046,0.01270059384053,1.3082910719408e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHRDL1,Chordin-like protein 1,29536,0.016779935152661,0.00210083693160309,0.012662294766719,0.0208975755386031,1.42952705020027e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRR3,Small proline-rich protein 3,24845,0.0362131382927571,0.00454530681010812,0.0273043369449452,0.045121939640569,1.69301470743823e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNLIP,Pancreatic triacylglycerol lipase,24951,0.0335339291453716,0.00422293309329069,0.0252569802825218,0.0418108780082213,2.09114657407643e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,0.026762135118571,0.00337348770951661,0.0201500992079185,0.0333741710292236,2.21494411481594e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT19,"Keratin, type I cytoskeletal 19",29378,-0.0358682872571643,0.00452265975001719,-0.044732700367198,-0.0270038741471306,2.25434947666796e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,0.0202326408163308,0.00255163534349349,0.0152314355430836,0.0252338460895781,2.28171550185261e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTPN,Myotrophin,28916,0.0173317104982451,0.00218895495293476,0.013041358790493,0.0216220622059973,2.5036385207696e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,0.0148870041032924,0.00188179725216128,0.0111986814890563,0.0185753267175285,2.66063144549433e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWC2,Brorin,29114,0.0209898816161147,0.00266244243704639,0.0157714944395038,0.0262082687927256,3.28899767974552e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINI2,Serpin I2,24805,0.0299259210417663,0.00379817633719423,0.0224814954208656,0.037370346662667,3.43428272565357e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ODAM,Odontogenic ameloblast-associated protein,28722,0.0281618731228959,0.00358100670061697,0.0211430999896866,0.0351806462561051,3.84334201373994e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RARRES1,Retinoic acid receptor responder protein 1,28797,0.0175327531369727,0.00223255755481592,0.0131569403295335,0.0219085659444119,4.19553666267789e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NADK,NAD kinase,29478,0.0282975773286802,0.00360357606898581,0.021234568233468,0.0353605864238924,4.21152842229934e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BGN,Biglycan,28750,-0.0627176892884905,0.00798676861976762,-0.0783717557832351,-0.047063622793746,4.21302028599682e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,0.0234906943814564,0.00299179123506779,0.0176267835607235,0.0293546052021893,4.27317407887584e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFIC,Nuclear factor 1 C-type,24867,0.0233777214196624,0.00297791812796046,0.0175410018888599,0.0292144409504649,4.31512645111071e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN4B,Sodium channel subunit beta-4,24240,0.0224228281070889,0.00285657152233395,0.0168239479233144,0.0280217082908635,4.34701483385994e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,28719,0.0221767787883121,0.00282943194083493,0.0166310921842756,0.0277224653923486,4.73967262414669e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,0.0196008222203014,0.00250533901098874,0.0146903577587634,0.0245112866818393,5.3037958720091e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPC1,Glypican-1,29725,0.0153660660890424,0.00196462952216896,0.0115153922255912,0.0192167399524935,5.39819449533481e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHCHD6,MICOS complex subunit MIC25,24793,0.0151260661626816,0.00193940625364805,0.0113248299055314,0.0189273024198318,6.46796515149983e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH17,Cadherin-17,29478,-0.0353093605172863,0.00453215403303553,-0.0441923824220359,-0.0264263386125366,6.87372629408482e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFTPD,Pulmonary surfactant-associated protein D,29478,0.0346465617239728,0.00445945387765374,0.0259060321237715,0.0433870913241742,8.15176734391875e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,0.0400976192667878,0.00516648504386276,0.0299713085808167,0.0502239299527588,8.75088147166851e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOM2,Myomesin-2,24111,-0.0264101205659378,0.00342073573649217,-0.0331147626094625,-0.0197054785224132,1.2027437051499e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,0.0147305837587033,0.00191361655076212,0.0109798953192096,0.0184812721981971,1.4278816239461e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAGA,Alpha-N-acetylgalactosaminidase,24177,0.0301221131930401,0.00391753909124739,0.0224437365741952,0.0378004898118849,1.53880255782109e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.0247380099480461,0.00322197726518787,-0.0310530853878143,-0.0184229345082778,1.66727320978518e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KITLG,Kit ligand,29478,-0.0190780435009173,0.00248685390795439,-0.0239522771605079,-0.0142038098413267,1.75154252075814e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPB6,Heat shock protein beta-6,29725,0.0196442536019576,0.00256294930141249,0.0146208729711891,0.0246676342327261,1.84696400685649e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRSF1,G-rich sequence factor 1,23862,0.0414607908616879,0.00541030905334804,0.0308565851171257,0.0520649966062501,1.8811339063963e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,-0.0127829011337742,0.00166922930303922,-0.0160545905677311,-0.00951121169981739,1.95949328465019e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM3C,Protein FAM3C,29433,0.0153096713621701,0.00200036877162183,0.0113889485697913,0.0192303941545489,2.01677563662521e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,0.0370458377691045,0.00484100911759746,0.0275574598986135,0.0465342156395955,2.04375091897471e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PVR,Poliovirus receptor,29694,0.0188878144991498,0.00246885592798233,0.0140488568803044,0.0237267721179951,2.06362998429513e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL10RB,Interleukin-10 receptor subunit beta,29581,0.0147871153880035,0.00193583127001876,0.0109928860987667,0.0185813446772402,2.26154687896731e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPR,Nucleoprotein TPR,24111,0.0244275669956862,0.00319819672197649,0.0181591014206122,0.0306960325707601,2.28956432871906e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,0.0403480740217351,0.00529160901690506,0.0299765203486012,0.0507196276948691,2.51711020500406e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRTG,Protogenin,29725,0.0126599861366742,0.00166260580322277,0.00940127876235756,0.0159186935109908,2.72468601140342e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,-0.0231074561450972,0.00303674912201457,-0.0290594844242457,-0.0171554278659486,2.8379849244127e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAS2,Growth arrest-specific protein 2,24445,0.0269018937419526,0.0035350559189622,0.0199731841407867,0.0338306033431185,2.83910754879211e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTX1,Neuronal pentraxin-1,29443,0.0206207083894902,0.002713288523607,0.0153026628832205,0.0259387538957599,3.05175359021645e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LUZP2,Leucine zipper protein 2,24793,0.0227570134512137,0.00299530452826926,0.016886216575806,0.0286278103266215,3.1242123491134e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL3,Myosin light chain 3,24240,-0.0371530697477715,0.00489362005761171,-0.0467445650606904,-0.0275615744348525,3.25996054622703e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MST1,Hepatocyte growth factor-like protein,24615,0.0325306585695003,0.00429567702925967,0.0241111315921513,0.0409501855468492,3.77854648231176e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,0.0289017571053528,0.00381968814524019,0.0214151683406821,0.0363883458700236,3.94744401238439e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN5,Contactin-5,29511,0.0187026359264063,0.0024729265574581,0.0138556998737885,0.0235495719790242,4.05462736688723e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,-0.00997001491668292,0.00131838978120207,-0.012554058887839,-0.00738597094552687,4.07680088477176e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGLC2,Immunoglobulin lambda constant 2,24915,-0.0125888088607401,0.00166464738399182,-0.0158515177333641,-0.00932609998811618,4.09203732276154e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,-0.0144291074766204,0.00190826484000883,-0.0181693065630377,-0.0106889083902031,4.10529736425937e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKD2,Serine/threonine-protein kinase D2,24111,0.0231489048256359,0.00306372029586602,0.0171440130457385,0.0291537966055333,4.31042601691109e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL20,C-C motif chemokine 20,29786,0.0441258347375038,0.00585009172693581,0.0326596549527096,0.055592014522298,4.73239030815995e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRD1,Bromodomain-containing protein 1,24445,-0.0154544230694642,0.00205399214773165,-0.0194802476790182,-0.0114285984599101,5.49186963520014e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.0213701303584568,0.00284072826906828,0.015802302951083,0.0269379577658307,5.51524060909013e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAG3,Lymphocyte activation gene 3 protein,29349,-0.0205063220926504,0.00272722401628872,-0.0258516811645763,-0.0151609630207246,5.67216161071459e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNGR2,Interferon gamma receptor 2,29218,0.0261104275924012,0.00347655043735337,0.0192963887351886,0.0329244664496138,6.0611393164013e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VASN,Vasorin,29065,0.0137578521705872,0.00183519645057308,0.010160867127464,0.0173548372137105,6.7328064490562e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,-0.0151354696326273,0.00202052941513261,-0.0190957072862873,-0.0111752319789674,7.07159884819619e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDHB15,Protocadherin beta-15,24793,-0.0200589410884857,0.00267808104008269,-0.0253079799270477,-0.0148099022499236,7.1148997440692e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLPS,Colipase,29400,0.0354216524991892,0.00473209894293436,0.0261467385710378,0.0446965664273405,7.33272608295959e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL3,Fc receptor-like protein 3,28931,0.0270028388852485,0.00361438880424341,0.0199186368289314,0.0340870409415656,8.18804667842107e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDK,Midkine,29455,0.0253171253683944,0.00339055465495374,0.0186716382446851,0.0319626124921037,8.43422789175329e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTA,Lymphotoxin-alpha,29434,0.0199589180845034,0.00267400574823815,0.0147178668179566,0.0251999693510502,8.62218116031892e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,0.0266102314902388,0.00356986753615565,0.0196132911193737,0.0336071718611038,9.34137758328965e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTT2B,Glutathione S-transferase theta-2B,24845,0.119352429397357,0.0160237530504857,0.0879458734184054,0.150758985376309,9.75050777320492e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACTN2,Alpha-actinin-2,24111,-0.0295669065569882,0.00397237193592657,-0.0373527555514043,-0.0217810575625721,1.01614303750159e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL6ST,Interleukin-6 receptor subunit beta,29478,0.00874317251915589,0.00117567165385279,0.00643885607760443,0.0110474889607073,1.06003361178201e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCAM1,Neural cell adhesion molecule 1,29594,0.014969543331497,0.00201542174581065,0.0110193167097081,0.0189197699532859,1.13655089038902e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,28797,0.0201760363166689,0.00272527225170476,0.0148345027033276,0.0255175699300102,1.36466437183615e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAYN,Layilin,29163,-0.0172445976736566,0.0023350224766887,-0.0218212417279664,-0.0126679536193467,1.56303171209828e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RLN1,Prorelaxin H1,24867,-0.0339901780415107,0.00460997487494892,-0.0430257287964106,-0.0249546272866109,1.7181036100773e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,0.0349989825236414,0.00474835906433568,0.0256921987575435,0.0443057662897394,1.74163285559221e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSTB,Cystatin-B,29030,0.0208914347402512,0.00283854493441092,0.0153278866688058,0.0264549828116966,1.88915121980289e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSG3,Desmoglein-3,29589,0.0167589964603112,0.00228205632136717,0.0122861660704315,0.0212318268501908,2.12945303945921e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,0.0211286685711964,0.00289148393725379,0.015461360054179,0.0267959770882139,2.79686370095352e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LIFR,Leukemia inhibitory factor receptor,29434,-0.0118461501104589,0.0016216721201448,-0.0150246274659427,-0.0086676727549751,2.84519421843718e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,24793,0.0199543826687996,0.00273222184209938,0.0145992278582848,0.0253095374793144,2.89151713746403e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,28797,0.0174062627859891,0.00238764715596465,0.0127264743602984,0.0220860512116798,3.17623041797378e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSH,Pro-cathepsin H,28852,0.0355343025209879,0.00489376989059369,0.0259425135354243,0.0451260915065516,3.93575802350441e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPP1,Tripeptidyl-peptidase 1,29286,0.0221886693529304,0.00306020826771904,0.0161906611482011,0.0281866775576597,4.24875064296009e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPL14,60S ribosomal protein L14,24240,0.0195081936334413,0.00269414622105779,0.014227667040168,0.0247887202267145,4.58826832731087e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,0.0264306137196421,0.0036540819374044,0.0192686131223294,0.0335926143169547,4.83380728287373e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWF,von Willebrand factor,29820,-0.0349983819247224,0.00483967581125464,-0.0444841465147815,-0.0255126173346632,4.88985864057939e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBLIF,Cobalamin binding intrinsic factor,29433,0.0358137112133466,0.00496735393619331,0.0260776974984077,0.0455497249282855,5.73772903169201e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RCOR1,REST corepressor 1,28916,0.0214855177995861,0.00298177608276112,0.0156412366773743,0.0273297989217979,5.91985224582907e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTUS1,Microtubule-associated tumor suppressor 1,24445,0.0267981741470381,0.00375629164830588,0.0194358425163585,0.0341605057777176,1.00058934568636e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHI3L1,Chitinase-3-like protein 1,28935,-0.0374662220970351,0.00525235219274638,-0.047760832394818,-0.0271716117992522,1.00346206464307e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAA4,Serum amyloid A-4 protein,24966,0.0156330917949009,0.00219220789095445,0.0113363643286302,0.0199298192611716,1.02202536870134e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARB2,Lysosome membrane protein 2,28762,0.0151270699512906,0.00212271579064537,0.0109665470016257,0.0192875929009556,1.05545160068553e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA3,Alpha-1-antichymotrypsin,24883,0.00706605334382641,0.000992392099980609,0.00512096482786441,0.0090111418597884,1.1068052827994e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,28586,-0.018208886437688,0.0025636587481207,-0.0232336575840046,-0.0131841152913714,1.25208355550845e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNLY,Granulysin,29443,0.0247326721886712,0.00348223357495171,0.0179074943817659,0.0315578499955766,1.25272579816867e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF16,Fibroblast growth factor 16,24229,0.0227828689301377,0.003209180966816,0.0164928742351784,0.0290728636250971,1.28870446012547e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA7,Carbonic anhydrase 7,24445,-0.0163346965199141,0.00230130646313954,-0.0208452571876676,-0.0118241358521606,1.3002456007508e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,0.011769957215289,0.00166202613329004,0.00851238599404056,0.0150275284365375,1.45629780385046e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,0.0166527889670294,0.00235221493697208,0.0120424476905641,0.0212631302434946,1.4840379886543e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP1,Metalloproteinase inhibitor 1,29173,0.0133656038849595,0.00189408406005537,0.00965319912725096,0.017078008642668,1.74560832943123e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1B,Interleukin-1 beta,28745,0.0264968213927033,0.00375824449371005,0.0191306621850316,0.033862980600375,1.82539650944193e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYZL2,Lysozyme-like protein 2,24016,0.0169788515077653,0.00241591983020931,0.012243648640555,0.0217140543749755,2.15267103907129e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,0.0141710547232906,0.00201699376374307,0.0102177469463542,0.018124362500227,2.17532707653465e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,-0.0186671662469869,0.00265734802791028,-0.0238755683816911,-0.0134587641122828,2.19984162485695e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF23,Fibroblast growth factor 23,29693,0.0265752021978929,0.00378811862795024,0.0191504896871104,0.0339999147086753,2.34190010013095e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIMAP8,GTPase IMAP family member 8,24016,0.0239313906435863,0.00341661143388785,0.0172348322331661,0.0306279490540065,2.54551652610575e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LXN,Latexin,29117,-0.0314347803160165,0.00449101037468264,-0.0402371606503945,-0.0226323999816386,2.62461271319863e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGT,Angiotensinogen,24951,0.0108064087338102,0.00154549961747333,0.00777722948356251,0.013835587984058,2.77475348270985e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NELL1,Protein kinase C-binding protein NELL1,29566,0.0197153995121913,0.00282205609167755,0.0141841695725033,0.0252466294518793,2.88445494495646e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKK3,Dickkopf-related protein 3,29820,-0.013715803730651,0.00196388496415084,-0.0175650182603867,-0.00986658920091536,2.92872392471543e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300LF,CMRF35-like molecule 1,29725,0.0281050964973889,0.00402457527674569,0.0202169289549674,0.0359932640398105,2.94240746050806e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEPH,Hephaestin,24922,0.0123192362019168,0.00176759281169494,0.00885475429099473,0.0157837181128389,3.25998674558167e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTGDS,Prostaglandin-H2 D-isomerase,29291,0.0141330536826258,0.0020338926726543,0.0101466240442234,0.0181194833210282,3.76191500742377e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,0.0208099738808024,0.00301024218519979,0.0149098991978108,0.026710048563794,4.85827286492492e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITM2A,Integral membrane protein 2A,29434,-0.0278210069041875,0.00402814553327383,-0.0357161721494042,-0.0199258416589708,5.0630270440312e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,0.0161185406476824,0.00233387566023051,0.0115441443536307,0.0206929369417342,5.07298448560867e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEO1,Neogenin,24867,0.0101258676343168,0.00146763589506293,0.00724930127999347,0.0130024339886401,5.34602591868382e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,0.0184652723714953,0.00267837180270312,0.0132156636381972,0.0237148811047934,5.54598375482558e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,L1CAM,Neural cell adhesion molecule L1,29566,0.0133045260568138,0.00193237488227496,0.0095170712875549,0.0170919808260727,5.89154116994486e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTXR,Neuronal pentraxin receptor,29478,0.0156397561344347,0.00227156090289097,0.0111874967647684,0.020092015504101,5.89348295135601e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LHB,Lutropin subunit beta,28797,0.0398341957777069,0.00580258192084798,0.0284611352128449,0.051207256342569,6.78832406665161e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,0.0197744864726155,0.0028811976658056,0.0141273390476366,0.0254216338975945,6.86511052690618e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,28797,0.0264531796276956,0.00385500169778349,0.01889737630004,0.0340089829553513,6.92581886854012e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,24111,0.0457141557735621,0.00666656454214475,0.0326476892709584,0.0587806222761658,7.19057404213468e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,0.0313289185782264,0.00457369288787641,0.0223644805179887,0.0402933566384642,7.56787683006374e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYT1,Synaptotagmin-1,24845,0.0180752636658952,0.00264615104772355,0.012888807612357,0.0232617197194333,8.64064618845601e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP9,Fatty acid-binding protein 9,29434,0.025485713207884,0.00373697713483655,0.0181612380236043,0.0328101883921636,9.28817608007413e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.0156326960879275,0.00229418461526778,0.0111360942420026,0.0201292979338523,9.67204644315789e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMOD1,Leiomodin-1,24867,-0.0161590409644661,0.00237515536084465,-0.0208143454717217,-0.0115037364572106,1.04525610101403e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGR,Tyrosine-protein kinase Fgr,28774,0.0257504181433366,0.00379063803945675,0.0183207675860014,0.0331800687006718,1.11838332196795e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PZP,Pregnancy zone protein,24966,0.0242642201879773,0.00357208914387991,0.0172629254659727,0.0312655149099819,1.12507136687825e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA7,Thyroxine-binding globulin,24966,0.00837935535475705,0.00124013968536307,0.00594868157144544,0.0108100291380687,1.4419296553833e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,0.0220440392779417,0.00327972932865662,0.0156157697937748,0.0284723087621087,1.84018894828433e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,0.0133456834378213,0.00198729570402733,0.00945058385792778,0.0172407830177149,1.90857077205103e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,0.021755104493717,0.00323961956798444,0.0154054501404675,0.0281047588469665,1.91818583125411e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRELP,Prolargin,29454,0.0103968657166536,0.00155160031490743,0.00735572909943505,0.0134380023338722,2.11107174850657e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD302,CD302 antigen,29349,0.0136148393028539,0.00203735563736121,0.00962162225362596,0.0176080563520819,2.38933913696145e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPNMB,Transmembrane glycoprotein NMB,28733,0.0127805678539319,0.00191325498661613,0.0090305880801643,0.0165305476276995,2.43281345040165e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUCA2A,Guanylin,29333,-0.0151712678452196,0.0022856138918184,-0.0196510710731836,-0.0106914646172555,3.24122239626716e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.0217540798490964,0.00328247442434629,-0.0281877297208151,-0.0153204299773777,3.47669072941747e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPME1,Protein phosphatase methylesterase 1,29349,0.0264155945440646,0.003989816084484,0.0185955550184759,0.0342356340696532,3.63531901317568e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL14,C-C motif chemokine 14,29435,0.0174671349637043,0.00264191528653338,0.0122889810020989,0.0226452889253098,3.86839941402641e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,0.0207230365489902,0.00313558677886857,0.0145772864624078,0.0268687866355726,3.93745053148959e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUSP3,Dual specificity protein phosphatase 3,28774,0.0375743523136316,0.00568752674932678,0.0264267998849511,0.0487219047423121,4.00515702963954e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.0294058025561002,0.0044558333904076,-0.0381392360012991,-0.0206723691109013,4.19865752293827e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN2,Contactin-2,29725,0.019637707270318,0.00297822663514228,0.0138003830654391,0.0254750314751968,4.36013209525836e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,0.0254505098811238,0.00387699238570682,0.0178516048051384,0.0330494149571091,5.30755207216152e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,0.0306362956087569,0.00466714477519217,0.0214886918493802,0.0397838993681335,5.33539711360886e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,0.0191809424672158,0.0029229158392887,0.0134520274222099,0.0249098575122217,5.40679928748707e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,0.0172504451462325,0.00263541743753114,0.0120850269686715,0.0224158633237936,6.04028831422295e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSH3,Protein phosphatase Slingshot homolog 3,24016,0.0128371685725011,0.00196821626240928,0.00897946469817888,0.0166948724468233,7.06457800706344e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA1,Alpha-1-antitrypsin,24548,-0.0035509788410754,0.000545340289384378,-0.00461984580826879,-0.00248211187388202,7.58468995453133e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CX3CL1,Fractalkine,29218,-0.0146803512643952,0.00225612694398723,-0.0191023600746102,-0.0102583424541802,7.79680105621294e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS8,Prostasin,29347,0.0177864871216681,0.00273497354929927,0.0124259389650416,0.0231470352782947,7.98137795249886e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAPG,Macrophage-capping protein,29174,0.0252928595279691,0.00389167159619145,0.0176651831994338,0.0329205358565043,8.20354366046075e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIF1C,Kinesin-like protein KIF1C,24111,0.0157826788759126,0.00243480954871591,0.0110104521604294,0.0205549055913958,9.22042673262844e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,0.0129360899156531,0.00199890436218728,0.00901823736576603,0.0168539424655402,9.8488190203757e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A12,Protein S100-A12,29023,0.032147330849501,0.00500619745896025,0.0223351838299389,0.0419594778690631,1.37018257309092e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRISP3,Cysteine-rich secretory protein 3,24738,-0.011656714609294,0.00181520853568332,-0.0152145233392333,-0.0080989058793547,1.37213647415702e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CILP,Cartilage intermediate layer protein 1,24938,0.0233825886653655,0.00364443155467782,0.016239502818197,0.030525674512534,1.42434887355628e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB8,Serpin B8,29786,0.0240816615140285,0.00375479014951969,0.0167222728209699,0.0314410502070871,1.44268448189844e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.0148660129509895,0.00232005806666571,0.0103186991403247,0.0194133267616543,1.50029582062676e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST1,Cystatin-SN,21656,0.0450102134804851,0.00705006176332229,0.0311920924243734,0.0588283345365968,1.75596882390001e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFHD1,EF-hand domain-containing protein D1,24867,0.015044609256764,0.00236014681070127,0.0104187215077895,0.0196704970057385,1.86858199357088e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,0.0114952837911516,0.00180409422338269,0.00795925911332149,0.0150313084689816,1.90126035448248e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL34,Interleukin-34,28722,0.0153560384210857,0.00241347015721846,0.0106256369129375,0.0200864399292339,2.01305233300327e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,0.0229840963743567,0.00361537291262554,0.0158979654656107,0.0300702272831028,2.08315943050355e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAT,Catalase,24587,0.0227303579632068,0.00358126037199715,0.0157110876340924,0.0297496282923212,2.23346294717529e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DIPK2B,Divergent protein kinase domain 2B,24381,0.0119559650291072,0.00188718671535229,0.00825707906701673,0.0156548509911977,2.40960559858278e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12B,Interleukin-12 subunit beta,29786,0.0229937581403609,0.00363097066666442,0.0158770556336986,0.0301104606470232,2.4438203992231e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,0.0165218007612176,0.00261794204962609,0.0113906343439504,0.0216529671784847,2.81298416255899e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RL1,Interleukin-1 receptor-like 1,29736,-0.0194803157945302,0.00310276966808187,-0.0255617443439707,-0.0133988872450897,3.46879655002248e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBS,Cystathionine beta-synthase,24240,0.0214417376321136,0.00342858694212212,0.0147217072255542,0.028161768038673,4.07244292876035e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOF,Apolipoprotein F,24951,0.0104583122591719,0.00167309006183434,0.0071790557379766,0.0137375687803672,4.14713132466134e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,-0.018213459591279,0.00291523291806127,-0.0239273161106791,-0.0124996030718789,4.22247945192315e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,24240,0.0213020636501661,0.00342901486737817,0.0145811945101049,0.0280229327902273,5.30647750934637e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,0.0270631930076059,0.00435791076256893,0.0185216879129708,0.035604698102241,5.36495986261345e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,0.024737657055213,0.00398546595030956,0.0169261437926063,0.0325491703178197,5.47498608404262e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFDN2,Prefoldin subunit 2,28774,0.0230504454026226,0.00371460109353619,0.0157698272592916,0.0303310635459535,5.53149327818668e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COLEC12,Collectin-12,29454,0.0109038216003823,0.00175819118660737,0.00745776687463183,0.0143498763261327,5.65888017128651e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,0.01858839110082,0.00299932085769383,0.0127097222197401,0.0244670599819,5.81175054039083e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDO2,"Tryptophan 2,3-dioxygenase",24195,0.0161796136314151,0.00261090092361978,0.0110622478211203,0.0212969794417098,5.84984360913048e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EXTL1,Exostosin-like 1,24111,0.0197724687535149,0.00319261953486572,0.0135149344651781,0.0260300030418517,5.99151463802204e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,0.0164455657457151,0.00265699918968712,0.0112378473339283,0.0216532841575019,6.12910151082717e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTRC,Chymotrypsin-C,29456,0.0263618831366463,0.00426099908047383,0.0180103249389176,0.034713441334375,6.22117593998967e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL2,Fc receptor-like protein 2,29645,0.0203265778247567,0.00328863691934456,0.0138808494628413,0.026772306186672,6.45869922102534e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NME3,Nucleoside diphosphate kinase 3,29497,0.0098513545529158,0.0015946340370876,0.00672587184022411,0.0129768372656075,6.58438381237358e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,0.0354117475281776,0.00573920990453736,0.0241628961152844,0.0466605989410708,6.93148224642904e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL1,Angiopoietin-related protein 1,29030,0.0120046089754875,0.00194663324075583,0.00818920782360611,0.015820010127369,7.05790884785067e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,0.0208406511047247,0.00338518240393641,0.0142056935930093,0.0274756086164401,7.53619696502903e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,24681,0.0249162820925916,0.00404753922771686,0.0169831052062666,0.0328494589789167,7.57989999804167e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB1A1,Uteroglobin,29523,0.0226980855529899,0.003688960308441,0.0154677233484455,0.0299284477575343,7.70191789699428e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECTIN1,Nectin-1,24229,0.013343474826477,0.00216957136158298,0.00909111495777433,0.0175958346951796,7.85559244249719e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.0116200324751804,0.00189236399345213,0.00791099904801425,0.0153290659023466,8.33202345549165e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD74,HLA class II histocompatibility antigen gamma chain,29694,0.0142001711997616,0.00231256086961842,0.00966755189530955,0.0187327905042137,8.33292765292785e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JCHAIN,Immunoglobulin J chain,28931,-0.0252456880257415,0.00411488210718597,-0.033310856955826,-0.017180519095657,8.61464993880696e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM3B,Protein FAM3B,29349,0.0145856636892685,0.00237927096129267,0.00992229260513486,0.0192490347734021,8.88264910864175e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS22,Brain-specific serine protease 4,24229,0.0143704424413931,0.002344774517769,0.00977468438656581,0.0189662004962203,8.99620408435014e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100P,Protein S100-P,28916,0.0218410692370403,0.00357597073472102,0.0148321665969871,0.0288499718770935,1.02345161314856e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OBP2B,Odorant-binding protein 2b,29137,-0.0254883084691452,0.00418272437106536,-0.0336864482364333,-0.0172901687018571,1.1170645047984e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUC2,Mucin-2,24938,0.0373122800175622,0.00612559853934776,0.0253061068804406,0.0493184531546838,1.13703696690075e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,0.00902894410810349,0.00148655450352114,0.00611529728120206,0.0119425909350049,1.26496896968128e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL3A1,Collagen alpha-1(III) chain,24938,-0.00947568900297331,0.00156011008178034,-0.0125335047632628,-0.00641787324268384,1.26780574661873e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFR4,Fibroblast growth factor receptor 4,24381,0.0215246297898027,0.00354597692310476,0.0145745150205174,0.028474744559088,1.29674293345958e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADM,Pro-adrenomedullin,29725,0.0107458270307853,0.00177230076603443,0.00727211752935785,0.0142195365322128,1.35040782915845e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG1B,Lithostathine-1-beta,29820,-0.0227229558701832,0.00376130619937836,-0.0300951160209648,-0.0153507957194016,1.54744063614217e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OMG,Oligodendrocyte-myelin glycoprotein,29349,0.0264456834158929,0.00438664582943582,0.0178478575901987,0.0350435092415871,1.67276593363106e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,24867,0.0212406861830934,0.00352386127532568,0.014333918083455,0.0281474542827317,1.68679448466353e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,0.0269181869479095,0.00447673352041176,0.0181437892479025,0.0356925846479166,1.84857430781366e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF1,Signaling lymphocytic activation molecule,28931,-0.0238444469479059,0.00397556569603496,-0.0316365557121344,-0.0160523381836774,2.02444292779573e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMOX1,Heme oxygenase 1,29165,-0.0191854242405973,0.00320635830004474,-0.025469886508685,-0.0129009619725097,2.20863243045581e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRTAP,Cartilage-associated protein,24195,0.0195377985931103,0.00326614258873656,0.0131361591191866,0.025939438067034,2.23623916618849e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4M,C-type lectin domain family 4 member M,24888,0.0195892199382394,0.00327818858241884,0.0131639703166985,0.0260144695597803,2.32330306340812e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL4,Myosin light chain 4,24240,-0.0208010395137813,0.00348515958603451,-0.0276319523024089,-0.0139701267251536,2.42831787367108e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPA2,Heat shock-related 70 kDa protein 2,24793,0.0135976471543651,0.00227920882420994,0.00913039785891361,0.0180648964498166,2.46514287551062e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRUNE2,Protein prune homolog 2,24445,0.0116708201111743,0.00195691700163115,0.00783526278797726,0.0155063774343714,2.49701903270122e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAX,Apoptosis regulator BAX,28722,0.0359461788783004,0.0060289836869277,0.0241293708519221,0.0477629869046787,2.51725648382449e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,24788,0.0171813636889435,0.0028898141785282,0.0115173278990282,0.0228453994788588,2.79320643140162e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,0.0412434009360318,0.00693820173721908,0.0276445255310824,0.0548422763409812,2.81287064297571e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLL1,Delta-like protein 1,29566,-0.0118140999216022,0.00199581432927531,-0.0157258960069818,-0.00790230383622263,3.26604210352347e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MET,Hepatocyte growth factor receptor,29507,0.00781007416639384,0.00131967841027434,0.00522350448225613,0.0103966438505315,3.29147123757635e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAMP5,Vesicle-associated membrane protein 5,28916,0.0213574020578759,0.00361207244682424,0.0142777400621004,0.0284370640536514,3.40149825130047e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,0.0147085375652354,0.00249180204665878,0.00982460555378424,0.0195924695766866,3.62204726516823e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,28774,0.0161642734353429,0.00274955830940483,0.0107751391489094,0.0215534077217764,4.17652815751014e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APLP1,Amyloid-like protein 1,29478,-0.0201533097345765,0.00343167413366269,-0.0268793910365554,-0.0134272284325976,4.3326101334523e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DGCR6,Protein DGCR6,24101,0.017171823018068,0.00293257340206285,0.0114239791500248,0.0229196668861112,4.81610570142267e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CIT,Citron Rho-interacting kinase,24195,0.0177642093091631,0.00303493279563243,0.0118157410297235,0.0237126775886026,4.88290848932998e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN2,Ataxin-2,24101,0.0434376373109077,0.00742876677341543,0.0288772544350135,0.057998020186802,5.06305147643169e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSPN,Persephin,29434,0.0366485760149759,0.00627114068412595,0.024357140274089,0.0489400117558627,5.14972941104648e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSTN2,Calsyntenin-2,29786,-0.0154327421368529,0.00264160103152931,-0.0206102801586503,-0.0102552041150554,5.20536802763301e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RETN,Resistin,29362,-0.0164519819244154,0.00281729629821385,-0.0219738826689145,-0.0109300811799163,5.28660626763618e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC25,Leucine-rich repeat-containing protein 25,29349,0.0151875788531311,0.00260542387640999,0.0100809480553676,0.0202942096508947,5.62707694983097e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS11D,Transmembrane protease serine 11D,24801,0.014986395876099,0.00257242205648884,0.00994444864538091,0.0200283431068172,5.75449033550766e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA2,Carbonic anhydrase 2,29368,0.0266554289002216,0.004580823946854,0.0176770139643877,0.0356338438360554,5.98453587476117e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPTLC1,Serine palmitoyltransferase 1,24845,0.0144427825460916,0.00248440265892956,0.00957335333458971,0.0193122117575936,6.19720576971212e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACE,Angiotensin-converting enzyme,24951,-0.010192494242079,0.00175333176247778,-0.0136290244965354,-0.00675596398762253,6.20308337619147e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZBP1,Z-DNA-binding protein 1,24229,0.0157607297439585,0.00272678943379122,0.0104162224537277,0.0211052370341893,7.56356952231784e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM5,Intercellular adhesion molecule 5,29478,0.0172949804451267,0.00300175623127808,0.0114115382318216,0.0231784226584317,8.41389429941093e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGN,Mimecan,29443,-0.0161917909677289,0.00281111838015544,-0.0217015829928336,-0.0106819989426242,8.49957180328787e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA14,Carbonic anhydrase 14,29725,0.0136598849033233,0.00237407274798074,0.00900670231728107,0.0183130674893656,8.81277374861803e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE3,Eosinophil cationic protein,29343,0.0416616747563617,0.00724681831543749,0.0274579108581043,0.0558654386546192,9.06833846821832e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD28,T-cell-specific surface glycoprotein CD28,28797,0.0139454600851235,0.00243611271959374,0.00917067915471974,0.0187202410155272,1.04786051520638e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEZ6L,Seizure 6-like protein,29566,0.0104792373784428,0.00183551692294957,0.0068816242094616,0.0140768505474239,1.14629965733309e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THBS4,Thrombospondin-4,29518,0.0171462752361693,0.0030180268274689,0.0112309426543303,0.0230616078180083,1.34942601345725e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RHOC,Rho-related GTP-binding protein RhoC,29089,0.0441942999433231,0.00778245847508235,0.0289406813321617,0.0594479185544845,1.37009920952329e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNPY2,Protein canopy homolog 2,28916,0.0230955894923349,0.00406912292153581,0.0151201085661248,0.0310710704185451,1.39350134823492e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGN,Secretagogin,28931,-0.0166389163934032,0.00294632623844868,-0.0224137158207626,-0.0108641169660438,1.64473651087394e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM3,Intercellular adhesion molecule 3,29820,-0.00983029873701214,0.00174109448851274,-0.0132428439344971,-0.00641775353952717,1.65672160599185e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CREBZF,CREB/ATF bZIP transcription factor,24016,-0.00988259389132472,0.00175857889161289,-0.013329408518886,-0.00643577926376345,1.9346904420988e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECTIN4,Nectin-4,29566,-0.0119773061686851,0.00213397857887142,-0.016159904183273,-0.00779470815409708,2.01018617845196e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB37,Ras-related protein Rab-37,28931,0.0308177484648764,0.00549264072745094,0.0200521726390726,0.0415833242906803,2.03311207119986e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2,Apoptosis regulator Bcl-2,24805,0.0201577056402092,0.00359375864213476,0.013113938701625,0.0272014725787933,2.05563905961502e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFYA,Nuclear transcription factor Y subunit alpha,24111,0.0144423425707235,0.00257590279200326,0.00939357309839715,0.0194911120430499,2.08464710507386e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLL4,Delta-like protein 4,24240,0.0322373501500901,0.00575506820628355,0.0209574164657744,0.0435172838344059,2.14737909690833e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,24229,0.011520164784074,0.00206551481252741,0.00747175575152033,0.0155685738166278,2.46771266418376e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROBO4,Roundabout homolog 4,24240,-0.00669042161182956,0.00120578643799439,-0.00905376303029856,-0.00432708019336056,2.90983481061471e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JAM2,Junctional adhesion molecule B,29694,0.0098653728142459,0.00178235144552987,0.00637196398100737,0.0133587816474844,3.13798915599127e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,0.0166058097292115,0.00302121791375123,0.0106842226182591,0.0225273968401639,3.90831147975991e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,-0.0117980761254453,0.00214733278615427,-0.0160068483863077,-0.00758930386458292,3.9559768643094e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,0.0105767484657464,0.00192676778183998,0.00680028361334002,0.0143532133181527,4.06645685691175e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,24229,0.0137578792704056,0.00251059835929755,0.00883710648618241,0.0186786520546288,4.29756651388133e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BSG,Basigin,29760,0.00750156587068783,0.0013702539017212,0.00481586822331427,0.0101872635180614,4.42088911705191e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN3,Neuronal-specific septin-3,24867,-0.0277527526787317,0.00507097522689873,-0.0376918641234532,-0.0178136412340102,4.47099158727125e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPA2,Replication protein A 32 kDa subunit,24229,0.0116569689651193,0.00213325597501741,0.00747578725408516,0.0158381506761534,4.69045743112012e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSV,Cathepsin L2,29618,0.015094487654177,0.0027666530899729,0.00967184759783017,0.0205171277105239,4.91249531797556e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,0.0100332284919158,0.00184223135175102,0.0064224550424838,0.0136440019413478,5.1933022337075e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFF1,Trefoil factor 1,29319,-0.0286536720696678,0.00527045627671348,-0.0389837663720263,-0.0183235777673094,5.47220386570714e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,0.00679012778704079,0.00125142922775907,0.00433732650063301,0.00924292907344857,5.82001540322646e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLASP1,CLIP-associating protein 1,24016,0.0265400673038055,0.00489660152661861,0.016942728311633,0.036137406295978,6.0139589265676e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMP10,Bone morphogenetic protein 10,24381,0.0103595666016759,0.00191150993310187,0.00661300713279621,0.0141061260705555,6.03082605777389e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,0.0186687227208282,0.00344862677253692,0.0119094142466559,0.0254280311950006,6.24369484006539e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,0.0151420942691289,0.00279969124967721,0.0096546994197616,0.0206294891184963,6.41438657096123e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTF3,Neurotrophin-3,29434,0.0125293592419171,0.00231684533370738,0.00798834238785059,0.0170703760959835,6.42502119471137e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POF1B,Protein POF1B,24229,-0.0166290807485219,0.0030773557239218,-0.0226606979674086,-0.0105974635296352,6.58991195214427e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MENT,Protein MENT,24381,-0.00816762797191581,0.00151833536745626,-0.0111435652921301,-0.00519169065170153,7.5452001029654e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GZMB,Granzyme B,29434,0.0233646115516521,0.00435235548733583,0.0148339947964739,0.0318952283068304,8.00975872592615e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPA2,Carboxypeptidase A2,29577,0.0233218065820017,0.00435204517216672,0.0147917980445549,0.0318518151194485,8.43956573498449e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,-0.0117346172427845,0.00219239776383345,-0.0160317168598981,-0.00743751762567097,8.74430483276936e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTSL5,ADAMTS-like protein 5,24922,-0.0141171034961454,0.00263881305891872,-0.0192891770916261,-0.00894502990066466,8.88315787923953e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX25,ATP-dependent RNA helicase DDX25,24195,-0.0134961723812373,0.00252440504476991,-0.0184440062689863,-0.00854833849348829,9.05947406886084e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP2,Metalloproteinase inhibitor 2,24922,-0.00950172035722256,0.00177957534413248,-0.0129896880317222,-0.00601375268272291,9.41130339822909e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCND2,G1/S-specific cyclin-D2,24445,0.0131585394922316,0.00246857955355195,0.00832012356726978,0.0179969554171934,9.88605421507545e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOSB,Protein fosB,28774,0.0137770430280203,0.0025882508060303,0.00870407144820095,0.0188500146078397,1.02881170549443e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,-0.0069336685715045,0.00130260153610412,-0.00948676758226857,-0.00438056956074043,1.02985539164398e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.0153666728860592,0.00288896016836094,0.00970431095607175,0.0210290348160466,1.05179234966771e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD59,CD59 glycoprotein,28277,0.00813993786797786,0.00153879914839345,0.0051238915371267,0.011155984198829,1.23361639573059e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,24938,-0.0116919499591326,0.00221126931839067,-0.0160260378231783,-0.00735786209508689,1.25085885950223e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUC16,Mucin-16,29349,0.066320084730286,0.012621624786001,0.041581700149724,0.091058469310848,1.49478837519999e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,29434,-0.0229012794522182,0.00437376383231742,-0.0314738565635603,-0.014328702340876,1.65169064705553e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSC,Dipeptidyl peptidase 1,29446,0.0151043702995992,0.00289379539880871,0.00943253131793415,0.0207762092812643,1.80553993240557e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,24845,0.0107446118807632,0.00206333684848749,0.00670047165772771,0.0147887521037987,1.93035047105644e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP9,Matrix metalloproteinase-9,29411,-0.0210330755862124,0.0040395125744718,-0.0289505202321772,-0.0131156309402477,1.93380281266514e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.0243305094484366,0.0046759202186753,-0.0334953130770402,-0.015165705819833,1.97264083561611e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,0.0115685734116145,0.00222432173699375,0.00720890280710677,0.0159282440161223,1.99619472769221e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MNDA,Myeloid cell nuclear differentiation antigen,29426,0.0336897039457864,0.00649315739393614,0.0209631154536716,0.0464162924379012,2.13407701296268e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,0.00955583007184498,0.0018461596851697,0.00593735708891236,0.0131743030547776,2.28144940315531e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRNN,Cornulin,28580,0.0230845455866879,0.00446620020828704,0.0143307931784453,0.0318382979949305,2.3728590139893e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,29443,-0.0147404038243043,0.00285551843653992,-0.0203372199599225,-0.00914358768868606,2.45812143692378e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A11,Protein S100-A11,29208,0.0156760342192019,0.00303701219449047,0.0097234903180006,0.0216285781204032,2.46367493788594e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFNA4,Ephrin-A4,29169,0.0105867709375084,0.00205342304941503,0.00656206176065496,0.0146114801143619,2.5437515039259e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPC2,NPC intracellular cholesterol transporter 2,24609,0.0110053553369392,0.00213486064423138,0.00682102847424566,0.0151896821996327,2.55497822838096e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,29394,0.0103243948566526,0.00200449332104844,0.00639558794739763,0.0142532017659075,2.61293506259371e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,24240,-0.0209548211705439,0.00407395757370925,-0.028939778015014,-0.0129698643260737,2.71616953413378e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.0137055731923112,0.00267252141326751,-0.0189437151623155,-0.00846743122230685,2.94584858501221e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSF,Cathepsin F,29566,0.0137120875834749,0.00267631364511257,0.00846651283905426,0.0189576623278955,3.01803241229327e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL9A2,Collagen alpha-2(IX) chain,24445,0.0155658665004333,0.00304753998937886,0.00959268812125073,0.0215390448796158,3.28584566599862e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,0.0189473038883969,0.00371016035123566,0.011675389599975,0.0262192181768188,3.29626817234042e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELL,L-selectin,24966,0.00793651650339708,0.00155472413859802,0.00488925719174497,0.0109837758150492,3.33619710911784e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM2,Intercellular adhesion molecule 2,29820,-0.0108415673381072,0.00212542182079471,-0.0150073941068648,-0.00667574056934958,3.40109509894471e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA1549L,UPF0606 protein KIAA1549L,24445,-0.00963197471560293,0.00189160028764588,-0.0133395112793889,-0.005924438151817,3.56990324406811e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,0.0115135157664525,0.00226129157243843,0.00708138428447312,0.0159456472484318,3.57777124865122e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,0.0132381284552179,0.00260664747389871,0.00812909940637643,0.0183471575040594,3.83038882306005e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP4,Guanylate-binding protein 4,28774,0.0166410949020325,0.00328039000525937,0.0102115304917241,0.0230706593123408,3.9422990224523e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CR2,Complement receptor type 2,29594,0.0157029298009203,0.0031086622414937,0.00960995180759263,0.0217959077942479,4.41313348977018e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MELTF,Melanotransferrin,24922,0.0100088658040122,0.00198311284952808,0.0061219646189372,0.0138957669890873,4.51845649522904e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL22,Interleukin-22,24793,-0.0228454614578188,0.00452852336991984,-0.0317213672628617,-0.0139695556527759,4.57219086628229e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGLYRP1,Peptidoglycan recognition protein 1,29673,-0.0142675551098113,0.00282884085852673,-0.0198120831925236,-0.00872302702709888,4.595337432794e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM171B,Protein FAM171B,24793,0.00915620700337812,0.00181748409594395,0.00559393817532798,0.0127184758314283,4.74103749664458e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK8,Kallikrein-8,28443,0.0120932749396017,0.00240482317359454,0.00737982151935639,0.016806728359847,4.96665544448445e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRD3,Bromodomain-containing protein 3,24111,0.0160658190131614,0.00321348496657137,0.00976738847868154,0.0223642495476413,5.78821385200965e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,0.0147376492717369,0.00294865579871851,0.00895828390624867,0.0205170146372252,5.83043203881906e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA1,Carbonic anhydrase 1,28867,0.0198990318988943,0.00398603953080065,0.0120863944185251,0.0277116693792636,6.00486743304582e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL19,Interleukin-19,28654,-0.0233572972137855,0.00469934168802843,-0.0325680069223212,-0.0141465875052497,6.72230481551269e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,0.0232266195502359,0.00467412553111707,0.0140653335092464,0.0323879055912253,6.76051335368786e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA5,Protein disulfide-isomerase A5,24016,0.0204325983646282,0.00411740130222978,0.0123624918122578,0.0285027049169986,7.00681084274586e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NELL2,Protein kinase C-binding protein NELL2,29581,0.00945797662446388,0.00190657778176607,0.00572108417220238,0.0131948690767254,7.06258109220654e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,-0.0135710314847928,0.00273834668929861,-0.0189381909958181,-0.00820387197376751,7.24762358077084e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRTN3,Myeloblastin,28671,-0.0156739527227445,0.00317134304271505,-0.021889785086466,-0.00945812035902301,7.76134247957331e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRA2,GDNF family receptor alpha-2,29349,0.00693754783700634,0.00140568046085828,0.00418241413372411,0.00969268154028858,8.04386753641318e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THY1,Thy-1 membrane glycoprotein,29694,-0.00938422662333753,0.00190610573381405,-0.0131201938616131,-0.005648259385062,8.55769460055894e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,0.0105641022332223,0.00215088211838949,0.00634837328117892,0.0147798311852657,9.08523491246079e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOS1,"Nitric oxide synthase, brain",28774,-0.0177526175231512,0.00361744937775611,-0.0248428183035532,-0.0106624167427493,9.27508602166127e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD2,Sushi domain-containing protein 2,29443,-0.00935369346135273,0.0019069273259947,-0.0130912710203024,-0.00561611590240311,9.38715227614688e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERC2,ERC protein 2,24195,0.0247598186304886,0.00505158658019939,0.0148587089332978,0.0346609283276795,9.57746704737585e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSBP1,Heat shock factor-binding protein 1,24240,0.031336455799719,0.00640643996057481,0.0187798334769923,0.0438930781224456,1.00763380235823e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNC,Tenascin,29594,-0.0155535186654663,0.00318406678159749,-0.0217942895573974,-0.00931274777353524,1.04076110547624e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEG1,Protein LEG1 homolog,23603,-0.0228691897145857,0.00469234389442371,-0.0320661837476562,-0.0136721956815153,1.10224842544641e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXADR,Coxsackievirus and adenovirus receptor,29434,0.0166176605216256,0.00342156325498976,0.00991139654184564,0.0233239245014055,1.19943586108626e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,-0.00895912656021382,0.00184804786540571,-0.012581300376409,-0.00533695274401864,1.25419495277642e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHNAK2,Protein AHNAK2,24240,0.00965038418573418,0.00199238623700786,0.00574530716119877,0.0135554612102696,1.28274250061576e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17A,Interleukin-17A,28879,-0.0138096315745991,0.00285492939920455,-0.01940529319704,-0.00821396995215815,1.32413502543011e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SBSN,Suprabasin,24905,-0.01115502395958,0.00230816052542802,-0.0156790185894189,-0.00663102932974105,1.35384735819318e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,0.0116153438944029,0.00240412263841018,0.006903263523119,0.0163274242656869,1.36390620669776e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCB,Calcitonin gene-related peptide 2,24845,0.0129474626975894,0.00269021152423563,0.00767464811008754,0.0182202772850912,1.49700970646095e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMP4,Bone morphogenetic protein 4,29169,-0.0148557596631867,0.00308982723889684,-0.0209118210514245,-0.00879969827494891,1.53239433218226e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MATN3,Matrilin-3,29169,-0.010311678124294,0.00214816518580806,-0.0145220818884778,-0.00610127436011019,1.59271476842448e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSL5,Insulin-like peptide INSL5,24805,0.0311866651920565,0.00654159756755737,0.018365133959644,0.0440081964244689,1.87641253200212e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPA4,Carboxypeptidase A4,23902,0.0139954307864953,0.00294052556635083,0.00823200067644768,0.0197588608965429,1.95208717751657e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH6,Cadherin-6,29478,-0.0121753322739185,0.00256076969632292,-0.0171944408787114,-0.00715622366912556,1.99818552203962e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,-0.0271382912548339,0.00571244001279443,-0.038334673679911,-0.0159419088297568,2.03665155670224e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLIC5,Chloride intracellular channel protein 5,24195,-0.0101237282901457,0.00213590197335488,-0.0143100961579212,-0.00593736042237012,2.15155902785543e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,-0.0123041006535913,0.00259732960651669,-0.017394866682364,-0.00721333462481855,2.17688312743582e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRR4,Proline-rich protein 4,24203,-0.0221285790979441,0.00467226210562359,-0.0312862128249663,-0.0129709453709218,2.19040803990721e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,0.0198701546659138,0.0042028800280258,0.0116325098109832,0.0281077995208444,2.28300744470799e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD1,Programmed cell death protein 1,29661,0.013521790865296,0.00286343677345899,0.00790945478931636,0.0191341269412756,2.34345525621749e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG3G,Regenerating islet-derived protein 3-gamma,24793,0.0126336463775494,0.00267607246384021,0.00738854434842256,0.0178787484066762,2.36010435275488e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLB1,"Phospholipase B1, membrane-associated",24845,0.0188779872718244,0.00401779101168319,0.0110031168889253,0.0267528576547234,2.63355566504264e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,0.0118466835545911,0.00253329214493667,0.00688143095051523,0.016811936158667,2.93237104552667e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT1,Vascular endothelial growth factor receptor 1,29288,0.00701477875654781,0.00150189650833685,0.00407106160020758,0.00995849591288805,3.01633616957871e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH17,Protocadherin-17,29478,-0.011226843720151,0.00240563537176019,-0.015941889048801,-0.00651179839150107,3.07132156393561e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,28774,0.0451995874658971,0.00969249738245377,0.0262022925962877,0.0641968823355065,3.12487497209369e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL5A1,Collagen alpha-1(V) chain,24381,-0.0126217393069807,0.0027065580718275,-0.0179265931277626,-0.00731688548619876,3.12689677090385e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFB2,Transforming growth factor beta-2 proprotein,24793,0.0163268237106504,0.0035095719598964,0.00944806266925343,0.0232055847520473,3.30294371253861e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HLA_E,,29434,0.00898516596238331,0.00193601569311491,0.00519057520387808,0.0127797567208885,3.48119414261385e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPO,Lactoperoxidase,28452,-0.0186879082378162,0.00402914053073415,-0.0265850236780551,-0.0107907927975773,3.53041675081253e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PON1,Serum paraoxonase/arylesterase 1,24951,0.00821098234813727,0.00177035442235784,0.0047410876803159,0.0116808770159586,3.5350563610034e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH12,Protocadherin-12,24867,0.00791619804577117,0.00171094161039402,0.0045627524893989,0.0112696436021434,3.73217494223776e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1D,V-type proton ATPase subunit D,29349,0.00805773471202845,0.00174322514814888,0.00464101342165663,0.0114744560024003,3.81097126437762e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLYR1,Putative oxidoreductase GLYR1,24793,0.0183475352240915,0.00397058884860143,0.0105651810808327,0.0261298893673503,3.84076051808326e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,0.0569403417373197,0.0123726053156368,0.0326900353186716,0.0811906481559678,4.19941597645054e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CENPF,Centromere protein F,24445,0.0167072906344254,0.00363143507114082,0.00958967789498939,0.0238249033738614,4.23104981053049e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300A,CMRF35-like molecule 8,24381,0.00920016617192733,0.00200858435671438,0.00526334083276714,0.0131369915110875,4.66332571700284e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHX2,Bifunctional epoxide hydrolase 2,28916,0.0188575015776963,0.00412901746675659,0.0107646273428534,0.0269503758125392,4.96634634784265e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP12,Macrophage metalloelastase,29466,0.0161777198836497,0.00354416444318781,0.00923115757500157,0.0231242821922978,5.02450720952675e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNU13,NHP2-like protein 1,24111,0.0191460380019567,0.00419680870376741,0.0109202929425726,0.0273717830613408,5.09069519226291e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR158,Probable G-protein coupled receptor 158,24867,0.0109542002085539,0.00240223764734314,0.00624581441976139,0.0156625859973465,5.13979333152466e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYAR,Cell growth-regulating nucleolar protein,28797,0.0160635603686586,0.00352791799493438,0.00914884109858721,0.02297827963873,5.30348353614286e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,0.0170053094767244,0.00373493722196332,0.00968483252167634,0.0243257864317725,5.31318690296214e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,0.0216074577592719,0.00474970913136208,0.0122980278618022,0.0309168876567415,5.40589099998773e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEO1,RNA polymerase-associated protein LEO1,24867,0.00914656101763103,0.00201571019492025,0.00519576903558735,0.0130973529996747,5.71543315641167e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB2A2,Mammaglobin-A,24111,-0.00960052929951665,0.00211906109707692,-0.0137538890497874,-0.00544716954924589,5.91103654363267e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP1,"Fatty acid-binding protein, liver",29454,-0.0283722691272274,0.00627037266446935,-0.0406621995495873,-0.0160823387048675,6.06848659026032e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,0.0103911005202721,0.00229655193242562,0.0058898587327179,0.0148923423078263,6.07318612427746e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,0.0110716778165767,0.00244881967531669,0.006271991252956,0.0158713643801974,6.17739280737655e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,-0.0102407500972647,0.00226721488666976,-0.0146844912751374,-0.00579700891939194,6.29990065261177e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTX2,Neuronal pentraxin-2,24938,-0.0100845310948421,0.00223319793347212,-0.0144615990444474,-0.00570746314523672,6.33864365844485e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PEAR1,Platelet endothelial aggregation receptor 1,29820,0.00684987274684952,0.00151797014477024,0.00387465126309986,0.00982509423059919,6.43061260493001e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EP300,Histone acetyltransferase p300,24229,0.00912652546777754,0.00202561135448062,0.00515632721299553,0.0130967237225596,6.65057347648436e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,0.013546607083215,0.00300752129855349,0.00765186533805021,0.0194413488283799,6.69138579530511e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMOD4,Tropomodulin-4,24016,-0.0123469459384486,0.00275154183328795,-0.017739967931693,-0.00695392394520424,7.24722993286227e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLP1R,Glucagon-like peptide 1 receptor,24101,-0.0114011233502085,0.00254150241303649,-0.0163824680797601,-0.00641977862065701,7.29157540528822e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,0.0123683052439359,0.00275958963221708,0.0069595095647904,0.0177771009230814,7.42526332024887e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALB1,Calbindin,29349,0.0130367098201901,0.00291666027412367,0.00732005568290773,0.0187533639574725,7.86081574714173e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,24938,0.0183359230390231,0.00410734086455485,0.0102855349444956,0.0263863111335506,8.07270259991021e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.0143688267129599,0.00322124763612371,-0.0206824720797623,-0.00805518134615742,8.20826149893658e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALPI,Intestinal-type alkaline phosphatase,24229,-0.0365860543428049,0.00824722843154646,-0.0527506220686359,-0.0204214866169738,9.19796485171534e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.0190343431474453,0.00429287211516961,-0.0274483724931778,-0.0106203138017129,9.29300453590161e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,28797,0.015504714694121,0.00351081900409399,0.00862350944609676,0.0223859199421452,1.00785644882744e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SATB1,DNA-binding protein SATB1,24867,0.0087794162646675,0.00198830496140108,0.00488233854032138,0.0126764939890136,1.01188511063857e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLAU,Urokinase-type plasminogen activator,29443,0.00856726511867524,0.00194235174108749,0.00476025570614376,0.0123742745312067,1.03369199784986e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT8,"Keratin, type II cytoskeletal 8",24101,-0.0214269310079949,0.0048749770028695,-0.0309818859336191,-0.0118719760823706,1.11098491195248e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,0.0109690962254204,0.0025002141188255,0.00606867655252239,0.0158695158983184,1.15259516675932e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSTN1,Calsyntenin-1,28774,0.0151099919864512,0.00345183309567438,0.00834439911892945,0.021875584853973,1.20536559894675e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF5,Eukaryotic translation initiation factor 5,24111,0.012928024516164,0.00295669191296742,0.00713290836674789,0.0187231406655802,1.23367448489078e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,24101,-0.00970931412258243,0.00222459833144234,-0.0140695268522094,-0.00534910139295544,1.27929612053197e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDKL5,Cyclin-dependent kinase-like 5,24101,-0.0155861449849185,0.00357157809694882,-0.0225864380549382,-0.00858585191489886,1.28273104364851e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC1,Sialoadhesin,29581,-0.0123617604511593,0.00283389010979629,-0.01791618506636,-0.00680733583595853,1.29245483215946e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM4,Intercellular adhesion molecule 4,29434,-0.0153167652870476,0.00351188049433156,-0.0222000510559374,-0.00843347951815769,1.29663397188183e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC38,Leucine-rich repeat-containing protein 38,24195,0.0141121113503723,0.00323805966726556,0.00776551440253182,0.0204587082982128,1.31677089525722e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUCA1,Tissue alpha-L-fucosidase,29623,0.0238991926196149,0.00548871969233662,0.0131413020226351,0.0346570832165947,1.33978287587543e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A14,Protein S100-A14,24867,0.0153689058666821,0.0035409937355748,0.00842855814495546,0.0223092535884087,1.42862722050091e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,-0.011912379052571,0.00274492176702,-0.0172924257159302,-0.00653233238921179,1.43194111927643e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROCR,Endothelial protein C receptor,24111,-0.0104367038450494,0.00240541581905445,-0.0151513188503961,-0.00572208883970268,1.43822071691092e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,24445,0.0202128521278017,0.00465972728079267,0.011079786657448,0.0293459175981553,1.44508607989069e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,-0.00863112481681753,0.00199296998632894,-0.0125373459900222,-0.00472490364361282,1.49069681337241e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YAP1,Transcriptional coactivator YAP1,24845,0.00784100683973798,0.00181071636989191,0.00429200275474985,0.0113900109247261,1.49466387081261e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSC1,Hamartin,24229,0.0217784197653732,0.00503554454730917,0.0119087524526472,0.0316480870780992,1.53184398229518e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHRM1,Muscarinic acetylcholine receptor M1,24195,-0.010687220688307,0.00247525109147733,-0.0155387128276026,-0.00583572854901145,1.58340092344909e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMEM25,Transmembrane protein 25,24867,-0.0130537152824886,0.00302732032237666,-0.0189872631143468,-0.00712016745063035,1.62429148542309e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPR1,Atrial natriuretic peptide receptor 1,24111,-0.0119425699692448,0.00277164899266135,-0.017375001994861,-0.00651013794362855,1.64768861207133e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFD,Vascular endothelial growth factor D,29732,-0.0102882912374941,0.0023889033671069,-0.0149705418370236,-0.00560604063796458,1.66238695497286e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIT,Mast/stem cell growth factor receptor Kit,29545,0.00842375650184459,0.00196253749199282,0.00457718301753867,0.0122703299861505,1.77412309149695e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBA,Lysosomal acid glucosylceramidase,24195,0.0154871935030598,0.00361353003180867,0.00840467464071481,0.0225697123654048,1.82712513308101e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPSAB1,Tryptase alpha/beta-1,29753,0.0149708013104261,0.00349446551806214,0.00812164889502433,0.0218199537258279,1.84017924191635e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TTN,Titin,24111,-0.0192973826540532,0.00450788579798992,-0.0281328388181134,-0.010461926489993,1.86937286108413e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,-0.00813545235267007,0.00190075655538854,-0.0118609352012316,-0.00440996950410853,1.8739130549724e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FSTL3,Follistatin-related protein 3,29351,-0.0091040850923583,0.00212855441565124,-0.0132760517470347,-0.00493211843768187,1.89924338042538e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN10,Ataxin-10,28774,0.0207451248879572,0.0048589451715247,0.0112215923517688,0.0302686574241457,1.96564829025848e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTF4,Neurotrophin-4,28797,0.0112132433672483,0.00263499851583016,0.00604864627622115,0.0163778404582754,2.09239090984758e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD109,CD109 antigen,29443,-0.00956025674571692,0.00225333912023344,-0.0139768014213745,-0.00514371207005937,2.2151497029566e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN3,CCN family member 3,29795,0.0095676189892936,0.00225972351829692,0.00513856089343164,0.0139966770851556,2.30281636564656e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UROS,Uroporphyrinogen-III synthase,24195,0.0193352151986306,0.00457312070394049,0.0103718986189072,0.028298531778354,2.36629407694299e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTRK3,NT-3 growth factor receptor,29694,0.00610131126893121,0.00144561468793155,0.00326790648058539,0.00893471605727704,2.44414232347297e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,0.0120610048298453,0.0028648532213405,0.00644589251601793,0.0176761171436727,2.56135327891086e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPS10,40S ribosomal protein S10,24111,-0.0118471964951054,0.00281513012358778,-0.0173648515373374,-0.00632954145287334,2.58114993618747e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.0158804474196749,0.00377359717504461,0.00848419695658751,0.0232766978827624,2.58225121325634e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLH1,Glutamate carboxypeptidase 2,24229,0.0299353514587441,0.00711490266956931,0.0159901422263882,0.0438805606910999,2.59237527228384e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP10,Inactive dipeptidyl peptidase 10,29434,0.00990519004679905,0.00235449249088696,0.00529038476466062,0.0145199953289375,2.59627076233977e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,0.0119417943533746,0.00284158488259612,0.00637228798348623,0.017511300723263,2.6474637809763e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G2A,"Phospholipase A2, membrane associated",29402,-0.0156167657601744,0.00371673415525148,-0.0229015647044673,-0.00833196681588147,2.65647611788492e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP152,Centrosomal protein of 152 kDa,24016,0.0117604099064121,0.00279968810614622,0.00627302121836553,0.0172477985944587,2.67152213814487e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA1,Annexin A1,24281,0.012033385695805,0.00286689378375496,0.00641427387964526,0.0176524975119647,2.71005207077475e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMNB1,Lamin-B1,24756,0.0164982519105411,0.0039382903203634,0.00877920288262881,0.0242173009384533,2.80919981263191e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NGF,Beta-nerve growth factor,29218,0.0034006031531044,0.000812952385067075,0.00180721647837293,0.00499398982783587,2.88490389064428e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NINJ1,Ninjurin-1,28797,0.0154550125988063,0.00369530601287373,0.00821221281357383,0.0226978123840388,2.89382381914433e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOD,Apolipoprotein D,23787,-0.0122017310706804,0.00291781902996981,-0.0179206563694212,-0.00648280577193954,2.90248057829205e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSAP,Gamma-secretase-activating protein,28797,0.0242218088059227,0.00580410881205247,0.0128457555342998,0.0355978620775455,3.01209137381439e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCN,Decorin,28916,-0.00637487285573314,0.00152962148067765,-0.00937293095786133,-0.00337681475360495,3.08698595866167e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,0.010473976548108,0.00252637943971526,0.00552227284626609,0.0154256802499499,3.39527769794163e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HLA_DRA,,29322,-0.00998540931912506,0.00241259518215207,-0.0147140958761431,-0.005256722762107,3.50000629166044e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCF2,Neutrophil cytosol factor 2,29395,0.0229039870955841,0.00553823805065173,0.0120490405163067,0.0337589336748615,3.54997689082278e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC6A,C-type lectin domain family 6 member A,28797,-0.0129492655618585,0.00314094697349332,-0.0191055216299055,-0.00679300949381162,3.75462949530226e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,0.0171280610523886,0.00415530245826292,0.00898366823419329,0.0252724538705839,3.76884986081747e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPO,Erythropoietin,29434,-0.0208792346650199,0.00506559949843574,-0.0308078096819539,-0.0109506596480859,3.77002470568985e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC10A,C-type lectin domain family 10 member A,29218,-0.00995338841735434,0.00242007550811994,-0.0146967364132694,-0.00521004042143926,3.91886996246281e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDK2,Protein sidekick-2,24381,0.0106716487949239,0.00259666105291177,0.00558219313121681,0.0157611044586309,3.97369130684361e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,-0.00656114107864399,0.00159851540775805,-0.00969423127784976,-0.00342805087943822,4.06239387212867e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA1549,UPF0606 protein KIAA1549,24445,0.0191272237522341,0.00466621993818851,0.00998143267338461,0.0282730148310836,4.16129596303115e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,0.00857038539715578,0.00209282467965931,0.00446844902502354,0.012672321769288,4.23304704362022e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,0.0183286308116783,0.00447624017657029,0.00955520006560052,0.0271020615577561,4.24149917004119e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,-0.008649702230419,0.00211588449361984,-0.0127968358379139,-0.00450256862292411,4.3654820994036e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMS1,PMS1 protein homolog 1,24195,0.0138293889818413,0.00340217570994786,0.0071611245903435,0.0204976533733391,4.82119447569304e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXNB2,Plexin-B2,29701,0.00646739943291279,0.00159306282933166,0.00334499628742273,0.00958980257840285,4.92560863953432e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,24445,0.0119273366224487,0.00294019008745968,0.00616456405102774,0.0176901091938697,4.99350962695188e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,24016,0.0161630327747771,0.00398448903795579,0.00835343426038378,0.0239726312891705,4.99734823649494e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM26,Tripartite motif-containing protein 26,24016,0.0152288686511404,0.00375954315394727,0.00786016406940379,0.0225975732328771,5.12200461013694e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN5,CCN family member 5,29443,0.0104954053260307,0.00259726490837141,0.00540476610562278,0.0155860445464387,5.33713643022878e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC13A1,Solute carrier family 13 member 1,24793,0.0165163755547781,0.00408887452339136,0.00850218148893106,0.0245305696206252,5.37620682421498e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAM,Integrin alpha-M,29443,-0.00852723994907827,0.00211240936844328,-0.0126675623112271,-0.00438691758692944,5.43369753519225e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,24938,0.00582149258228496,0.00144324419920127,0.00299273395185047,0.00865025121271945,5.5088672035125e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,0.00706352774270007,0.00175530170553995,0.00362313639984176,0.0105039190855584,5.73603885056423e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,-0.00704855752097511,0.00175165228978217,-0.0104817960089482,-0.00361531903300206,5.74043552349511e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRISP2,Cysteine-rich secretory protein 2,29725,0.0154583009393267,0.00384506538476095,0.00792197278519522,0.0229946290934582,5.82684458276312e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDRG1,p53 and DNA damage-regulated protein 1,24195,0.0140580009004297,0.00350333806319138,0.00719145829657459,0.0209245435042848,6.01974845718667e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTPP1,dCTP pyrophosphatase 1,29478,0.00847447463784059,0.00212088039383552,0.00431754906592297,0.0126314002097582,6.46507650749355e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,0.0167824963720397,0.00421640846829456,0.00851833577418242,0.0250466569698971,6.90290917261407e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RALY,RNA-binding protein Raly,24793,0.0127926933684971,0.00322104392149211,0.00647944728237254,0.0191059394546216,7.1593619315685e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLGN,Calmegin,24195,0.0119299905932501,0.00301078219671544,0.00602885748768779,0.0178311236988123,7.44060409672329e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VNN2,Vascular non-inflammatory molecule 2,29349,-0.0121489875889581,0.00307012735602912,-0.0181664372067751,-0.006131537971141,7.60243461823584e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKCQ,Protein kinase C theta type,28931,0.0115019869607403,0.0029118901284821,0.00579468230891541,0.0172092916125653,7.83341156814626e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB5,Integrin beta-5,29566,0.00993205939450286,0.00251658444422099,0.00499955388382972,0.014864564905176,7.94379850310765e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGFLAM,Pikachurin,24805,0.00813778406263178,0.0020631939928283,0.0040939238366883,0.0121816442885752,8.02652368536173e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,29400,0.0222190098855143,0.00563705641671155,0.0111703793087596,0.0332676404622689,8.11278855410691e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.0224184369171849,0.00569416229002599,-0.0335789950056359,-0.011257878828734,8.27057802912122e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBPMS,RNA-binding protein with multiple splicing,24229,0.0169417301553455,0.00432160319690589,0.00847138788940992,0.025412072421281,8.87035259159589e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,0.0170188518655282,0.00434496027146132,0.00850272973346402,0.0255349739975924,8.99321710823571e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX3,Syntaxin-3,24845,0.0100628460789558,0.0025706358960074,0.00502439972278133,0.0151012924351303,9.0820041843344e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CENPJ,Centromere protein J,24445,0.0188036448365326,0.00481184094841982,0.00937243657762972,0.0282348530954354,9.33967408859334e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSL4,Early placenta insulin-like peptide,24793,-0.0134468291077266,0.00344346330481059,-0.0201960171851553,-0.00669764103029782,9.4463159469154e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PREB,Prolactin regulatory element-binding protein,28931,0.00756903497165847,0.00193850874133731,0.00376955783863735,0.0113685121046796,9.46089064573665e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,0.0227604644696115,0.00583280041565272,0.0113281756549321,0.0341927532842908,9.55996875253384e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR4,Toll-like receptor 4,24229,0.00741955358647749,0.00190244422933123,0.00369076289698827,0.0111483442759667,9.64478366255793e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDHR1,Cadherin-related family member 1,28774,0.0111410628516786,0.00285776057998695,0.00553985211490418,0.016742273588453,9.69982912331022e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAPS,Calcyphosin,24845,0.0247311692179906,0.00634841590146059,0.0122882740511278,0.0371740643848533,9.81947201747374e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX5,Syntaxin-5,24229,0.0106462902572722,0.0027403138307528,0.00527527514899672,0.0160173053655477,0.000102575682302679
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF3,Granulocyte colony-stimulating factor,28931,0.0125299650303895,0.00323482879582505,0.00618970059057244,0.0188702294702066,0.000107539306817215
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMNB2,Lamin-B2,24845,0.00725324188649301,0.00187505042423184,0.00357814305499859,0.0109283407179874,0.000109880171468291
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRLF1,Cytokine receptor-like factor 1,29581,0.00657118575367754,0.00172204689196889,0.00319597384541851,0.00994639766193657,0.000135954944929661
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,0.00900138369408563,0.0023592783596593,0.00437719810915341,0.0136255692790179,0.000136293816063622
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,28916,0.0135472706043798,0.00356335680642622,0.00656309126378446,0.0205314499449752,0.000143927170952899
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD55,Complement decay-accelerating factor,28490,0.0066657975294973,0.00175532371558124,0.00322536304695806,0.0101062320120365,0.00014648094635634
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMRK2,Nicotinamide riboside kinase 2,24016,-0.0105891972209756,0.00278920266670855,-0.0160560344477243,-0.00512235999422683,0.000147116587203348
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,28797,0.0100720085296978,0.00266015634735674,0.00485810208887861,0.015285914970517,0.000153250224007252
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHPK,Sedoheptulokinase,24445,-0.0105267274697114,0.00278141515351691,-0.0159783011706046,-0.00507515376881826,0.000154282684727585
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF9,Fibroblast growth factor 9,23970,0.010353253866989,0.00274009213168421,0.00498267328888797,0.0157238344450901,0.000158200438013239
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFF2,Trefoil factor 2,29536,-0.0145211002171672,0.00384898707280768,-0.0220651148798702,-0.00697708555446415,0.000161801247130452
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WIF1,Wnt inhibitory factor 1,29725,0.00855668313988169,0.00227422310127807,0.00409920586137667,0.0130141604183867,0.000168570459284049
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FRMD7,FERM domain-containing protein 7,24195,0.00844672825163795,0.0022490049945026,0.00403867846241286,0.012854778040863,0.00017321973592083
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TK1,"Thymidine kinase, cytosolic",24445,0.0114991941207017,0.00306666468439521,0.00548853133928709,0.0175098569021163,0.000177426500565671
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGA4,Pepsin A-4,24951,0.0178257686540683,0.00476237117722566,0.00849152114670602,0.0271600161614306,0.000182211806877697
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GM2A,Ganglioside GM2 activator,24421,0.00960327025768206,0.00257197379499609,0.00456220161948973,0.0146443388958744,0.000189030700657189
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD209,CD209 antigen,29527,0.00966070440293547,0.00259646398058645,0.00457163500098603,0.0147497738048849,0.000199027230281734
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOX9,Transcription factor SOX-9,24195,0.00680203085179652,0.00183140249758896,0.00321248195652216,0.0103915797470709,0.000204378239503675
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIL1,Nucleotide exchange factor SIL1,24240,0.0080322017941504,0.00216438706600436,0.00379000314478185,0.012274400443519,0.000206842926415052
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX18,Sorting nexin-18,24805,0.0110833066972824,0.00298881521632332,0.00522522887328872,0.0169413845212761,0.000209142403185978
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UMOD,Uromodulin,29750,-0.013300836075471,0.00360129654356474,-0.0203593773008579,-0.00624229485008407,0.000221718180736676
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRND,Prion-like protein doppel,24845,-0.0127512394779494,0.00345324080637157,-0.0195195914584377,-0.00598288749746115,0.000222498443897102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,0.0105000743149849,0.00284551446112919,0.00492286597117169,0.0160772826587981,0.00022462627522689
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,0.0152593995139108,0.00413940956662727,0.0071461567633214,0.0233726422645003,0.000227973709401583
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STC2,Stanniocalcin-2,29396,-0.00638419428136324,0.00173254520438682,-0.00977998288196141,-0.00298840568076508,0.000229235236738777
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBM19,Probable RNA-binding protein 19,24111,-0.0118279098101562,0.00321233025762115,-0.0181240771150937,-0.00553174250521875,0.000231885571249112
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAL,Galanin peptides,29581,0.0158444272233179,0.0043046286225867,0.00740735512304792,0.0242814993235878,0.000232927044928816
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTP1,Glutathione S-transferase P,28604,-0.0171426631551176,0.00466089256370093,-0.0262780125799714,-0.0080073137302638,0.000235520459322961
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,24195,0.007317186699559,0.00199291157103348,0.00341108002033337,0.0112232933787846,0.000241549656927083
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,0.0134929862946636,0.00367790104901683,0.00628430023859064,0.0207016723507366,0.000244330059224623
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACTA2,"Actin, aortic smooth muscle",28916,-0.0106721110964375,0.00291213602859568,-0.016379897712485,-0.00496432448038995,0.000248069425515932
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TERF1,Telomeric repeat-binding factor 1,24229,-0.0072183375071361,0.00196991164913486,-0.0110793643394404,-0.00335731067483178,0.000248549948998362
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,0.0135913386517434,0.00372118999867308,0.00629780625434418,0.0208848710491427,0.000260241790948852
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCAM2,Neural cell adhesion molecule 2,29443,-0.0065602808363715,0.00179945934016995,-0.0100872211431046,-0.0030333405296384,0.000267128856905679
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNGR1,Interferon gamma receptor 1,29581,0.00508081292545731,0.00140417242134774,0.00232863497961573,0.00783299087129889,0.000296960418726482
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BABAM1,BRISC and BRCA1-A complex member 1,24229,0.00713561348890303,0.0019737545742059,0.00326705452345947,0.0110041724543466,0.000300668215045914
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRP2,Neuropilin-2,29443,-0.00690750648496897,0.00191344951630149,-0.0106578675369199,-0.00315714543301805,0.00030673384562021
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,-0.0171043161906553,0.00475122903180322,-0.0264167250929896,-0.00779190728832094,0.000318764532391184
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC4A1,Band 3 anion transport protein,24938,-0.0112541906778138,0.00313306690856098,-0.0173950018185933,-0.00511337953703428,0.000328694860982491
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MB,Myoglobin,29820,-0.0125781371376468,0.00350333004455984,-0.0194446640249841,-0.00571161025030953,0.000330780395845341
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP7,Dipeptidyl peptidase 2,29279,0.0143579794818789,0.00401749837626258,0.00648368266440429,0.0222322762993536,0.000352321596158191
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRK1,NKG2-D type II integral membrane protein,24845,0.0111008131341147,0.00311292258448713,0.00499948486851997,0.0172021413997095,0.000363094192692262
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBC1D17,TBC1 domain family member 17,28774,0.0106259985761316,0.00298068406048906,0.00478385781757305,0.0164681393346902,0.000364511158986736
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.00616924806962246,0.00173423602913214,0.00277014545252345,0.00956835068672146,0.000375367865685302
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCAR,Immunoglobulin alpha Fc receptor,29434,-0.0113353749598688,0.00318725563696524,-0.0175823960083207,-0.00508835391141697,0.000376463391842465
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,24229,-0.0144433189648085,0.00407534693868159,-0.0224309989646244,-0.00645563896499263,0.000394741046238476
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,0.00692750506933326,0.00195570354326732,0.0030943261245293,0.0107606840141372,0.000397541019238317
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RCC1,Regulator of chromosome condensation,24793,0.012200579952093,0.00344737473068833,0.00544372547994384,0.0189574344242421,0.000402239283875803
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANSC4,MANSC domain-containing protein 4,24111,0.0158169828297709,0.0044699652014913,0.00705585103484798,0.0245781146246939,0.000403160562683393
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,0.00704361831802615,0.00200335844712238,0.00311703576166629,0.010970200874386,0.000438931348904266
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFASC,Neurofascin,29786,0.00664509263962753,0.00189074488952564,0.00293923265615728,0.0103509526230978,0.000441175378671707
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,0.0109656379763855,0.00312229666454324,0.00484593651388078,0.0170853394388903,0.000445465870992801
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FMR1,Synaptic functional regulator FMR1,28797,0.00832581196255376,0.00237261700885176,0.00367548262520431,0.0129761412999032,0.000450268221199234
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,-0.00604113432220213,0.00172194621097897,-0.00941614889572091,-0.00266611974868335,0.000451747556543666
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCN2,Transcobalamin-2,29757,-0.00699508884411147,0.00200330153984549,-0.0109215598622086,-0.00306861782601431,0.000480508556618844
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB39B,Ras-related protein Rab-39B,24111,0.0211485052986827,0.00606306867055038,0.00926489070440393,0.0330321198929614,0.000487358935396756
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP8,Neutrophil collagenase,29640,-0.0168235842263915,0.00483319722892205,-0.0262966507950787,-0.00735051765770426,0.000500564024870685
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PI16,Peptidase inhibitor 16,24951,0.00571751390787146,0.0016435986905003,0.00249606047449087,0.00893896734125205,0.00050479520994
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,0.0110300473040032,0.00317448890063839,0.00480804905875193,0.0172520455492544,0.000512388096705044
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,24240,0.00717163312393991,0.00206635712601018,0.00312157315695995,0.0112216930909199,0.00052007525531271
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIF1L,Allograft inflammatory factor 1-like,24240,0.0133065470036141,0.00383967324959621,0.00578078743440553,0.0208323065728227,0.000530080960377818
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA2,Ephrin type-A receptor 2,28347,-0.00728664041426482,0.00210264850476895,-0.011407831483612,-0.00316544934491768,0.000530112315395513
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCC,Netrin receptor DCC,24195,0.00531063795331042,0.00153335026905837,0.00230527142595602,0.00831600448066482,0.000534275603108006
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INHBB,Inhibin beta B chain,24381,0.0120219774500382,0.00347544104706387,0.005210112997793,0.0188338419022834,0.00054286408520938
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP2,Guanylate-binding protein 2,28931,0.0137916580905664,0.00400532958114361,0.00594121211152491,0.0216421040696078,0.000575418437049314
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPP1,Osteopontin,29757,-0.0105981397984696,0.00307835007825964,-0.0166317059518585,-0.00456457364508072,0.000576519672290062
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,0.00832348382111193,0.00242266112290158,0.00357506802022483,0.013071899621999,0.000592064043733632
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP5,Rho GTPase-activating protein 5,24016,0.0176603153104683,0.00514391607735837,0.00757823979884591,0.0277423908220907,0.000597413142143743
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NME1,Nucleoside diphosphate kinase A,24229,-0.00503104151031114,0.00146944822114791,-0.00791116002376105,-0.00215092299686123,0.000618628501715904
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SULT1A1,Sulfotransferase 1A1,29694,-0.0293321148394915,0.00856867728272073,-0.0461267223136241,-0.0125375073653589,0.000619768783970206
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENO1,Alpha-enolase,29392,0.017974164995491,0.00526496070080928,0.00765484202190481,0.0282934879690772,0.000641213559785675
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UNC5D,Netrin receptor UNC5D,24229,0.00602067721514624,0.00177175928510737,0.00254802901633579,0.00949332541395669,0.000679561621991259
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA6C,Semaphorin-6C,24229,0.00594553731869767,0.00175754694940431,0.00250074529786523,0.0093903293395301,0.0007184845682093
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUP50,Nuclear pore complex protein Nup50,24111,-0.00764821333183823,0.00226871000624631,-0.012094884944081,-0.00320154171959547,0.000749664682751057
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOA4,Apolipoprotein A-IV,24966,0.00805965317375283,0.0023960458692301,0.00336340327006184,0.0127559030774438,0.000770122049761921
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOM1,Myomesin-1,24101,0.0107416548640406,0.00319912939175364,0.00447136125620341,0.0170119484718777,0.000787210399009421
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,0.0143023325316674,0.00426691475885943,0.00593917960430294,0.0226654854590319,0.000803596339777564
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNR,Tenascin-R,29218,0.00941965823173947,0.00282039838564443,0.00389167739587639,0.0149476390676026,0.000839338592514903
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG4,Regenerating islet-derived protein 4,29497,0.0110377575429861,0.00331688346242389,0.00453666595663527,0.0175388491293369,0.000876576295722161
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,0.00941453520850702,0.00282969699625026,0.00386832909585652,0.0149607413211575,0.000878988184473604
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARTN,Artemin,28931,0.00994806562746297,0.0029919462433421,0.00408385099051245,0.0158122802644135,0.000885449911651844
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTRL,Chymotrypsin-like protease CTRL-1,24845,-0.0151260887081918,0.00456049523378557,-0.0240646593664115,-0.00618751804997203,0.000911970129316241
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK15,Kallikrein-15,24754,0.0114793764469185,0.00346573324920692,0.00468653927847289,0.018272213615364,0.000926812759422213
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF1,Macrophage colony-stimulating factor 1,29581,-0.00595304729163041,0.00180254025715787,-0.00948602619565983,-0.00242006838760098,0.000959107419672565
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYO6,Unconventional myosin-VI,24867,0.0082470888738924,0.00250331277968853,0.00334059582570287,0.0131535819220819,0.000987453468894426
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,24229,0.00806343059402636,0.00245377156925146,0.0032540383182935,0.0128728228697592,0.00101715849522734
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,0.0156947794150666,0.00477608282414199,0.00633365707974832,0.0250559017503849,0.00101718573446548
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,-0.00696858797359927,0.00212726200065808,-0.0111380214948891,-0.00279915445230944,0.00105493318767764
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA4C,Semaphorin-4C,29349,0.00614302138399699,0.00188055975031468,0.00245712427338022,0.00982891849461376,0.00108975392825325
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL12,Stromal cell-derived factor 1,28931,0.00868553631214512,0.00267608713402054,0.00344040552946485,0.0139306670948254,0.00117332366263102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,24445,0.0126078028773436,0.00390042259923735,0.0049629745828384,0.0202526311718488,0.00122909372760438
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.0105672637580313,0.00328568030168699,-0.0170071971493378,-0.00412733036672482,0.00130090557400556
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,0.00805126535835061,0.00251239066956764,0.00312697964599804,0.0129755510707032,0.00135383591833399
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTN,Neuroplastin,28797,0.0174413322037854,0.00545218691789721,0.00675504584470689,0.028127618562864,0.00138073289906227
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFB,Vascular endothelial growth factor B,24229,0.00619850675914811,0.00193989908936636,0.00239630454399005,0.0100007089743062,0.00139877811096911
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G15,Phospholipase A2 group XV,29566,0.0056544994978017,0.0017710191409112,0.00218330198161576,0.00912569701398765,0.00141050936884114
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPON1,Spondin-1,29497,0.00696092972514848,0.00219188185816313,0.00266484128314875,0.0112570181671482,0.00149589182327294
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARG1,Arginase-1,29216,0.0109219100995733,0.00346072604741355,0.00413888704664272,0.0177049331525038,0.00160133708445461
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,28967,0.00922055465649826,0.00292808897549684,0.00348150026452444,0.0149596090484721,0.00163996170097654
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,-0.00724206039956663,0.00230063765553364,-0.0117513102044126,-0.00273281059472068,0.00164677126961125
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMBS,Porphobilinogen deaminase,29725,0.00904673473668026,0.00287606324843702,0.0034096507697437,0.0146838187036168,0.00165951339105591
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.00621790046257896,0.00198678886996674,-0.0101120066477138,-0.00232379427744415,0.00175233208608625
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCN15,Lipocalin-15,24867,-0.0130483427434273,0.00417281591204571,-0.0212270619310369,-0.00486962355581768,0.00176811220412764
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTA4H,Leukotriene A-4 hydrolase,29725,0.012178715012518,0.00391464371935561,0.00450601332258103,0.019851416702455,0.00186589785210644
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GZMH,Granzyme H,28916,0.0158625688026542,0.0051078739343836,0.00585113589126235,0.025874001714046,0.00190132980944182
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VIM,Vimentin,28916,0.024133662188033,0.0077931164448779,0.00885915395607234,0.0394081704199937,0.00195814203391007
NMR metabolomics,X23503.Total Lipids in Medium VLDL,METAP1,Methionine aminopeptidase 1,28774,0.00618266482258968,0.00199886576879226,0.00226488791575685,0.0101004417294225,0.00198276057139897
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFC1,Cryptic protein,28797,0.00970910221019855,0.00314124600163763,0.00355226004698881,0.0158659443734083,0.00199778760306096
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEDD9,Enhancer of filamentation 1,24229,0.00690474110829934,0.00223649811386582,0.00252120480512234,0.0112882774114763,0.00202211671140096
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTO1,Protein LTO1 homolog,28931,0.0084877841618212,0.00275108911474586,0.00309564949691932,0.0138799188267231,0.00203576408283364
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRCAM,Neuronal cell adhesion molecule,29478,0.00582310699252047,0.00189137217691227,0.00211601752577242,0.00953019645926852,0.00208045497540833
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA10,Annexin A10,28774,-0.016846815584508,0.00548593922987501,-0.027599256475063,-0.00609437469395294,0.00213607831058122
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,-0.00867065264373215,0.00282349875915669,-0.0142047102116793,-0.00313659507578505,0.00213616667239161
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIMAP7,GTPase IMAP family member 7,24381,-0.00662337634173063,0.00216580563400581,-0.010868355384382,-0.00237839729907924,0.00222943419402175
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,0.0104480616381463,0.00343067280880937,0.00372394293287996,0.0171721803434127,0.00232557439375493
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,29581,0.005375443756698,0.00176528602478013,0.00191548314812894,0.00883540436526705,0.00232820158595121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,29443,-0.00688676537647827,0.00226440891504367,-0.0113250068499639,-0.00244852390299268,0.00235759825678628
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFDC2,WAP four-disulfide core domain protein 2,27939,-0.00811310003885122,0.00267161949279135,-0.0133494742447223,-0.00287672583298018,0.00239346529324819
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AOC3,Membrane primary amine oxidase,29594,-0.00611682876066435,0.00201597291271837,-0.0100681356695924,-0.00216552185173635,0.00241398168018479
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,29694,0.00471711129506795,0.00155627497695798,0.0016668123402303,0.00776741024990559,0.00243933536306966
NMR metabolomics,X23503.Total Lipids in Medium VLDL,QSOX1,Sulfhydryl oxidase 1,24502,0.00865794584619083,0.0028587180894264,0.00305485839091509,0.0142610333014666,0.00245936401260367
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17RA,Interleukin-17 receptor A,29443,0.00889976945951009,0.00294274153003269,0.00313199606064602,0.0146675428583741,0.0024941382722369
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR101,Probable G-protein coupled receptor 101,24101,-0.0125013580157983,0.00413361830308106,-0.0206032498898371,-0.00439946614175938,0.00249460427733637
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL6,Interleukin-6,29349,-0.0148800709293023,0.0049259123206714,-0.0245348590778183,-0.00522528278078639,0.002523460362202
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOBR,Apolipoprotein B receptor,24240,-0.00861430231885552,0.00285304401696021,-0.0142062685920975,-0.0030223360456135,0.00253591956686364
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.0175672736278477,0.00581991218261361,-0.0289743015057704,-0.00616024574992502,0.00254306561054821
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.00761135114243135,0.00252309969255082,0.00266607574503174,0.012556626539831,0.00255797612334325
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDRG1,Protein NDRG1,28774,0.0135928631306808,0.00450716852726542,0.00475881281724062,0.0224269134441211,0.0025649892090893
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIRREL2,Kin of IRRE-like protein 2,28774,0.00805587900740482,0.00267139558771165,0.00281994365548998,0.0132918143593197,0.0025668933142348
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD80,T-lymphocyte activation antigen CD80,24922,0.00690007851447681,0.00228972955757344,0.00241220858163287,0.0113879484473207,0.00258520630225782
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYH7B,Myosin-7B,24016,-0.00892748253255811,0.00297922055031185,-0.0147667548111693,-0.00308821025394689,0.00273302642216376
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPO,Myeloperoxidase,29443,0.00916031274122688,0.00306481861273805,0.0031532682602603,0.0151673572221935,0.00280251895442629
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP290,Centrosomal protein of 290 kDa,24445,0.0106267459192502,0.00355714632028929,0.00365473913148319,0.0175987527070172,0.00281607771487579
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,0.010759051272896,0.00360314916137854,0.0036968789165941,0.017821223629198,0.00282878310512574
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAFB2,Scaffold attachment factor B2,24867,0.00546184093050057,0.00183808749916172,0.00185918943214359,0.00906449242885755,0.00296651462575205
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,-0.00800294503790052,0.00269499634710842,-0.013285137878233,-0.00272075219756802,0.00298523254163804
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LIF,Leukemia inhibitory factor,28774,0.0101820760337748,0.00343426612255444,0.00345091443356812,0.0169132376339815,0.00303081227207038
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ART3,Ecto-ADP-ribosyltransferase 3,29594,-0.00680845251759439,0.00229828072972802,-0.0113130827478613,-0.00230382228732747,0.00305482590796605
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEPACAM2,HEPACAM family member 2,24845,-0.00833739682625209,0.00281466111458684,-0.0138541326108423,-0.00282066104166188,0.00305806425251169
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP164,Centrosomal protein of 164 kDa,28931,0.0124705972216135,0.00421576521007041,0.0042076974098755,0.0207334970333515,0.00309805933234888
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB7,Integrin beta-7,29725,0.00903698370932349,0.00306081812485487,0.00303778018460795,0.015036187234039,0.00315485893585614
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC16A1,Monocarboxylate transporter 1,28774,0.0113954827946763,0.00386014182466065,0.00382960481834144,0.0189613607710112,0.00315886675853565
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPESP1,Sperm equatorial segment protein 1,24922,0.00599029364248022,0.00203385558089253,0.00200393670393087,0.00997665058102958,0.00322950876918424
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GKN1,Gastrokine-1,28114,0.00552785181898584,0.00187882037206848,0.00184536388973161,0.00921033974824007,0.00326163014179148
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSRP3,Cysteine and glycine-rich protein 3,24111,-0.0194572521543269,0.00661509278030695,-0.0324228340037285,-0.00649167030492528,0.0032710402698443
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFA,Protransforming growth factor alpha,29434,0.00915080901337235,0.00311847899972872,0.00303859017390406,0.0152630278528406,0.00334470598101715
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAG,S-arrestin,24101,-0.0103884620889501,0.00354102498003242,-0.0173288710498137,-0.00344805312808656,0.00335215592830727
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.00585361264807054,0.00200291147959521,0.00192790614806393,0.00977931914807715,0.0034744463251997
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA11,Serpin A11,29820,-0.0079845063760362,0.00273413788851296,-0.0133434166375216,-0.0026255961145508,0.00349955094585672
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FBLN2,Fibulin-2,24938,-0.00612695340756278,0.00210366117768882,-0.0102501293158329,-0.00200377749929269,0.00358844341120201
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDA1,DET1- and DDB1-associated protein 1,24111,0.00780921890725938,0.00268228639209277,0.00255193757875756,0.0130665002357612,0.00360138368132977
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN2B,Sodium channel subunit beta-2,24195,-0.00565148064673624,0.00194181496405888,-0.00945743797629164,-0.00184552331718083,0.00361282369919037
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,24845,0.00762891881182382,0.00262329446613865,0.00248726165819207,0.0127705759654556,0.0036390256714854
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEZ6L2,Seizure 6-like protein 2,29349,-0.00463062850535483,0.00160199937934885,-0.00777054728887858,-0.00149070972183109,0.00384873909185816
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMPD3,AMP deaminase 3,24845,0.0136882400672827,0.0047468248310324,0.00438446339845915,0.0229920167361062,0.00393417594561351
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL11,Interleukin-11,28931,0.0120304539742256,0.00417250438158163,0.00385234538632563,0.0202085625621256,0.0039386089106976
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD6,Programmed cell death protein 6,29478,-0.013441704783273,0.00467600816267022,-0.0226066807821066,-0.00427672878443939,0.00404814968922493
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,0.0130464466439849,0.00455087829406149,0.00412672518762439,0.0219661681003454,0.00414949218553433
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,-0.00748082022264973,0.00261179561315922,-0.0125999396244418,-0.00236170082085765,0.00418301421363777
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,0.0113690102296126,0.00397279293348043,0.0035823360799909,0.0191556843792342,0.00421653222375438
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,0.00525614503461269,0.00183777514222981,0.00165410575584227,0.00885818431338311,0.00423856934716406
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPA,Apolipoprotein(a),24484,-0.0342130067845107,0.0119686774989316,-0.0576716146824165,-0.0107543988866048,0.00425947710090982
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HYAL1,Hyaluronidase-1,29265,-0.00438655178149948,0.00153616772896343,-0.0073974405302678,-0.00137566303273116,0.0042997169670401
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,0.0225196458845109,0.00788652599928963,0.00706205492590326,0.0379772368431186,0.00430053566177772
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHL1,Neural cell adhesion molecule L1-like protein,29542,0.00587484261163996,0.0020641785500557,0.00182905265353079,0.00992063256974914,0.00442898528016225
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,-0.0108676963738653,0.00383785011873253,-0.0183898826065811,-0.00334551014114956,0.00463305257650989
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NLGN2,Neuroligin-2,24101,-0.00902404957455858,0.00318714813002878,-0.015270859909415,-0.00277723923970216,0.00463850239724775
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD177,CD177 antigen,29413,-0.0241872547534397,0.00855204577449114,-0.0409492644714423,-0.00742524503543702,0.00468360658194413
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGBL2,Cytosolic carboxypeptidase 2,24101,0.0172973350550597,0.00612167474777014,0.0052988525494302,0.0292958175606892,0.00472326390721286
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,0.00507559999231526,0.00179764101645436,0.00155222360006471,0.00859897638456581,0.00475374232449551
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMMD9,COMM domain-containing protein 9,24793,0.00738621959860075,0.0026426554305472,0.00220661495472825,0.0125658242424733,0.00519397568748768
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN1,Tetraspanin-1,28916,-0.0106005619047549,0.0037929678573237,-0.0180347789051094,-0.00316634490440044,0.00519670964171147
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YY1,Transcriptional repressor protein YY1,24229,0.00519396265944254,0.00187488570436902,0.00151918667887926,0.00886873864000582,0.00560504015101067
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUK1,Guanylate kinase,24111,-0.00743209379682878,0.0026928728171219,-0.0127101245183877,-0.00215406307526985,0.00578604884378436
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPM1B,Protein phosphatase 1B,24229,0.0115722539996048,0.00419414779643022,0.00335172431860158,0.019792783680608,0.00579966685954455
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEF,Thyrotroph embryonic factor,24111,0.00793052364369489,0.00287721827171589,0.00229117583113174,0.013569871456258,0.00585003863601547
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUSP29,Dual specificity phosphatase 29,24195,-0.0123262257555997,0.00448302868355504,-0.0211129619753676,-0.00353948953583182,0.00597249603783992
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL10RA,Interleukin-10 receptor subunit alpha,28931,0.0106641740257531,0.00389254906876847,0.00303477785096689,0.0182935702005393,0.00615446529764092
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNXB,Tenascin-X,29443,0.00471576133326127,0.00172429670725558,0.00133613978704034,0.00809538287948221,0.00624385298078259
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIF20B,Kinesin-like protein KIF20B,24101,0.0139560731995338,0.00513018425408062,0.00390091206153576,0.0240112343375318,0.0065252852133826
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,-0.0251132785491324,0.00923852806777413,-0.0432207935619697,-0.00700576353629513,0.00656596558421205
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ID4,DNA-binding protein inhibitor ID-4,24445,-0.00795052888032079,0.00294090595096397,-0.0137147045442102,-0.00218635321643141,0.006867568694059
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAMDC2,MAM domain-containing protein 2,24922,-0.00626941922241084,0.00232100489405766,-0.0108185888147639,-0.00172024963005782,0.00691436055951757
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,0.0090398571605494,0.00334737972646302,0.00247899289668188,0.0156007214244169,0.00692598009245508
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGMA,Repulsive guidance molecule A,29694,-0.00566286248439353,0.0021011877660308,-0.00978119050581389,-0.00154453446297317,0.00704120252013853
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL15,C-C motif chemokine 15,29820,0.00789603247484407,0.0029377761375036,0.00213799124533702,0.0136540737043511,0.00719733646101098
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCUN1D1,DCN1-like protein 1,24101,-0.0135014270770269,0.00502503797089032,-0.0233505014999719,-0.00365235265408186,0.00721829723886351
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBH,Dopamine beta-hydroxylase,24919,0.0196223427033482,0.00732025617277055,0.00527464060471791,0.0339700448019784,0.00735487590998451
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSM,Oncostatin-M,29293,-0.0126815938999752,0.00474230765393135,-0.0219765169016807,-0.00338667089826979,0.00749627859594233
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRXN3,Neurexin-3,24195,0.00632596328019409,0.00236634943597867,0.00168791838567589,0.0109640081747123,0.00751593461479023
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC51B,Organic solute transporter subunit beta,24111,-0.0136959162882714,0.00512916252562213,-0.0237490748384908,-0.003642757738052,0.00758557694267652
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,0.00882261939838353,0.0033059036464623,0.00234304825131742,0.0153021905454496,0.00761844228281882
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.00584246148981471,0.00219230286693983,0.00154554787061265,0.0101393751090168,0.00770422948366866
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSLN,Mesothelin,29293,0.0099395824641516,0.00374043985145847,0.002608320355293,0.0172708445730102,0.0078805081502054
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,0.0125383562938665,0.00472115034775408,0.00328490161226854,0.0217918109754645,0.00791755951231577
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UNG,Uracil-DNA glycosylase,24793,0.00612408516536196,0.00230614400382195,0.00160404291787094,0.010644127412853,0.00792293933831319
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC1A,C-type lectin domain family 1 member A,28916,-0.00594453946087431,0.00223858973427812,-0.0103321753400594,-0.0015569035816892,0.00792380957629204
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3GL3,Endophilin-A3,24307,0.0148919684272433,0.00561392974089673,0.00388866613508568,0.0258952707194009,0.00799070524367991
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,24229,0.00415322288789782,0.00156605446190186,0.00108375614257018,0.00722268963322546,0.00800616406663824
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNMA2,Paraneoplastic antigen Ma2,24101,0.00778778780841796,0.00294038016125163,0.00202464269236476,0.0135509329244712,0.00808870160205197
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B4,Protein ATP1B4,24016,-0.00743286745631572,0.00282352055061363,-0.0129669677355184,-0.001898767177113,0.00848177396978802
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,-0.0135992185334857,0.00516646630544697,-0.0237254924921618,-0.00347294457480966,0.00848769560938385
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDI2,Protein DDI1 homolog 2,24381,0.0135024674363143,0.00513582526175942,0.00343624992326581,0.0235686849493627,0.00856713319659606
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,0.00682979912000484,0.00259814544335137,0.00173743405103616,0.0119221641889735,0.00857513441203663
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,-0.010818857261011,0.0041166079249301,-0.018887408793874,-0.00275030572814801,0.00859177208218291
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNG,Interferon gamma,28931,0.0199602031445686,0.00759995965634312,0.00506428221813611,0.0348561240710012,0.00863498625892495
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PADI4,Protein-arginine deiminase type-4,28722,0.0124597683690371,0.00474592577223051,0.00315775385546534,0.021761782882609,0.00866030271684276
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRHR1,Corticotropin-releasing factor receptor 1,28916,0.0106996613150646,0.00408290463886964,0.00269716822288012,0.0187021544072491,0.00878210103596857
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,0.0215807421789436,0.0082388551791238,0.00543258602786094,0.0377288983300262,0.00881343960545935
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,24101,-0.00877448953393267,0.00335295196808472,-0.0153462753913787,-0.00220270367648662,0.00887761544541417
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTTG1,Securin,24445,0.00722165902347084,0.00277349973611486,0.00178559954068572,0.012657718506256,0.00922503246394151
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,0.00498522799942719,0.0019165856848257,0.00122872005716882,0.00874173594168557,0.00929810015675419
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD58,Lymphocyte function-associated antigen 3,29409,0.00305569418726205,0.00117745474585624,0.00074788288538382,0.00536350548914027,0.00945913562486005
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.00728867051945526,0.00280888322612226,0.00178325939625563,0.0127940816426549,0.00946838790372525
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS5,Transmembrane protease serine 5,29079,0.00660818299222668,0.00254685739629334,0.00161634249549173,0.0116000234889616,0.00947370495423296
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMBN,Ameloblastin,28931,-0.00495558339193631,0.00191106065197528,-0.00870126226980785,-0.00120990451406476,0.00951612676885342
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL6,Fc receptor-like protein 6,29434,-0.0117236395707727,0.00453566762566711,-0.0206135481170803,-0.0028337310244652,0.0097492782149753
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.00611287227048344,0.00236663981805765,0.00147425822709044,0.0107514863138764,0.00980131972884612
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCG3,Secretogranin-3,29497,-0.005710195349142,0.00222069801814675,-0.0100627634647096,-0.00135762723357437,0.0101350985624014
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,28797,0.00886198649573017,0.00344727070941741,0.00210533590527204,0.0156186370861883,0.0101535536546437
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.00609171062713858,0.0023723709804546,0.00144186350544757,0.0107415577488296,0.0102413540432098
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,-0.00648823511416883,0.00252788810513072,-0.011442895800225,-0.00153357442811261,0.0102742390136688
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,0.00894837467359382,0.00350345552547805,0.00208160184365685,0.0158151475035308,0.010650544184739
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAT1,Diamine acetyltransferase 1,24111,-0.00864464639332446,0.00338549113989261,-0.015280209027514,-0.00200908375913495,0.010672586884111
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RSPO3,R-spondin-3,29725,0.00483489200599219,0.00189353681504057,0.00112355984851267,0.00854622416347171,0.0106736903221083
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA11,Integrin alpha-11,29434,0.00584132862812571,0.00228773383436528,0.00135737031276976,0.0103252869434817,0.0106749787842967
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSPN,Claspin,28719,0.00591388750837747,0.00232184097148353,0.00136307920426976,0.0104646958124852,0.0108683884749177
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,0.00649198155375329,0.00255076171536883,0.00149248859163039,0.0114914745158762,0.0109303361763444
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRPB1,Signal-regulatory protein beta-1,29409,-0.00781739365156041,0.00308072899553756,-0.013855622482814,-0.00177916482030679,0.0111694041423576
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABO,Histo-blood group ABO system transferase,24951,0.0244931757917948,0.00966493160593459,0.00554990984416304,0.0434364417394267,0.0112754854717869
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,29673,-0.00512327170243076,0.00203278396846015,-0.00910752828061264,-0.00113901512424887,0.0117299304567752
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,0.00437484618397449,0.00174507685470992,0.000954495548743056,0.00779519681920593,0.0121826611764363
NMR metabolomics,X23503.Total Lipids in Medium VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,0.00680380107526627,0.00272468026167919,0.00146342776237506,0.0121441743881575,0.0125279227377126
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP1,Caspase-1,28774,0.0113280975011776,0.00453791343242787,0.00243378717361893,0.0202224078287362,0.0125543815517871
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHRDL2,Chordin-like protein 2,29478,-0.00886416876864628,0.00356470980884626,-0.0158509999939849,-0.00187733754330762,0.0129008846910235
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,0.00639866521354384,0.00258299950159401,0.00133598619041959,0.0114613442366681,0.013247710518764
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHB6,Ephrin type-B receptor 6,29163,0.00528061116082095,0.00213224218667238,0.00110141647494309,0.0094598058466988,0.0132714173370835
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENOPH1,Enolase-phosphatase E1,24793,0.00918407025172732,0.00371323252802358,0.00190613449680109,0.0164620060066535,0.0133924908053526
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,0.0080480236247567,0.00326928448372204,0.0016402260366615,0.0144558212128519,0.0138344610989659
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOX2,Transcription factor SOX-2,24826,0.00393058856662144,0.0015976069020266,0.000799279038649301,0.00706189809459358,0.013888945750735
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HTR1B,5-hydroxytryptamine receptor 1B,24101,-0.00705412730120304,0.00288325735662593,-0.0127053117201899,-0.00140294288221622,0.0144288721419439
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,-0.00777553266740705,0.00317893010580882,-0.0140062356747923,-0.00154482966002177,0.0144526925607647
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,0.00946746419940111,0.00387740512692087,0.0018677501506362,0.017067178248166,0.0146253899203946
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORF4L2,Mortality factor 4-like protein 2,24016,-0.00605364262115702,0.00248190798255073,-0.0109181822669565,-0.00118910297535759,0.0147307447791131
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,-0.00800918552857119,0.0032884027786547,-0.0144544549747344,-0.00156391608240797,0.0148735997337105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGT5,Glutathione hydrolase 5 proenzyme,29218,0.00379071891312166,0.00155748906711072,0.000738040341584635,0.00684339748465868,0.0149444984257563
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFRC,Transferrin receptor protein 1,29565,-0.00626017060170501,0.00257503327411981,-0.0113072358189798,-0.00121310538443019,0.0150588482392207
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,-0.0114632225994909,0.00472211118625721,-0.0207185605245551,-0.0022078846744268,0.0152077167673491
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AZU1,Azurocidin,28534,0.0123408087955391,0.00511155264126914,0.00232216561865159,0.0223594519724266,0.0157718378627454
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,0.00645981642245398,0.00268337162502752,0.00120040803740005,0.0117192248075079,0.0160759505353906
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUMF1,Formylglycine-generating enzyme,24229,0.0107216334958541,0.00446142239134708,0.00197724560881386,0.0194660213828944,0.0162603341809183
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNL1,Interferon lambda-1,28774,-0.00726084967103431,0.00302905404198273,-0.0131977955933205,-0.00132390374874816,0.0165331796556971
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDK1,Cyclin-dependent kinase 1,24016,0.00585761585352317,0.00244969603366786,0.00105621162753415,0.0106590200795122,0.0168028736147154
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCP2,Non-specific lipid-transfer protein,28797,0.0121527349969767,0.00508797293359082,0.00218030804713868,0.0221251619468147,0.0169227023780926
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,-0.0045307270673262,0.00189833520918679,-0.00825146407733231,-0.000809990057320087,0.0170085308034972
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RLN2,Prorelaxin H2,24326,-0.0181547514853765,0.00760770504341802,-0.0330658533704759,-0.00324364960027721,0.0170235142788456
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,0.00535698005424781,0.00224502927986858,0.000956722665705388,0.00975723744279023,0.0170319568648188
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKLR,Pyruvate kinase PKLR,29491,-0.0102729527060411,0.00430865074040433,-0.0187179081572336,-0.00182799725484859,0.0171196954829762
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDDM3B,Epididymal secretory protein E3-beta,24793,0.00831132358271674,0.0034879109576517,0.00147501810571941,0.0151476290597141,0.017184611520359
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN8,Tetraspanin-8,24805,0.0159320604481881,0.00670850410743737,0.00278339239761087,0.0290807284987654,0.0175610268228155
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAPRT,Nicotinate phosphoribosyltransferase,24845,0.00524332174397527,0.00222720708192653,0.000877995863399276,0.00960864762455127,0.0185696737738345
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.00562459502582863,0.00239269724760364,0.000934908420525504,0.0103142816311318,0.0187444034501621
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHISA5,Protein shisa-5,24938,-0.00397278876038738,0.00169576791745424,-0.00729649387859768,-0.000649083642177077,0.0191491659031438
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,-0.0185744919153621,0.00793328330303035,-0.0341237271893016,-0.00302525664142261,0.0192214363080447
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.00873303200114765,0.00373128651266739,-0.0160463535659757,-0.00141971043631956,0.0192666324658764
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,-0.00526820022363995,0.00226326481664145,-0.00970419926425719,-0.000832201183022711,0.0199348055118093
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,-0.00815735981704405,0.00351765538909832,-0.0150519643796768,-0.00126275525441134,0.0204046858791614
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,-0.00524052877805012,0.00226070239687719,-0.00967150547592941,-0.000809552080170832,0.0204523470440435
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD160,CD160 antigen,29786,-0.00725387897458853,0.00313084902894453,-0.0133903430713198,-0.00111741487785725,0.0205156719270315
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.00484317454026253,0.00209360971762383,0.000739699493719824,0.00894664958680524,0.0207124202918551
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP6,Guanylate-binding protein 6,24111,-0.00716621597902728,0.00309833276197238,-0.0132389481924931,-0.00109348376556142,0.0207350591541523
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADRA2A,Alpha-2A adrenergic receptor,24111,-0.0109454060776343,0.00474703986234272,-0.020249604207826,-0.00164120794744254,0.0211340090313166
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,0.0160078434414046,0.00698914262595875,0.00230912389452546,0.0297065629882838,0.0220059687019224
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRC1,Macrophage mannose receptor 1,24951,0.00432698350706008,0.00189671039429728,0.000609431134237404,0.00804453587988275,0.0225385281648468
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGBL1,Integrin beta-like protein 1,24938,-0.00568665626437327,0.00249507055871025,-0.0105769945594454,-0.000796317969301189,0.0226661799484427
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,29216,-0.00885749287696131,0.00389713975348133,-0.0164958867937847,-0.00121909896013791,0.0230443287375424
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,0.00622755614865073,0.00274616660412631,0.000845069604563152,0.0116100426927383,0.0233529771725826
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOC,Myocilin,29443,0.00690436594773041,0.00305050836536195,0.000925369551620986,0.0128833623438398,0.0236214175381091
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECTIN2,Nectin-2,29433,0.00448348783577769,0.00198915577449546,0.000584742517766594,0.00838223315378878,0.024205686735801
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MN1,Transcriptional activator MN1,24195,-0.00892828842068276,0.00397148777840049,-0.0167124044663477,-0.00114417237501779,0.024578997665436
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL28,C-C motif chemokine 28,29327,0.00886458964570188,0.00395649754055434,0.00110985446621538,0.0166193248251884,0.0250650077093727
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PODXL2,Podocalyxin-like protein 2,29566,0.00417029508634733,0.00186372463408871,0.000517394803533461,0.0078231953691612,0.0252537032750026
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,0.00748938034084185,0.00335126603986562,0.000920898902705243,0.0140578617789785,0.0254404190853643
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOCK9,Dedicator of cytokinesis protein 9,24101,0.0175785420563459,0.0079398287826574,0.00201647764233739,0.0331406064703544,0.0268401785402601
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RSPO1,R-spondin-1,29218,-0.0051591835121497,0.00234328141774458,-0.00975201509092908,-0.000566351933370321,0.0276948759835402
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKAP12,A-kinase anchor protein 12,24381,0.00316690099241217,0.00144414263350709,0.000336381430738274,0.00599742055408606,0.0283219764994297
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,29820,-0.00443677713181675,0.00202702845438949,-0.00840975290242016,-0.000463801361213344,0.0286184915817316
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,0.00388031949438319,0.00177454397972363,0.000402213294124878,0.00735842569464151,0.0287754244304227
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,-0.00859232347210834,0.00393702687927143,-0.0163088961554803,-0.000875750788736346,0.0290867240537795
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINT3,Kunitz-type protease inhibitor 3,24805,0.0215239824978988,0.00987046850302628,0.00217786423196728,0.0408701007638303,0.0292190921482152
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,0.00668360318084114,0.00307572069225139,0.00065519062402842,0.0127120157376539,0.0297885063076168
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,0.00612382784706844,0.00283374669986812,0.000569684315326926,0.0116779713788099,0.0307008074635447
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,0.00393969566176806,0.00182326391109469,0.000366098396022474,0.00751329292751365,0.0307195318108497
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,0.00485408151916141,0.00226119130981216,0.000422146551929565,0.00928601648639325,0.0318259350829165
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMIGO1,Amphoterin-induced protein 1,24195,0.00722461939880971,0.00336702601744272,0.000625248404621971,0.0138239903929974,0.0319070438405904
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPN1,Epsin-1,24445,0.00627680141060426,0.00292949287976168,0.000534995366271381,0.0120186074549371,0.0321531629970143
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFNA1,Ephrin-A1,29390,0.0040355074554622,0.00188726886115413,0.000336460487600102,0.0077345544233243,0.0325023275490769
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,0.00976218716635159,0.00456833570066471,0.000808249193048763,0.0187161251396544,0.0326138903916281
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH23,Cadherin-23,24845,-0.00378806612483163,0.00177793673175009,-0.00727282211906181,-0.000303310130601448,0.0331321801376699
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEFL,Neurofilament light polypeptide,28674,0.00635846082401142,0.00299500368944342,0.000488253592702331,0.0122286680553205,0.033760495755512
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,0.00410306763979073,0.00193573167883389,0.000309033549276308,0.00789710173030515,0.034044126757253
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP112,Centrosomal protein of 112 kDa,24111,0.00651497944019958,0.00307906928037651,0.00048000365066161,0.0125499552297375,0.0343641839986459
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAD51,DNA repair protein RAD51 homolog 1,24445,0.00755773183335295,0.00357979745370742,0.00054132882408641,0.0145741348426195,0.0347637314032417
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXDC2,Plexin domain-containing protein 2,24845,0.0038240338728832,0.00181307221616961,0.00027041232919076,0.00737765541657565,0.0349419719558479
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRTN,Neurturin,28931,0.0069534323889336,0.00330487376546846,0.000475879808615424,0.0134309849692518,0.0353876391912153
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,0.00374164755619759,0.00178137886256634,0.000250144985567561,0.00723315012682763,0.0357021315005328
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.00333129850176348,0.00159627430950567,-0.00645999614839459,-0.00020260085513237,0.0369054334073167
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL15,Interleukin-15,29434,-0.00456956111005833,0.00218998424483773,-0.00886193022994028,-0.000277191990176385,0.0369353753805821
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,0.00391380721342628,0.0018848652650454,0.000219471293937302,0.00760814313291525,0.0378639155442045
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,29581,-0.00390005963288879,0.00188397240686302,-0.00759264555034031,-0.000207473715437276,0.0384492394559916
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,-0.00664520471200203,0.0032151112226192,-0.0129468227083357,-0.000343586715668399,0.038757418987392
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSB,Cathepsin B,29480,-0.00718576171317032,0.00350244744878146,-0.014050558712782,-0.000320964713558659,0.0402134688797966
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCR1,Natural cytotoxicity triggering receptor 1,29375,-0.00505736324502407,0.00247291719944102,-0.00990428095592846,-0.000210445534119675,0.0408538844492122
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DENND2B,DENN domain-containing protein 2B,24111,-0.00697899139846522,0.00341308140893197,-0.0136686309599719,-0.000289351836958563,0.040887659644539
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,-0.00369916988733526,0.00181850743885837,-0.00726344446749766,-0.00013489530717286,0.0419423729867623
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMEM132A,Transmembrane protein 132A,24240,0.00854200626314616,0.00420039824262295,0.000309225707605184,0.0167747868186871,0.0420009817097431
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD48,CD48 antigen,29536,-0.00406220150500676,0.00200002557185096,-0.00798225162583464,-0.000142151384178882,0.0422563502144572
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNPEP,Aspartyl aminopeptidase,24845,0.00791556620268281,0.00390444825476376,0.000262847623345841,0.0155682847820198,0.0426403531406312
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CORO6,Coronin-6,24101,-0.00507996390179476,0.00252038892820786,-0.0100199262010822,-0.000140001602507346,0.0438583863419208
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,-0.00474681105013076,0.00235721671454479,-0.00936695581063856,-0.000126666289622966,0.0440483478616322
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,0.0116656905981758,0.00580836581902685,0.000281293592883165,0.0230500876034684,0.0446088999816196
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPVL,Probable serine carboxypeptidase CPVL,29662,0.00545894765418488,0.00272036813688914,0.000127026105882172,0.0107908692024876,0.0447912694882366
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,0.00910129290641582,0.0045475492695256,0.000188096338145644,0.018014489474686,0.045362756011346
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,-0.00727300328331802,0.0036447103037893,-0.014416635478745,-0.000129371087891002,0.0460000992229621
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB44,Ras-related protein Rab-44,24793,0.0056220270925212,0.00282061096315735,9.3629604732786e-05,0.0111504245803096,0.0462510671207955
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDAN1,Codanin-1,24845,0.00301482231231682,0.00151269014989909,4.99496185146003e-05,0.00597969500611904,0.0462701391401262
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,24111,0.00501737269931195,0.00251934057315366,7.94651759307811e-05,0.00995528022269311,0.0464325956517262
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE1,Ribonuclease pancreatic,24951,-0.00324262665777737,0.00163289058104891,-0.00644309219663323,-4.21611189215122e-05,0.0470642540934892
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBQLN3,Ubiquilin-3,24111,-0.00667608201205578,0.00338075282555931,-0.013302357550152,-4.98064739595403e-05,0.0483099258843316
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.00987373112195806,0.00500104592650752,-0.0196757811379128,-7.16811060033316e-05,0.0483552708519122
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJA4,DnaJ homolog subfamily A member 4,24845,-0.00926748948868139,0.0047015076167786,-0.0184824444175675,-5.25345597953229e-05,0.0487150654541409
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIPC2,PDZ domain-containing protein GIPC2,24845,-0.00392701545170646,0.00199464161030742,-0.00783651300790901,-1.75178955039035e-05,0.0489891792499302
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,-0.0110925437485749,0.00563716977005521,-0.0221413964978831,-4.36909992666459e-05,0.0491082450604015
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DRAXIN,Draxin,29218,0.00563951863990335,0.00286793703257127,1.83620560636642e-05,0.011260675223743,0.049261587188362
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RALB,Ras-related protein Ral-B,24229,0.0038943040629356,0.00198388567751657,5.88813500311969e-06,0.00778271999086808,0.0496613241213229
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEL1L,Protein sel-1 homolog 1,24240,0.00418762591986911,0.00213974693093695,-6.27806476731843e-06,0.00838152990450554,0.0503511793279238
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB2,Integrin beta-2,29274,0.00375244625250857,0.00192013611671033,-1.1020536243684e-05,0.00751591304126082,0.0506799239232886
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,-0.00666132156497188,0.00341119141718443,-0.0133472567426534,2.46136127095946e-05,0.0508567017320943
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC12A2,Solute carrier family 12 member 2,24111,-0.00361309695478232,0.00185119891294079,-0.00724144682414627,1.52529145816373e-05,0.0509782110899815
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB116,Beta-defensin 116,24101,-0.0101018365349456,0.00517684821826901,-0.0202484590427528,4.47859728616787e-05,0.0510271436046616
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYB5A,Cytochrome b5,24016,0.00938328886472204,0.00485348800880939,-0.000129547632544368,0.0188961253619884,0.0532099702338429
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,0.00335216061929501,0.00173804379937708,-5.44052274840589e-05,0.00675872646607409,0.0537801663508522
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMI,N-myc-interactor,24706,0.0092514543437065,0.00482521878563783,-0.000205974476143659,0.0187088831635566,0.0552097141837959
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,-0.00633430893403276,0.00330530907119754,-0.0128127147135799,0.000144096845514416,0.0553254128733022
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPSG1,Tryptase gamma,24229,0.00343833139527571,0.00179492018569235,-7.97121686812916e-05,0.00695637495923271,0.0554290505841052
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",24016,0.0119007903429764,0.00621419088992569,-0.000279023801277947,0.0240806044872308,0.0554917595813616
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GH2,Growth hormone variant,28797,0.0210858453845334,0.0110540181827461,-0.000580030253648913,0.0427517210227157,0.0564622356356099
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEB,Nebulin,24111,-0.00482993712122396,0.00254578696252765,-0.00981967956777815,0.000159805325330242,0.0578098579092552
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,-0.00600068691993762,0.0031752425745947,-0.0122241623661432,0.000222788526267987,0.0587918807892219
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,0.00627357201447849,0.00334962351742396,-0.000291690079672465,0.0128388341086295,0.0610917309034248
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX1B,Syntaxin-1B,24195,0.00522900478698474,0.00279247195760425,-0.000244240249919584,0.0107022498238891,0.0611445183220692
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN1,Contactin-1,29820,0.00340401717455085,0.00182022333651939,-0.000163620565027157,0.00697165491412885,0.0614783908577052
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB118,Beta-defensin 118,24101,0.00720743340341929,0.00386296697907453,-0.000363981875566792,0.0147788486824054,0.0620847731649104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,0.00583597369790982,0.00314664248565423,-0.000331445573972467,0.0120033929697921,0.0636560137001743
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA3G,Semaphorin-3G,24381,0.00549850543425464,0.00296599371667427,-0.000314842250426935,0.0113118531189362,0.0637727966518954
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPK13,Mitogen-activated protein kinase 13,24016,0.00525956114830775,0.00283829829561197,-0.00030350351109172,0.0108226258077072,0.063884806595479
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL10,Interleukin-10,28931,-0.0100848768485775,0.00546988983712629,-0.020805860929345,0.000636107232190042,0.0652360061942664
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RYR1,Ryanodine receptor 1,24111,-0.00421262199232502,0.00229104105999717,-0.00870306246991947,0.000277818485269421,0.065966175031634
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300C,CMRF35-like molecule 6,29694,0.00423063918390482,0.00230838654200423,-0.000293798438423481,0.00875507680623312,0.0668533954449908
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF5,Fibroblast growth factor 5,28931,-0.00404721360676221,0.00221283944849494,-0.00838437892581229,0.000289951712287866,0.0674146232477072
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HCG22,Protein PBMUCL2,24111,-0.00679851310351256,0.00372319523611559,-0.0140959757662991,0.000498949559274008,0.067864304991758
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALPP,"Alkaline phosphatase, placental type",29349,0.0126179658367033,0.00691450962992986,-0.000934473037959276,0.0261704047113658,0.0680333323035928
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,0.00387845109506086,0.0021264508667857,-0.000289392603839111,0.00804629479396084,0.0681760818110512
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OTOA,Otoancorin,24101,-0.00656877877223499,0.0036024101012019,-0.0136295025705907,0.000491945026120746,0.0682491597245344
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,-0.0061630977108557,0.00338175781113971,-0.0127913430206895,0.000465147598978136,0.0683985298338007
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AXL,Tyrosine-protein kinase receptor UFO,29594,0.00335837762556805,0.00184387873308806,-0.000255624691284548,0.00697237994242065,0.0685613692652733
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.0043204878016019,0.00237510190156158,-0.000334711925458798,0.0089756875286626,0.0689122684457285
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL6A3,Collagen alpha-3(VI) chain,29820,0.00424878098173583,0.00233589082912949,-0.00032956504335797,0.00882712700682964,0.068934813258056
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VCAN,Versican core protein,29694,-0.00364077876770937,0.00200648268929207,-0.00757348483872182,0.000291927303303081,0.0696096527731827
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLR1,Folate receptor alpha,29383,-0.00349886074079476,0.00192911684674987,-0.00727992976042451,0.00028220827883498,0.0697324083825445
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,0.00676784359123647,0.00375231087913922,-0.000586685731876407,0.0141223729143494,0.0712988064438763
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBR3,Transforming growth factor beta receptor type 3,29820,-0.00380617776966768,0.00211444324557875,-0.00795048653100202,0.000338130991666668,0.071857310311398
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1A,Interleukin-1 alpha,28931,0.00668603368515727,0.00372031959925885,-0.000605792729390079,0.0139778600997046,0.0723196241915988
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK3,Prostate-specific antigen,24938,-0.010678344229989,0.00595791567299892,-0.0223558589490669,0.000999170489088881,0.0730978005974879
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNN,Tenascin-N,24938,0.00521377092307913,0.00291341594056129,-0.000496524320420996,0.0109240661665793,0.0735346958053765
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYH4,Myosin-4,24111,-0.00560509096555283,0.00313552151711814,-0.0117507131391044,0.000540531207998717,0.0738514441361883
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A3,Protein S100-A3,24793,0.00531732933473278,0.00297521771668822,-0.000514097389976139,0.0111487560594417,0.0739162892424951
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,29454,0.0351431120645878,0.0197074616655033,-0.00348351279979857,0.0737697369289742,0.0745577236211292
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM3D,Protein FAM3D,24805,-0.0100620384900342,0.00566447081546138,-0.0211644012883385,0.00104032430827012,0.0756887948170883
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFDC12,WAP four-disulfide core domain protein 12,29662,-0.00755120159975632,0.00425612028842692,-0.0158931973650731,0.000790794165560445,0.07604060736829
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORF4L1,Mortality factor 4-like protein 1,24445,-0.00469414787680062,0.00269091225046122,-0.00996833588770461,0.000580040134103376,0.0810941343365518
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGLYRP4,Peptidoglycan recognition protein 4,24111,0.0071362176963469,0.00409517547165538,-0.000890326228097635,0.0151627616207914,0.0814177640822642
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST6,Cystatin-M,28830,0.00565791386875736,0.00325888332730128,-0.000729497452753158,0.0120453251902679,0.0825478094798624
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,-0.00467130592159442,0.00269784516413724,-0.00995908244330341,0.000616470600114565,0.0833762128074074
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTR,Methionine synthase,24111,0.007564765558289,0.00438152516238451,-0.00102302375998465,0.0161525548765626,0.0842677576424889
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRRT3,Proline-rich transmembrane protein 3,24240,0.00440031154468774,0.00254912073170691,-0.000595965089457804,0.00939658817883329,0.0843228234245895
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4D,C-type lectin domain family 4 member D,29434,-0.00707497884319404,0.00410401088494074,-0.0151188401776779,0.000968882491289813,0.0847331260872309
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD4,Sushi domain-containing protein 4,24793,-0.00483446829686221,0.00280663491548908,-0.0103354727312208,0.00066653613749639,0.0849889034080896
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,-0.00385733170714113,0.00224027736910392,-0.00824827535058482,0.000533611936302561,0.0851145062639526
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,-0.00309630288856071,0.00180001106358183,-0.0066243245731811,0.000431718796059674,0.0854142491917308
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA6,Carbonic anhydrase 6,29372,-0.00725116803715614,0.00421934061572714,-0.0155210756439813,0.00101873956966905,0.0857060122556289
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,-0.00521140848727771,0.0030560518201943,-0.0112012700548585,0.000778453080303113,0.0881560589505532
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIDA,"Axin interactor, dorsalization-associated protein",24195,0.00960324028330986,0.00565939049425013,-0.00148916508542039,0.0206956456520401,0.0897344335398803
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,0.0141645864739649,0.00835421235115474,-0.00220966973429837,0.0305388426822282,0.0899909847933436
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,-0.00277812107556296,0.00164434995499073,-0.0060010469873448,0.000444804836218878,0.0911350620043937
NMR metabolomics,X23503.Total Lipids in Medium VLDL,H2AP,Huntingtin-interacting protein M,24016,-0.00580284561743279,0.00344153964976289,-0.0125482633309681,0.000942572096102481,0.0917858654644296
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300E,CMRF35-like molecule 2,29642,0.00458237486185382,0.00271992009659922,-0.000748668527480654,0.00991341825118829,0.092048094001987
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLMP,CXADR-like membrane protein,29725,0.0023767559197169,0.00141429336525955,-0.000395259076191812,0.00514877091562561,0.0928656490935726
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLNS1A,Methylosome subunit pICln,24195,-0.00377816682948815,0.00224855932065951,-0.00818534309798078,0.000629009439004492,0.0929194365112599
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,-0.00569778771654667,0.00339353382189254,-0.012349114007456,0.000953538574362698,0.0931601899652159
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GHRHR,Growth hormone-releasing hormone receptor,28774,0.00613785144795155,0.00367699806322168,-0.00106906475596295,0.013344767651866,0.0950775200601492
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FDX2,"Ferredoxin-2, mitochondrial",24111,0.00631505546406602,0.00378551298162521,-0.00110454997991939,0.0137346609080514,0.0952857360331963
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELAVL4,ELAV-like protein 4,24101,0.00941992614747801,0.00567809009804735,-0.0017091304446948,0.0205489827396508,0.0971297103620426
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSTN,Osteocrin,24195,-0.00465303434623053,0.00280478775375578,-0.0101504183435919,0.000844349651130799,0.0971365590605346
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF12,Fibroblast growth factor 12,24229,0.00521025417719631,0.0031423796008392,-0.000948809840448523,0.0113693181948411,0.0973182925950311
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCN1,Transcobalamin-1,24546,0.00378278508425099,0.00229026404959096,-0.000706132452947294,0.00827170262144928,0.098612443924001
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFD,Complement factor D,24966,0.00216008168720479,0.00131110195742538,-0.000409678149348962,0.00472984152375855,0.0994614521956331
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,-0.00672388674368715,0.00409597071680487,-0.0147519893486247,0.00130421586125041,0.100688953683409
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,-0.00710063469751022,0.00432658217550971,-0.0155807357615092,0.00137946636648881,0.100776066827396
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASET2,Ribonuclease T2,29697,-0.00290908813328916,0.00177263426470521,-0.00638345129211138,0.000565275025533064,0.100785141048268
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,0.00517875868277101,0.00317698890544807,-0.0010481395719072,0.0114056569374492,0.103096461677108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PYDC1,Pyrin domain-containing protein 1,24240,-0.00456442119922817,0.00281333591227428,-0.0100785595872858,0.000949717188829414,0.104725796480957
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTNNA1,Catenin alpha-1,24101,-0.0037947728864171,0.00235616863028425,-0.00841286340177424,0.000823317628940032,0.107286730576835
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDAC8,Histone deacetylase 8,24229,0.00661249785634172,0.00411811708921302,-0.00145901163851579,0.0146840073511992,0.108350892778178
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,24101,0.00527781190346898,0.00329625064712747,-0.00118283936490086,0.0117384631718388,0.109355458301164
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRR5,Proline-rich protein 5,24229,0.00511155674589359,0.00319875492772726,-0.00115800291245185,0.011381116404239,0.110059755959354
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK14,Kallikrein-14,29725,0.00491728993748914,0.00307906567847923,-0.00111767879233015,0.0109522586673084,0.110274745812611
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,0.00614340091987979,0.00384939500338744,-0.00140141328675959,0.0136882151265192,0.110515502599751
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNDC15,Thioredoxin domain-containing protein 15,29566,-0.00290922774696572,0.00182613993497132,-0.00648846201950951,0.000670006525578074,0.111147936315441
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TJP3,Tight junction protein ZO-3,24101,-0.0045671861750988,0.00287292625196822,-0.0101981216289565,0.0010637492787589,0.11190808626902
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPEP2,Dipeptidase 2,29349,0.0031095347066801,0.00195774406675419,-0.000727643664158111,0.00694671307751831,0.112223544784228
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN7,Septin-7,24445,0.00558928029787284,0.00353347411022183,-0.00133632895816195,0.0125148895539076,0.113706179538595
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,-0.00513853711379768,0.00325198443857332,-0.0115124266134014,0.00123535238580602,0.114089523938815
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRA3,GDNF family receptor alpha-3,29157,0.00295904723954661,0.00188334693642505,-0.000732312755846482,0.00665040723493971,0.116155374751765
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,-0.00442289830358367,0.00282079990072226,-0.00995166610899931,0.00110586950183197,0.116901510848604
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,-0.00588880200598842,0.00377020009599541,-0.0132783941941394,0.00150079018216258,0.118316776654431
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENG,Endoglin,29820,0.00179490986188783,0.00114951036353241,-0.000458130450635694,0.00404795017441136,0.118426812901308
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UPK3BL1,Uroplakin-3b-like protein 1,24404,-0.00566397545018098,0.00364386218000704,-0.0128059453229948,0.00147799442263282,0.120104881607877
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HBQ1,Hemoglobin subunit theta-1,29725,-0.00622288398662089,0.00401703123465063,-0.0140962652065361,0.00165049723329435,0.121362296796805
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC44A4,Choline transporter-like protein 4,24195,-0.0071846457319256,0.00465296593684128,-0.0163044589681345,0.00193516750428331,0.122577141334865
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTSL2,ADAMTS-like protein 2,24938,0.00337886688163813,0.00220160181754359,-0.000936272680747306,0.00769400644402358,0.124862574887617
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL1A1,Collagen alpha-1(I) chain,29820,-0.00255557644143922,0.00166981719509311,-0.00582841814382171,0.00071726526094327,0.125915294747217
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RELB,Transcription factor RelB,24229,0.00502367982855253,0.00331498783368748,-0.00147369632547494,0.01152105598258,0.129672947193942
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDN1,Endothelin-1,24240,0.00296032552008191,0.00195572339327831,-0.000872892330743566,0.00679354337090739,0.130121864230663
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,-0.0026295359564286,0.00173760938988297,-0.00603525036059923,0.000776178447742024,0.130214441011738
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA3,Carbonic anhydrase 3,29761,-0.00606335398282209,0.00400717730877354,-0.0139174215080182,0.00179071354237404,0.13025892596289
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT14,"Keratin, type I cytoskeletal 14",27986,0.00294362650183357,0.00194611088514675,-0.000870750833054058,0.00675800383672121,0.130400535385266
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REXO2,"Oligoribonuclease, mitochondrial",24111,-0.00485691763433837,0.00321130362457195,-0.0111510727384994,0.00143723746982266,0.130434004455583
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAP1,Antigen peptide transporter 1,24445,-0.00606633821573992,0.00402627370750255,-0.0139578346824449,0.00182515825096508,0.131903582187481
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,-0.00341374046266383,0.00226885116416419,-0.00786068874442565,0.00103320781909798,0.132434619773356
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,0.00594509239063544,0.0039535079453643,-0.00180378318227859,0.0136939679635495,0.13265854661355
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,0.00322729123739367,0.00215456146467099,-0.000995649233361465,0.0074502317081488,0.134175519340862
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUCL3,Mucin-like protein 3,24016,-0.00440054036117619,0.00294875495722522,-0.0101801000773376,0.00137901935498525,0.135623588621092
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP3,"Fatty acid-binding protein, heart",24922,0.00506265916267516,0.00339263352371607,-0.00158690254380833,0.0117122208691587,0.135646146100209
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2RG,Cytokine receptor common subunit gamma,24793,0.00370761278129896,0.00249360774128796,-0.00117985839162545,0.00859508395422336,0.137067991758022
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,-0.00571200337383471,0.00384407836924772,-0.0132463969775602,0.00182239022989082,0.137312651872628
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,-0.00440354495132467,0.00296583023429509,-0.010216572210543,0.0014094823078937,0.137620415667718
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOP56,Nucleolar protein 56,24111,0.0110453286184106,0.00745456955092868,-0.00356562770140962,0.0256562849382308,0.138437036970217
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OLFM4,Olfactomedin-4,23498,0.0122098127049182,0.00826719820961994,-0.00399389578593686,0.0284135211957733,0.13971625399589
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACRV1,Acrosomal protein SP-10,24229,-0.00757859547007499,0.00515346300147445,-0.0176793829529649,0.00252219201281494,0.141416897118266
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMCN2,Hemicentin-2,24343,-0.00565163474530723,0.00386511464943426,-0.0132272594581984,0.00192398996758393,0.143694784727205
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COPE,Coatomer subunit epsilon,28774,0.00461815754416418,0.0031668560654101,-0.00158888034403961,0.010825195432368,0.144774763249416
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNL1,Thioredoxin-like protein 1,24069,0.00958471269654752,0.00658055500649342,-0.00331317511617959,0.0224826005092746,0.145261862785435
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,-0.00556904356482782,0.00383047760841522,-0.0130767796773216,0.001938692547666,0.145991024485852
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOC2B,Double C2-like domain-containing protein beta,24195,0.00352798814367816,0.00243240441662344,-0.00123952451290379,0.00829550080026011,0.146956680460534
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSAPL1,Proactivator polypeptide-like 1,24805,0.00488121014639004,0.00337483738935557,-0.00173347113674687,0.0114958914295269,0.148090530414104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MERTK,Tyrosine-protein kinase Mer,29786,0.00245234933368519,0.00169951466470691,-0.000878699409140346,0.00578339807651073,0.149039334051833
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HIP1,Huntingtin-interacting protein 1,24111,0.00322230463440001,0.0022475939829143,-0.00118297957211201,0.00762758884091203,0.151679867940055
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,0.00262443202520247,0.00183228776144511,-0.000966851987229938,0.00621571603763488,0.152061247069924
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNPO1,Transportin-1,24445,0.00337557883280839,0.00237363356355342,-0.00127674295175632,0.0080279006173731,0.155005765060267
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",24111,-0.00379507188307337,0.00267195687563399,-0.009032107359316,0.00144196359316925,0.155523330554887
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,-0.0136874938682772,0.00964624157610617,-0.0325941273574453,0.00521913962089086,0.155927806445157
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,0.00279762348583198,0.00197238528957366,-0.00106825168173239,0.00666349865339635,0.156085756135033
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL20RA,Interleukin-20 receptor subunit alpha,28931,0.0042948148168207,0.00302844618186384,-0.00164093969963242,0.0102305693332738,0.156155452121237
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH4,Cadherin-4,24101,0.0045538816863901,0.00322682467297153,-0.00177069467263411,0.0108784580454143,0.158181510722799
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,0.00458707581116387,0.00327024043111204,-0.00182259543381572,0.0109967470561435,0.160727339275082
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMA1,Laminin subunit alpha-1,24111,-0.00508941487550169,0.00362999503373368,-0.0122042051416197,0.00202537539061633,0.160914814806173
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CADPS,Calcium-dependent secretion activator 1,24195,-0.00402937397920942,0.00289087986740189,-0.00969549851931712,0.00163675056089829,0.163383960382664
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.00515060031262638,0.0036978192361709,-0.0123983260155213,0.00209712539026859,0.163670466161695
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GID8,Glucose-induced degradation protein 8 homolog,24867,0.00314335917063607,0.0022671124487499,-0.00130018122891374,0.00758689957018588,0.165605672728634
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,-0.00275825316622468,0.00199099673364092,-0.00666060676416087,0.00114410043171152,0.165953910600331
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF8,SLAM family member 8,28797,-0.00495378349022233,0.00357884021488531,-0.0119683103113975,0.00206074333095288,0.166311986840007
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,-0.00678094131030378,0.0049166699649514,-0.0164176144416085,0.00285573182100097,0.16785172879138
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G1B,Phospholipase A2,29787,-0.00396072734635561,0.00287790149096549,-0.00960141426864796,0.00167995957593675,0.168752939461629
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,-0.00340837232692068,0.00247842097212482,-0.00826607743228532,0.00144933277844397,0.169075876839446
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCNE1,G1/S-specific cyclin-E1,24229,0.00851132666620838,0.00620967347936065,-0.0036596333533385,0.0206822866857552,0.170494898921642
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,-0.00257578662104882,0.00188106657694404,-0.00626267711185914,0.0011111038697615,0.170910853573195
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,24229,0.00601606876941191,0.00440388484805452,-0.00261554553277495,0.0146476830715988,0.171925846039095
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ULBP2,UL16-binding protein 2,29218,0.00348570207530343,0.0025516989192626,-0.00151562780645127,0.00848703195705812,0.171939475867313
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MKI67,Proliferation marker protein Ki-67,24229,0.00357157990454726,0.00261832753127094,-0.00156034205674378,0.00870350186583831,0.172558469857988
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,0.00674252323309923,0.00494872465191275,-0.00295697708464975,0.0164420235508482,0.173059735039684
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL25,Interleukin-25,23913,0.00316101871569442,0.00232389332802459,-0.00139381220723379,0.00771584963862263,0.17377143893013
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGM2,Phosphoglucomutase-2,24195,0.00546443968130646,0.0040368908434424,-0.00244786637184064,0.0133767457344536,0.175868436866565
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUOX2,Dual oxidase 2,28916,0.00645451284234945,0.00477196639281921,-0.00289854128757619,0.0158075669722751,0.176197309646474
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,-0.00608506833918199,0.0044998911824295,-0.0149048550567438,0.00273471837837983,0.17630161317189
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,0.00705538903665634,0.00522183948366337,-0.00317941635132387,0.0172901944246365,0.176664059251306
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAPPA,Pappalysin-1,28931,0.00424069123599115,0.00315240180649194,-0.00193801630473305,0.0104193987767154,0.178562978914844
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4C,C-type lectin domain family 4 member C,29434,0.00421177496312851,0.00313108525356253,-0.00192515213385405,0.0103487020601111,0.178587617719969
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARB1,Scavenger receptor class B member 1,28774,0.00515943827525865,0.00384424611877818,-0.00237528411754658,0.0126941606680639,0.179567796641717
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,0.00420929828241141,0.0031393706448894,-0.00194386818157181,0.0103624647463946,0.179992541708153
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL3RA,Interleukin-3 receptor subunit alpha,28931,-0.00283079700994646,0.00211382276148679,-0.00697388962246056,0.00131229560256764,0.180521399934588
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZP4,Zona pellucida sperm-binding protein 4,24016,-0.00286182667439493,0.00214225138101679,-0.00706063938118785,0.00133698603239799,0.181595686880192
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,0.00453529293053455,0.0033951721244366,-0.00211924443336119,0.0111898302944303,0.181624796378403
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD33,Myeloid cell surface antigen CD33,29566,0.00704992969709272,0.00529513080986645,-0.00332852669024553,0.017428386084431,0.18306816288862
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PXDNL,Peroxidasin-like protein,24793,0.00515455885389772,0.0038768999657209,-0.00244416507891523,0.0127532827867107,0.183676567132306
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTKN2,Rhotekin-2,24111,-0.00460987789337745,0.00347728685023763,-0.0114253601198432,0.0022056043330883,0.18494796528034
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSB,Lupus La protein,28774,0.00525618479387047,0.00398513859681946,-0.00255468685589567,0.0130670564436366,0.187197484537235
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,-0.00702650493752645,0.0053334819816531,-0.0174801296215665,0.00342711974651362,0.187705894661774
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL14,C-X-C motif chemokine 14,28931,0.00523037574901973,0.00397904450809565,-0.00256855148684775,0.0130293029848872,0.188695037864903
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMC3,Structural maintenance of chromosomes protein 3,24016,0.00476441415269712,0.00363236010447179,-0.00235501165206758,0.0118838399574618,0.189648103130954
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA10,Ephrin type-A receptor 10,28774,0.00573495862813743,0.00437450877936979,-0.00283907857942736,0.0143089958357022,0.189869959568587
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,0.0073708326929133,0.00563136482412642,-0.00366664236237449,0.0184083077482011,0.190584318426443
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERCC1,DNA excision repair protein ERCC-1,24016,0.00293096236310203,0.00224702492023352,-0.00147320648055566,0.00733513120675972,0.192118378521058
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINT1,Kunitz-type protease inhibitor 1,29333,-0.00227293604067796,0.00174286355856789,-0.00568894861547101,0.0011430765341151,0.192196490026619
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACTN4,Alpha-actinin-4,28931,0.00276796054735691,0.00213957887252496,-0.001425614042792,0.00696153513750583,0.195781439871702
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18RAP,Interleukin-18 receptor accessory protein,29038,0.0148017481844118,0.0114908654668849,-0.00772034813068262,0.0373238444995062,0.197710387847163
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,28862,-0.00451165530948726,0.00350599021846491,-0.0113833961376785,0.00236008551870397,0.198159705656945
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,0.00287555263555974,0.00225108146405698,-0.00153656703399193,0.00728767230511141,0.201467804624877
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WNT9A,Protein Wnt-9a,28931,-0.00246227390870474,0.00192898334070103,-0.00624308125647876,0.00131853343906927,0.201802507009772
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,0.00594468868429271,0.00466324724373931,-0.00319527591343634,0.0150846532820218,0.202393724803353
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMC3,26S proteasome regulatory subunit 6A,24016,-0.00258739513931408,0.00203178623783953,-0.00656969616547957,0.0013949058868514,0.202867777391235
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL6B,Myosin light chain 6B,24195,-0.00783602401937174,0.00615570225574177,-0.0199012004406256,0.00422915240188213,0.203040942044566
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,-0.0055236845643874,0.00435973364644445,-0.0140687625114185,0.00302139338264372,0.205175574711962
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP4,Caspase-4,24445,-0.0142800624616149,0.0112861203140663,-0.0364008582771849,0.00784073335395518,0.205784305978605
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,24101,-0.00593695755230449,0.00470459165761753,-0.0151579572012348,0.00328404209662587,0.206979142474902
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOS,Proto-oncogene c-Fos,23970,-0.00300355138622764,0.0023839424344794,-0.00767607855780727,0.00166897578535198,0.207714335318422
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,0.00807592592105667,0.00650810541040327,-0.00467996068333375,0.0208318125254471,0.214653423610503
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAMT,Guanidinoacetate N-methyltransferase,24111,-0.00309878113830991,0.0025040028804261,-0.00800662678394506,0.00180906450732524,0.215902078632395
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLIN3,Perilipin-3,29478,-0.00350391596159402,0.00284119187637565,-0.0090726520392903,0.00206482011610226,0.217490233776885
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY9,T-lymphocyte surface antigen Ly-9,29116,0.00242284144356898,0.00196527275233467,-0.00142909315100698,0.00627477603814494,0.217650249121144
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLI2,Zinc finger protein GLI2,24229,-0.00275773117885487,0.00223976622149179,-0.00714767297297877,0.00163221061526903,0.218238159144459
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,-0.00358406969104126,0.00291133991986232,-0.00929029593397142,0.0021221565518889,0.218307870612082
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAP1A,Ras-related protein Rap-1A,24229,-0.00571908324907076,0.00465227454917523,-0.0148375413654542,0.00339937486731269,0.218967896832124
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN3B,Sodium channel subunit beta-3,24101,0.00378814588176276,0.00309420781434982,-0.00227650143436289,0.00985279319788841,0.220862354281356
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL9,C-X-C motif chemokine 9,29581,0.00541920496150496,0.00443559346975405,-0.00327455823921299,0.0141129681622229,0.221810332860739
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCNA,Proliferating cell nuclear antigen,24016,0.00518988071061944,0.00425172743469288,-0.00314350506137861,0.0135232664826175,0.222229701068753
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAST,Gastrin,24845,0.0106108938311343,0.00872421926581997,-0.00648857592987283,0.0277103635921414,0.223898550589471
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXDC1,Plexin domain-containing protein 1,28797,0.00269248909088892,0.00221604055497852,-0.00165095039686897,0.00703592857864682,0.224376089573673
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNF830,Zinc finger protein 830,24793,-0.00644772133443999,0.00530928358737734,-0.0168539171656996,0.00395847449681959,0.22459743395404
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,0.00257209014741053,0.00212556991960445,-0.00159402689501419,0.00673820718983525,0.226261613420979
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,0.0046507092742698,0.00385614561308316,-0.0029073361273732,0.0122087546759128,0.22780961450739
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,0.00291768527657214,0.00242796623984944,-0.00184112855353276,0.00767649910667705,0.229491479144903
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,0.00334973539791429,0.00279900060404863,-0.00213630578602102,0.00883577658184959,0.231411367727439
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL20RB,Interleukin-20 receptor subunit beta,24229,0.00337929920688544,0.00283522046173588,-0.00217773289811687,0.00893633131188776,0.233312147514625
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHP1,Calcineurin B homologous protein 1,24101,0.00585464501414022,0.00491212222953899,-0.00377311455575621,0.0154824045840366,0.233321259863004
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK11,Kallikrein-11,29296,0.00245338688696087,0.0020605717671192,-0.00158533377659276,0.00649210755051449,0.23380693433022
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,0.00495418947786003,0.00417705775509534,-0.00323284372212683,0.0131412226778469,0.235614860240328
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDC1,Syndecan-1,29478,0.00317971730412887,0.00268416004877439,-0.00208123639146894,0.00844067099972668,0.236176157150063
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,0.00313121620327607,0.00264501764660636,-0.00205301838407238,0.00831545079062453,0.236497286379213
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TYMP,Thymidine phosphorylase,29301,0.00525441140122894,0.00443964092608064,-0.00344728481388912,0.013956107616347,0.236612055668993
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOH,Beta-2-glycoprotein 1,29443,-0.00283937680573681,0.00240037751478278,-0.00754411673471105,0.00186536312323743,0.236863251306109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OMD,Osteomodulin,29581,0.00340269957608883,0.00287932507264795,-0.00224077756630116,0.00904617671847882,0.237306536212097
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH1,Cadherin-1,28477,0.00315998805054518,0.00267996596481939,-0.00209274524050083,0.00841272134159118,0.238362245190155
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF7,Fibroblast growth factor 7,24016,-0.00627590657335944,0.00533446876351844,-0.0167314653498556,0.00417965220313671,0.23941398181215
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TUBB3,Tubulin beta-3 chain,24101,-0.00221180610145468,0.00188671031404764,-0.00590975831698805,0.00148614611407869,0.241084907398814
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC7A,C-type lectin domain family 7 member A,29786,-0.00460243605433906,0.00393307854683109,-0.012311270006128,0.00310639789744988,0.24193522642011
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL7R,Interleukin-7 receptor subunit alpha,29443,-0.00409682383509365,0.00350175662617676,-0.0109602668224001,0.0027666191522128,0.242037039320902
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC12A,C-type lectin domain family 12 member A,24229,0.00159855577778338,0.00136821371066804,-0.00108314309512598,0.00428025465069273,0.242676147743351
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPSD1,Tryptase delta,24867,-0.00292025767095689,0.00250657923321682,-0.00783315296806185,0.00199263762614807,0.244015178605695
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHEK2,Serine/threonine-protein kinase Chk2,28916,0.00258357006985499,0.00223209474383241,-0.00179133562805652,0.00695847576776651,0.247092265764207
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DIPK1C,Divergent protein kinase domain 1C,24195,0.00328025343691577,0.00284624778990913,-0.00229839223130612,0.00885889910513767,0.249133864907479
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA2013,Uncharacterized protein KIAA2013,24793,0.00430104756244163,0.00373308401847369,-0.0030157971137668,0.0116178922386501,0.249273327575686
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBR2,TGF-beta receptor type-2,29566,0.00252047233799552,0.00218788329268356,-0.00176777891566426,0.00680872359165529,0.249324610742321
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP1,Retinol-binding protein 1,24195,-0.00534794203068506,0.00465439994063142,-0.0144705659143226,0.00377468185295251,0.250564112178464
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDNRB,Endothelin receptor type B,24229,0.00352041003510522,0.00306764544477299,-0.00249217503664985,0.00953299510686029,0.251147743610886
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RAP,Interleukin-1 receptor accessory protein,29443,0.00331648298286453,0.00292770744151906,-0.00242182360251283,0.00905478956824188,0.257310924672304
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAG,Myelin-associated glycoprotein,24195,0.00357255808151992,0.00318290192584718,-0.00266592969314056,0.0098110458561804,0.261694341393
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,24195,0.00272541820543417,0.00243262357419307,-0.00204252399998424,0.00749336041085259,0.262570799745271
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A16,Protein S100-A16,28722,-0.00458187369628661,0.00411171834265813,-0.0126408416478965,0.00347709425532332,0.265140441878004
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TG,Thyroglobulin,24793,-0.00829184685915302,0.00748047470943801,-0.0229535772896515,0.00636988357134549,0.267671663264736
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY6D,Lymphocyte antigen 6D,29283,0.00284251311193548,0.00256546720777818,-0.00218580261530975,0.00787082883918071,0.267875054216019
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPT,Microtubule-associated protein tau,28774,0.00391527999647733,0.00353698848985625,-0.00301721744364091,0.0108477774365956,0.26832351058912
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BEX3,Protein BEX3,24016,-0.00351092070344664,0.00317266857360997,-0.00972935110772218,0.0027075097008289,0.268471773022466
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,0.00579000775704933,0.00524712937949653,-0.00449436582676388,0.0160743813408625,0.269835827758676
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,24016,-0.00361916352342254,0.00329358959852811,-0.0100745991365376,0.00283627208969256,0.271844177429497
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHH,Sonic hedgehog protein,24229,-0.00316458756776499,0.00288591540111942,-0.00882098175395906,0.00249180661842907,0.272843447183603
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,-0.00250314361584685,0.00229977397032196,-0.00701070059767789,0.0020044133659842,0.276414058200125
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MBL2,Mannose-binding protein C,24610,-0.00783621653730922,0.00724721954687269,-0.0220407668491797,0.00636833377456125,0.279586680874051
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSLNL,Mesothelin-like protein,24195,-0.00273247927668481,0.00252720030751286,-0.00768579187941001,0.00222083332604039,0.279606569078324
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD7,T-cell antigen CD7,24177,0.00316370325141096,0.00292915035951142,-0.00257743145323143,0.00890483795605335,0.280119384984061
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE6,Ribonuclease K6,24828,-0.00222001279701905,0.00205741338880756,-0.00625254303908188,0.00181251744504377,0.280584403117814
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF2RB,Cytokine receptor common subunit beta,24229,-0.00314144564588217,0.00291428921245905,-0.00885345250230191,0.00257056121053756,0.281068708647529
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL4,Interleukin-4,28931,0.0066053300180324,0.0061378962184706,-0.00542494657016998,0.0186356066062348,0.281866751056824
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEX33,Testis-expressed protein 33,24445,-0.00280667085798056,0.00261454073949422,-0.00793117070738923,0.0023178289914281,0.283064066278905
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP7,Retinoid-binding protein 7,24805,-0.00430618088190985,0.00403319362806896,-0.012211240392925,0.00359887862910532,0.285672962756673
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,0.00149543519381341,0.00140725380479377,-0.00126278226358238,0.0042536526512092,0.287945835557348
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPE,Carboxypeptidase E,29468,0.0027372931375898,0.00257963267639864,-0.00231878690815154,0.00779337318333113,0.288645248520299
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.0187543886911318,0.0176911714538381,-0.0534290847406545,0.0159203073583909,0.28911024653857
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSCA,Prostate stem cell antigen,24805,0.018371296443697,0.0173843276750785,-0.0157019857994568,0.0524445786868509,0.290625278245041
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,0.002437369069293,0.00230961485907022,-0.00208947605448463,0.00696421419307064,0.291290397026876
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP73,Tumor protein p73,24195,0.00244273700682968,0.00231977650234269,-0.00210402493776199,0.00698949895142134,0.292349074030982
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSME2,Proteasome activator complex subunit 2,29081,0.00251932968861751,0.00241939518665483,-0.00222268487722597,0.00726134425446098,0.29774241240305
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCNIP4,Kv channel-interacting protein 4,28774,0.0035356134145894,0.00341364483966541,-0.00315513047115479,0.0102263573003336,0.300336961360822
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,0.00608156152408685,0.00589174755775765,-0.00546626368911816,0.0176293867372918,0.301980930352243
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,-0.00182804741371133,0.00177257315241959,-0.00530229079245374,0.00164619596503107,0.302412090409519
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTNAP2,Contactin-associated protein-like 2,29434,-0.00282835809892749,0.00276410397311865,-0.00824600188624005,0.00258928568838507,0.306200002257287
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP350,Centrosome-associated protein 350,24016,0.00253081494219365,0.00248510870378672,-0.00233999811722833,0.00740162800161562,0.308501944584555
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL15RA,Interleukin-15 receptor subunit alpha,28931,0.0023942142583954,0.00235112622705486,-0.00221399314663212,0.00700242166342292,0.30853131485518
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL20,Interleukin-20,28931,0.00332887341353545,0.00327467717274498,-0.00308949384504472,0.00974724067211562,0.309376006779467
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RANGAP1,Ran GTPase-activating protein 1,28797,-0.00331466838893042,0.00327166926804145,-0.00972714015429166,0.00309780337643083,0.311000440765519
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PI3,Elafin,29014,-0.00372104010528744,0.00367877511326123,-0.0109314393272794,0.00348935911670456,0.311790941539626
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPLX2,Complexin-2,24016,-0.00209003104722216,0.00206757622477719,-0.00614248044778545,0.00196241835334113,0.312093412443434
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH15,Cadherin-15,29639,0.00389962710977432,0.00385986800494282,-0.00366571417991361,0.0114649683994622,0.312359526775311
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJA1,DnaJ homolog subfamily A member 1,24016,-0.00315409141886824,0.00314515783309803,-0.00931860077174037,0.00301041793400389,0.315947970327662
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,-0.00202324736518181,0.00201767589680702,-0.00597789212292357,0.00193139739255996,0.315986104272085
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,-0.00219960712509792,0.00219852025663383,-0.00650870682810023,0.0021094925779044,0.31708137450444
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,29169,-0.00224017480353766,0.00224763431181709,-0.00664553805469916,0.00216518844762384,0.318927562566726
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KDM3A,Lysine-specific demethylase 3A,24229,-0.00605513318562967,0.00608410689688384,-0.017979982703522,0.00586971633226265,0.319630564343507
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,-0.00563833533649349,0.00567630242898683,-0.0167638880973077,0.00548721742432068,0.32056644257156
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,24101,-0.00470916778223512,0.00475013533101157,-0.0140194330310178,0.00460109746654756,0.321512218199448
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUCY2C,Heat-stable enterotoxin receptor,24445,-0.00553477868471781,0.0055897379171476,-0.0164906650023271,0.00542110763289149,0.322101898230363
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCP11,T-complex protein 11 homolog,24445,-0.00392536062485716,0.00398010234488944,-0.0117263612208405,0.00387563997112614,0.324022103429532
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NXPE4,NXPE family member 4,24111,-0.00226853453354395,0.00230938889567979,-0.00679493676907633,0.00225786770198844,0.325957283150964
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRING1,SREBP regulating gene protein,24016,0.00390001522019298,0.00399974589832157,-0.0039394867405173,0.0117395171809033,0.329537475049748
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA8,Carbonic anhydrase-related protein,24229,0.00177668496307207,0.00182821188641956,-0.00180661033431026,0.00535998026045441,0.331151964800644
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,-0.00401567697045797,0.00422676827530475,-0.0123001427900553,0.00426878884913934,0.342092042569945
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,24195,-0.00396476663760814,0.00418625967778055,-0.012169835606058,0.00424030233084173,0.343602145557363
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EVPL,Envoplakin,24445,0.00214856141404125,0.00227535902428663,-0.00231114227356055,0.00660826510164304,0.345039200730146
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KEL,Kell blood group glycoprotein,28774,0.0022616523498785,0.00239882285982096,-0.00244004045537058,0.00696334515512759,0.34578214051057
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,-0.00324110097316228,0.00344467127124743,-0.00999265666480724,0.00351045471848268,0.346764085285989
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA5,Annexin A5,28650,-0.00189198455664497,0.00203518868913444,-0.00588095438734846,0.00209698527405853,0.352567447141824
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMCH,Pro-MCH,24111,-0.00521510702627906,0.00561987024811481,-0.0162300527125841,0.00579983866002597,0.3534291003267
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,0.00347085209490601,0.00376345707210147,-0.00390552376641287,0.0108472279562249,0.356406897375332
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,-0.00386927467411272,0.0042031178588808,-0.0121073856775191,0.00436883632929366,0.357282885871637
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC123,Cell division cycle protein 123 homolog,24016,0.0039187860474193,0.0042581512050538,-0.00442719031448614,0.0122647624093247,0.357424093484923
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTM4,Glutathione S-transferase Mu 4,24111,-0.00449799211891714,0.00489382459451717,-0.0140898883241708,0.00509390408633651,0.358044140441105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMG4,Proteasome assembly chaperone 4,24229,-0.0034468600976392,0.003765064051608,-0.0108263856387909,0.00393266544351248,0.359946129362434
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,0.00168506503676635,0.00184311022825507,-0.00192743101061358,0.00529756108414628,0.360592493212516
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB6B,Ras-related protein Rab-6B,28774,0.0029223212599881,0.00321250050925529,-0.00337417973815227,0.00921882225812847,0.363003220853302
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HTR1A,5-hydroxytryptamine receptor 1A,24101,-0.00467136721650961,0.00516763079508895,-0.0147999235748839,0.00545718914186473,0.366021990901737
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,0.0035645839063739,0.00397213090698293,-0.00422079267131265,0.0113499604840604,0.369513726887216
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNW1,Interferon omega-1,24111,-0.00216948708026552,0.00242077286747362,-0.00691420190051382,0.00257522773998279,0.370157017842797
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,0.00191677423111299,0.00214119261486906,-0.00227996329403036,0.00611351175625634,0.370692849963201
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMA1,Proteasome subunit alpha type-1,28797,-0.00275920267746953,0.00309684208647473,-0.00882901316696,0.00331060781202094,0.372951103933778
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,0.00182053930093398,0.00204373307968668,-0.00218517753525192,0.00582625613711988,0.373048680004217
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,-0.00224665765638757,0.00254173196562584,-0.00722845230901421,0.00273513699623907,0.376752929143827
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,0.0019622729408245,0.00222190924637157,-0.00239266918206378,0.00631721506371278,0.377165505565123
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROK1,Prokineticin-1,29434,-0.00356314652232044,0.00409975734030817,-0.0115986709093244,0.00447237786468357,0.384793201189499
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN15,Tetraspanin-15,24111,-0.00295042803302796,0.00339757701196073,-0.00960967897647099,0.00370882291041506,0.385188528088493
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,-0.00346689896884929,0.00399517294590608,-0.0112974379428252,0.00436364000512664,0.385527836798986
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,24101,-0.00422054186617094,0.00491710637080518,-0.0138580703529491,0.00541698662060721,0.390714099210189
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,0.00302419305858468,0.00352581240847563,-0.00388639926202756,0.00993478537919691,0.391050417329317
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TET2,Methylcytosine dioxygenase TET2,24421,-0.00576249837014384,0.00673017906977313,-0.0189536493468992,0.00742865260661149,0.391885785766283
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FBN2,Fibrillin-2,24195,0.00346302866355729,0.00405332292251492,-0.00448148426457196,0.0114075415916865,0.392909685041823
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK12,Kallikrein-12,28797,-0.00790632488687987,0.00925771435799625,-0.0260514450285525,0.0102387952547928,0.393097922976566
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53BP1,TP53-binding protein 1,24229,-0.00500625959545601,0.00586704121496976,-0.0165056603767967,0.00649314118588473,0.393509590516027
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIGR,Polymeric immunoglobulin receptor,29115,0.0020445561741548,0.00241597451968377,-0.00269075388442539,0.00677986623273499,0.397411541202346
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAGLN3,Transgelin-3,24016,-0.00343346921813373,0.00406026240996719,-0.0113915835416694,0.00452464510540197,0.397769054934416
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENDOU,Poly(U)-specific endoribonuclease,23037,0.00296682039656895,0.00356902084650722,-0.0040284604625852,0.0099621012557231,0.405829669821995
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP13,Collagenase 3,28774,-0.00181723001620619,0.00218888132373291,-0.00610743741072269,0.00247297737831031,0.406427249980459
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPEP1,Dipeptidase 1,29163,-0.00269505273466512,0.00324637454702301,-0.00905794684683022,0.00366784137749998,0.406447735963444
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BSND,Barttin,24016,-0.00188051549493622,0.00227656827015337,-0.00634258930443683,0.00258155831456438,0.408794834401797
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,-0.00311444821027741,0.00378844798390889,-0.0105398062587388,0.00431090983818402,0.411033362154252
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.00362726029859862,0.00442023977674934,-0.0122909302610273,0.00503640966383008,0.411880777837524
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,24805,-0.00298658703257955,0.00367298879546821,-0.0101856450716973,0.00421247100653815,0.416156073121783
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STEAP4,Metalloreductase STEAP4,24101,0.00403693968876165,0.00496915413239126,-0.00570260241072523,0.0137764817882485,0.416570305357917
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC1A4,Neutral amino acid transporter A,24195,-0.00279802370048776,0.0034652929238666,-0.00958999783126629,0.00399395043029077,0.4194197115045
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,-0.00375006646605931,0.00465851765141784,-0.0128807610628383,0.00538062813071966,0.420832607235912
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD2,T-cell surface antigen CD2,24111,-0.00205280985313467,0.00258073728908629,-0.00711105493974379,0.00300543523347446,0.426368097170354
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,0.00113918276305373,0.00143698158057474,-0.00167730113487275,0.00395566666098022,0.427924746871758
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,24867,-0.00203505619205044,0.00257840826293055,-0.00708873638739431,0.00301862400329344,0.429962674721246
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DHODH,Dihydroorotate dehydrogenase,24111,0.00250696391454253,0.0031826466089182,-0.00373102343893715,0.0087449512680222,0.430881207016137
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,0.0040999946386157,0.00521441406515533,-0.00612025692908874,0.0143202462063201,0.431710593652675
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPHA2,Glycoprotein hormone alpha-2,24805,0.00245207885281278,0.00312121839335884,-0.00366550919817055,0.00856966690379612,0.432100044274589
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKKL1,Dickkopf-like protein 1,29349,-0.00448576338101284,0.00573978094244176,-0.0157357340281987,0.00676420726617301,0.434502023992095
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPB41L5,Band 4.1-like protein 5,24195,-0.0032944359546106,0.00421901916446833,-0.0115637135169685,0.00497484160774732,0.434896297542977
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCLN,Nicalin,28931,-0.00273130339888364,0.00349788703522394,-0.00958716198792256,0.00412455519015527,0.434900762458766
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,0.00329741115387392,0.00422872085494166,-0.00499088172181174,0.0115857040295596,0.43553639790515
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PITHD1,PITH domain-containing protein 1,23970,-0.00416624820231677,0.00535891688799845,-0.0146697253027937,0.0063372288981602,0.436905592924729
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFNB2,Ephrin-B2,24195,-0.00300452434111746,0.00387472673872772,-0.0105989887490238,0.00458994006678888,0.438101583651044
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIPR,Gastric inhibitory polypeptide receptor,24229,0.00245365184852908,0.00316497941714807,-0.00374970780908114,0.00865701150613929,0.438199228309697
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALM3,Paralemmin-3,24111,0.00384374909244678,0.00495872878913742,-0.00587535933426256,0.0135628575191561,0.438259770992843
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,24195,-0.00196443708703766,0.00253524810275393,-0.00693352336843537,0.00300464919436005,0.438435854664423
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,0.00308211349756983,0.00398358598793332,-0.00472571503877947,0.0108899420339191,0.43911366809994
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA4,Ephrin type-A receptor 4,24381,0.00147579184939038,0.00191867284104024,-0.0022848069190485,0.00523639061782925,0.441797915970314
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLR3,Folate receptor gamma,29461,-0.00963045031011199,0.0125248318987469,-0.0341791208316558,0.0149182202114319,0.441953769316338
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL5,Interleukin-5,28931,0.00730229148864737,0.00950346390496603,-0.011324497765086,0.0259290807423808,0.44226649048326
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,24111,-0.00255421627964195,0.0033346112192227,-0.00909005426931845,0.00398162171003454,0.443700919692544
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCIN,Adseverin,24101,-0.00376349347732162,0.00492786423468882,-0.0134221073773117,0.00589512042266847,0.445043413890492
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD70,CD70 antigen,29434,0.00217765109636834,0.0028541668063525,-0.00341651584408257,0.00777181803681925,0.445485848711612
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UPK3A,Uroplakin-3a,24101,0.00250500516432196,0.0033038113500642,-0.00397046508180388,0.0089804754104478,0.448328642790481
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HRAS,GTPase Hras,24421,0.00496714499475667,0.00660670063723725,-0.00798198825422833,0.0179162782437417,0.452157884953203
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F3,Tissue factor,29541,-0.0013643813882725,0.00182472703444351,-0.00494084637578178,0.00221208359923678,0.454636180195916
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,24445,0.00218678252076728,0.00292579077401626,-0.0035477673963046,0.00792133243783915,0.454819748955883
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD248,Endosialin,24938,-0.00201303275970427,0.00269433206666991,-0.00729392361037728,0.00326785809096875,0.454988457577581
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDAC9,Histone deacetylase 9,24101,-0.00324895973836661,0.0043488159127053,-0.011772638927269,0.00527471945053577,0.455016131857854
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNF75D,Zinc finger protein 75D,24445,0.00300789004607937,0.00403193796243898,-0.00489470836030103,0.0109104884524598,0.455664955345381
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,-0.00329977971093403,0.00442715211881342,-0.0119769978638083,0.00537743844194028,0.456067203968561
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP2BP,LRP2-binding protein,24195,-0.00412182711931487,0.00554681213493791,-0.0149935789037932,0.00674992466516343,0.457429338707837
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT17,"Keratin, type I cytoskeletal 17",24111,0.00193407030944386,0.00263087825125388,-0.00322245106301374,0.00709059168190146,0.462259892100026
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLVRB,Flavin reductase,29443,0.00317532329058339,0.00434686556750504,-0.0053445332217265,0.0116951798028933,0.465099144256988
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH22,Cadherin-22,24445,-0.001399396612786,0.00191593031939791,-0.0051546200388059,0.0023558268132339,0.465152368902313
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,-0.00458627484398633,0.0062831288547676,-0.0169012073993308,0.00772865771135816,0.465437120212911
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSMB,Beta-microseminoprotein,29313,0.00338661608768895,0.00464595200415516,-0.00571944984045517,0.0124926820158331,0.466044740417881
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLINT1,Clathrin interactor 1,24016,0.00232530589281767,0.00320433282999558,-0.00395518645397368,0.00860579823960901,0.468044787664799
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL13,Interleukin-13,28931,-0.00233406619232237,0.00322087231952638,-0.00864697593859408,0.00397884355394933,0.468661005597379
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTLA,B- and T-lymphocyte attenuator,24016,0.00422109823849884,0.00586323703044526,-0.00727084634117386,0.0157130428181715,0.471577415985944
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK1,Kallikrein-1,29199,-0.00605573578359339,0.00851954331848469,-0.0227540406878234,0.0106425691206366,0.477210631407
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL36G,Interleukin-36 gamma,24149,0.00324732884254349,0.00456866738791462,-0.00570725923776916,0.0122019169228561,0.477225893076368
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOS2,"Nitric oxide synthase, inducible",24111,-0.00188877187810708,0.00266411596927534,-0.00711043917788674,0.00333289542167258,0.478351448263779
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,0.00285665383307826,0.00407435815453568,-0.00512908814981167,0.0108423958159682,0.483227613983302
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALY,Neuron-specific vesicular protein calcyon,24111,-0.00180407197209258,0.00258164261402309,-0.00686409149557785,0.00325594755139268,0.484678903186961
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP15,Matrix metalloproteinase-15,24922,0.00230066791621863,0.00329753657951568,-0.0041625037796321,0.00876383961206937,0.485375770936901
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,0.0013707243361952,0.00198339851445952,-0.00251673675214545,0.00525818542453585,0.489510078356709
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,0.00227622825693711,0.00329427293192372,-0.00418054668963339,0.00873300320350761,0.4895940117251
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,0.00177597961117852,0.00259050841038368,-0.0033014168731735,0.00685337609553054,0.492988483732335
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPLA2,Acyl-protein thioesterase 2,24101,0.00497416581439121,0.00725797112836926,-0.00925145759721254,0.019199789225995,0.493137044848241
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEBP1,Heme-binding protein 1,28916,-0.00243789579300898,0.00356203036172091,-0.00941947530198196,0.004543683715964,0.493720622518936
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,-0.00259407532072597,0.00381639464095639,-0.0100742088170005,0.00488605817554854,0.496689062560843
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,0.00124767367351841,0.00184080282845806,-0.00236029987025939,0.00485564721729621,0.497911560123125
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BOC,Brother of CDO,28916,-0.0010608673506363,0.00156632475143951,-0.00413086386345774,0.00200912916218514,0.498222835442251
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,0.00173343543497953,0.00260007345165956,-0.00336270853027322,0.00682957940023227,0.504977285847707
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA11,Carbonic anhydrase-related protein 11,28797,0.00141497437625207,0.00213027689658209,-0.00276036834104882,0.00559031709355296,0.506554277839441
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX2,Peroxiredoxin-2,24556,0.00273440933731251,0.00412907424399934,-0.0053585761809262,0.0108273948555512,0.507828108920276
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALLD,Palladin,24229,0.00177007189267593,0.00268025134881441,-0.00348322075100032,0.00702336453635218,0.508995339295916
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNL2,Interferon lambda-2,24101,-0.00273421386106078,0.00415303667118564,-0.0108741657365846,0.00540573801446308,0.510309931924809
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NLGN1,Neuroligin-1,24195,-0.00300686987012198,0.00459048737628244,-0.0120042251276356,0.0059904853873916,0.512459869775745
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCUN1D2,DCN1-like protein 2,24016,-0.00349591123668405,0.00539006064668615,-0.0140604301041889,0.0070686076308208,0.516613008217268
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF3,Fibroblast growth factor 3,24229,0.00130648119195185,0.00201544961658929,-0.00264380005656317,0.00525676244046687,0.516840330349599
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSH1,Chorionic somatomammotropin hormone 1,24951,0.00139242870945007,0.00215326186184099,-0.00282796453975827,0.0056128219586584,0.51785784974351
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZPR1,Zinc finger protein ZPR1,24101,0.00416733504791219,0.00648352156709251,-0.00854036722358913,0.0168750373194135,0.520387288594521
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESPL1,Separin,24016,-0.00235747994129741,0.00372551467067989,-0.00965948869583,0.00494452881323518,0.52687479797518
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL36A,Interleukin-36 alpha,24229,-0.00247271854073598,0.00390936159681257,-0.0101350672704886,0.00518963018901666,0.527058272000328
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPHS2,Podocin,24229,-0.00435021989013239,0.00693527599274756,-0.0179433608359176,0.00924292105565284,0.530494858648296
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRP15,RRP15-like protein,24101,-0.00382276172038411,0.00610605100732308,-0.0157906216947373,0.00814509825396913,0.531280721937474
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,-0.00173008747752623,0.00276623659333957,-0.00715191120047179,0.00369173624541933,0.531694773262573
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17F,Interleukin-17F,28931,-0.0031991197818817,0.00512437317117438,-0.0132428911973835,0.00684465163362008,0.532438890382813
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OPTC,Opticin,29349,0.00185509322439921,0.00301718760152389,-0.00405859447458761,0.00776878092338603,0.538663933469743
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAPN3,Calpain-3,24793,0.0015441782436429,0.00254200329980378,-0.0034381482239725,0.00652650471125831,0.543547875269377
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,-0.00146297484732309,0.00244228417536107,-0.00624985183103079,0.00332390213638461,0.549165707863869
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,-0.00166267726177681,0.00278056282586282,-0.00711258040046794,0.00378722587691432,0.549869364247463
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,0.00285910464091992,0.00478267282746434,-0.00651493410091019,0.01223314338275,0.549975804281679
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMY2A,Pancreatic alpha-amylase,28334,0.00191202542972292,0.00320186007692193,-0.00436362032104406,0.0081876711804899,0.55040478042453
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,-0.00194926467008475,0.00328073568034093,-0.00837950660355298,0.00448097726338349,0.552414218123127
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCLRE1C,Protein artemis,24016,-0.00124157194808868,0.00208983263716792,-0.00533764391693779,0.00285450002076044,0.552450069011894
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2L15,Bcl-2-like protein 15,24229,0.00224116696642761,0.00378427293373066,-0.00517600798368448,0.0096583419165397,0.553700872850844
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,29628,-0.000796950758186973,0.00135196740479597,-0.00344680687158708,0.00185290535521314,0.555547287750631
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORC3,MORC family CW-type zinc finger protein 3,24845,-0.00110831477200368,0.00188459495899727,-0.00480212089163832,0.00258549134763096,0.556476050033343
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPA33,Cell surface A33 antigen,29349,-0.00529930582007572,0.00901792750796418,-0.0229744437356855,0.0123758320955341,0.556777668145087
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,-0.00100042464572864,0.00170273673920851,-0.00433778865457732,0.00233693936312003,0.556846928644906
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,0.00226200561243363,0.00387564615283372,-0.00533426084712047,0.00985827207198772,0.559463947960811
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,0.00160119744337781,0.00275195208535029,-0.00379262864390877,0.00699502353066438,0.560679424785651
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLK,STE20-like serine/threonine-protein kinase,24445,0.00303737240146511,0.00523731045706925,-0.00722775609439062,0.0133025008973208,0.561954431067519
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REST,RE1-silencing transcription factor,24016,-0.00136337368554445,0.00235554770921824,-0.0059802471956122,0.0032534998245233,0.562734526648604
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDSN,Corneodesmosin,29676,0.00167554130187826,0.00289652494445483,-0.0040016475892532,0.00735273019300973,0.56295391359103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP30,Rho GTPase-activating protein 30,24445,0.00150179712575269,0.00259958855175213,-0.00359339643568149,0.00659699068718687,0.563468153810339
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESR1,Estrogen receptor,24229,0.00220994221995172,0.00386620632194141,-0.00536782217105345,0.00978770661095688,0.56759502576354
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRN1,Neuritin,24867,-0.00136052439410537,0.0023946926651628,-0.00605412201782446,0.00333307322961371,0.569943991564156
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,24229,0.00217951849157937,0.00387828653186736,-0.00542192311088065,0.00978096009403939,0.574135018284174
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,-0.00166588850350608,0.00297295848445691,-0.00749288713304163,0.00416111012602948,0.575247973750782
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SKIV2L,Helicase SKI2W,24111,-0.0014937416148905,0.00268903991176802,-0.00676425984195581,0.00377677661217482,0.578562967124197
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSLP,Thymic stromal lymphopoietin,28916,0.00224047281865202,0.00404453029020541,-0.0056868065501506,0.0101677521874546,0.579616459794459
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAX,Integrin alpha-X,24445,0.0019823200327162,0.00358961556756949,-0.00505332647972,0.00901796654515241,0.580790752892373
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAD1,Glutamate decarboxylase 1,24016,0.000964868287263111,0.0017482050135048,-0.00246161353920629,0.00439135011373251,0.581008704870303
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBR1,T-box brain protein 1,24195,0.00178295355600947,0.00324151901203813,-0.00457042370758526,0.0081363308196042,0.582299464945898
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,0.00177747461157313,0.00326432332993515,-0.00462059911509976,0.00817554833824601,0.586091831906369
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RUVBL1,RuvB-like 1,28797,-0.00368314868144158,0.00691151327855128,-0.0172297147074021,0.00986341734451892,0.594106593332679
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,0.0015612069702985,0.00298949929526084,-0.00429821164841275,0.00742062558900975,0.601514693569303
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXK,Tyrosine-protein kinase TXK,24445,-0.00259859482899028,0.00499717629515278,-0.0123930603674897,0.00719587070950917,0.60305947813537
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,-0.00145326724803649,0.00279585328166373,-0.00693313968009741,0.00402660518402442,0.603212040906246
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPT1,Translationally-controlled tumor protein,28931,0.0022680648774478,0.00436545440144721,-0.00628822574938873,0.0108243555042843,0.603382342660796
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,28774,0.00171168186093008,0.00329592148531734,-0.0047483242502919,0.00817168797215206,0.603532315165042
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN8,Septin-8,24801,0.00111497801209552,0.00215486179108088,-0.00310855109842301,0.00533850712261404,0.604864566269275
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,-0.0021667184666913,0.00419628757117378,-0.0103914421061919,0.00605800517280932,0.605620481830757
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ART5,Ecto-ADP-ribosyltransferase 5,24101,-0.00216192664500414,0.00421323424818322,-0.0104198657714432,0.00609601248143496,0.607866794273453
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,0.00178074087135402,0.00347684447565043,-0.00503387430092082,0.00859535604362886,0.608535507715785
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPGN,Epigen,24793,-0.00164287003949248,0.00321540314591464,-0.00794506020548518,0.00465932012650021,0.609399374842574
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA2,Protein disulfide-isomerase A2,24016,0.00139863158403969,0.00273988858841128,-0.00397155004924642,0.00676881321732579,0.609726753592229
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBM25,RNA-binding protein 25,24016,-0.00158318659942058,0.00312105199726981,-0.0077004485140694,0.00453407531522825,0.611976664845346
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHC1,SHC-transforming protein 1,24016,-0.00395887473085459,0.00783799273119748,-0.0193213404840016,0.0114035910222925,0.613501787057052
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,-0.00166260240560754,0.00344116082794155,-0.00840727762837297,0.00508207281715789,0.628992463211216
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,0.00119812180680229,0.002489213466626,-0.00368073658778467,0.00607698020138925,0.630288849740911
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNF174,Zinc finger protein 174,24229,0.00120191822233893,0.00253870976646592,-0.00377395291993427,0.00617778936461213,0.635905962321025
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,0.00204519135705933,0.00432060978892293,-0.00642320382922961,0.0105135865433483,0.635961924887169
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPARCL1,SPARC-like protein 1,29489,0.000867417052627132,0.00183491200844862,-0.00272901048393216,0.00446384458918643,0.636409671197016
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,0.0027306728849551,0.0057932143880906,-0.00862402731570248,0.0140853730856127,0.637389936353101
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRLB,Fc receptor-like B,28797,-0.00192470319457734,0.00408943062597757,-0.00993998722149337,0.00609058083233869,0.637892049150199
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL21,C-C motif chemokine 21,29581,-0.00126611610039861,0.00270984683434959,-0.00657741589572381,0.00404518369492659,0.640340263114473
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CKAP4,Cytoskeleton-associated protein 4,29678,-0.000845786238335108,0.00181454123119517,-0.00440228705147765,0.00271071457480743,0.641136076082311
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGLON5,IgLON family member 5,24016,-0.00289473231737035,0.00626951004108298,-0.015182971997893,0.00939350736315229,0.64428926939997
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC2L,C-type lectin domain family 2 member L,24195,-0.00155023177953879,0.00337061310854961,-0.00815663347229603,0.00505616991321845,0.64557364802279
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,-0.000658074076996799,0.00143355600951196,-0.00346784385564025,0.00215169570164665,0.646201617588003
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,-0.00219560006463938,0.00479317497097612,-0.0115902230077526,0.00719902287847382,0.646907663361806
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR2,Toll-like receptor 2,24445,-0.000698493491579951,0.0015427552958437,-0.00372229387143361,0.00232530688827371,0.650727642162962
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JUN,Transcription factor AP-1,28931,0.00150971391840661,0.00335195485774381,-0.00506011760277126,0.00807954543958447,0.652426830259046
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,-0.00133886029613919,0.00297782789637063,-0.00717540297302562,0.00449768238074724,0.652995919599344
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,0.00153972429082875,0.00345342729651467,-0.00522899321034001,0.00830844179199751,0.655706083013224
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD99,CD99 antigen,29443,-0.000584662493953114,0.0013138821364048,-0.00315987148130652,0.00199054649340029,0.656331308512372
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC11A,C-type lectin domain family 11 member A,29388,0.00142601073328161,0.00321634516810458,-0.00487802579620338,0.00773004726276659,0.65750594421058
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEZ6,Seizure protein 6 homolog,24195,-0.000926314577157843,0.00209473031468377,-0.00503198599393803,0.00317935683962234,0.658339863488534
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH3,Cadherin-3,29694,-0.00105983980046453,0.00241744760018771,-0.00579803709683243,0.00367835749590338,0.661090311401541
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN7,Tetraspanin-7,24101,-0.00274746510195275,0.00631783938759585,-0.0151304303016406,0.00963550009773512,0.663657667010326
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCL2,Phosducin-like protein 2,24016,0.00154838738452628,0.00356413371257836,-0.0054373146921273,0.00853408946117986,0.663975889721956
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,0.00145445733652248,0.00336836642540259,-0.00514754085726659,0.00805645553031156,0.665891353518072
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD82,CD82 antigen,24445,-0.00119767378483889,0.00278862301251572,-0.0066633748893697,0.00426802731969192,0.667573565409941
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOA1,Apolipoprotein A-I,24966,-0.000786438097527506,0.00184152583752022,-0.00439582873906714,0.00282295254401213,0.669340864298926
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARG2,"Arginase-2, mitochondrial",24793,-0.00123813098288992,0.00290412560369161,-0.00693021716612547,0.00445395520034563,0.669867312283158
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIRREL1,Kin of IRRE-like protein 1,24101,-0.00164738632892485,0.00395952831967739,-0.00940806183549254,0.00611328917764284,0.67737258207771
NMR metabolomics,X23503.Total Lipids in Medium VLDL,QPCT,Glutaminyl-peptide cyclotransferase,29517,0.000745962028511819,0.00179666509942735,-0.00277550156636579,0.00426742562338943,0.678003945176713
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAGE2A,G antigen 2A,24016,0.00175009563478459,0.00426970942294403,-0.00661853483418571,0.0101187261037549,0.68189297296956
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,-0.00171857627468532,0.00422193838657584,-0.00999357551237397,0.00655642296300333,0.683967987980354
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPT1,Palmitoyl-protein thioesterase 1,24195,0.00209484942781264,0.00520735986645832,-0.00811157591044566,0.0123012747660709,0.687476906726719
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFDN6,Prefoldin subunit 6,24195,0.00175831052855274,0.00438913798098278,-0.0068443999141735,0.010361020971279,0.688714518580211
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC50,Coiled-coil domain-containing protein 50,24867,-0.00203539959414901,0.00512640402076701,-0.0120831514748523,0.00801235228655432,0.691339626858189
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RASA1,Ras GTPase-activating protein 1,28774,0.000854532568731187,0.00217490961420872,-0.0034082902751179,0.00511735541258027,0.694392660149502
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FH,"Fumarate hydratase, mitochondrial",24101,0.00213526307065153,0.00563195945186928,-0.00890337745501226,0.0131739035963153,0.704592260914969
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPEP,Glutamyl aminopeptidase,24111,0.00112668029592157,0.00299151041457363,-0.00473668011664274,0.00699004070848589,0.706454955047202
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,-0.00150292671912329,0.00399508576004543,-0.00933329480881233,0.00632744137056574,0.706776095636009
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,0.00160562219279007,0.00428676243480515,-0.00679643217942802,0.0100076765650082,0.707995814655822
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,24111,-0.00282106061840124,0.00761110520460561,-0.0177388268194282,0.0120967055826258,0.710901055957842
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,0.00120555263920083,0.00328460823124399,-0.00523227949403739,0.00764338477243904,0.713599193676552
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OMP,Olfactory marker protein,24101,-0.00119836906286986,0.00331113028825152,-0.00768818442784284,0.00529144630210312,0.717413907838668
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,24445,-0.0016027286507667,0.00444004173464687,-0.0103052104506746,0.00709975314914116,0.718123852337927
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,0.000720612851285825,0.00199699548583748,-0.00319349830095563,0.00463472400352728,0.718215752843197
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL3,Interleukin-3,24016,0.00146252963601431,0.00406845290653216,-0.00651163806078871,0.00943669733281733,0.71923879770723
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM171A2,Protein FAM171A2,24867,0.00377079579224033,0.0106186057140906,-0.0170416714073773,0.024583262991858,0.722508596093672
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,-0.00187506677797292,0.00535840352316157,-0.0123775376833696,0.00862740412742375,0.726394213624626
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFDN4,Prefoldin subunit 4,24016,0.001247869353472,0.00359631124066994,-0.00580090067824107,0.00829663938518508,0.728604940990693
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMOD2,Leiomodin-2,24101,-0.00145747552279673,0.00424854172204491,-0.00978461729800477,0.0068696662524113,0.731561486718818
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,-0.000809648757773298,0.00237102401296732,-0.00545685582318925,0.00383755830764265,0.732747941642064
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,-0.00175305214912245,0.00513554489259353,-0.0118187201386058,0.00831261584036087,0.732838036847754
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLGAP5,Disks large-associated protein 5,24867,-0.00117530134465777,0.00346735550749001,-0.0079713181393382,0.00562071545002266,0.734641310338735
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRX,Cone-rod homeobox protein,28916,-0.0024186074606239,0.0071752141864775,-0.0164820272661198,0.011644812344872,0.736060484618711
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,-0.000458630596651913,0.00137199078452254,-0.00314773253431609,0.00223047134101226,0.738170355712779
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD200,OX-2 membrane glycoprotein,29434,0.000588210250976491,0.00177174543554409,-0.00288441080268993,0.00406083130464291,0.739895559352443
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,-0.00120587550346016,0.00365523084956436,-0.0083701279686063,0.00595837696168597,0.74147530817235
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,24229,-0.000898041326873087,0.00274055423502209,-0.00626952762751639,0.00447344497377022,0.743151902915923
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,-0.00138283846939718,0.00422228590662165,-0.00965851884637562,0.00689284190758125,0.743285414623981
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,-0.000789388869616606,0.00249342763602584,-0.00567650703622724,0.00409772929699403,0.751559106139393
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,24751,-0.000854459258004538,0.00270252320259847,-0.00615140473509753,0.00444248621908846,0.751875443538599
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL24,Interleukin-24,28931,-0.000990578170279844,0.0032587134283424,-0.00737765648983094,0.00539650014927125,0.761146610141361
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTF,Ciliary neurotrophic factor,24101,0.00069463700381397,0.00228870918509144,-0.00379123299896525,0.00518050700659319,0.761506885740252
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGN,Cingulin,24195,-0.000802982591356128,0.00267725299875105,-0.00605039846890819,0.00444443328619594,0.764234809714725
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP3L,Microfibrillar-associated protein 3-like,24195,-0.00131013183434346,0.00441451208817883,-0.00996257552717397,0.00734231185848706,0.766638246210869
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBLN1,Cerebellin-1,24101,0.00187968697162237,0.00640833663192306,-0.0106806528269468,0.0144400267701916,0.769280849638118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,0.000637669836334861,0.00218586255660716,-0.00364662077461517,0.0049219604472849,0.770499725328447
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,0.00142171570863102,0.00494296704868716,-0.00826649970679582,0.0111099311240579,0.773637084007556
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPBGL,Trophoblast glycoprotein-like,24195,-0.000786043639250303,0.00276233547508565,-0.00620022117041818,0.00462813389191757,0.775985511890285
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAD2,Glutamate decarboxylase 2,24229,-0.000883910591174866,0.00311067159412088,-0.0069808269156518,0.00521300573330206,0.776294594516234
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FZD8,Frizzled-8,24101,0.000820986765081649,0.00295175811030941,-0.0049644591311248,0.0066064326612881,0.780911240545618
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRG3,Proteoglycan 3,24938,-0.000912094302579441,0.00334422881054552,-0.00746678277124866,0.00564259416608978,0.785057795092303
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF6,Fibroblast growth factor 6,24229,0.000736809800328605,0.00276444144172296,-0.0046814954254484,0.00615511502610561,0.789832429770505
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAGEA3,Melanoma-associated antigen 3,24445,-0.00151190224063048,0.00570573311453552,-0.0126951391451201,0.00967133466385913,0.791027498696364
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,24101,0.000709011482443338,0.00269364557521808,-0.0045705338449841,0.00598855680987078,0.792386102143065
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2RB,Interleukin-2 receptor subunit beta,28931,-0.000655308816015938,0.00251781360532985,-0.00559022348246244,0.00427960585043056,0.794658140373905
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR1,Toll-like receptor 1,24229,-0.000460253670233073,0.00177088130409885,-0.00393118102626682,0.00301067368580068,0.794942415551019
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,0.00201140021180259,0.00773925246542787,-0.013157534620436,0.0171803350440412,0.794946204206502
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,-0.000848241369405287,0.0033061517977371,-0.00732829889296999,0.00563181615415942,0.797517099511847
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRD2,Bromodomain-containing protein 2,24101,0.000596863370124659,0.00232761993582772,-0.00396527170409766,0.00515899844434698,0.79762373867372
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGR,Progesterone receptor,24229,0.00175005182257982,0.00683480025319454,-0.0116461566736815,0.0151462603188411,0.797914266833844
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNNI3,"Troponin I, cardiac muscle",28916,-0.00137140798129962,0.00563090869876499,-0.012407989030879,0.00966517306827975,0.80758106195296
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRR1B,Cornifin-B,24445,-0.00135829463034206,0.00573793551851402,-0.0126046482466295,0.00988805898594543,0.812874578410548
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL33,Interleukin-33,28931,0.000605710384394504,0.00260530118049689,-0.0045006799293794,0.00571210069816841,0.816157932247232
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,-0.00266869201268468,0.0115602559857574,-0.0253267937447693,0.0199894097193999,0.817432775795989
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBR1,TGF-beta receptor type-1,24229,0.00033215293110613,0.00145585515374429,-0.00252132317023268,0.00318562903244494,0.819531782403542
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHGB,Secretogranin-1,29590,0.000626574680830675,0.00274942330211811,-0.00476229499132081,0.00601544435298216,0.819730899377164
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,0.000821453979826069,0.00364213495634153,-0.00631713053460333,0.00796003849425547,0.821559659373598
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GJA8,Gap junction alpha-8 protein,24016,-0.000936298750089916,0.00417915967521428,-0.0091274517135099,0.00725485421333007,0.822728119788199
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX1,ATP-dependent RNA helicase DDX1,24805,-0.000747357502936392,0.0033555405327351,-0.00732421694709719,0.0058295019412244,0.8237525983289
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,0.00132841823088289,0.00608994795246505,-0.0106078797559486,0.0132647162177144,0.827327373616538
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAP18,Histone deacetylase complex subunit SAP18,24445,-0.00106132141584283,0.00492504014574722,-0.0107144001015074,0.00859175726982173,0.829383226273821
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B2M,Beta-2-microglobulin,24966,-0.000447983272612346,0.0020845481096706,-0.00453369756756672,0.00363773102234203,0.829841848311857
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD164L2,CD164 sialomucin-like 2 protein,24195,0.000527571159921823,0.00245781366759099,-0.00428974362855653,0.00534488594840017,0.830041556154382
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYBB2,Beta-crystallin B2,24845,0.000977770301099332,0.00463663226420236,-0.00811002893673729,0.010065569538936,0.832983097540893
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRC1,Protein regulator of cytokinesis 1,24793,0.00063724066398917,0.00304331717367808,-0.00532766099641986,0.0066021423243982,0.83414539655586
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,0.000527370878395706,0.0025233384637101,-0.00441837251047608,0.0054731142672675,0.834452108085135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,24111,-0.000790771852425373,0.00380889230650694,-0.00825620077317897,0.00667465706832822,0.835533667207977
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL31,Interleukin-31,24229,-0.000780947280525728,0.0038208707762287,-0.00826985400193398,0.00670795944088253,0.838050563549743
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HBZ,Hemoglobin subunit zeta,24922,0.00144497990343822,0.00709445318485929,-0.012460148338886,0.0153501081457624,0.838607254372477
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDDC2,5'-deoxynucleotidase HDDC2,24805,0.000584147768038963,0.00291997439748657,-0.00513900205103472,0.00630729758711264,0.841441272586868
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL9,Interleukin-9,24445,-0.000755780328166003,0.00380683369224528,-0.00821717436496676,0.00670561370863475,0.842630087132911
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMY2B,Alpha-amylase 2B,27585,0.000635743476851882,0.00327935842345245,-0.00579179903311491,0.00706328598681868,0.846285248955528
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOD3,Extracellular superoxide dismutase,24951,-0.000772069630812349,0.00401237351262165,-0.00863632171555078,0.00709218245392608,0.84741309214875
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,-0.0019268827133091,0.0100163063472888,-0.0215588431539951,0.0177050777273769,0.847450131563706
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,24445,-0.000676749954106206,0.00362051022960534,-0.00777295000413268,0.00641945009592027,0.851724004280072
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL4A4,Collagen alpha-4(IV) chain,24405,-0.000661512352032583,0.00354471046361279,-0.00760914486071364,0.00628612015664848,0.85196047162512
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACHE,Acetylcholinesterase,24381,0.000412494262507341,0.00221471986285722,-0.00392835666869281,0.00475334519370749,0.852249314201884
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASQ2,Calsequestrin-2,24111,0.000611314225610239,0.00328338095239516,-0.00582411244108428,0.00704674089230476,0.852301745059053
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP3,Microfibril-associated glycoprotein 3,28916,0.000570025673742677,0.00326356704042579,-0.00582656572549186,0.00696661707297722,0.861345361652973
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,0.000396574363646379,0.00228564287446699,-0.00408328567030893,0.00487643439760169,0.862254621248654
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA7A,Semaphorin-7A,29736,0.000319082839753608,0.00184629181940111,-0.00329964912627256,0.00393781480577977,0.862791245437099
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSP90B1,Endoplasmin,28626,0.000773881330096354,0.00448526911222274,-0.00801724612986022,0.00956500879005293,0.863015465057135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,-0.000791016207215892,0.00461042667573618,-0.00982745249165881,0.00824542007722703,0.863776110948315
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,0.000385490002802321,0.00230899055542326,-0.00414013148582727,0.00491111149143191,0.867409155851827
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UGDH,UDP-glucose 6-dehydrogenase,24111,-0.00107784721174433,0.00659156029282402,-0.0139973053856794,0.0118416109621908,0.870110963302128
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,-0.000452063644944575,0.00279264835218528,-0.00592565441522772,0.00502152712533857,0.871404368742006
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGR2,Anterior gradient protein 2 homolog,28553,-0.00108206708451267,0.00673806357224956,-0.0142886716861218,0.0121245375170965,0.872417297999129
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,0.000336682501743198,0.00214300422388569,-0.00386360577707275,0.00453697078055914,0.875161272410067
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FZD10,Frizzled-10,24195,0.000629241709285368,0.00403994319179446,-0.00728904694663177,0.0085475303652025,0.876227372807816
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,0.000354797371838054,0.00231222957923959,-0.00417717260347154,0.00488676734714764,0.878049567229941
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALMS1,Alstrom syndrome protein 1,24445,-0.000456758968841472,0.00299528775311911,-0.00632752296495494,0.00541400502727199,0.878799751196326
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EXOSC10,Exosome component 10,24111,-0.000615946360058579,0.0040749341038179,-0.00860281720354167,0.00737092448342451,0.87985477134656
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTK7,Inactive tyrosine-protein kinase 7,28774,-0.000374910488085042,0.00256727178648005,-0.00540676318958594,0.00465694221341586,0.883895104095339
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EVI2B,Protein EVI2B,24016,-0.00040152776744877,0.00276036927842676,-0.00581185155316521,0.00500879601826767,0.884347643265099
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERVV_1,,24111,-0.000444739649986754,0.00309968853076058,-0.00652012917027749,0.00563064987030399,0.885913237798922
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,-0.000455655979895174,0.00338023598725008,-0.00708091851490534,0.00616960655511499,0.892771079038982
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IKZF2,Zinc finger protein Helios,28797,-0.000792188474627115,0.00610327652270316,-0.0127546104591253,0.0111702335098711,0.896727750095886
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OFD1,Oral-facial-digital syndrome 1 protein,24445,-0.000577997222213569,0.00449259731436942,-0.00938348795837762,0.00822749351395049,0.897631330718243
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRAL,GDNF family receptor alpha-like,24025,0.000535925384029518,0.00420465305015978,-0.00770519459428364,0.00877704536234268,0.898577340003432
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,-0.000246613315788939,0.0019372991810573,-0.00404371971066126,0.00355049307908338,0.898706012452878
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FDX1,"Adrenodoxin, mitochondrial",24111,-0.00048738169541384,0.0042156467424058,-0.0087500493105292,0.00777528591970152,0.907960574678449
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2,Interleukin-2,28931,0.000237661338586303,0.00211109866388452,-0.00390009204262735,0.00437541471979996,0.910366632668592
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100G,Protein S100-G,24867,-0.000348755198098746,0.00311236314797856,-0.00644898696813673,0.00575147657193924,0.910780869100755
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHIT1,Chitotriosidase-1,29579,-0.00113037761540209,0.010181605340214,-0.0210863240822216,0.0188255688514174,0.911600010855459
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF20,Fibroblast growth factor 20,24229,0.000318082542842528,0.00294790297325381,-0.00545980728473495,0.00609597237042,0.914074885303142
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HK2,Hexokinase-2,28916,0.000193391796324077,0.00183523469975218,-0.0034036682151902,0.00379045180783835,0.916077280595112
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEX101,Testis-expressed protein 101,24195,0.000352401521666032,0.00339715505602706,-0.00630602238814701,0.00701082543147907,0.917381061637752
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,29349,-0.000215779822560665,0.00209046421057403,-0.00431308967528576,0.00388153003016443,0.917788272747385
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HLA_A,,24867,-0.000214253308873314,0.00219097213052148,-0.00450855868469542,0.00408005206694879,0.922100509339385
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAND5,DAN domain family member 5,24229,0.000350509246945235,0.00365389750599575,-0.00681112986480644,0.00751214835869691,0.92357894857776
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS11B,Transmembrane protease serine 11B,24101,0.000487797818552244,0.00518218032886186,-0.009669275626017,0.0106448712631215,0.925006797615337
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOP1,DNA topoisomerase 1,24805,0.00071451316821573,0.00759096044838717,-0.0141637693106231,0.0155927956470546,0.925009155385877
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC25A,M-phase inducer phosphatase 1,24016,-0.000253412881693893,0.00271913395806368,-0.00558291543949871,0.00507608967611092,0.925748491661051
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD5L,CD5 antigen-like,24833,0.00028769031141447,0.00316965171313917,-0.0059248270463383,0.00650020766916724,0.927680837373581
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORN4,MORN repeat-containing protein 4,24016,-0.000470418916088519,0.00527121046117123,-0.0108019914199841,0.0098611535878071,0.928889494875213
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C9orf40,Uncharacterized protein C9orf40,24805,-0.000472177055585789,0.00537470844539649,-0.0110066056085629,0.0100622514973913,0.92999528778086
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,0.000495421440606936,0.00579678435852127,-0.0108662759020948,0.0118571187833086,0.93189253036085
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KHDC3L,KH domain-containing protein 3,24016,0.000379359664314433,0.00454056322736446,-0.00852014426131991,0.00927886358994877,0.933415688155447
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCARE,Photoreceptor cilium actin regulator,24101,-0.000462698293361879,0.0056813605915035,-0.0115981650527087,0.010672768465985,0.935091556067746
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,0.000263129017162981,0.00327129854945535,-0.00614861613976951,0.00667487417409547,0.935891444069062
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBX2,Chromobox protein homolog 2,24111,0.00020510497106902,0.00270613028431219,-0.00509891038618288,0.00550912032832092,0.93958463838869
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGS8,Regulator of G-protein signaling 8,28931,0.000330196864414191,0.0043587960325067,-0.00821304335929893,0.00887343708812731,0.939615222688752
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ISM2,Isthmin-2,24938,-0.000217833064423305,0.00294663879090585,-0.00599324509459877,0.00555757896575216,0.941069902501369
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,0.000342767836822433,0.00524539462499589,-0.0099382056281695,0.0106237413018144,0.947898712050072
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,-0.000158094177858351,0.00244820299860144,-0.00495657205511717,0.00464038369940047,0.948512431792874
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,-0.000181463289831951,0.00283055070624287,-0.00572934267406798,0.00536641609440407,0.948884087761384
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST7,Cystatin-F,29498,0.000390284011932538,0.0062086630731557,-0.0117786956114526,0.0125592636353177,0.949877457644378
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,0.000126767946782744,0.00215477166527694,-0.00409658451716005,0.00435012041072554,0.953086977254132
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANK2,Ankyrin-2,24111,0.00027350783309165,0.00484591166899438,-0.00922447903813734,0.00977149470432064,0.95499100762589
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,0.000185485902433837,0.00332000008746166,-0.00632171426899101,0.00669268607385868,0.955446435515009
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,24016,-9.26078928857647e-05,0.00170825055498874,-0.0034407789806637,0.00325556319489217,0.956766611607595
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTNAP4,Contactin-associated protein-like 4,24195,0.000333085132803841,0.0069186424090102,-0.0132274539888561,0.0138936242544638,0.961602567189139
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFAP2A,Transcription factor AP-2-alpha,24101,-0.000181376565853274,0.00402675454564873,-0.00807381547532478,0.00771106234361823,0.964073514782749
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC39A14,Zinc transporter ZIP14,28774,8.79975786202488e-05,0.00224053233894298,-0.00430344580570799,0.00447944096294848,0.968671172183256
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MLLT1,Protein ENL,24016,0.000157628297410548,0.00464716590035463,-0.00895081686728452,0.00926607346210562,0.972941839298646
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFL4,Insulin growth factor-like family member 4,24229,-0.000169030376881439,0.0050576288050631,-0.0100819828348051,0.00974392208104223,0.973339239079966
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN4,Contactin-4,29443,-4.94762789395503e-05,0.00160776453942282,-0.00320069477620828,0.00310174221832918,0.97545051353882
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHD,SH2 domain-containing adapter protein D,24059,-0.000165237592816648,0.00572564884183594,-0.0113875093228151,0.0110570341371818,0.976977132524014
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18BP,Interleukin-18-binding protein,29594,-5.46013728492259e-05,0.00206144938287145,-0.00409504216327727,0.00398583941757881,0.978869172815857
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCDC2C,Doublecortin domain-containing protein 2C,24016,-0.00010851372769873,0.004256834264738,-0.00845190888658522,0.00823488143118776,0.979663020856537
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMMR,Hyaluronan mediated motility receptor,23975,-7.83206040264942e-05,0.00325504032233877,-0.00645819963581049,0.0063015584277575,0.980803887794437
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD5,Sushi domain-containing protein 5,24273,-5.10693412072454e-05,0.00230039722792413,-0.00455984790793853,0.00445770922552404,0.982288418909912
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYTH3,Cytohesin-3,24016,0.000108209074655033,0.00492710217443322,-0.00954891118723408,0.00976532933654415,0.982478441209158
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANKRA2,Ankyrin repeat family A protein 2,24016,8.13663595368733e-05,0.0037420850267223,-0.00725312029283883,0.00741585301191258,0.982652673579743
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PADI2,Protein-arginine deiminase type-2,28931,7.46913716407863e-05,0.00377170375284873,-0.00731784798394273,0.00746723072722431,0.984200593177473
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB5,Serpin B5,28916,-6.37350506473258e-05,0.00325382168676675,-0.00644122555671015,0.0063137554554155,0.984372370054817
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,24229,5.72337813052813e-05,0.00324504389819094,-0.00630305225914896,0.00641751982175952,0.985928353240545
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLHL41,Kelch-like protein 41,24867,-5.41232916276619e-05,0.00333259661740044,-0.00658601266173253,0.00647776607847721,0.987042594408194
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNLZ,DNL-type zinc finger protein,24101,-8.06477697388422e-05,0.00605797683421887,-0.0119542823648078,0.0117929868253301,0.989378460245135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTNL10,Butyrophilin-like protein 10,24016,3.5524194808943e-05,0.00274749255273982,-0.0053495612085611,0.00542060959817899,0.989684004214701
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL21R,Interleukin-21 receptor,24229,-3.93599989008946e-05,0.00369476546039686,-0.00728110030127873,0.00720238030347694,0.991500457188275
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NENF,Neudesin,24793,3.31804249694865e-05,0.00736368195328482,-0.0143996362034688,0.0144659970534077,0.996404815922076
